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Abstract 
The current study is conducted to assess the rate of compliance with treatment regimen or plan 
of hypertensive patients and the factors that affect their compliance in the primary health care 
clinics in Hebron district. A cross-sectional design was utilized to achieve this purpose. The 
data was gathered between 10/07/2010 and 10/08/2010 using a self-reported questionnaire 
filled by the researcher and another two assistants for 292 patients attending the central 
primary health care centers in Hebron district (Karanteena: 109, Dora: 83, and Yatta: 100) 
who met the inclusion and exclusion criteria and agreed to participate in the study. The self-
reported questionnaire consisted of ten sections and included 102 items.  
Statistical analysis was performed using the statistical package for social sciences (SPSS), 
Version 15. Descriptive statistics, the Chi-squared and Fisher exact tests (p-value ≤0.05) were 
used to analyze the data. Also binary logistic regression was used to examine the association 
between the level of blood pressure control and some dependent variables. 
Analysis of the patients’ characteristics showed that the patients’ age ranged between 37-87 
years of which 65.1% were above the age of 55. Regarding their gender, 171(58.6%) were 
females and 121 (41.4%) were males. Only one fourth (23.6%) of participants were having 
normal body mass index (18-24.99kg/m2), 53.1% were overweight (25-29.99 kg/m2) and 
23.3% were obese (≥30kg/m2). Nearly 61% of them were under the Palestinian poverty line as 
defined by the Palestinian Central Bureau of Statistics. 
For the measurement of the participants compliance rate, the researcher adopted different 
subjective and objective methods. The researcher measured their BP. as indirect indicator for 
their compliance. He also asked the participants subjective questions about their regularity on 
the doctor's appointment, their abidance to their doctor's advices regarding the healthy diet and 
physical activity, and finally their regularity on taking their antihypertensive drugs as they are 
prescribed to them.  
The main result of the current study was that, in general, there is a poor compliance rate with 
the treatment plans among the hypertensive patients. Only 57.9% of the participants in the 
V 
 
study were compliant with their treatment plans and had their blood pressure controlled below 
the targeted level of 140/90 mm Hg. And 53.4% were admitted to hospital once or more times 
due to hypertension. Also, the cross-tabulation between the compliance rate and the 
independent variables revealed that gender, BMI, and the smoking status have significant 
effect on BP. 65.75% of the participants suffered from hypertension for less that ten years and 
69.5% of them had one or more co-morbidities. 35.29% were on single daily dose of 
antihypertensive medication, 51.36% were on twice daily dosing and 13.35% were on three 
doses a day. 
Also, the findings indicate that, in general, the patients have good family support and 
encouragement and positive relationship with the treating doctor in the clinic. They also 
showed variation in their knowledge about hypertension and its treatment and the majority of 
the participants (72.6%) indicated that the drugs' usage instructions were "always or often" 
clear and simple. 
The binary logistic regression analysis revealed a significant relationship between compliance 
and gender of patients, body mass index, the illness duration in years, the presence of diabetes 
as co-morbidity, the number of drugs, frequency of doctor visits, the patient's perception of 
hypertension as a serious disease, the clarity of treatment instructions given to the patient, the 
family support, the occurrence of drugs side effects and the cost. On the other hand, binary 
logistic regression showed no statistically significant relationship between compliance and age 
of the patient, education level, work status, smoking status, marital status, family history of 
hypertension, daily regimen, and drugs' regimen interruptions. 
Finally, the participants had low compliance rate (57.9%) with their treatment plans which 
could have adverse effects on their ability to control their blood pressure level and to minimize 
or delay the appearance of its complications. 
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 ﻣﻠﺨﺺ اﻟﺪراﺳﺔ
ﻣﻨﻄﻘѧﺔ اﻟﺨﻠﻴѧﻞ ﺑﺎﻟﺨﻄѧﺔ  ﻓѧﻲ اﻷوﻟﻴѧﺔ ﻋﻴѧﺎدات اﻟﺮﻋﺎﻳѧﺔ ﻰ اﻟѧﻀﻐﻂ ﻓѧﻲ ﺿѧ ﺎﻟﻴﺔ ﻣѧﻦ اﺟѧﻞ ﺗﻘﻴѧﻴﻢ ﻣѧﺪى اﻟﺘѧﺰام ﻣﺮ  اﻟﺪراﺳﺔ اﻟﺤ أﺟﺮﻳﺖ
اﺳﺘﺨﺪﻣﺖ دراﺳﺔ آﻤﻴѧﺔ ﻣﻘﻄﻌﻴѧﺔ ﻣѧﻦ اﺟѧﻞ ﺗﺤﻘﻴѧﻖ  .و آﺬﻟﻚ اﻟﺒﺤﺚ ﻋﻦ اﻻﺳﺒﺎب اﻟﺘﻲ ﺗﺆﺛﺮ ﻓﻲ ﻣﺪى اﻟﺘﺰاﻣﻬﻢ  اﻟﻌﻼﺟﻴﺔ ﻟﻜﻞ ﻣﻨﻬﻢ 
 292ﺖ اﻟﻤﻌﻠﻮﻣѧﺎت اﻟﻼزﻣѧﺔ ﻟﻠﺪراﺳѧﺔ ﺑﻮاﺳѧﻄﺔ اﺳѧﺘﺒﺎﻧﺎت ﻗѧﺎم اﻟﺒﺎﺣѧﺚ ﺑﺘﻌﺒﺌﺘﻬѧﺎ ﻣѧﻊ اﺛﻨѧﻴﻦ ﻣѧﻦ اﻟﻤѧﺴﺎﻋﺪﻳﻦ ﻣѧﻦ ﺟﻤﻌѧ . هﺬا اﻟﻬѧﺪف 
  ﻣѧﻦ 38 و اﻟﻜﺮﻧﺘﻴﻨѧﺎ  ﻣѧﻦ 901)ﻣﺮﻳﺾ ﻣﻤﻦ اﺳﺘﻮﻓﻮا ﺷﺮوط اﻟﻤﺸﺎرآﺔ ﻓﻲ هﺬا اﻟﺒﺤﺚ ﻣѧﻦ اﻟﻤѧﺮاﺟﻌﻴﻦ ﻓѧﻲ اﻟﻌﻴѧﺎدات اﻟﻤﺮآﺰﻳѧﺔ 
 هѧﺬﻩ اﻟﺪراﺳѧﺔ آﺎﻧѧﺖ أداة. 0102/8/01 و 0102/7/01ﻦ ﻌѧﺔ ﻣѧﺎ ﺑѧﻴﻓѧﻲ ﻣﻨﻄﻘѧﺔ اﻟﺨﻠﻴѧﻞ ﻓѧﻲ اﻟﻔﺘѧﺮة اﻟﻮاﻗ( ﻳﻄѧﺎ ﻣѧﻦ 001 و دورا
  .  ﺳﺆال201 و أﺑﻮابﺗﺘﻜﻮن ﻣﻦ ﻋﺸﺮة ﻋﺒﺎرة ﻋﻦ اﺳﺘﺒﺎﻧﺔ 
.  ﻣѧﻦ هѧﺬا اﻟﺒﺮﻧѧﺎﻣﺞ 51ﺣﻴѧﺚ اﺳѧﺘﻌﻤﻠﺖ اﻟﻨѧﺴﺨﺔ , ﻟﺘﺤﻠﻴѧﻞ اﻟﻌﻴﻨѧﺔ ( SSPS)اﻻﺣﺼﺎﺋﻴﺔ ﻟﻠﻌﻠﻮم اﻻﺟﺘﻤﺎﻋﻴѧﺔ اﺳﺘﺨﺪم ﺑﺮﻧﺎﻣﺞ اﻟﺮزم 
 %5  ﻣﻊ درﺟﺔ دﻗﺔ (tset tcaxe rehsif)وﻓﺸﺮ اﻟﻤﻀﺒﻮط ( x²)ﺮﺑﻊ ﺑﺎﻻﺿﺎﻓﺔ اﻟﻰ اﻟﻜﺎي اﻟﻤ, آﺬﻟﻚ اﺳﺘﺨﺪم اﻟﺘﺤﻠﻴﻞ اﻟﻮﺻﻔﻲ
آﻤѧﺎ اﺳѧﺘﺨﺪم ﺗﺤﻠﻴѧﻞ اﻻرﺗѧﺪاد اﻟﻠﻮﺟѧﺴﺘﻴﻜﻲ ﻣѧﻦ اﺟѧﻞ ﻓﺤѧﺺ اﻟﻌﻼﻗѧﺔ ﺑѧﻴﻦ اﻟѧﺘﺤﻜﻢ ﻓѧﻲ . ﻟﺘﺤﻠﻴѧﻞ اﻟﻤﻌﻠﻮﻣѧﺎت )50.0< eulav p( 
  . ﺘﺎﺑﻌﺔﺿﻐﻂ اﻟﺪم و ﺑﻌﺾ اﻟﻤﺘﻐﻴﻴﺮات اﻟﻣﺴﺘﻮى 
.  ﺳѧﻨﺔ55ﻣѧﻨﻬﻢ آѧﺎﻧﻮا ﻓѧﻮق ﺳѧﻦ % 1.56 ﺳѧﻨﺔ و ان 78-73ﺗﺤﻠﻴѧﻞ ﺑﻴﺎﻧѧﺎت اﻟﻤﺮﺿѧﻰ اﺷѧﺎرت اﻟѧﻰ ان اﻋﻤѧﺎرهﻢ ﺗﺮاوﺣѧﺖ ﺑѧﻴﻦ 
آѧﺎﻧﻮا ﺿѧﻤﻦ  %(6.32 )ﻓﻘѧﻂ  ﻣѧﻨﻬﻢ  ﺣѧﻮاﻟﻲ اﻟﺮﺑѧﻊ . آﺎﻧﻮا ﻣѧﻦ اﻟѧﺬآﻮر % 4.14ﻣﻨﻬﻢ اﻧﺎﺛﺎ ﺑﻴﻨﻤﺎ % 6.85ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﺠﻨﺪر ﻓﻘﺪ آﺎن 
( 2م/ آﻐѧﻢ 99.92-52)ﻣﻨﻬﻢ آﺎﻧﻮا ﻣѧﻦ زاﺋѧﺪي اﻟѧﻮزن % 1.35  ,(2م/ آﻐﻢ 42 و 99 -81)اﻟﻤﻌﺪل اﻟﻄﺒﻴﻌﻲ ﻟﻤﺆﺷﺮ آﺘﻠﺔ اﻟﺠﺴﻢ 
  (.2م/  آﻐﻢ 03≤ )ﻣﻨﻬﻢ آﺎﻧﻮا ﻣﻦ اﻟﺒﺪﻧﺎء % 3.32و 
ﻓﻘѧﺎم ﺑﻘﻴѧﺎس ﺿѧﻐﻂ اﻟѧﺪم آﻤﺆﺷѧﺮ ﻏﻴѧﺮ ﻣﺒﺎﺷѧﺮ ﻋﻠѧﻰ ﻣѧﺪى , اﺳѧﺘﺨﺪم اﻟﺒﺎﺣѧﺚ ﻋѧﺪة ﻃѧﺮق ﻣﺨﺘﻠﻔѧﺔ ﻟﻘﻴѧﺎس ﻣѧﺪى اﻟﺘѧﺰام اﻟﻤѧﺸﺎرآﻴﻦ
اﻟѧﺼﺤﻲ آﺬﻟﻚ ﻗﺎم ﺑﺴﺆال اﻟﻤﺸﺎرآﻴﻦ أﻧﻔﺴﻬﻢ ﻋﻦ ﻣﺪى اﻟﺘﺰاﻣﻬﻢ ﺑﻤﻮاﻋﻴﺪ اﻟﻄﺒﻴﺐ و ﻧѧﺼﺎﺋﺤﻪ ﺑﺎﻷآѧﻞ . اﻟﺘﺰاﻣﻬﻢ ﺑﺎﻟﺨﻄﺔ اﻟﻌﻼﺟﻴﺔ 
  .   و اﻟﻨﺸﺎط اﻟﺒﺪﻧﻲ و آﺬﻟﻚ ﻣﺪى اﻟﺘﺰاﻣﻬﻢ ﺑﺄﺧﺬ أدوﻳﺘﻬﻢ ﺑﺎﺳﺘﻤﺮار آﻤﺎ هﻲ ﻣﻮﺻﻮﻓﺔ ﻟﻬﻢ
 اﻧﻪ إذﻳﻮﺟﺪ ﺿﻌﻒ ﻓﻲ ﻣﺪى اﻟﺘﺰام ﻣﺮﺿﻰ ﺿﻐﻂ اﻟﺪم اﻟﻤﺮﺗﻔﻊ ﻣﻊ اﻟﺨﻄﺔ اﻟﻌﻼﺟﻴﺔ  ﺗﺸﻴﺮ اﻧﻪ اﻟﻨﺘﺎﺋﺞ اﻟﺮﺋﻴﺴﻴﺔ ﻟﻬﺬﻩ اﻟﺪراﺳﺔ
ﻴﺔ و ﺗﻤﻜﻨﻮا ﻣﻦ اﻟﺘﺤﻜﻢ ﺑﻀﻐﻂ اﻟﺪم ﻟﺪﻳﻬﻢ ﺿﻤﻦ اﻟﻤﻌﺪل ﻣﻦ اﻟﻤﺸﺎرآﻴﻦ ﻓﻲ اﻟﺪراﺳﺔ آﺎﻧﻮا ﻣﻠﺘﺰﻣﻴﻦ ﺑﺎﻟﺨﻄﺔ اﻟﻌﻼﺟ% 9.75ﻓﻘﻂ 
 .ﻣﻨﻬﻢ ﻗﺪ دﺧﻞ اﻟﻤﺴﺘﺸﻔﻰ ﻣﺮة أو أآﺜﺮ ﺑﺴﺒﺐ ﻣﺮض اﻟﺪم اﻟﻤﺮﺗﻔﻊ% 4.35آﻤﺎ أن . ﻣﻠﻢ زﺋﺒﻘﻲ09/041  اﻗﻞ ﻣﻦاﻟﻤﻄﻠﻮب و هﻮ
ﺆﺷﺮ ﻣ, ﻤﺮﺿﻰ وآﻞ ﻣﻦ اﻟﺠﻨﺲﻣﺴﺘﻮى ﺿﻐﻂ اﻟﺪم ﻟﻠآﻤﺎ أن اﻟﺠﺪوﻟﺔ اﻟﻤﺘﻘﺎﻃﻌﺔ أﻇﻬﺮت وﺟﻮد ﻋﻼﻗﺔ ذات دﻻﻟﺔ إﺣﺼﺎﺋﻴﺔ ﺑﻴﻦ 
% 5.96ﻣﻦ اﻟﻤﺸﺎرآﻴﻦ ﻳﻌﺎﻧﻲ ﻣﻦ اﻟﻤﺮض ﻟﻔﺘﺮ اﻗﻞ ﻣﻦ ﻋﺸﺮ ﺳﻨﻮات و % 57.56. آﺘﻠﺔ اﻟﺠﺴﻢ وﻧﺴﺒﺔ اﻟﺘﺪﺧﻴﻦ ﻟﻠﻤﺸﺎرآﻴﻦ
ﻣﻨﻬﻢ آﺎﻧﻮا ﻳﻌﺎﻟﺠﻮن ﺑﺠﺮﻋﺔ واﺣﺪة ﻳﻮﻣﻴﺎ ﻣﻦ % 92.53أﻣﺎ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﻌﻼج . ﻣﻨﻬﻢ ﻳﻌﺎﻧﻮن ﻣﻦ ﻣﺮض ﻣﺰﻣﻦ ﺁﺧﺮ ﻋﻠﻰ اﻷﻗﻞ
  .آﺎﻧﻮا ﻳﻌﺎﻟﺠﻮن ﺑﺄﺧﺬ ﺛﻼث ﺟﺮﻋﺎت ﻳﻮﻣﻴﺎ% 53.31ﻳﻌﺎﻟﺠﻮن ﺑﺠﺮﻋﺘﻴﻦ ﻳﻮﻣﻴﺎ و % 63.15, اﻟﺪواء
 ﺑﺪﻋﻢ و ﺗﺸﺠﻴﻊ ﺟﻴﺪﻳﻦ ﻣﻦ اﻟﻌﺎﺋﻠﺔ و آﺬﻟﻚ ﻟﻬﻢ  ﺑﺸﻜﻞ ﻋﺎمﻳﺘﻤﺘﻌﻮن ﻓﻲ اﻟﺪراﺳﺔ أن اﻟﻤﺮﺿﻰ اﻟﻤﺸﺎرآﻴﻦ اﻟﻨﺘﺎﺋﺞ أﻇﻬﺮت أﻳﻀﺎ
و أﻇﻬﺮت آﺬﻟﻚ وﺟﻮد ﻓﺮوﻗﺎت ﻓﻲ ﻣﺪى اﻟﻤﻌﺮﻓﺔ ﻟﺪﻳﻬﻢ ﺑﻤﺎ ﻳﺘﻌﻠﻖ ﺑﻤﺮض .ﻋﻼﻗﺔ اﻳﺠﺎﺑﻴﺔ ﻣﻊ اﻟﻄﺒﻴﺐ اﻟﻤﻌﺎﻟﺞ ﻟﻬﻢ ﻓﻲ اﻟﻌﻴﺎدة
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ﻗﺎﻟﻮا أن اﻟﺘﻌﻠﻴﻤﺎت اﻟﺨﺎﺻﺔ ﺑﺎﻟﻌﻼج آﺎﻧﺖ داﺋﻤﺎ ﺳﻬﻠﺔ %( 6.27) آﻤﺎ أن ﻣﻌﻈﻢ اﻟﻤﺮﺿﻰ.  اﻟﺪم اﻟﻤﺮﺗﻔﻊ و ﻋﻤﻠﻴﺔ ﻋﻼﺟﻪ ﺿﻐﻂ
   .وواﺿﺤﺔ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻬﻢ
 اﻻﻟﺘﺰام ﺑﺎﻟﺨﻄﺔ اﻟﻌﻼﺟﻴﺔ و اﻟﺴﻴﻄﺮة ﻋﻠﻰ  ﺑﻴﻦإﺣﺼﺎﺋﻴﺔذات دﻻﻟﺔ  هﻨﺎك ﻋﻼﻗﺔ أناﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﺟﺴﺘﻴﻜﻲ اﻻرﺗﺪادي اﻟﺜﻨﺎﺋﻲ ﺑﻴﻦ 
ﺗﻜﺮار ,  ﻋﺪد اﻻدوﻳﺔ,اﻟﻤﺼﺎﺑﻮن ﺑﺪاء اﻟﺴﻜﺮي, اﻟﻤﺮضﻃﻮل ﻓﺘﺮة , ﺠﺴﻢاﻟﻣﺆﺷﺮ آﺘﻠﺔ , م و ﺟﻨﺲ اﻟﻤﺮﻳﺾﻣﻌﺪل ﺿﻐﻂ اﻟﺪ
 وﺟﻮد, دﻋﻢ اﻟﻌﺎﺋﻠﺔ, وﺿﻮح اﻟﺘﻌﻠﻴﻤﺎت اﻟﻄﺒﻴﺔ, اﻟﻨﻈﺮة ﻟﻤﺮض ﺿﻐﻂ اﻟﺪم اﻟﻤﺮﺗﻔﻊ ﻋﻠﻰ اﻧﻪ ﻣﺸﻜﻠﺔ ﺟﺪﻳﺔ, زﻳﺎرة اﻟﻄﺒﻴﺐ
  . و اﻟﻜﻠﻔﺔﻟﻸدوﻳﺔ اﻟﺠﺎﻧﺒﻴﺔ أﻋﺮاض
 اﻻﻟﺘﺰام  ﺑﻴﻦإﺣﺼﺎﺋﻴﺔذات دﻻﻟﺔ  ﻟﻴﺲ هﻨﺎك ﻋﻼﻗﺔ ﺟﺴﺘﻴﻜﻲ اﻻرﺗﺪادي اﻟﺜﻨﺎﺋﻲ ﺑﻴﻦ اﻳﻀﺎ اﻧﻪاﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﻓﺎن , ﻣﻦ ﺟﻬﺔ أﺧﺮى
, اﻟﺤﺎﻟﺔ اﻻﺟﺘﻤﺎﻋﻴﺔ, ﻦﻴﺪﺧاﻟﺘ, اﻟﻌﻤﻞ, ﻣﺴﺘﻮى اﻟﺘﻌﻠﻴﻢ, ﻟﻤﺮﻳﺾﻋﻤﺮ اﺑﺎﻟﺨﻄﺔ اﻟﻌﻼﺟﻴﺔ و اﻟﺴﻴﻄﺮة ﻋﻠﻰ ﻣﻌﺪل ﺿﻐﻂ اﻟﺪم و 
  . ﺎﻟﺨﻄﺔ اﻟﻌﻼﺟﻴﺔﻋﺪم اﻻﻟﺘﺰام ﺑ ﻋﺪد ﻣﺮات اﺧﺬ اﻟﺪواء  ﻓﻲ اﻟﻴﻮم و ﻋﺪد ﻣﺮات, اﻟﺘﺎرﻳﺦ اﻟﻤﺮﺿﻲ ﻟﻠﻌﺎﺋﻠﺔ
ﺑﺎﻟﺨﻄﺔ اﻟﻌﻼﺟﻴﺔ اﻟﻤﻮﺿﻮﻋﺔ ﻟﻜﻞ ﻣﻨﻬﻢ ﻣﻤﺎ ﻗﺪ ﻳﻜﻮن ﻟﻪ %( 9.75) اﻇﻬﺮ اﻟﻤﺸﺎرآﻮن ﻓﻲ اﻟﺪراﺳﺔ ﻣﺴﺘﻮى اﻟﺘﺰام ﺳﻲء ,أﺧﻴﺮا
أﺛﺮا ﺳﻠﺒﻴﺎ ﻋﻠﻰ ﻣﻘﺪرﺗﻬﻢ ﻓﻲ اﻟﺴﻴﻄﺮة ﻋﻠﻰ ﻣﺴﺘﻮى ﺿﻐﻂ اﻟﺪم و آﺬﻟﻚ ﻣﻘﺪرﺗﻬﻢ ﻋﻠﻰ ﺗﻘﻠﻴﻞ أو ﺗﺄﺧﻴﺮ ﻇﻬﻮر ﻣﻀﺎﻋﻔﺎت 
 .  اﻟﻤﺮض ﻟﺪﻳﻬﻢ
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Definitions 
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Hypertension: Hypertension is a chronic medical condition in which the blood pressure is 
persistently elevated. It is also referred to as high blood pressure or shortened to HT, HTN or 
HPN. The word "hypertension" by itself normally refers to systemic arterial hypertension.  
Essential (primary) hypertension: It means that no medical cause can be found to explain 
the raised blood pressure. 
Secondary hypertension:  means that the high blood pressure is a result of another medical 
condition, such as kidney disease, tumors or disturbances in the endocrine system.  
Compliance with treatment: The extent to which the patient behavior coincides to the 
recommendations of his/her treating doctor and to his/her assigned therapeutic plan and drug 
regimen. 
Perception: the process of attaining apprehension or understanding of the environment by 
organizing and interpreting sensory information. The perception of hypertension is how does 
the patient evaluate and where does he/she rank hypertension from health point of view. 
Knowledge: acquaintance or familiarity with someone or something, that can include facts, 
information, principles gained through experience and or education. 
Chi-squared test: test of independence for the two qualitative variables to determine whether 
the observed frequencies markedly differ from that we would expect by chance. This test 
could be one-way or two-way chi-squared. 
Fisher test: is a statistical significance test used in the analysis of contingency tables where 
sample sizes are small to determine if there are non-random associations between two 
categorical variables. 
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 Chapter One 
Introduction 
 
1.1. Introduction 
This study is designed to assess the compliance rate with the treatment plan and the factors 
that affect it among the hypertensive patients attending the primary health care centers in 
Hebron city because a review of the literature revealed lack of compliance among the 
chronically diseased patients in general and the hypertensive patients in particular (WHO, 
2003). 
The Primary Health Care is the first level of contact between the individual and the health 
system where essential health care is provided and the majority of prevailing health problems 
can be managed. These services are provided by the primary health care centers which usually 
are located close to the people and include: health education and promotion, illness 
prevention, care of the sick people, advocacy and community development. Primary health 
care (PHC) became a core policy for the World Health Organization (WHO) with the Alma-
Ata declaration in 1978 and the "Health- For- All by the year 2000" program. 
Before discussing the problem statement, the aim and the objectives of the current study it is 
important to obtain an overview of the number and levels of the primary health care centers in 
the West Bank, Hebron, and south Hebron directorates. By the end of the year 2010, the 
population of Palestine reached 4048403, 62% in West Bank and 38% in Gaza strip. Hebron 
directorate located in the southern part of West Bank and is the biggest governance in regard 
to the total population which was 620417 (14.9%) of the population of Palestine (Palestine 
MoH 2010).  
In Palestine, the Ministry of Health is the major provider of primary health care services 
which are provided free of charge to all individuals enrolled in the government health 
insurance and they only pay a small co-payment for the drugs, the laboratory test, and the 
radiological examinations. Prenatal care, vaccination, and treatment for children under the age 
of three years are provided free of charge to all people regardless of their insurance status. 
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The network of the primary health care centers (PHC) has been considerably developed in 
Palestine and there are 706 centers (572 in West Bank and 134 centers in Gaza strip). The 
Palestinian Ministry of Health (MoH) operates 453  of them (64.16%) (394 in West Bank and 
59 in Gaza strip), the UNRWA operates 59 centers (8.35%) (41 in West Bank and 18 in Gaza 
strip) and the non-governmental organizations (NGOs) operates 194 centers (27.49%) (137 in 
West Bank and 57 in Gaza strip) (MoH, 2011). 
The  primary health care centers in Palestine are classified into four levels according to the 
services they provide and the number of people they serve in their catchment's area. These 
four levels are: 
Level one: provides preventive health services such as health education on MCH, safe water 
and sanitation, healthy nutrition ..etc, record keeping and follow-up and provision of first aid 
as well as MCH services. This also provides curative services such as first aid and the doctors 
visit them once or twice a week. It is staffed by a health guide or a registered nurse to serve 
population sites below 1,000 persons.  
Level two: health clinic provides preventive services such as MCH, vaccination, and health 
education. This clinic provides curative services in the form of general practitioner services 
and is staffed by a general practitioner and nurses. It provides all preventive, general curative 
and some laboratory services throughout the week and provide its services to sites populated 
by 1000 to 3000 persons. 
Level three: which involves health centre that provides the same services as level two clinic 
plus the routine laboratory tests and preventive dentistry. It provides a wider range of health 
services which includes preventive dentistry, laboratory services and specialist doctor 
services. They are located in sites of 3000-10000 persons. 
Level four centre: these are super specialist clinics which are usually available in the district 
hospitals, offers comprehensive health care services such as general medicine, consultations 
by a variety of specialists, laboratory services, X-ray and emergency care around the clock. 
The fourth level clinic is located in areas with more than 10,000 population and there are no 
services excluded from package. 
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In West Bank there are 86 centers of level one, 216 centers of level two, and 80 centers of 
level three. In Hebron & South Hebron there are 81 centers of level one, 28 centers of level 
two, and 16 centers of level three  and the major three central clinics are: Karanteena, Yatta 
and Dora. These PHC centers provide multiple activities and programs including preventive 
medicine, non-communicable diseases programs including diabetes and hypertension, 
community health, mother and child health, environmental health….etc (Hebron Health 
Directorate). The following table shows the number and levels of the 44 clinics (See table 
1.1). 
Table (1.1): Number and levels of PHC clinics in West Bank, Hebron and South Hebron 
directorates. 
Directorate Level- II  PHC clinics Level-III  PHC clinics Total 
West Bank  216 80 296 
Hebron 7 13 20 
South Hebron 21 3 24 
Totals 28 16 340 
 
1.2. Problem Statement   
Hypertension is one of the most common diseases all over the world and its prevalence is 
increasing by the years. The World Health Organization (WHO) considers it as the major risk 
factor for cardiovascular diseases (CVD) which in turn are responsible for around one third of 
the global deaths each year and thus it was named "the number one killer" by the WHO in its 
annual report (WHO, 2002). Globally, 972 million had hypertension in 2000 and this number 
will reach 1.56 billion by the year 2025 (Kearney et al. 2005). The WHO estimated that 
hypertension caused 7.1 million deaths, about 13% of the total, contributing by 4.5% to the 
global disease burden that is 64 million disability adjusted years (DALYs) (WHO/ISH, 2003).  
In Palestine, cardiovascular diseases is the number one killer contributing to 25.4% of the 
total deaths in 2010 (29.6%of those 20-59 years and 30.9% of those 60 years and above) and 
cerebrovascular diseases was the second cause of death in the same years counting for 12.1% 
(6.4% of those 20-59 years and 17% of those 60 years and above). Hypertension is one of the 
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most common non-communicable diseases and it constitutes 3.1% of the total deaths in 2010 
(1.4% of those 20-59years and 4.4% of those who were 60 years and above) (Palestine MoH. 
2010). 
High blood pressure, if left untreated or uncontrolled, it has many serious complications that 
might affect the vital organs of the body such as the heart, the brain, the kidneys and the eyes. 
For example, it may lead to arteioscelerosis (Riccioni, 2009), stroke and other CVAs 
((Donnan et al.,2008), hypertensive nephroscelerosis (Ruilope et al., 2001), and hypertensive 
retinopathy (Rodriguez & Zurutuza, 2008).  
Non-compliance with treatment might be one of the crucial factors that keep hypertension 
difficult to control leading to its various complications. Unfortunately, there is lack in studies 
that assess compliance with anti-hypertensive treatment among patients with hypertension in 
Palestine. Indeed, to our knowledge this may be the first study ever conducted among the 
Palestinian hypertensive patients for this purpose. 
1.3. The rationale and importance of the study 
As discussed formerly, this study may be the first in Palestine and the findings may help the 
health policy planners as well as the health professionals treating hypertension to gain more 
control over the disease and its complications by improving their patients’ compliance. Thus 
saving lives and huge amounts of money that are spent yearly on treating the complications of 
this disease. 
1.4. Study aim and objectives: 
1.4.1. Study aim   
The main aim of this study is to assess the rate of compliance and the factors that may affect 
the compliance with anti-hypertensive treatment plans among the hypertensive patients who 
attend the primary health care clinics in Hebron area. 
1.4.2. The specific objectives of the study 
1- To assess the relationship between the socio-demographic variables such as gender, age, 
marital status, level of education...etc and other independent variables that may affect patient's 
5 
 
compliance with anti-hypertensive treatment plan such as knowledge, cost, family 
support…etc. 
2- To assess the compliance rate of the hypertensive patients with their treatment plan. 
3- To identify the factors that may affects the compliance rate of the hypertensive patients 
with their treatment plan. 
1.5. Research questions 
What is the compliance rate of the hypertensive patients with their treatment plan and what 
are the factors that may affect their compliance ?. 
1.6. Feasibility of the study: 
1- The researcher’s interest and his professional knowledge of the disease and its 
treatment aspects facilitated the process of conducting this research. 
2- The researcher himself is working as a dispensing pharmacist in the study setting 
which facilitated the access to the patients who participated in the study and to the 
medical staff who were helpful. 
3- Ethical approval was obtained from Al-Quds University, the head of Primary Health 
Care Directorate in West Bank, the head of South Hebron Health Directorate and the 
head of Hebron Health Directorate.  
1.7. Possible limitations of the study 
 ● The participants may tend to answer in a manner which they consider socially or    
medically acceptable so as to please the researcher. 
● Only the three central clinics in Hebron city area were selected for this study, so the 
generalization of the study findings may be limited to other cities in Palestine. 
• This study was conducted in governmental primary heath care centers, so the 
generalization to other centers such as UNRWA and NGOs may be limited.  
• This study utilizes a cross-sectional design by which causal inferences or incident rate 
estimation of compliance is not possible. 
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1.8. Summary: 
 1-The main provider of primary health care in Palestine is the Palestinian Ministry of Health 
and it provides its services through a network of PHC clinics that cover the whole area of the 
West Bank and Gaza strip. 
2- The chronically diseased patients (hypertensive and diabetics) make a great part of those 
receiving treatment in the PHC clinics. 
 
3- The aim of the current study is to assess the rate of compliance with treatment regimen 
among the hypertensive patients who attend the PHC clinics in Hebron area and the factors 
that affect their compliance. 
 
4- The chapter also presents the problem statement, the study objectives, research questions, 
feasibility and the limitations of the current study. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
 
2.1. Section one: introduction  
Cardiovascular diseases are the class of diseases that involve the heart  and or blood vessels 
"arteries and veins". While the term technically refers to any disease that affects the 
cardiovascular system, it is usually used to refer to those related to atherosclerosis (arterial 
disease).These conditions usually have similar causes, mechanisms, and treatments. Due to 
the silent nature of the cardiovascular diseases as in general, these cardiovascular problems 
are detected by the time the problem is usually quite advanced and having progressed for 
decades. Therefore, there is an increased emphasis on preventing them by modifying their risk 
factors, such as healthy eating, exercise, and avoidance of smoking (Anthea. 1993). 
Most countries face high and increasing rates of cardiovascular diseases. Each year, heart 
diseases kill more Americans than cancer. In recent years, cardiovascular risk in women has 
been increasing and has killed more women than breast cancer (USA government, 1999). 
There are many types of the cardio-vascular diseases (CVDs) which can be shortly described 
as the follows: (American Heart Association, 2011) 
1-Atherosclerosis: which is a condition in which a substance called "plaque" builds up on the 
inner walls of the blood vessels. This buildup narrows the arteries, making them hard for the 
blood to flow through.  
2- Heart attack / myocardial infarction (MI): this occurs when the blood flow to a part of the 
heart is blocked by a blood clot. If this clot cuts off the blood flow completely, the part of the 
heart muscle supplied by that artery begins to die. 
3- Stroke of which there are three subtypes: (a) Ischemic stroke which happens when a blood 
vessel that feeds the brain gets blocked, usually from a blood clot. It is the most common type 
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and accounts for 87% of all stroke cases. When the blood supply to a part of the brain is shut 
off, brain cells will die. The result will be the inability to carry out some of the previous 
functions as before like walking or talking. (b): Hemorrhagic (bleeding) stroke which occurs 
when a blood vessel within the brain bursts. The most likely cause is uncontrolled 
hypertension and (c) transient ischemic attack (TIA): often called a “mini stroke”, and caused 
by a temporary clot but these warning strokes should be taken very seriously.  
3 - Heart Failure (HF): this doesn’t mean that the heart stops beating but that the heart isn’t 
pumping blood as well as it should. Heart failure, sometimes called congestive heart failure 
(CHF) as the heart keeps working, but the body's need for blood and oxygen isn't being met. 
4 - Arrhythmia: which is an abnormal rhythm of the heart. There are various types of 
arrhythmias. The heart can beat too slowly, too fast or irregularly. For example, bradycardia is 
when the heart rate is less than 60 beats per minute while tachycardia is when the heart rate is 
more than 100 beats per minute. An arrhythmia can affect how well the heart works. The 
heart may not be able to pump enough blood to meet the body's needs 
5- Heart valves problems: When heart valves don't open enough to allow the blood to flow 
through as it should, it's called stenosis. When the heart valves don't close properly and allow 
blood to leak through, it's called regurgitation. When the valve leaflets bulge or prolapse back 
into the upper chamber, it’s a condition called mitral valve prolapse. When this happens, they 
may not close properly. This allows blood to flow backward through them.   
Cardiovascular diseases (CVDs) are the main non-communicable diseases (NCDs) and are 
major public health concern world-wide. Globally, CVDs are the number one cause of deaths. 
An estimated 17.1 million died of CVDs in 2004 representing 29% of all global deaths and 
this number is expected to rise to 23.6 million by 2030. Of these deaths, 7.2 million were due 
to coronary heart diseases (CHD) and 5.7 million were due to stroke and 82% of all these 
deaths occurred in the low and middle-income countries (WHO, 2011). For example, in the 
United States of America (USA), CVD has been the number one killer every year since 1900 
except 1918 and in 2003. One or more types of the CVDs affected 71.3 million individuals 
representing 34.2% of all population and caused around 9.1 million (37.3%) of the deaths in 
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the same year. Of the CVDs, high blood pressure (HBP) affected 65 million (32.3%), 
coronary heart disease affected 13.2 million (6.9%), stroke affected 5.5 million (2.6%) and 
heart failure (HF) affected 5 million (2.3%) (NHANES 1999–2002). According to the WHO 
report (2001), CVDs accounted for 9.2% of the total deaths in the African region in 2000 
compared to 8.15% in 1990. (WHO, 2001) 
The following table (2.1) shows the estimated annual deaths that occurred in world regions 
due to the most common forms of the CVDs: (WHO report, 2004) 
REGION High Blood 
Pressure 
(HTN) 
Ischemic 
Heart 
Diseases 
Cerebrovascular 
Diseases 
Cardiovascular 
Diseases (CVD) 
THE AMERICAS 135 000 921 000 542 000 1 928 000 
EUROPE 179 000 2 373 000 1 447 000 4 927 000 
MIDDLE EAST 97 000 538 000 227 000 1 079 000 
AFRICA 60 000 332 000 359 000 1 036 000 
SOUTH ASIA 152 000 2 039 000 1 059 000 3 911 000 
WESTREN PACIFIC 284 000 993 000 1 957 000 3 825 000 
 
Finally, in Palestine, the CVDs is still the leading cause of deaths accounting for 25.4% of all 
deaths in general. It was responsible for 29.6% of deaths that occurred in 20-59 years old 
people and 30.9% of deaths occurred in those who were 60 years or over in the years 2010. 
Also, the cerebro-vascular disease was the second cause of deaths and accounted for12.1% of 
the total deaths (6.4% of those 20-59 years and 17% of those 60 years and above). 
Hypertension is among the most common non-communicable diseases in Palestine and it 
constitutes 3.1% of the total deaths in 2010 (1.4% of those 20-59years and 4.4% of those who 
were 60 years and above) (Palestinian MoH, 2010). 
The cost is a crucial factor in the treatment of diseases especially the chronic ones as they last 
for life and constitute a large proportion of the patient's income. For example, the United 
States of America pays nearly € 310.23 billion as direct and indirect annual costs for treating 
the patients affected by CVDs (Haase et al, 2006). In 2006, CVDs also cost the European 
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Union about €169 billion (Leal et al, 2006). Further, in China, the direct annual costs of 
CVDs were estimated to be €30.76 billion representing 4% of its gross national income 
(Gaziano, 2007) and in South Africa, 25% of the country's health care spending is devoted to 
the CVDs. (Center for Global Health and Economic Development, 2004).  
As hypertension is considered the first cause of CVD and is the main focus of this study, the 
next section discusses the definition, prevalence, and etiology in more details.   
2.2. Section two: High Blood Pressure (HBP)/ Hypertension. 
Hypertension is a chronic medical condition in which the blood pressure is persistently 
elevated. It is also referred as high blood pressure or shortened as HT, HTN, or HPN. High 
blood pressure is defined as a systolic blood pressure (SBP) which is equal or above 140 
mmHg and or a diastolic blood pressure (DBP) which is equal or above 90mmHg (Oscar & 
Oparil, 2000). 
There are four main types of hypertension which are classified according to its etiology as the 
following: 
1- Primary or essential hypertension which affects about 90-95% of hypertensive patients. It 
has unknown medical cause and might be caused by a combination of several factors 
(Carretero & Oparil, 2000) such as obesity, especially in those with body mass index over 25 
(Haslam & James, 2005), stress and potassium deficiency (Tsigos, 2006), high sodium intake 
(table salt) (Lackland, & Egan, 2007), some mutated genes (Dickson & Sigmund, 2006) or 
normally inherited from parents or ancestors (Luma & Spiotta, 2006) (Wang & Sun, 2009). 
The risk of primary hypertension also increases with age (Kosugi et al. 2009). 
2- Secondary hypertension, which as the name implies, is occurred as a result of a condition 
that affects other organ(s) of the body such as the kidneys' tumors, brain tumors, blood 
arteries, heart, congenital problems (e.g. coarctation of the aorta) or the endocrine system 
which affects 5-10% of the patients (Mayo Clinic, 2008). For example, hypertension appears 
in more than 80% of those who suffer from Cushing syndrome (Dodt et al. 2009). 
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3- Exercise hypertension which is the elevation in blood pressure during exercise. The upper 
normal systolic values during exercise reach levels between 200-230 mmHg and it may be 
regarded as a precursor to establish hypertension at rest (Pierdomenico et al, 2009). 
4- Pregnancy hypertension which appears in about 2-3% of pregnant women and disappears 
after delivery. It may continue with some ladies and considered as precursor or indicator for 
the possibility of developing hypertension in the future (Gibson, 2009). 
Also, the American Heart Association (AHA) classified the blood pressure for adults who are 
18 years and above into four types as seen the table (2.2): (1) normal blood pressure which is 
defined as a systolic blood pressure less than 120mmHg and a diastolic blood pressure of less 
than 80mmHg, (2) systolic blood pressure of 120-139 mm Hg or a diastolic blood pressure of 
80-89 mmHg which is known as pre-hypertension or borderline hypertension, (3) 
hypertension which is defined as systolic blood pressure of ≥140 mmHg or diastolic blood 
pressure ≥90 mmHg which is divided into two stages; stage one includes those patients with 
systolic blood pressure 140–159 mmHg or diastolic blood pressure 90–99 mmHg and stage 
two includes patients with systolic blood pressure ≥160 mmHg or diastolic blood pressure 
≥100 mmHg (4) finally, there is isolated systolic hypertension which refers to an elevated 
systolic pressure to ≥140 mm Hg with normal diastolic pressure which is common in old 
people. 
Table 2.2. Classification of blood pressure according to the AHA. 
Classification SBP (mmHg) DBP (mmHg) 
Normal 90-119 60-79 
Pre-Hypertension 120-139 80-89 
Stage-1 140-159 90-99 Hypertension 
Stage- 2 ≥ 160 ≥ 100 
Isolated systolic hypertension ≥ 140 < 90 
Source: American Heart Association (AHA), 2003. 
SBP: systolic blood pressure, DBP: diastolic blood pressure. 
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Prevalence of hypertension: 
Hypertension is one of the most common diseases in the world and its prevalence is 
increasing by the years because of the increasing life expectancies and the contributing risk 
factors such as: increasing obesity, physical inactivity, unhealthy diet, and the modern life 
styles. The World Health Organization (WHO) considers hypertension as the major risk factor 
for cardiovascular diseases (CVD) which in turn are responsible for around one third of the 
global deaths each year. In 2002, hypertension was named "the number one killer" by the 
WHO in its annual report (WHO, 2002). Also, in the year 2000, the WHO estimated the 
number of patients with hypertension in the world to be 972 million of which 640 million are 
living in the developing countries and 330 million are living in the developed world. Also, it 
expected this number to increase and reach 1.2 billion in 2010 and 1.56 billion by the year 
2025 (Kearney et al.2005). 
Further, high blood pressure affected 20.1% of all Americans who were 20-100 years of age 
in the years 2002 (NHANES 2002), 32.1% of the British who were 16-100 years of age in 
2003 (MoH England, 2003) and 14% of the Australians who were 18-100 years in the year 
2005 (AIHW, 2006). In the Eastern Mediterranean Region, the prevalence of hypertension 
averages 26% and it affects about 125 million individuals (EMRO WHO. 2005). For example, 
it affected 22.2% of the Jordanians who were 18-100 years in the year 2002 (Jordanian MoH, 
2002), 26.7% of the Egyptians who were 15-65 years in 2006 (Egyptian MoH, 2006), 26.1% 
of the Saudis who were 30-100 years in 2001(SHA. 2001), 28.8% of the Syrians who were 
15-65 years in 2002 (Syrian MoH, 2002) and 23.1% of the Lebanese who were 30-100 years 
in 2005 (Tohme, 2005). 
In Palestine, Hypertension is one of the most common non-communicable diseases but there 
is a lack of studies that assess its prevalence in the general population of the West Bank or 
Gaza strip. The Palestinian Ministry of Health reported that hypertension was the seventh 
direct cause of death in the Palestinian territories in the year 2003. Further, it was responsible 
for 2.58% of the deaths that occurred in 2009 among those who were 20-59 year and for 
5.32% of the deaths of those who were 60 years and above. In 2010, it constitutes 3.1% of the 
total deaths of Palestine (1.4% of those 20-59 years and 4.4% of those who were 60 years and 
above). Furthermore, it was a major risk factor for the cardiovascular diseases (CVDs) which 
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are the number one killer in Palestine contributing to 25.4% of the total deaths in 2010 
(29.6%of those 20-59 years and 30.9% of those 60 years and above). The cerebrovascular 
diseases were the second cause of death in the same years counting for 12.1% (6.4% of those 
20-59 years and 17% of those 60 years and above). (Palestine MoH. 2010). 
Finally, in 2010, the UNRWA in its annual report stated that they had  40424 hypertensive 
registered patients in their clinics in the West Bank and Gaza (12918 in West Bank & 27506 
in Gaza strip) and other 30066 registered patients with hypertension and diabetes (12584 in 
West Bank & 17482 in Gaza strip) which means a total of 70490 hypertensive patients in 
Palestine attending the UNRWA clinics. They also have indicated that the prevalence of 
hypertension among the Palestinian refugees who aged 40 years and over was 15.8% in the 
West Band and 17.3% in Gaza strip (UNRWA, 2010) 
Causes of hypertension: 
Usually  the exact causes of hypertension are unknown. When the causes are known such as 
preeclampsia, kidney disease, tumors or certain medicines, it is called secondary hypertension 
and this constitute only 5-10% of all hypertension cases. For primary hypertension which 
accounts for 90-95% of all hypertension cases, the exact cause is not known but there are 
several risk factors that have been highly associated with the condition. These include: 
smoking, obesity or being overweight, diabetes, sedentary lifestyle, aging…etc. Although 
these are not causes by themselves, they can increase a person's chances of developing the 
condition. All these factors are discussed in more detail below. Some well-known causes of 
secondary hypertension are: (Mayo clinic, 2008) 
 (1) Preeclampsia : It is also known as pregnancy-induced hypertension (PIH) or toxemia of 
pregnancy. It is a condition that can occur during pregnancy and results from a narrowing of 
the blood vessels. Because of this narrowing, women with this condition can have decreased 
blood flow to the kidneys, brain, liver, retina, and placenta. Symptoms include high blood 
pressure, swelling of the hands and face, and protein in the urine (Drife & Magowan, 2004). 
Preeclampsia affects 5-8% of all pregnancies and women who have PIH are at greater risk for 
developing hypertension and other coronary artery disease later in life ( Sabour et al. 2007) 
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 (2) Pheochromocytoma which is a tumor that most commonly occurs within special cells of 
the adrenal gland called chromaffin cells. This type of tumor produces too many hormones 
called catecholamines, which include adrenaline. The high levels of these hormones can cause 
potential serious complications, including severe high blood pressure, headaches, and 
sweating (Young, 2007). 
(3) Aldosteronism in which the adrenal glands produce too much of the hormone 
"aldosterone", and one of the main symptoms of aldosteronism is high blood pressure (Young, 
2007).  
(4) Hyper- and hypothyroidism: in which the thyroid produces an excess amount of its 
hormones more than the body needs and it is also known as an overactive thyroid or 
thyrotoxicosis. Excessive thyroid hormone induces systemic vasoconstriction, an increase in 
blood volume, and an increase in cardiac activity which can lead to hypertension (Klabunde, 
2011). Hypothyroidism is a condition in which the thyroid doesn't produce enough hormones 
to meet the body needs and it causes secondary hypertension. The exact mechanism is not 
clear but it may be related to decreased tissue metabolism reducing the release of vasodilator 
metabolites, thereby producing vasoconstriction and increased systemic vascular resistance 
and hypertension (Stabouli et al. 2010) 
(5) Coarctation of the aorta which is a rare hereditary disorder that is one of the most common 
causes of hypertension in children. This condition is characterized by a narrowing of a 
segment of the aorta, the main large artery coming from the heart. The aorta delivers blood to 
the arteries that supply all of the body's organs, including the kidneys. This defect causes 
hypertension (Mayo Clinic, 2008). 
(6) Acromegaly: which is a hormonal disorder that results when the pituitary gland (the gland 
responsible for regulating several key hormones) produces too much growth hormone. The 
condition is usually caused by a tumor, and the most common symptoms are the abnormal 
growth of the hands and feet, fatigue, impaired vision, impotence, and high blood pressure. Its 
prevalence is about 35%, ranging from 18-60% and the incidence is higher than that in 
general population (Bondanelli et al. 2001). Also a retrospective study was conducted by 
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Vitale et al. (2005) in Italy to determine the prevalence and determinant of hypertension in 
acromegalic patients among 200 patients with acromegaly and 200 nonacromegalic subjects, 
matched for sex, age, body mass index (BMI) and smoking habits. The finding revealed that 
hypertension was found in 46% of patients of acromegaly and in 25% of controls (P < 
0.0001), without any difference between men and women (Vitale et al. 2005).   
(7) Cushing's syndrome: which is a hormonal disorder that occurs when a person's tissues are 
exposed to an excess of the hormone cortisol. This disease is sometimes called 
"hypercortisolism.". The symptoms vary, but can include extreme weight gain, excess hair 
growth, and high blood pressure appears in more than 80% of people with this syndrome 
(dodt et al. 2009). 
 (8) Sleep apnea: which is a sleep disorder characterized by interruptions of a person's 
breathing while he or she is asleep. People who have it will often snore loudly and be sleepy 
during the daytime. If sleep apnea is untreated, the chances of having high blood pressure, a 
heart attack, or stroke are increased (Dempsey, 1997; Goodfriend & Calhoun, 2004) 
 (9)  Birth control pills: for millions of women, oral contraceptive pills are an effective way to 
avoid pregnancy. According to the Centers for Disease Control and Prevention, oral 
contraceptives are the leading birth control method used by women age 30 and younger (17% 
of these women use birth control pills). While oral contraceptives are safe, birth control pills 
can increase the risk for high blood pressure. Users who are older than 35, obese, and/or 
smoke are generally more at risk. Also, the risk for high blood pressure increases with age and 
the duration of birth control pill use (O'Brien et al. 2007). 
For primary (or essential) high blood pressure which is much more common than secondary 
and accounts for 90-95% of hypertension, the basic cause is multi-factorial, that is, there are 
several factors whose combined effects produce hypertension and no single cause has been 
identified (Carretero & Oparil, 2000). Most people with primary hypertension don't even 
realize that they have it as the majority of people with this type of high blood pressure feel no 
different from those who have normal blood pressure. That's why hypertension is often 
referred to as "the silent killer". Nevertheless, certain risk factors have been recognized in 
people with essential hypertension (WHO. 2002). For example: 
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(1) High salt intake: essential hypertension develops more in persons or societies that have a 
fairly high intake of fat and salt. Salt is responsible for water regulation in the body, it is taken 
up by the gastro-intestinal tract and excreted by the kidneys and excess fat stick to the inner 
walls of the blood vessels making them narrower and less elastic  (Forrester, 2004; Bachtler, 
2009). 
 (2) Ethnicity: African Americans have more risk than others in USA to develop hypertension. 
One explanation is genetic, even though no causative gene has been confidently identified. 
Environmental and behavioral correlates to ethnicity are alternative explanations (Forrester, 
2004; Fejerman, 2006) 
 (3) Obesity: the WHO has set  an international formula to calculate the body fat contents and 
put an indicator called body mass index (BMI) to describe that. The body mass index (BMI) 
equals a person's weight in kilograms (kg) divided by his/her height in meters (m) squared. 
Since BMI describes body weight relative to height, it is strongly correlated with total body 
fat content in adults. According to the WHO criteria, the BMI is categorized as follow: (1) 
underweight when the BMI is below 18.5 kg/m², (2) normal BMI when it lies between 18.5-
24.9kg/m², (3) overweight when BMI is 25-29.9kg/m², and (4) obesity is defined as BMI of 
30kg/m² or more (WHO, 2011). 
Excess weight gain contributes to increased blood pressure in most patients with essential 
hypertension. Although the mechanisms of obesity hypertension are not fully understood, 
increased renal sodium re-absorption and impaired pressure natriuresis play key roles (Kevin, 
2004; Rahmouni et al. 2005; Hall et al. 2010). Also, the American Obesity Association 
(AOA) states that the risk of developing hypertension is five to six times greater in obese 
Americans, age 20 to 45, compared to non-obese individuals of the same age (AOA, 2010). 
(4) Family history (genetic susceptibility): Approximately 30% of cases of essential 
hypertension are attributable to genetic factors. For example, in individuals who have one or 
two parents with hypertension, high blood pressure is twice as common as in the general 
population (Winnicki et al. 2006; Luma & Spiotta, 2006; Wang & Sun, 2009).  
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 (5) Aging: as age increases, the risk of hypertension also increases ((Kosugi et al. 2009). 
Generally the risk increases in stages as the person gets older. Usually men develop 
hypertension more often between the ages 35-55 years while women develop it more after 
menopause (Stibich, 2007; Pergola et al. 2011). Hypertension is very prevalent in older (60-
79 years) and elderly (>=80 years) people. For example, a population bases survey in Canada 
found that 21.3% of the overall population of adults aged 20-79 years and 51.6% of  those 60-
79 years of age had hypertension (Logan, 2011)    
 (6) Having diabetes: Hypertension affects approximately 70% of patients with diabetes and it 
is approximately twice as common in persons with diabetes as in those without (Lago et al. 
2007). 
 (7) Smoking: It is the number one risk factor over which we have control. Not only does 
smoking immediately raise the blood pressure temporarily, but the chemicals in tobacco can 
damage the lining of the arteries' walls causing endothelial dysfunction and dyslipidemia. 
Smoking-induced alterations in growth factors, adhesion molecules, and even in genes can 
accelerate the progression of atherosclerosis which increases the blood pressure. Secondhand 
smoke can also increase your blood pressure (Tsiara et al. 2003). A prospective cohort 
conducted by Bowman et al. (2007), including 28,236 individuals and lasted for nearly ten 
years, revealed that the incidence of hypertension increases among people who smoke 15 or 
more cigarettes a day  (Bowman et al. 2007). 
(8) Excessive alcohol consumption: Epidemiological studies have demonstrated a positive 
relationship between heavy alcohol use and hypertension. For example, a study conducted by 
Stranges et al. (2004) to investigate the association of current alcohol consumption and 
aspects of drinking pattern with hypertension risk in a sample of 2609 white men and women 
from western New York, aged 35 to 80 years, and free from other cardiovascular diseases. 
Hypertension was defined by systolic blood pressure ≥140 mm Hg or diastolic blood pressure 
≥90 mm Hg or use of antihypertensive medication. Odds ratios (95% confidence intervals) 
were computed after adjustment for several covariates. The findings of this study showed that 
compared with lifetime abstainers, participants reporting drinking on a daily basis (OR, 1.75; 
95%CI; 1.13 - 2.72) or mostly without food (OR, 1.64; 95%CI; 1.08-2.51) exhibited 
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significantly higher risk of hypertension independent of the amount of alcohol consumed 
(Stranges et al. 2004).  
 (9) Prolonged and poorly managed stress and potassium deficiency increases the risk of 
developing high blood pressure (Tsigos, 2006)  
(10) A lack of exercise and sedentary life style increases the risk of being overweight and 
hence increases the risk of developing hypertension. Also people who are inactive tend to 
have higher heart rates (Pickering, 2003). For example, a cross sectional study was conducted 
by Guo et al (2001) in Hangzhou, China to study the compliance of antihypertensive drugs 
and its related factors in inpatients and outpatients with hypertension. Also it aimed to 
investigate the utilization of antihypertensive medicament and to explore the difference of the 
blood pressure control between the compliant and incompliant groups. In this study, the 
findings revealed that the main risk factors of the hypertensive patients were in the order as: 
disorder of lipo-metabolism, smoking, left ventricular hypertrophy (LVH), and diabetes 
mellitus (Guo et. al. 2001).  
 
Possible complications of hypertension 
The complication in medicine is defined as "an unfavorable evolution of a disease or a health 
condition as a result of another disease or a medical treatment. The disease can become worse 
in its severity, show a higher number of signs and symptoms, show new pathological changes, 
or become widespread throughout the body and affect other organ systems. A medical 
treatment such as drugs or surgery may produce adverse effects and/or produce new health 
problem(s) by itself or a new disease may also appear as a complication to a previous existing 
disease" (Dorland Medical Dictionary, 1998).    
As mentioned previously, hypertension is one of the risk factors for other cardiovascular 
diseases in the developed and developing countries as well (Chobanian et al. 2003). Its 
complications are numerous and life threatening. The speed and severity of appearance of 
these complications are influenced by many factors such as: genetics, dietary habits and the 
general life style. Patients who are aware of their medical condition and take the preventive 
measures seriously may have better control over their blood pressure and minimize and delay 
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its complications (Safar et al, 2009 & Gaddam et al, 2009). The complications of hypertension 
may affect many organs in the body such as: the heart, the kidneys, the brain…etc. 
Globally, hypertension is one of the major risk factors for the death (Chobanian et al. 2003). 
For example, 62% of cardiovascular diseases and 49% of the ischemic heart diseases are 
attributable to high blood pressure. The WHO estimated that hypertension caused 7.1 million 
deaths, about 13% of the total, contributing by 4.5% to the global disease burden that is 64 
million disability adjusted years (DALYs) (WHO/ISH, 2003). In 2009, the WHO indicated 
that the risk of myocardial infarction (MI) is doubled in patients with hypertension compared 
to normal people and the risk increases as blood pressure level increases. It also estimated 
hypertension to cause 12.8% of the premature deaths (WHO, 2009). According to the WHO 
report, hypertension had killed "135000" Americans, "179000" in Europe, "97000" in the 
Middle East, "60000" in Africa, "152000" in South Asia and "284000" individuals in the 
Western Pacific region in the year 2004 and the number is increasing with years.(WHO, 
2010). 
For example, a meta-analysis carried out by Munger et al. (2007) to examine the prevalence 
of non-adherence as a risk factor in the management of chronic diseases, with a specific focus 
on antihypertensive medications, factors leading to increased incidence of non-adherence and 
the strategies needed to improve adherence. The findings of this meta-analysis revealed that 
patients with hypertension are at greater risk of stroke, end-stage renal failure, and heart 
disease and that hypertension contributes to the prevalence of other cardiovascular risk factors 
(Munger et. al. 2007). 
  
Further, the effects of hypertension on the heart can cause many diseases such as myocardial 
infarction (or heart attack) whose risk is doubled in hypertensive patients (WHO, 2009), heart 
failure which is manifested by the inability of the heart to pump the blood to the different 
parts of the body adequately (Pedrinelli et al.2009), and left ventricular hypertrophy (LVH) 
(Levy et. al. 1994). 
 
On blood vessels, hypertension increases the hardness of the blood arteries causing a 
condition known as arteriosclerosis (Riccioni, 2009). It is also the most modifiable risk factor 
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for stroke or cerebrovascular accident (CVA), a condition in which the brain losses some of 
its functions as a result of a shortage of blood supply either due the blockage of some artery 
(clot) or due to leakage of blood (hemorrhagic) (Donnan et. al. 2008).  
 
Also, uncontrolled hypertension is associated with increased risk of incident of HF and that 
the risk was significant only for those with SBP ≥160 mmHg. Uncontrolled hypertension was 
also associated with increased risk of other cardiovascular morbidity and mortality. For 
example, a prospective cohort study was conducted by lyer et al (2010) in USA to assess the 
effect of uncontrolled BP on the incident of heart failure (HF) in a propensity-matched cohort 
of cardiovascular health study (CHS) community-dwelling participants with a history of 
hypertension and without HF at baseline in old adults (≥ 65 years). This cohort study included 
1021 pairs of participants with controlled and uncontrolled hypertension who were recruited 
from four US counties and from four states and were balanced on 31 baseline characteristics. 
The participants were picked from 5795 cardiovascular health study participants, ≥ 65years, 
of which 2562 with self-reported physician diagnosed hypertension with no heart failure (HF) 
at baseline of whom 1391 had uncontrolled hypertension (defined as SBP ≥ 140 or DBP ≥ 90 
mmHg). At the beginning, BP was measured using a sphygmomanometer and the average of 
two readings was used. The findings of this study revealed that new-onset HF developed in 
23% and 26% of participants with controlled and uncontrolled hypertension respectively with 
a hazard ratio (HR) of 1.39 (95%CI,1.12-1.73;P=0.003) associated with uncontrolled 
hypertension. Also, all-cause mortality occurred in 44% and 48% of participants with 
controlled and uncontrolled hypertension respectively, with hazard ratio of 1.21 (95% CI; 
1.04-1.41; P=0.014) associated with uncontrolled hypertension. The dose-response 
association between the uncontrolled hypertension and the incident HF occurred in 22%, 23% 
and 31% of matched patients with SBP <140 mmHg, 140-159 mmHg and ≥160 mmHg 
respectively. Compared with SBP <140 mmHg, hazard ratios for incident HF associated with 
SBP 140-159 mmHg and ≥160 mmHg were 1.06 (95% CI, 0.86-1.31; P=0.572) and 1.58 
(95% CI; 1.27-1.96; P<0.0001) respectively (lyer et al. 2010). 
 
Finally, hypertension also exerts its effects on the small blood vessels of the retina which is 
the lining of the inner surface of the eye causing a condition known as hypertensive 
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retinopathy which might be asymptomatic for a long period of time or be manifested as visual 
disturbances and headache. It is used as a sign of accelerated or sever hypertension 
(Rodríguez & Zurutuza, 2008). Furthermore, hypertension affects and damages the nephrons 
(building blocks) of the kidneys leading to a chronic renal disease named as hypertensive 
nephropathy or hypertensive nephroscelerosis. The effects of hypertension on the human 
kidneys can be identified by some laboratory tests such as blood urea nitrogen, serum 
creatinine, serum electrolytes and urinalysis particularly for proteinuria (Ruilope et. al. 2001) 
 
Treatment of hypertension 
The ultimate goal of treatment of hypertension is to reduce the blood pressure as much as 
possible toward the optimal level (≤120/80mmhg) so that the patient has a lower risk of 
complications. For the hypertensive patients who are on medication treatment, the World 
Health Organization (WHO) has set the goal of treatment to get a blood pressure level of less 
than 140/90 mmHg for those with no co-morbidity (Chobanian et. al. 2003) and a blood 
pressure level of less than 130/80 mm Hg if the patient suffers from chronic kidney disease 
(National Kidney Foundation Guideline, 2002) or if he is diabetic (American Diabetes 
Association, 2003). 
 
The stages of the treatment of hypertension depend on the stage of the disease and the 
presence of other chronic diseases such as diabetes mellitus or kidneys insufficiency. But in 
general, in the pre-hypertension stage (SBP: 120-139 & DBP: 80-89) the same preventive life 
style modifications that are recommended for the general population are applied. These 
measure may include: dietary changes such as consuming less salty foods, quitting smoking, 
and limiting alcohol intake which have been proved effective in reducing blood pressure 
(Blumenthal et. al. 2010) ( Pubbey et. al. 1992). Physical exercise also improves the blood 
flow through the arteries and reduces the blood pressure (Elley & Arroll, 2002). The most 
important segment of the life style changes is the reduction of body weight as more than 80% 
of hypertensive patients are those with body mass index (BMI) of more than 25 ( Haslam & 
James, 2005). 
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After applying all the possible adaptive measure, if the blood pressure remains above the 
targeted level, the pharmacological (drug) therapy may be started. In some instances such as 
the presence of other chronic co-morbidities or if the patient shows up with more advanced 
stage of hypertension in which its complications already appeared, the medication treatment 
should be started directly in conjunction with the life style changes (Chobanian et al. 2003).  
 
As mentioned above, the start of the medication therapy should not depend solely on the 
values of blood pressure ≥140/90, but also should take into account the patients risk of 
developing other diseases associated with hypertension such as cardiovascular and cerebro-
vascular diseases or the presence of current end-organ damage. When the decision of the drug 
therapy is taken, the choice of particular antihypertensive drug(s) for treatment should be 
done carefully taking into consideration the patient's age, possible interactions with other 
drugs that the patient is taking for other conditions and the cost and adherence to treatment 
(Mark, 2010). 
 
Nowadays there are many effective antihypertensive agents in the market and they belong to 
different classes and work by different mechanisms. Therefore, the choice of drug therapy 
should be based primarily on evidence from the clinical trials that document satisfying 
reduction in blood pressure and of cardiovascular and renal disease risks by reversing the 
targeted organ damage done by hypertension as well and be suited with the individual 
characteristics (age & race) and co-morbidities of each patient. As there is no single drug or 
class of drugs that have all these effects together, the medical practitioners often use 
combinations of different drugs to treat hypertension (ESH/ESC, 2003). 
There are the different classes of the antihypertensive agents such as: (EMRO, 2005) 
1- Diuretics: the drugs of this class work in the kidneys and make them excrete more 
water and sodium from the body that’s why they are sometimes called "water pills". 
Examples of diuretics are Hydrochlorothiazide and Furosemide. 
 
2- Beta-blockers: these drugs reduce the nerve impulses to the heart and blood vessels, 
this makes the heart beat slower and with less force. Blood pressure drops and the 
heart woks less hard, an example of this category is Atenolol. 
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3- Angiotensin converting enzyme inhibitors: ACE-inhibitors prevent the formation of a 
hormone known as angiotensin which is a natural chemical that narrows the blood 
vessels. The ACE inhibitors cause the blood vessels to relax and the BP is reduced. A 
well known example of these agents is the drug Enalapril. 
 
4- Angiotensin II receptor blockers: these medications help relax the blood vessels by 
blocking the action but not the formation  of the hormone "angiotensin" that narrows 
blood vessels such as Losartan. 
 
5- Renin inhibitors: which slow down the production of "Renin" which is an enzyme 
produced by the kidneys that starts a chain of chemical reactions that increases blood 
pressure such as Aliskiren. 
 
6- Calcium channel blockers: (CCBs) which work on the calcium channels in the smooth 
muscles of the blood vessels and the heart. The vessels relax and become wider and 
the blood pressure goes down. Amlodipine is an example of this category. 
 
7- Alpha-blockers: these drugs reduce the nerve impulses to the blood vessels, thereby 
reducing the effects of the natural chemicals that narrow the blood vessels such as 
Doxazocin.  
 
8- Alpha-Beta blockers: they act by both mechanisms of alpha and beta blocker such as 
Carvedilol. They reduce the nerve impulses to the blood vessels and slow the heart 
beat to reduce the amount of blood that is pumped with each beat. 
 
9- Centrally-acting agents: these medications prevent the brain from signaling the 
nervous system to increase the heart rate and narrow the blood vessels. Methyldopa is 
the example of this class of drugs. 
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10- Vasodilatators: which act directly on the smooth muscles of the blood vessels causing 
them to relax and the blood pressure goes down. Isosorbide mono-nitrate and 
Isosorbide di-nitrate are two examples.   
 
Despite the availability of effective antihypertensive agents and the wide experience of 
medical professionals in the treatment of hypertension, it is still one of the leading causes of 
death worldwide and a major risk factor for cardiovascular morbidity and mortality 
(Chobanian et al. 2003). Many studies in the USA and Europe indicated that patients with 
well-controlled blood pressure represent only a small fraction of the hypertensive population. 
For example, Lioyd-Jones et al. (2002) in USA,  conducted a prospective analysis of the cross 
sectional national data in which he included all Framingham Heart Study subjects examined 
between 1987-1999 who had untreated or uncontrolled hypertension (SBP ≥140 or DBP ≥90 
mmHg). The results indicated that out of 2475 hypertensive participants who were 
uncontrolled (treated or untreated) at baseline, only 988 (39.9%) were controlled at follow up.  
Another study conducted by Hajjar (2003) in USA, to analyze and compare the results of the 
NHANES survey conducted in 1999-2000 (n=5448) with the two phases of NHANES III 
conducted in 1988-1991 (n=9901) and 1991-1994 (n=9717). Only those individuals who were 
18 years and above were included in this analysis. The results revealed that hypertension was 
controlled in only 31% of the patients. Similar findings were found by Wang (2004) who 
conducted a cross-sectional analysis of a representative data collected from 4805 adults aged 
18 years and over who were surveyed in 1999-2000 NHANES. The results showed that 
hypertension was controlled only in 31 % of the hypertensive patients. 
 
Such a failure in the control of hypertension has been largely attributed to poor compliance 
with long-term antihypertensive medication. For example, Schroeder et al (2004) had 
performed a systemic review of randomized controlled trials in which he searched for all-
language publications in the Cochrane Controlled Trials Register, MEDLINE, EMBASE, and 
CINAHL in April 2002. He included 38 studies testing 58 different interventions and 
containing data on 15519 patients. These studies were conducted in 9 countries between 
1975-2000. They concluded that the lack of adherence to the antihypertensive medications 
was the major reason for poor control of hypertension. As well, Krousel-Wood et al. (2004) 
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conducted a meta-analysis of many studies that dealt with hypertension treatment aspects. The 
results of the meta-analysis showed that adherence to antihypertensive treatment is a complex 
but important factor in achieving blood pressure control and reducing the risk of 
cardiovascular diseases. Also it reported that approximately 50% of hypertensive patients 
adhere to their prescribed medications and less than one third of them have controlled blood 
pressure. The next section discusses compliance in more details. 
 
2.3. Section three: Compliance/ Adherence to treatment  
 
Compliance and adherence are synonyms and have been defined as “the extent to which a 
person’s behavior coincides with the medical instructions” (Haynes, 1979). However, the 
WHO stated that this definition is not sufficient as the term “medical” does not cover all the 
intervention techniques used in the treatment of chronic diseases and the term “instructions” 
implies that the patient is a passive recipient of expert advice as opposed to an active partner 
in the treatment process (WHO, 2001). The WHO re-defined adherence as “the extent to 
which a person’s behavior – taking medication, following a diet, and/or executing lifestyle 
changes, corresponds with agreed recommendations from a health care provider” (Sabaté, 
2003). 
 
The WHO believed that the compliance rate with the long term treatment of chronic diseases 
averages 50% in the developed countries and much less than that in the developing countries 
because of the differences in health resources and inequity in access to health care (WHO. 
2003). Many studies have been conducted worldwide among chronically diseased patients 
such as hypertension to assess their compliance rates with their treatment. For example, it was 
found that only 51% of the hypertensive patients in USA and 66% in France appeared to be 
compliant with their prescribed treatment (Munger, 2000: Girerd et al. 2001).  
 
In Finland, a cross sectional study was conducted by Jokisalo et al (2002) in the primary 
health care centers to study the factors that were related to the health care system as well as 
the patients self-reported non-compliance with their antihypertensive medications. In this 
study 30 PHC centers were randomly selected out of 250 health centers and 2219 patients 
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were contacted and 1782 (80%) agreed to participate and filled in and returned the self-
reported questionnaire. The results of this study revealed that 14% of males and 13% of 
females reported non-compliance with the antihypertensive medication. The prevalence rates 
of reported non-compliance for men were as follow in different age groups: 17% (<55 years), 
18 %( 55-64 years), 9% (65-74 years) and 13% (≥75 years) and the respective prevalence 
rates for women were 15%, 17%, 13% and 9% (Jokisalo et al.2002). 
Also, a prospective case control study was conducted by Nuesch et al. (1997) in Switzerland 
to compare the compliance with treatment among patients with hypertension responsive to 
treatment versus patients with treatment resistant hypertension. About 5000 new patients have 
been seen and about 20000 patient visits have occurred in this hospital each year over the 
previous five years of this study. All the patients who were in the department during May to 
December 1997 were systemically and prospectively screened for inclusion into the study 
irrespective of the reason of the admission. 110 hypertensive patients who were taking stable 
treatment with at least two antihypertensive drugs for at least four weeks were included in the 
study. A questionnaire was filled out by the treating resident for each participant after taking 
their written consent. The patient was defined as having hypertension if his BP was >140/90 
mmHg if he aged ≤60years or >160/90 mm Hg if aged > 60 years or if he was taking 
antihypertensive drugs and had a history of arterial hypertension. BP level was considered 
within the normal range if the mean daytime SBP was <135 mmHg and DBP <85mmHg. The 
patients whose daytime mean BP was normal at the beginning of the study were defined as 
responsive to treatment (control group), while those with BP above the normal range were 
defined as non-responsive. The compliance of the patients with their treatment was monitored 
over four weeks using a medical event monitoring system (MEMS) in which the drugs were 
supplied in two containers which allow electronic recording of cap openings and closures and 
at the end of the observation period. The researchers calculated the mean percentage of the 
prescribed doses removed from the MEMS devices and considered patients whose values 
were ≥80% as compliant. The final results of this study revealed that complete data were 
available for 103 patients (5 patient were lost on follow up) of whom 86 (83.5%) took ≥85% 
of their prescribed doses (compliant) and 17 (16.5%) took <85% (non-compliant) (Nuesch et. 
al. 2001).          
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Another cross-sectional study was conducted by Guenette et al. (2005) in the Quebec City 
area, Canada, from May 2001 to June 2002 to assess the level of agreement between self 
reported adherence with prescribed drug and a measure of adherence based on pharmacy data. 
In this study, 17 pharmacists from 17 different pharmacies were recruited for the study and in 
each pharmacy, the clients were selected randomly from a computerized list of people aged 65 
years or more who had filled drugs at least four times until one day before the list was printed. 
A total of 514 individuals aged ≥ 65 years were approached to participate in this study. Of 
these, 379 met the inclusion criteria and 189 (48.6%) agreed to participate. So 189 individuals 
(52males & 137females) and 880 drugs were included in this study. Data collection took place 
by interviewing the participants in their homes. The interview included a test to identify those 
having cognitive impairment (Katzman validated instrument). The findings of the study 
showed that 90 individuals (48%) of the self reported participants were adherent to their 
treatment (63.5%males and 41.6%females) whereas 95 individuals (50%) were adherent to 
their treatment according to the pharmacy records (59.6%males and 46.7 females). Also self-
reported individuals were adherent to 81% of the drugs, while the pharmacy records showed 
adherence for 83% of the drugs (Guenette et al, 2005).  
 
In Greece, one observational cross sectional study was conducted by Eugenia et al. (2005) 
from January 1997 to December 1999 to compare rates of blood pressure control with the 
level of adherence to anti-hypertensive treatment. The patients in this study were interviewed 
by the same doctor using pre-coded questionnaire and data were obtained in the first two days 
after admission and prior to surgery. The inclusion criteria included awareness of 
hypertension and hypertensive medications and those aged more than 80 years as well as 
those with acute disease, mental disorders or evidence of malignancy were excluded from the 
study. From 1380 initially judged eligible, 1000 (55% men and 45% women) were finally 
included in the study. After the participants had filled the questionnaire, three sitting BP 
measurements were taken in the right arm with a pre-tested mercury sphygmomanometer two 
minutes apart. The average of the three readings was used as the BP level and hypertension 
was regarded controlled if the average reading was less than 140/90 mmHg. The findings of 
this study revealed that only 15% of the participants had compliance (95% CI, 12-17) and 
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uncontrolled BP was significantly more common among non-compliant hypertensive patients 
(Eugenia et al. 2005). 
 
Further, a cross sectional study was conducted by Guo et al (2001) in Hangzhou, China to 
study the compliance of antihypertensive drugs and its related factors in inpatients and 
outpatients with hypertension. Also it aimed to investigate the utilization of antihypertensive 
medicament and to explore the difference of the blood pressure control between the compliant 
and incompliant groups. In this study, the clinical data of 816 inpatients and 497 outpatients 
of Sir Run Run Shaw Hospital of Zhejiang University were reviewed. The findings of this 
study revealed that compliance rate was 63.4% among the inpatients, 77.3% when being 
discharged and 43.7% among the outpatients (Guo et. al. 2001). 
 
In addition, a population based cross-sectional survey of cardiovascular risk factors was 
conducted by Bovet et al. (1994) in the Seychelles. In this survey, a random age and sex 
stratified sample of the residents aged 25-64 years was drawn from the entire population of 
Mahe using a computerized census data. Of the 1226 eligible subjects, 1067 participated in 
the study (504 men and 563 women) with an overall 87% participation rate. Of these 1067 
participants, 161 had BP readings ≥ 160/95 mm Hg at the time of the survey and 155 of them 
participated in further checks of whom 50 participants (33 males and 17 females, aged 35.9-
58.6 years) had BP ≥ 160/95 mm Hg at their third visit. These 50 participants were put on a 
daily one-pill regimen of hypertension treatment for one year and the medications were 
supplied to them in small bottles with a cap containing a microelectronic chip that recorded 
the date and time the bottle was opened. The satisfactory compliance was defined as taking 
the medication on 6-7 days a week on average which corresponds to a mean compliance level 
of ≥86%. The findings of this study showed that 46% of the new hypertensive patients 
achieved satisfactory compliance and only 26% of them achieved this level over the twelve 
month period (Bovet et al, 2002). 
 
In Africa, a cross-sectional study was conducted by Van Der Sande (2000) in the capital 
Banjun and the rural areas around Farafenni, Gambia to explore the blood pressure patterns 
and the cardiovascular risk factors in the rural and urban communities of Gambia. The 
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findings of this study revealed that the overall compliance with treatment was as low as 27% 
and the researcher recommended interventions to modify the risk factors of hypertension at 
the population level and to improve control of diagnosed hypertension to prevent future 
increase in cardiovascular morbidity and mortality (Van Der Sande, 2000). 
 
In Arab countries, a cross-sectional study was carried out by Al-Swielem and Elzubair (1998) 
in Saudi Arabia to investigate the compliance of hypertensive patients and their knowledge 
and misconceptions about hypertension in a primary health care setting. In this study, four 
primary health care centers were randomly selected from a total of 10 centers serving the city 
population. All patients with primary hypertension for at least one year and who were 
registered in those selected centers were included in the study. 190 hypertensive patients (139 
females and 51 males) attending those clinics were eligible for participation in the study. The 
mean age was 49.9 +- 11.7 years. The Saudi nationals constituted 72.6% of the participants 
and the overall BMI was 30.04 +- 5.64: 27.6 +- 3.98 for males and 30.8 +-5.96 for females. 
The mean duration of hypertension was 7.03 +-6.23 years. The data were collected by trained 
interviewer using a structured questionnaire. The findings of this study revealed that 34.2% of 
the participants were compliant with treatment when assessed according to the therapeutic 
outcome; while, the self-reported method revealed that 74.7% of the participants were 
compliant (Al-Swielem & Elzubair, 1998). 
 
Finally, a cross-sectional study was conducted by Elzubair (1997) in Sudan to assess the 
hypertensive patients’ drug compliance, the factors associated to compliance, status of BP 
control and the occurrence of complications. This study included 198 hypertensive patients 
(76.3% females and 23.7% males) who were registered at and attended the Department of 
Medicine, Kassala Teaching Hospital. The data were collected using a structured 
questionnaire and included information about the patients’ sex, age, education, and 
information regarding the aspects of treatment such as disease duration, treatment duration, 
number of antihypertensive drugs, drugs regimen and the source of drugs. The presence of 
complications was documented by the presence of symptoms of cardiovascular, neurological 
or renal complications. The overall mean age of participants was 53.03 +-11.2 years for males 
and 56.1 +-11.1 years for females. About two thirds (61.6%) of the participants had some 
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education while the rest were illiterate. Each patient was ordered a three-weeks supply of anti-
hypertensive pills and was requested to return the remaining pill container after two weeks 
without telling them the reason for supplying them that particular number of pills. On return, 
the remaining pills were counted and the compliance rate was calculated as a percentage of 
the used pills to the total prescribed pills. The findings of the study showed that the 
compliance rate was 59.6% (n=118) as measured by the pill-count method. It was found that 
92% of the compliant patients had controlled BP compared to 18% of the un-compliant 
patients and 30.1% of the compliant patients had complications in comparison with 46.3% of 
the un-compliant participants (Elzubair et al, 2000).   
 
Factors that affect the compliance of hypertensive patients  
 
Patients’ compliance with their antihypertensive treatments is a complex but important factor 
in achieving blood pressure control and reducing adverse cardiovascular outcomes, health 
care costs and increased morbidity and mortality. Several studies have shown the importance 
of patient’s adherence and have outlined factors that affect patient compliance with prescribed 
therapy (Krousel-Wood et al. 2004). The patient's noncompliance with treatment may occur 
through a variety of mechanisms and manifested by behavior patterns such as delay in 
acquiring medical care, avoiding community preventive programs, appointment irregularity, 
medication failure and resisting or not maintaining the prescribed therapeutic regimen. 
Further, the patient's compliance with his/her treatment is influenced by many factors such as: 
the awareness of the disease health education, clarity of written instructions for taking 
medications, complexity of treatment schedule, family support, patient's perception of his/her 
medical condition, the cost of treatment plan and the physician-patient relationship (Mahender 
et al, 1978). Several studies have been conducted to assess these factors including systemic 
reviews in many countries and they examined more than one factor. 
 
For example, a systematic review of literature was done by Jin et al. (2008) to identify the 
most common factors that affect non-compliance from the patient's perspective. The 
researchers searched through the Medline database from 1970 to 2005. Only English-
language journal articles with abstracts were included. The populations were adolescents aged 
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13-18 years and adults aged 19 years and older. The identified articles were retrieved 
manually to select original articles which focused on the topics of interest. A total of 2095 
articles that evaluated the factors contributing to therapeutic non-compliance were identified. 
Out of these articles 102 articles have met the inclusion and exclusion criteria and hence were 
selected and used in the review. The factors that were identified from these reviews were 
categorized as following: patient-centered factors, therapy-related factors, healthcare system 
factors, social and economic factors, and disease factors. A large proportion of the retrieved 
studies suggested that the elderly people might have higher compliance and that the trend of 
compliance increase with the increasing age. Regarding race, 16 studies were retrieved and 
findings indicated that the Caucasians were believed to have good compliance, while African-
Americans, Hispanics and other minorities were found to have poor compliance. Also, 22 
studies related to gender revealed contradictory results and the researcher concluded that 
gender may not be a good predictor of non-compliance. The effect of educational level on 
non-compliance was assessed after reviewing 13 articles which focused on the impact of 
educational level and several studies found that patients with higher educational level might 
have higher compliance while some studies found no association. The marital status (being 
married) was positively associated with patient's medication compliance but some recent 
studies found no effect. The patient's beliefs and motivation about therapy were the focus of 
23 studies and the findings of these studies revealed that it was strongly related to their 
compliance, while 15 studies showed an association between the patient's negative attitude 
towards therapy and their compliance. Further, 17 articles evaluated the effect of the patient-
prescriber relationship to the patient's compliance and concluded that a healthy relationship 
based on patients trust in the prescriber and prescriber support, empathy, and respect to the 
patient gave rise to good compliance. Regarding the health literacy, patients with low health 
literacy were reported to be less compliant with their therapy. The patients' knowledge about 
their disease and treatment was not always adequate. The researcher concluded that patient's 
education and counseling about medications were very useful strategies in improving the 
patient's compliance. Several studies about compliance among patients with asthma, 
hypertension and renal transplantation found that patients who smoked or drank alcohol were 
more likely to be non-compliant. This review also revealed that compliance did not correlate 
with the number of drugs prescribed, but with the number of dosing times every day of all 
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prescribed drugs and that the rate of compliance decreased as the number of daily doses 
increased. The duration of treatment period also affected the compliance, as acute illnesses are 
associated with higher compliance than chronic diseases. Also the duration of treatments that 
lasts for several months had adverse effect on the patient’s compliance. However, some 
studies found that the longer duration of the disease resulted in good compliance. The cost of 
therapy was a crucial issue in the patient's compliance and some studies found that patients 
who had no insurance cover or had no income were more likely to be non-compliant to their 
treatment. Moreover, the general findings from these articles showed that patients who had 
emotional support and help from family members, friends or healthcare providers were more 
likely to be compliant to the treatment. Finally, the main factors identified relating to the 
healthcare system include the availability and the accessibility to healthcare, long waiting 
time during the clinic visits, difficulty in getting prescriptions filled, and the patients general 
satisfaction with the clinic visit contributed to poor compliance (Jin et al. 2008). 
Another meta-analysis carried out in USA by Munger et al. (2007) to examine the prevalence 
of non-adherence as a risk factor in the management of chronic diseases, with a specific focus 
on antihypertensive medications. Also it aimed to identify the factors leading to increased 
incidence of non-adherence and the strategies needed to improve adherence. Regarding the 
factors affecting adherence, the findings showed that only 20% of the old patient (≥65years) 
exhibit good adherence (defined as ≥80% of days that patient has antihypertensive drugs 
available) and that blood pressure becomes more difficult to control with increasing age. Also 
taking more than one antihypertensive drug decreases the patient's willingness or ability to 
comply with the overall regimen and the patient 's adherence with the antihypertensive agents 
was consistently lower in patients with another chronic conditions such as asthma, chronic 
obstructive pulmonary disease, depression, gastrointestinal disorders, and osteoarthritis.  
Regarding the effects of race and gender; African American (AA) were found to be less 
compliant with their hypertensive medications when compared to Hispanics and Whites and 
women exhibited more non-adherence than men. The adverse effects of antihypertensive 
medications lead to increase adherence interruptions. Also, the findings revealed that 
adherence was poorer in patients receiving poly-pharmacy and that the drugs cost was a 
barrier to adherence with therapy. The researcher suggested some strategies to improve 
adherence. For example, the proper selection of antihypertensive agents with a good 
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tolerability profile and least side effects, the use of long-acting drugs to minimize dosing 
frequency, the use of complex interventions that include patient’s education and motivational 
approaches, the use of improved methods for monitoring adherence and the development of 
new drugs with improved characteristics such as symptoms reduction, tolerability and dosing 
schedule (Munger et al.2007). 
 
Moreover, a prospective cohort study was conducted by Kressin et al. (2001) in the USA to 
explore the associations between the patients’ race, self-reported experiences with clinicians, 
attitudes and beliefs about hypertension, and ultimately, medication adherence among a 
sample of hypertensive patients with no racial disparities in BP control. The study recruited 
793 white and African-American patients previously diagnosed with hypertension from three 
medical centers and the patients were provided with informed consent. The original study 
population was 11731 hypertensive patients and after a 14-month period of tracking them as 
they presented for care, 1210 were approached to participate in the study. 203 were excluded 
for different reasons and 214 refused to participate in the study, thus 793 patients were 
included in the final cohort (78.7% response rate). The researchers assessed three primary 
domains of interest that were (1) patient experience with the provider (2) patient 
characteristics and (3) antihypertensive medication adherence. All analyses were conducted 
using SAS 9.1.3 software. The results of this study revealed that less than half of the study 
participants had controlled BP indicating a room for improvement in BP care. Also, the 
patients’ beliefs appeared to be significantly associated with BP medication adherence. 
African-American and White patients were equally likely to have a blood pressure greater 
than 140/90 mm Hg (54% vs. 57%, p=.41) and the adherent patients were 1.5 times more 
likely to have controlled BP than non-adherent patients after controlling for co-morbidities, 
BMI, age, and site of care (p=.0433). African Americans (AA) reported that their providers 
were more active in counseling and advising them about BP and how important were their 
medications. There were some similarities in perception about BP medications and the 
differences between races were not statistically significant in this regard. African Americans 
were less adherent on 3 of the 6 single items assessing adherence, more likely to stop 
medication when one feels worse, not taking medications on purpose, and forgetting to take 
medications (Kressin et al. 2007). 
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Further, in UK, a meta-analysis was conducted by Schroeder et al. (2002) at the University of 
Bristol including randomized controlled trials and it searched for all language publications in 
the Cochrane Controlled Trials Register, MEDLINE, EMBASE, and CINAHL in April 2002. 
This review included 38 studies testing 58 different interventions and containing data on 
15519 patients. The studies were conducted in 9 countries between 1975 and 2000 and the 
duration of follow-up ranged from 2 to 60 months. The findings of these studies showed that 
reducing the number of daily doses appeared to be effective in increasing adherence to blood 
pressure and it lowered medication with a relative increase in adherence of 8% to 19.6%. 
Motivational strategies were partly successful in 10 of 24 studies with increase of adherence 
of about 23%. Complex interventions with more than one technique increased adherence in 8 
of 18 studies ranging from 5% to a maximum of 41%. The patients’ education alone seemed 
largely unsuccessful (Schroeder et. al. 2004). 
 
In Finland a cross sectional study was conducted by Jokisalo et al (2002) in the primary health 
care centers to assess the factors that affect the compliance of patients with their 
antihypertensive medications. In this study 30 PHC centers were randomly selected out of 250 
health centers and 26 health centers with a total of 255 general practitioners agreed to 
participate in the study. 2219 patients were contacted and 1782 (80%) agreed to participate 
and filled in and returned the self-reported questionnaire. Later on, one patient was excluded 
because of missing data and 220 were excluded from the analysis because they were not 
currently using any antihypertensive medication. Thus the final study population consisted of 
1561 patients and 615 (39.4%) were men and 946 (60.6%) were women with a mean age of 
64.2 +- 11.4 years. The mean SBP was 152.8 mmHg +- 19.9 and the mean DBP was 88.2 
mmHg +- 10.1. Also, 20% of men and 21% of the women had their blood pressure under 
140/90 mmHg. The mean number of antihypertensive drugs was 1.6 +- 0.7 and half of the 
patients were on one drug only. The researchers used a self-reported questionnaire which 
consisted of 82 items about lifestyle, the health care system, medications, BP measurement 
and the patients' experience related to the treatment of hypertension. The original questions 
were answered on a 5-point likert scale (1= absolutely agree, 2=somewhat agree, 3=somewhat 
disagree, 4=absolutely disagree and 5= does not concern me). The blood pressure was 
measured by trained nurses twice after 15 minutes of rest in the sitting position using a 
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mercury sphygmomanometer. The results of this study revealed that the majority of patients 
(88%) reported having one or more health care system related problems and 92% reported 
having patient-related problems. Those with system-related problems were four times more 
likely to be non-compliant and those with patient-related problems were over two times more 
likely to be non-compliant. The patients who had experienced adverse drug effects were 
significantly more likely to be non-compliant (17%) than those without adverse drug effects 
(11%). Also, in patients group using two drugs, non-compliance was less prevalent among the 
more highly educated than among the less educated (OR: 0.5, 95% CI: 0.26-0.98). Further, 
among the patients with higher education, non-compliance was less prevalent in the group 
with two drugs than in that with one drug (OR: 0.47, 95% CI: 0.23-0.97) (Jokisalo et al.2002). 
 
Also, in Canada, a post hoc exploratory analysis was conducted by Sigrid et al. (2011) as a 
subset to the Simplified Therapeutic Intervention to Control Hypertension (STITCH) study. 
STITCH was a cluster randomized controlled trial of hypertension management conducted in 
southwestern Ontario between 2005 and 2007 to assess the determinants of BP control. Data 
were collected in 45 general practices which enrolled patients with uncontrolled hypertension 
each enrolling up to 50 patients with uncontrolled hypertension. Antihypertensive medication 
changes throughout a 6-month follow-up period were documented. The eligibility criteria for 
participating in this study were as follow: men or women, 18 years or older, had uncontrolled 
hypertension (defined as SBP≥140 mmHg or DBP ≥90 mmHg for patients without diabetes 
and SBP≥130 mmHg or DBP≥80 mmHg for patients with diabetes), with no history of 
ischemic heart disease, atrial fibrillation, peripheral vascular disease, stroke or chronic kidney 
disease of final stages. The analysis included 2030 patients and the results of this study had 
identified many factors that contribute to poor BP control. These factors included systemic 
health care delivery factors, financial consideration (both for the patient as well for the health 
care system), the number of drugs prescribed, the low use of single-pill combinations, and a 
number of factors related to the patient's behaviors reflected by measures of adherence to 
antihypertensive prescriptions. It also revealed that patients with diabetes and 
hypertension(co-morbidity) demonstrated the lowest rates of BP control as only 35% of these 
patients had BP below the recommended target for them ( 130/80 mmHg) as compared to 
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66% control in the general hypertensive population whose target was 140/90 mm Hg (Sigrid 
et al. 2011).   
Furthermore, in Greece, an observational cross sectional study was conducted by Eugenia et 
al. from January 1997 to December 1999 to compare rates of blood pressure control with the 
level of adherence to anti-hypertensive treatment and factors influencing compliance in Greek 
patients. From 1380 initially judged eligible, 1000 (55% men and 45% women) were finally 
included in the study. The findings of the study revealed that compliance was more common 
among those aged <60 years (22.3% vs 3.8% of those over 60, p=0.005), those living in city 
and those with better level of education. Compliance was also better among those followed by 
private doctor and the difference was attributed to the effect of counseling which was 
frequently provided by private doctors. Compliance was also more common among those 
taking single dose per day and those who never changed their antihypertensive regimen 
(Eugenia et. al. 2005). 
 
In addition, in Portugal, a cross-sectional study was conducted by Morgado et al. (2010) to 
assess the factors associated with poor blood pressure control in Portuguese hypertensive 
population. The study was conducted in hypertension outpatient clinic in the university 
teaching hospital of Cova da Beira Hospital Center in the Eastern Central Region of Portugal. 
All the patients who attended the clinic from July to September 2009 were requested to 
participate in a structured interview including demographic data, medication adherence, 
knowledge about hypertension and its risks, indications of antihypertensive medications and 
the presence of drugs side effects. The inclusion was for all patients who were 18 years and 
over with diagnosis of hypertension and on medication for at least 6 months. The exclusion 
criteria were dementia, pregnancy, and breast feeding. A total of 197 (out of 222 attended the 
clinic) (89%) patients meeting the inclusion criteria and consenting to participate completed 
the interview.  The statistical analysis of the study variables was conducted using SPSS for 
Windows, version 17.0. The overall mean age of the included participants was 60+-12 years 
and 40.1% were males and 59.9% were females. The findings showed that the predictors of 
medication non-adherence were: unawareness of target BP values (OR, 3.7, P<0.001), a 
report of drugs side effects (OR=3.7, P<0.002), lack of BP monitoring (OR= 2.5, P=0.015) 
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and unawareness of medication indications (OR= 2.4, P=0.021), and the hypertension risks 
(OR=2.1, P=0.026) (Morgado et al. 2010). 
As well, in China, one study was conducted by Guo et al (2001) to study the compliance with 
antihypertensive drugs and its related factors in inpatients and outpatients to investigate the 
utilization of antihypertensive medications and to explore the difference of the blood pressure 
control between the compliant and incompliant groups. In this study, the clinical data of 816 
inpatients and 497 outpatients of Sir Run Run Shaw Hospital of Zhejiang University were 
reviewed. The findings of this study revealed that the causes of incompliance were as the 
following: the side-effects of the medications, the failure to control blood pressure and the 
financial problems. It was found that the compliant patients controlled their blood pressure 
well with little fluctuation while the outpatients were worst compliers and the range of 
fluctuation in their BP was large (Guo et al, 2001).  
 
Further, in Seychelles, a population based cross-sectional survey of cardiovascular risk factors 
was conducted by Bovet et al. (1994) and a stratified sample of the residents aged 25-64 years 
was drawn from the entire population of "Mahe" using a computerized census data. The 
sample included 1067 participants with an overall 87% participation rate and the compliance 
was defined as taking the medication on 6-7 days a week on average which corresponds to a 
mean compliance level of ≥86%. The findings showed that the compliance was better among 
23 participants who regularly attended medical follow-up and there was direct association 
between 12-month compliance level and having highly skilled occupation, having good health 
awareness and regularity at medical appointments. On the contrary, there was an inverse 
relationship between mean compliance level and heavy drinking (Bovet et al, 2002). 
 
In Arab countries such as Sudan, the multiple regression analysis of the study that was 
conducted by Elzubair (1997) showed that the only variable that was positively and 
significantly associated with non-compliance was the inability to purchase the drugs 
(Elzubair, 2000). 
 
Moreover, in Saudi Arabia, the cross-sectional study that was carried out by Al-Sowielem and 
Elzubair (1998) revealed that the compliance rate was significantly higher among illiterate 
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participants than the educated ones and those participants who were over 55 years of age were 
more compliance than those who were younger than 55 years. Also the patients who were 
regular on follow-up had higher compliance rate than those who were irregular (37.8% and 
17.6% respectively: P<0.02). There were no significant differences between males and 
females and they concluded that there is a need for health education for the hypertensive 
patients (Al-Sowielem and Elzubair, 1998). 
 
Finally, a prospective case-control study was conducted by Catherine et al (1995) in the 
Seacroft General Hospital, Leeds, to determine the effects of self medication program on 
knowledge of drugs and compliance with treatment in elderly patients. In this study 88 
patients from four hospital wards were recruited to participate (45 patients were on self 
medication program and 43 were controls). The researchers excluded those patients who were 
discharged to a nursing home or other institution or were terminally ill. Verbal consent was 
obtained from all participants. On admission, the eligible patients were referred to the 
pharmacist who took a drug history for each patient, their drug regimen was simplified as 
possible and all unnecessary medications were stopped. The participants in the self 
medication program were asked for additional written consent and were initially assessed by 
the pharmacist and a primary nurse regarding their understanding of medication, ability to 
read labels, and ability to open closures. On discharge, they were supplied by medications for 
two weeks with a reminding chart and were ordered not to get other medications from their 
general practitioners. The investigator visited the patients at home after 10 days of discharge 
and conducted a structured interview and a tablet count. The compliance rate was calculated 
for each medicine by dividing the number of tablets taken by the correct number and 
expressed as percentage. The results of this study showed that the mean compliance score for 
the patients in the self medication program was 95% compared with 83% in the control group 
(difference 12%, 95%CI, P< 0.02). The number of patients who knew the purpose of their 
medicine in the self medication group was 90% compared to 46% in the control group 
(difference 44%, 95% CI, p<0.001). Also, 95% of the patients in the self medication group 
stated that they preferred to take the drugs by themselves instead of the nurse given then, 88% 
felt that it helped them to feel in control of their medicines, 43% felt more confident taking 
their medicines at home as a result of the program and 43% reported that it had increased their 
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understanding of their drug treatment. These results showed the clear benefits of the 
educational programs on compliance and treatment outcomes (Catherine et al 1995). 
 
In summary, previous studies concluded that many factors may affect the patients’ 
compliance with their hypertension treatment regimen such as the cost, the number of drugs, 
the drugs' side effects, the daily regimen, their relationship with the medical staff…etc. 
However, in Palestine, there is a lack of studies that assess the compliance rate and the factors 
that affect compliance with treatment plan among the Palestinian patients with hypertension. 
Next section discusses the framework of the current study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                            
40 
 
                                                            Chapter three 
Conceptual framework 
 
3.1. Introduction 
The conceptual framework, is  a tool structured from a set of broad ideas and theories taken 
from relevant fields of enquiry that help researchers to properly identify the problem they are 
looking at, guide their inquiry, frame their questions and find suitable literature. Most 
academic researchers use a conceptual framework at the outset because it helps the researcher 
to clarify his research question and aims (Smyth, 2004). 
As the research moves on, the conceptual framework became the heart of the study. It 
strengthen the researcher and keep the research on the track by providing clear links from the 
literature to the research goals and questions, informing the research design, and providing 
reference points for discussion of literature, methodology and analysis of data. In the current 
study, the conceptual frame work was developed depending on the literature review of prior 
studies that tackled the same topic and the valuable advices and comments from 
knowledgeable and expert people working in the field of medicine and public health in the 
School of Public Health, School of Pharmacy, and the Faculty of Human Medicine in Al-
Quds University as will be discussed in more detail in chapter four. 
The major concepts of study framework focus on compliance and the different factors that 
affect it, as seen in figure (3.1.). Each concept will be discussed in more details below. 
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Figure (3.1.): Factors affecting the compliance with hypertension treatment regimen. 
Note: this figure was created based on the literature review. 
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3.2. Definition and measurement of compliance 
Compliance and adherence are defined as “the extent to which a person's behavior –taking 
medication, following a diet, and or executing lifestyle changes, corresponds with agreed 
upon recommendations from a health care provider" (WHO, 2011). This definition was 
adopted in this current study. As mentioned in earlier chapters, the non-compliance or non-
adherence with treatment may occur through a variety of mechanisms and manifested by 
behavior patterns such as: (Mahender et al 1978) 
- Delay in acquiring medical care. 
- Avoiding community preventive programs.  
- Appointment irregularity. 
- Medication failure and resisting or not maintaining the prescribed therapeutic regimen. 
The rate or degree of compliance with treatment can be measured by many ways, of which 
each has its advantages and drawbacks, such as: 
1- Self-report of medication adherence: in which the patient is asked to report his or her 
degree of adherence to the prescribed drugs regimen and this is usually conducted by a pre-
coded questionnaire or by interviewing the patient in person. This method was used by 
Guenette et al (2005), Girerd (2001), Elzubair et al. (2000) and Jokisalo (2001). The main 
drawback of this method is that the interviewee might try to please the researcher by reporting 
good compliance/adherence and because there are no stable factors that can reliably predict 
compliance. 
2- Revision of pharmacy records: some pharmacies keep records of their customers which 
record the types of the medications they purchase and dates and amounts of each refill they 
make. By this method the researcher can assess the amounts of each drug that the patient has 
taken. It was also used as a comparison method by Guenette et al. (2005). The major 
disadvantage of this method is that the researcher can not be sure if the patient has taken the 
drugs he/she purchased or not.  
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3- Pill-count method: in which the patient is supplied by a certain number of pills and 
requested to return the remaining pills in the container after some time. On return, the 
remaining pills are counted and the compliance rate is calculated as a percentage of the used 
pills to the total prescribed pills and this method was used by Elzubair et al (2000). The 
remaining dosage units (e.g. tablet) are counted at the clinic visits and counting inaccuracies 
may result in inaccurate estimation of compliance. The important information (such as the 
timing of dosage and patterns of missed doses) is not captured using this strategy. 
4- A recent innovation is the electronic monitoring device (medication event monitoring 
system (MEMS) and these are specially designed containers with an electronic chips at their 
edges. These chips record the time and frequency of container openings and on return these 
chips are removed. By using some computer software their contents can be printed out, thus 
the researcher can calculate the degree of the patient's adherence to his or her drugs and better 
describes the way patients take their medication. This method was used by Cramer (1991) and 
Nuesch et al (2001).            
5- Biological-marker method in which blood or other body fluid samples are drawn from the 
patients and the drugs or their metabolites' levels in these samples are measured by chemical 
analysis and then compared to the supposed therapeutic levels according to pharmacologic 
calculations. If the levels match each other then the patient is said to be compliant with his or 
her treatment, otherwise he is not. This method is rarely used because it is invasive technique 
and need skilled personnel and laboratory work so it is more expensive. Furthermore, the 
findings can be misleading and are influenced by a variety of individual factors such as diet, 
absorption and the rate of excretion (Vitolins, 2000). 
6- Treatment or therapeutic outcomes method, in which the patient is said to be compliant if 
he or she attains the required or targeted result of the treatment. For example, the targeted 
level of hypertensive patient might be blood pressure of <140/90 mm Hg and so every patient 
who reached this level is said to be compliant or adherent to his treatment. Those whose blood 
pressure level remains above this limit are said to be non-compliant. This method was used by 
Al-Sowielem and Elzubair (1998) and it is utilized in the current study. 
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3.3. Factors that affect compliance 
The patient's compliance with his or her treatment is influenced by many factors (Mahender et 
al. 1978) and in the current study these variables were classified into ten components as 
follows: socio-demographic variables, duration of illness, patient-physician relationship, 
regularity on appointments and follow-up, patient's knowledge and perception of the disease, 
the clarity of treatment's instructions, the treatment schedule, the family support, and finally 
the total cost of the treatment plan as shown in figure (3.1). 
A: Socio-demographic variables: these included the independent factors such as age, gender, 
place of residence, education level, socioeconomic level, BMI, and the smoking status of the 
participants and were presented in section one of the questionnaire (questions 1-10) (See 
appendix C). These variables were studied by Al-Soweilem & Elzubier (1998), Munger 
(2007), Kressin (2007). 
B: The medical history of the patient: it was explored in section two including questions 11 to 
30 of the questionnaire such as the duration of illness and treatment, the way they were 
diagnosed, the presence of other chronic diseases, the number of medications they are taking 
for hypertension and other chronic diseases if present, the number of times they were 
hospitalized due to hypertension, the presence of hypertension in their relatives, the place and 
methods of obtaining their medications, the frequency of visiting their treating doctor, the 
frequency of measuring their blood pressure, the possession of sphygmomanometer at home, 
the frequency of changing the drugs regimen by the doctor, and the frequency of medication 
interruption against the prescribed regimen (See appendix C). This section enables us to 
quantify the effects of the different aspects of the patient medical history on his or her 
compliance or adherence rate and were studied by Al-Soweilem & Elzubier (1998), Coyne 
(2000) Tozawa (2001) Nuesch et al (2001), Ayumu & Fujita (2003), Munger (2007),  Kressin 
(2007), and Boris & Wijk (2009). 
C: Patient's knowledge and perceptions of the disease: the patient's knowledge is defined as 
the amount of facts and correct information that the patient has about the disease, where the 
perception is how do they evaluate their disease. Section three of the questionnaire (questions 
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31-46) included a self-assessment of general health, their perception of hypertension as a 
serious disease and the possibility of controlling and or preventing it, their knowledge about 
the risk factors of hypertension (such as heredity, age, gender, physical inactivity, foods and 
body mass index, tension and anger), their knowledge and perceptions about the medications 
of hypertension such as their side effects, doses and the necessity to take them correctly and 
regularly (See appendix C). Many previous studies found an association between the patients' 
knowledge and perception of their disease and the rate of their compliance to their treatment 
such as: Coyne (2000), Volpe & Dedhiya (2006), Kressin (2007), Khan (2008), Gupta (2009), 
Dolor (2009), and Morgado (2010).  
D: The duration of illness: which means how long the patient has been living with the disease 
as this was studied by many previous studies such as Al-Soweilem & Elzubier (1998), Nuesch 
et al. (2001), Bovet et al. (2002), Ayumu & Fujita (2003), Cramer (2008), and Jin (2008).      
Section four of the questionnaire included four questions (questions 47-50) that assess the 
effect of the long duration of hypertension as a chronic disease on the patient's desire to take 
his/her drugs regularly and continuously, the patients desire to abide by the dietary style 
advised by the treating doctor, and the effects of the chronic nature of hypertension on the 
patient's general mood and his general life style (See appendix C). 
E: The treatment schedule which is defined as the frequency and timing of taking the drugs 
per day and the number of drugs. Section five of the questionnaire included five questions 
(q51-q55) that asses the effect of these issues on the patients' desire to take their medications 
and their ability to remember the regimen all the time (See appendix C). The questions 
focused on the effects of other chronic conditions and their medications on the patients’ 
compliance with the daily treatment regimen. Also, patients were asked about their preference 
of the combined pills that contains more than one drugs at the same time. Previous studies that 
reported statistically significant associations between the patients' treatment schedule and 
their compliance with the treatment plan were: Al-Soweilem & Elzubier (1998), Coyne 
(2000), Bloom (2001),  Nuesch et al. (2001), Ayumu & Fujita (2003), Thrail (2004), 
Schroeder (2004), Eugenia (2005), Kressin (2007), Jin (2008), Ingersoll & Cohen (2008), and 
Sigrid (2011).          
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F: Patient- physician relationship: including the patient-provider interaction especially that the 
doctor has been shown to have a strong impact on the patients’ compliance with their 
treatment (Coyne 2000, Jin 2008, and Thrail 2004). Section six of the questionnaire included 
twelve questions (q56-q67) about the type of relationship between the patients and their 
doctors, the way their doctors behaved with them and whether they were seen by the same or 
different doctors in every visit.  They were also asked about the time span they were spending 
with the doctor in every visit and the behaviors of the medical staff in the clinic they attended 
for their treatment. These variable have been reported to affect the patient's compliance in 
many previous studies such as Ayumu & Fujita (2003), Schroeder (2004), Eugenia (2005), 
Kressin (2007), Torrey (2009), and Jokisalo (2001). 
G: Clarity of treatment instructions: Section seven of the questionnaire included nine 
questions (q68-q76) about how clear and understood the written medical instructions that 
were given to them by the doctor, the clarity and simplicity of the explanations that were 
given by the medical staff and the simplicity of the language that the doctor and the medical 
staff in general were using. Also they were asked if they were given advices about their 
recommended life style modifications and whether they had ever received explanation about 
the medical tests they performed, the changes that were recommended to their drugs or drugs 
–regimens, and if they were ever trained to self-measure their blood pressure at home (See 
appendix C). From the literature, Torrey (2009) and Jokisalo (2001) reported that the clarity 
and simplicity of the medical instructions given to patients had a significant effect on their 
compliance with their treatment plans.   
H: Family support: The social support from friends and family members has been observed to 
have great effect of the patient's attitudes and behaviors (Kressin 2007, Jin 2008, and Jokisalo 
2001). Section eight of the questionnaire included seven questions (q77-q83) about the 
support and the help that the patients got from their family members such as financial support, 
help in taking their drugs, in measuring their blood pressure, in reaching the medical facility 
when needed, and the help and the encouragement to abide by the drugs regimen and the 
recommended life style (See appendix C).  
47 
 
I: Patient's regularity on appointments and follow-up: section nine of the questionnaire 
included thirteen questions (q84-q96) about the patient's regularity on the medical 
appointments, measuring of blood pressure, taking their antihypertensive medications, doing 
the recommended physical activities, and doing the recommended life style modifications. 
These factors were tested in Al-Soweilem & Elzubier (1998), Bovet et al. (2002), Eugenia 
(2005), Morgado (2010), and Jokisalo (2001) studies. 
J: Cost of treatment: which means the amounts they pay to get the medication and the money 
they spend to achieve the recommended lifestyle changes…etc. The treatment costs play a 
major role in the availability of the medications and other medical needs (Coyne 2000, Guo et 
al 2001, and Munger 2007). So section ten of the questionnaire included six questions (q97-
q102) about the continuity of health care needs that this care be affordable at the patient level, 
the total cost of treatment of hypertension and whether it was affordable, reasonable, and if it 
caused troubles to the patients and made them less compliant with their treatment plans (See 
appendix C). In Sudan, Elzubair et al (2000) found that the treatment cost was the only 
statistically important obstacle to the patient compliance. Similar results were reported by Jin 
(2008), Torrey (2009), and Sigrid (2011). 
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3.3. Summary:  
1- This chapter presented the conceptual framework which was taken from different studies  
and a group of experts in public health and medicine. 
2- Compliance was assessed indirectly by measuring the blood pressure of the patients and 
considering it as indirect indicator for compliance. 
3- The factors that affect compliance were grouped into ten components as the follow: 
- The socio-demographic variables.  
- The medical history variables. 
- The duration of illness variables.  
- The patient-physician relationship variables. 
-  The regularity on appointments and follow-up variables.  
- The patient's knowledge and perception of the disease. 
- The clarity of treatment's instructions. 
- The treatment schedule variables. 
- The family support variables. 
- And finally the total cost of the treatment plan of the patient.  
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Chapter four 
Methodology 
 
4.1 Introduction 
As discussed in previous chapters, there is a lack in studies that assess the factors that affect 
the compliance of hypertensive patients with their treatment plan in Palestine. This chapter 
discusses the methodological issues of the current study including: the study design, the target 
population, sampling approach, data collection, analysis and the ethical considerations. 
4.2. The study design 
As discussed above, the main aim of the current study is to assess the participants’ 
compliance with their antihypertensive treatment plans and to identify the factors that affect 
their compliance in three central clinics in Hebron area. Therefore a descriptive cross-
sectional study was utilized because it is highly useful for descriptive purposes. This design is 
also known as prevalence study because the exposure to the risk factor(s) and the occurrence 
of the outcome are measured concurrently over a short period of time in the study population. 
The chosen design can give some indications about the association among the different factors 
under investigation and their outcomes (Polgarr & Thomas, 1997). 
4.3. The study target population 
The study targeted population was the patients with primary hypertension who attend the 
three central primary health care clinics in Hebron area and aged 18 years old and over. 
4.4. Settings of the study 
The study was conducted in the three primary health care clinics in Hebron that are: Dora, 
Karanteena and Yatta. These three settings were selected because they are appropriate for the 
purpose of the study. Moreover, these are the three largest, third level and central Primary 
Health Care clinics serving the people in Hebron and South Hebron area. The third level 
clinic as defined by the Palestinian Ministry of Health is a medical center that works at all 
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days of the week, provides the following services; preventive medicine, general medicine, 
laboratory tests, specialized services to child and mother care and a pharmacy for dispensing 
drugs and serves area with more than 6000 population. (MoH, 2009) 
 
4.4.1. Karanteena PHC clinic 
Karanteena primary health care clinic is located in the old city of Hebron. It was built during 
the ottoman era in the 19th century. It was under the Israeli civil administration until the year 
of 1994 in which the Palestinian Liberation Organization signed the peace agreement with 
Israel, after which the responsibility of the Palestinian Health Care System was transferred to 
the Palestinian Authority. Karanteena clinic, being a third level center, provides a variety of 
medical services to the people of the area in addition to people who come from the 
surrounding villages. As a part of the Palestinian health care system, it provides its services to 
all citizens of the area who carry a valid insurance card issued by the Palestinian Ministry of 
Health or that issued by the Labor Ministry without charges but a small amount of co-
payment (Hebron Health Directorate, 2009). 
Karanteena center provides diversity of medical services through different clinics such as: 
general medicine clinic, high risk pregnancy clinic, maternity and child health care, 
orthopedic clinic, diabetes clinic, dermatology clinic, ENT clinic, and laboratory and 
pharmacy services. There are about five thousand files of patients who attend the clinic for 
health care services out of which there are 448 files for patients with hypertension (Hebron 
Health Directorate, 2009). 
4.4.2. Dora PHC clinic 
It is a central third level primary health care center located in the middle of the city of Dora, 
about 15 kilometer from Hebron. It was a part of Hebron Health Directorate until June 2008 
in which south Hebron Health Directorate was inaugurated and since then Dora PHC center 
became part of it and under its administration.  
It provides its services to about 25,000-30,000 citizens of the catchment area and deals with 
them according to the Palestinian Ministry of Health protocols regarding the insurance card 
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and the co-payments. Similar to Karanteena clinic, it provides a variety of health care services 
such as: general medicine clinic, maternity and child health care, vaccination, diabetes clinic, 
dermatology clinic, ENT clinic, laboratory tests and pharmacy services. There are 3700 files 
in the clinic for patients who attend the clinic for health care services out of which there are 
342 files for hypertensive patients (South Hebron Health Directorate, 2009). 
4.4.3. Yatta PHC clinic 
It is the largest primary health care center in South Hebron area and located in the city center 
of Yatta. It was administered by Hebron Health Directorate until June 2008 after which its 
administration was transferred to South Hebron Health Directorate. It provides its services to 
more than 40,000 citizens in its catchment's area (South Hebron Health Directorate, 2009). 
As a central and third level health care center in the area, it provides numerous medical 
services such as: maternity and child health care, vaccination, general medicine clinic, 
dermatology specialist doctor, ENT specialist doctor, diabetic and other chronic clinics, 
laboratory tests and pharmacy services. There are 4500 files in the clinic for patients who 
attend the clinic for health care services out of which there are 410 files for hypertensive 
patients (South Hebron Health Directorate, 2009). 
4.5.1. Inclusion criteria 
• Patients with primary hypertension regardless of other co-morbidities such as DM, 
Asthma and Arthritis. 
• Patients who attend the selected PHC clinics for their anti-hypertensive treatment. 
• Men and women aged 18 years and above.  
• Men and women regardless of their literacy 
4.5.2. Exclusion criteria 
● Patients with any form of cognitive disability such as: autism and dementia because they 
generally depend on others to give them their medications. 
• Patients with mental problems such as schizophrenia and sever depression because they 
are usually given their drugs by others. 
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● Patients who were recently diagnosed with hypertension (<1year) because such patients 
usually do not have a stable treatment plan (Al-Sowielem, 1998). 
● Patients with secondary hypertension. 
4.5.3. Sample Size  
The total population of hypertensive patients who attended these clinics was 1200. The study 
sample was calculated using computer software (PEPI-for- Windows) which used the 
following formula and the sample size was found to be 292 patients. 
          Z ² * (p) * (1-p)       (1.96)² * (0.5) * (1-0.5) 
ss = --------------------  =    ---------------------------         = 384.16 
                c ²                           (0.05)² 
Where: 
Z = Z value (here 1.96 for 95% confidence level)  
p = percentage picking a choice, expressed as decimal (here 0.5). 
c = confidence interval, expressed as decimal (here 0 .05 = ±5) 
Then the correction for finite population: 
                                 ss                                       384.16 
New  ss = ----------------------   = ------------------------------------  =   291.81 ≈ 292 
                    1+  ( ss-1/ pop)           1+ (384.16-1 /1200) 
Where: pop = population (here= 1200) 
 The number of patients to be recruited from each clinic was calculated proportionally to the 
total number of the hypertensive patients who attend the clinic regularly for anti-hypertensive 
treatment services using the formula: 
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Clinic sample size = (hypertensive patients who attend the clinic / total population of 
hypertensive patients) * (sample size).                                                               
                                 = (hypertensive patients who attend the clinic / 1200) *( 292). 
The numbers were as follow: 109 patients from Karanteena, 100 patients from Yatta and 83 
patients from Dora as shown in table (4.1) below.                                                                                               
Table (4.1): The population number and sample size from each clinic. 
Clinic Hypertensive patients who 
attend the clinic. 
Sample size from the clinic 
patients*. 
Karanteena 448 109 
Yatta 410 100 
Dora 342 83 
Total 1200 292 
* Clinic sample size= (hypertensive patients who attend the clinic /1200) * 292 
4.5.4. The sampling approach 
The sample was selected from the Primary Health Care clinics that belong to the Palestinian 
Ministry of Health in Hebron district. Purposive sampling of clinics was utilized in the current 
study because these are the three central and biggest clinics in Hebron area and hypertensive 
patients receive their treatment from them. Purposive sampling is a form of non-probability 
sampling in which the individual units are selected by some purposive method in a deliberate 
and non random fashion to achieve a certain goal. It is easier than other types of sampling and 
it can examine the participants’ beliefs, practices and experiences. However, it is subject to 
bias of personal selection and as non-probability sampling, subsequent generalization from 
the findings of this method of sampling may not be valid (Polit & Hungler, 1999).  
The systemic sampling method was used to select the participants from the three clinics. 
Systemic sampling is a convenient and objective way of selecting sample cases from a larger 
population according to a random starting point and fixed interval. The start point is random 
and then proceeds with the selection of kth element from the start point onward (usually 
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k=population size/sample size). It is easy, fast and inexpensive. The limitations of this method 
of sampling are that systemic bias may exist, and the results will not be representative of the 
population. In addition, estimating the sampling error is difficult when using systematic 
sampling design (Laura, 1995). Having decided the total sample size and the sample size from 
each clinic, the sampling interval was calculated by dividing the total study population by the 
sample size and found to be "four". 
Formula: k= total population / sample size = 1200 / 292 ≈ 4. 
 So every fourth patient who attended these clinics and met the inclusion and exclusion 
criteria and agreed to participate in the study was recruited until they fulfilled the number 
needed from each clinic. The data collection took place during the period of July/10/2010 to 
August/10/2010.  
4.6. Instrument of the current study 
The data collection instrument of this study was a self- reported questionnaire. The 
questionnaire items were derived from six previous studies, the Long Form Patient's 
Satisfaction (PSQ-III) questionnaire and some were suggested by five PhD holder experts 
from AL-Quds University, as shown in table (4.2). 
Table (4.2) Previous studies from which this study items were derived 
Section Question(s) and it’s source 
Independent Socio-demographic 
variables (12 questions). 
From Al-Sowielem (1998) and Elzubair (2000) Studies. 
 
Medical History related 
questions (18 questions). 
 
Q1, Q2, Q6 from Al-Sowielem (1998) Study. 
Q3, Q7, Q10, Q11 from Elzubair (2000) Study 
Q14, Q15, Q17 from Eugenia et al. (2004) Study 
Q4, Q5, Q8, Q9, Q12, Q13, Q16, Q18 suggested by the 
experts. 
Knowledge and Perception 
of hypertension related 
questions (16 questions). 
Q6, Q7, Q16 from Al-Sowielem (1998) Study. 
Q11 from Thrall et al. (2004) Study. 
Q3, Q4, Q8 from Yadlapalli et al. (2009) Study. 
Q1, Q2, Q5, Q9, Q10, Q12, Q13, Q14 and Q15 were 
suggested by the experts. 
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Duration of illness related 
questions (4 questions). 
All 4 questions were suggested by the experts. 
Treatment Regimen related 
questions (5questions) 
  
Q3 from Eugenia et al. (2004) Study. 
Q5 suggested by the experts. 
Q2 from Quenette et al (2005) Study. 
Q1, Q4 were suggested by the experts. 
Patients’ Relationship 
With the Medical Staff  related 
questions (12 questions) 
Q1 from Al-Sowielem (1998) Study. 
Q8, Q11 from Thrall et al. (2004) Study. 
Q2, Q6, Q7 from (PSQ-III)*. 
Q3, Q4, Q5, Q9, Q10, Q12 were suggested by the experts. 
Clarity of Drugs-Usage 
Instructions related questions (9 
questions) 
Q2, Q4, Q7 from Eugenia et al. (2004) Study. 
Q6 from (PSQ-III)*. 
Q1 from Thrall et al (2004) Study. 
Q3, Q5, Q8 Q9 were suggested by the experts. 
Family support related 
questions (7 questions) 
All 7 questions were suggested by the experts. 
Regularity on Treatment Plan 
related questions (13 questions) 
Q1, Q6 from AlSowielem (1998) Study. 
Q10 from Eugenia et al. (2004) Study. 
Q8, Q9 from Quenette et al (2005) Study. 
Q3, Q4, Q5 from Thrall et al (2004) Study. 
Q2, Q7, Q11, Q12, Q13 were suggested by the experts. 
Costs of Treatment related 
questions (6 questions). 
Q1, Q3 from (PSQ-III)*. 
Q2, Q4, Q5, Q6 were suggested by the experts. 
* The Long-Form Patient’s Satisfaction Questionnaire (PSQ-III).    
The process of developing the questionnaire was that an initial draft of the questionnaire was 
prepared by the main researcher and his supervisor from the previous studies in literature 
review, five Ph.D. holder experts in public health, medicine and pharmacy from Al-Quds 
University were approached to evaluate the questionnaire and give their comments. They 
were two experts from the School of Public Health, two experts from the Faculty of Human 
Medicine and one expert from the School of Pharmacy. They revised the English and the 
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Arabic versions of the instrument and gave a number of valuable comments on the content, 
clarity and relevance of the questionnaire. 
For better assessment of the clearance and relevance questionnaire to the topic, in the late 
stage of the questionnaire developing process, four focus groups (20 patients) of hypertensive 
patients (five patients in each) were carried out at Dahriyya, Yatta, Dora and Karanteena 
primary health care clinics to test the contents of the questionnaire and its language. Minor 
changes were done to the language of some questions. 
In general, the questionnaire consisted of ten sections including 102 items, as shown in table 
(4.3) below. The topics of these ten sections were identified based on the previous studies 
related to hypertension and patients’ compliance with treatment. Some questions of section 
one and section two were multiple choice questions, while all other questions were answered 
on a five-point likert scale (1-always, 2-often, 3-sometimes, 4-rarely, and 5-never). (See 
appendix C) 
Table (4.3) Components of the questionnaire of the current study     
No. Sections of the questionnaire Number of questions of the component. 
1 Independent variables (eg. Socio-
demographic data) 
12 questions. 
2 Medical history. 18 questions. 
3 Knowledge and perception of HTN. 16 questions. 
4 Duration of the illness. 4 questions. 
5 Treatment regimen. 5 questions. 
6 Relationship with the medical staff. 12 questions. 
7 Clarity of drugs-usage instructions. 9 questions. 
8 Family support. 7 questions. 
9 Regularity on doctor’s appointments 
and treatment plan. 
13 questions. 
10 Cost of treatment. 6 questions. 
Total   102 questions 
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4.7. Validity and Reliability of the instrument 
Reliability (also termed “reproducibility” or “repeatability”) refers to the stability and 
consistency of information and assesses the extent to which the results agree when obtained 
by different approaches that is, different observers, study instrument, or procedures (Szklo & 
Javier, 2000). 
The content validity of the current study instrument was done by conducting the four focus 
groups of hypertensive patients who attend four different PHC clinics in Hebron and South 
Hebron area in order to assess the language and content of the questionnaire. Also, the 
validity was examined by five experts from Al-Quds University.   
4.8. Data collection  
After sending a formal letter to the head of the Palestinian Primary Health Directorate 
explaining the purpose of the study, permission was granted in June 2010 from the Palestinian 
Ministry of Health. 
After that the researcher trained two experienced staff nurses who were working in the PHC 
clinics in which the study was conducted to help in data collection. The purpose of the study, 
the items of the questionnaire, the inclusion and exclusion criteria of the study and the ethical 
considerations were discussed with them.   
After that, the researcher and the two assistants started interviewing the participants and 
filling out their questionnaires in the three clinics. The data collection process took one 
month, starting on July, 10th and ending on August, 10th 2010. The medical teams in these 
clinics were very helpful and cooperative which played a crucial role in obtaining a high 
response rate from the participants   
At the primary health care clinics, blood pressure was measured twice by qualified nurses, the 
first time before filling the questionnaire and after ten minutes of rest in the sitting position 
using a digital sphygmomanometer according to the WHO protocol. The second measurement 
was done after filling the questionnaire. The mean of the two readings was noted down in the 
questionnaire paper. 
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4.9. Data analysis: 
The data were analyzed by using the Statistical Package for Social Sciences (SPSS), 
version15.0. The data were checked for entry errors (data clearance). Characteristics of the 
sample were obtained through descriptive analysis (frequencies and percentages). 
Relationships between selected variables were analyzed by using of chi-squared, Fisher exact 
test and the logistic regression.  
4.10. Ethical considerations: 
In order to conduct this study, a proposal of the study was submitted to the research 
committee of the School of Public Health at Al-Quds University, who gave approval to 
conduct this study according to the thesis preparation guide of the Faculty of Graduate Studies 
on the 12th of January, 2010. 
Also before starting the survey and to gain access to the primary health care clinics, the head 
of the Palestinian Primary Health Directorate in West Bank was formally approached via an 
introductory letter from the School of Public Health at Al-Quds University. The letter 
presented information about the proposed study and its purpose, and he was asked to give his 
permission to conduct the study in the PHC clinics of Hebron area. A positive response was 
received on February 17th, 2010. 
Furthermore, in order to maintain the ethical standards in this study, the questionnaire of this 
study was introduced to the participants along with a cover letter about its objectives and 
importance. An accompanying statement assuring the voluntary nature of their participation 
and that the participants had the right to refuse to participate. In addition, the participants were 
assured that anonymity and confidentiality would be maintained at all times, and that the data 
provided by the participants would be used for research purposes only and would be 
expressed only in general terminology. No names or codes or any other mechanism would be 
used to trace responses back to an individual participant. 
Finally, all the data of this research were stored in a computer which was protected by a 
password and no body was allowed to access it except the researcher and the supervisor. 
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4.11. Summary 
• A cross-sectional design was utilized in this study because it is cheap, quick and 
ethically safe. 
 
•  292 patients from those who attended the targeted clinics (Karanteena, Yatta and 
Dora) between July 10th, and August 10th, 2010 were recruited to participate in the 
study. 
 
•  The data collection tool was self-reported questionnaire which was developed from 
many previous studies in the same field. The questionnaire consisted of ten questions 
about socio-demographic data of the participants and ninety two items related to 
different factors that affect compliance. 
 
• The validity of the questionnaire was assessed by five experts from the Faculty of 
Medicine, the School of Pharmacy and the School of Public Health in Al-Quds 
University. The reliability of the instrument was tested by using Cronbach’s Alpha 
coefficient and it was high 92%.  
 
• The data was analyzed by using the Statistical Package for Social Sciences (SPSS), 
version 15.0. 
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Chapter five 
          Results 
5.1. Introduction 
 In order to achieve the main aim of the current study of assessing the patients’ compliance 
with the antihypertensive treatment and regimen and the factors that affect it, a cross-sectional 
study was utilized and a total of 292 questionnaires were filled in the three major primary 
healthcare clinics in Hebron area (Karanteena, Yatta, Dora) during July 2010. 
This chapter presents the findings of the current study as following: 
1- The characteristics of the study participants. 
2- The compliance rate. 
3-  Participants’ responses to the factors related to compliance questions. 
5.2. Characteristics of the study participants 
The hypertensive patients who attended the major three clinics in Hebron area (Karanteena, 
Yatta and Dora) were targeted to participate in this study. The sample consisted of 292 
patients (109 (37.3%) from Karanteena clinic, 100 (34.2%) from Yatta clinic and 83 (28.5%) 
were from Dora clinic). (See figure 5.1) 
 
Figure (5. 1): The distribution of the participants by the clinic they attended. 
37.3%
34.2%
28.5% 
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Regarding the gender of the participants, 58.6% (n=171) were females and 41.4% (n=121) 
were males (See figure5.2). 
 
Figure (5. 2): The distribution of the participants by gender 
The participants’ ages ranged from 37 to 87 years of which 34.9% (n=102) were fifty-five 
years or less and 65.1% (n=190) were above the age of fifty-five years (See figure 5.3) 
 
                                                                       
 
 
 
 
 
Figure (5. 3): The distribution of the participants by their age group. 
The majority of participants (76.4%, n=223) were either overweight (BMI= 25-29.99 kg/m2) 
or obese (BMI=30 kg/m2 or more) and only 23.6% (n=69) were having normal body mass 
indexes (BMI=18.5-24.99kg/m2). Whereas the minimum weight among the participants was 
52 kilograms and the maximum weight was 117 kilograms (See figure 5.4). 
41.4% 
58.6% 
65.1% 
 
65.1% 
34.9%
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Figure (5.4): participants distribution  according to their BMI. 
*BMI: normal=18.5-24.99kg/m2, overweight=25-29.99 kg/m2, and obese=30 or more kg/m2. 
 For the marital status, two-thirds of participants (70.9 % n=207) were married, 3.4% (n=10) 
were single, 3.1% (n=9) were divorced and 22.6% (n=66) were widowed (See figure 5.5).  
                                     
Figure (5. 5): The distribution of the participants by their marital status. 
The educational level varied among the participants as 36.6% (n=107) received no education, 
26.7% (n=78) had primary education that is one to six years of school education, 16.8% 
(n=49) received elementary education (seven to nine years of education), 5.2% (n=15) 
reached the secondary school and 14.7% (n=43) had a college or university degree (See figure 
5.6). 
70.9%
22.6% 
3.1%
3.4% 
63 
 
 
Figure (5.6): The distribution of the participants by their level of education. 
 Also the participants were asked about their employment and they responded as the 
following: 48.3% (n=141) were house wives and this is consistent with the high percentage of 
females in the study, 16.1% (n=47) were employed, 18.8% (n=55) were unemployed, 5.5% 
(n=16) were retired from their jobs and 11.3% (n=33) had their own business plans (See 
figure 5.7). 
 
 
Figure (5.7): The distribution of the participants by their work status. 
Regarding the participants’ monthly income, 13.0% (n=38) were earning one thousand Israeli 
shekels or less, 35.3% (n=103) were earning 1001-2000 NIS, 25.3% (n=74) were earning 
2001-3000 NIS, 9.6% (n=28) were earning more than three thousand Israeli shekels. 16.8% 
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(n= 49) were without income at all as neither they nor their direct guardian were employed 
(See figure5.8). 
 
Figure (5. 8): The distribution of the participants by their monthly income. 
In relation to their smoking status, 8.2% (n=24) indicated that they smoke less than ten 
cigarettes per day, 21.9% (n=64) smoke 10-20 cigarettes per day, 6.9% (n=20) smoke more 
than twenty cigarettes per day, 7.9% (n=23) were ex-smokers and interestingly 55.1% 
(n=161) stated that they had never smoked at all and this might be because the majority 
(58.6%) of the sample were females. (See figure 5.9). 
 
 
Figure (5.9): The distribution of the participants by their smoking status. 
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The compliance rate. 
Out of the 292 participants who participated in this study, 57.9% (n=169) were with blood 
pressure measurement of  less than 140/90 mmHg which is within the target level according 
to the World Health Organization (WHO) and these participants were considered compliant 
with their treatment plans. Also 42.1% (n=123) were with uncontrollable blood pressure 
which read ≥140/90 mmHg. When cross tabulation was done between participants 
compliance and independent variables in section one of the questionnaire, only gender, BMI, 
and smoking status showed statistically significant relationships (as shown in table 5.1). For 
example, females were more compliant than males (62.6% vs 51.2%, P=0.05). Also those 
participants with normal body mass index were more compliant than others as 72.5% of them 
had controlled blood pressure versus 56.8% of the overweight and 45.6% of the obese 
(p=0.00). Furthermore, the smoking status had a significant relationship (p=0.05) with 
compliance and the smokers were ( 55-57% compliance) less compliant than the non or ex-
smokers (61-64% compliance). 
On the other hand, no significant relationship was found between the blood pressure reading  
and the age group of the participants, the clinic they attended, the marital status, the level of 
education, the work status, or the monthly income of the participants as shown in table (5.1). 
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Table (5.1): Cross tabulation of the participants' compliance rate by socio-demographic 
variables. 
BLOOD PRESSURE READING INDEPENDENT 
VARIABLE 
BP<140/90mmHg.      
(Compliant)        
57.9%, n=169
BP≥140/90mmHg. 
(Noncompliant)      
42.1%, n=123 
P 
 F % F % 
Male 62 51.2% 59 48.8% Gender 
Female 107 62.6% 64 37.4% 
0.05 
≤55 65 63.7% 37 36.3% Age 
>55 104 54.7% 86 45.3% 
0.17 
Yatta 63 63% 37 37% 
Dora 47 56.6% 36 43.4% 
Clinic 
They Attend Karanteena 59 54.1% 50 45.9% 
0.41 
 
Normal 50 72.5% 19 27.5% 
Over Wt. 88 56.8% 67 43.2% 
BMI  
(Kg/m² ) Obese 31 45.6% 37 54.4% 
0.00 
Single 5 50% 5 50% 
Married 118 57.3% 88 42.7% 
Divorced 6 66.7% 3 33.3% 
Marital 
Status 
Widow 39 59.1% 27 40.9% 
0.89 
None 59 57.8% 43 42.2% 
Primary 37 47.4% 41 52.6% 
Elementary 32 65.3% 17 34.7% 
Secondary 8 53.3% 7 46.7% 
Education 
Level 
University 31 72.1% 12 27.9% 
0.08
Employed 28 70% 12 30% 
Unemployed 26 47.3% 29 52.7% 
Retired 9 56.3% 7 43.7% 
House Wife 88 62.4% 53 37.6% 
Work 
Status  
Own Business 15 45.5% 18 54.5% 
0.08 
≤1000  20 52.6% 18 47.4% 
1001-2000  56 61.5% 35 38.5% 
2001-3000 44 59.5% 30 40.5% 
>3000 14 50% 14 50% 
Monthly 
Income 
None 29 59.2% 20 40.8% 
0.78 
<10 cig/day 7 57% 17 43% 
10-20 cig/day 36 56.3% 28 43.7% 
>20 cig/day 11 55% 9 45% 
Ex-smoker 14 60.9% 9 39.1% 
Smoking 
Status 
Never smoke 99 61.5% 62 38.5% 
0.05 
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Also, the patients' compliance was assessed by other subjective questions that are related to 
important aspects of hypertension treatment. For example, the participants were asked about 
their obedience with the doctor's advices regarding their physical activity, food changes, 
weight reduction ….etc and cross tabulation was done between their BP readings and their 
answers to the previous questions, three questions (q2, q3 & q5) showed significant 
differences between the participants. For example, 64.5% of those who measure their BP on 
regular basis had controlled BP level while 35.5% of then had not, whereas 53.2% of those 
who answered "no" to this questions had controlled BP (p=0.05). Further, 69% of those who 
managed to do physical exercise as advised by their doctor had controlled BP while 31% had 
BP ≥140/90mmHg, whereas 55.1% of those who did not do physical exercise had controlled  
BP (p=0.05). Finally, 63.4% of those who managed to eat healthy foods as advised by their 
doctor had controlled BP level whereas 36.6% had BP ≥140/90mmHg, while only 52.7% of 
those who did not manage to eat healthy foods had controlled BP level (See table 5.2).  
 
Table (5.2): Cross-tabulation between the compliance rate (BP. level) and some 
important aspects of treatment of hypertension. 
 BP<140/90 mmHg 
57.9%, n=169
BP≥ 140/90 mmHg 
42.1%, n=123
P-value 
1- You are always regular at your doctor's appointments?  
Yes    (t= 227) 136  = 59.9% 91  = 40.1% 
No     (t= 65) 33    = 50.8% 32  = 49.2% 
0.15 
2- You measure your BP on regular basis?   
Yes    (t= 121) 78  = 64.5% 43  = 35.5% 
No     (t= 171) 91  = 53.2% 80  = 46.8% 
0.05 
3- You manage to do physical exercise as advised by your doctor? 
Yes   (t= 58) 40  = 69% 18  = 31% 
No    (t= 234) 129  = 55.1% 105  = 44.9% 
0.05 
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4- You manage to maintain a healthy weight as advised by your doctor? 
Yes     (t= 90) 53  = 58.9% 37  = 41.1% 
No      (t= 202) 116  = 57.4% 86  = 42.6% 
0.79 
5- You manage to eat healthy food (e.g. less salt) as advised by your doctor?  
Yes     (t= 142) 90  = 63.4% 52  = 36.6% 
No      (t= 150) 79  = 52.7% 71  = 47.3% 
0.05 
6- You manage to use your HTN drugs on regular basis as prescribed to you? 
Yes    (t= 181) 105  = 58% 76  = 42% 
No     (t= 111) 64  = 57.7% 47  = 42.3% 
0.9 
 
 
5.3. Section three: participants' responses to the factors related to compliance questions 
The findings of each section are discussed below in more detail.  
5.3.1. Section two: participants’ medical history related questions: 
This section included 18 questions related to participants’ health in general and their state as 
hypertensive patients in particular as shown in table (5.3). For example, less than half of the  
participants (47.6%, n=136) reported that they were diagnosed by chance while they were 
doing a routine check up or going to the doctor for any other reason and 65.75% (n=192) 
suffered from hypertension for less than ten years. Further, 69.5% of them had a co-morbidity 
with other physical disease and 32.2% had diabetes mellitus. 
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Table (5.3): Participants' responses to the questions related to their medical history.  
Variable Answer F. %. 
By chance 139 47.6%How you were diagnosed as hypertensive? 
After symptoms 153 52.4%
< 10 years 192 65.75%
≥10<20 years 82 28.08%
The duration of your illness in years.  
 ≥20years 18 6.17%
Yes 203 69.5%Do you take medications to treat chronic 
condition other than hypertension? No 89 30.5%
One 21 10.3%
Two 99 48.8%
Number of drugs you take for chronic 
conditions other than hypertension. 
3 or more 83 40.9%
Presence of other chronic disease as a co-morbidity: 
Diabetes Yes 94 32.2%
Asthma Yes 21 7.2%
Heart diseases Yes 50 17.1%
Arthritis Yes 81 27.7%
Cancer Yes 6 2.1%
Other disease Yes 12 4.1%
One 63 21.6%
Two 167 57.2%
How many drugs do you take to treat your 
HTN (including diuretics)? 
3 or more 62 21.2%
PHC 265 91.4%
UN clinic 33 11.4%
Private sector 70 24.1%
Source of drugs (you can choose more 
than one answer): 
 Other place (NGOs) 2 0.7%
Free 4 1.4%
Co-payment 276 95.8%
How do you get your medications 
financially? 
Full cost 8 2.8%
Yes 166 56.8%Do family members have HTN? 
No 126 43.2%
Your brother? Yes 25 15.1%
Your sister? Yes 37 22.3%
Your mother? Yes 66 39.8%
Your father? Yes 51 30.7%
Your son? Yes 26 15.7%
Your daughter? Yes 10 6%
Once 103 35.30%
Twice 150 51.35%
How many times do you take your drug(s) 
per day? 
3 or more 39 13.35%
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Once 35 12%
Twice 62 21.2%
≥3 times 48 16.4%
None 32 11%
In the last month, how often you did not 
take your medications? 
Don’t remember 115 39.4%
Once 59 20.2%
Twice 41 14%
3 times or more 52 17.8%
None 78 26.7%
How many times did your doctor change 
your drugs or drug regimen since you were 
diagnosed with HTN? 
 Don’t remember 62 21.3%
Yes 95 32.5%Do you have a sphygmomanometer at 
home? No 197 67.5%
I don't measure it at all 26 8.9%
Once a day 15 5.1%
Once a week 74 25.3%
Once a month 124 42.5%
Once/ 3 months 51 17.5%
How often do you measure your BP? 
 
Less frequently 2 0.7%
Once a month 158 54.1%
>1 visit / month 65 22.3%
Once/ 3 months 43 14.7%
Once/ 6 months 21 7.2%
How often do you visit your doctor for 
your HTN? 
 
Other (specify) 5 1.7%
Every visit 18 6.2%
Once a month 39 13.3%
Every 3 months 35 12%
Every 6 months 89 30.5%
Never 89 30.5%
How often does your doctor do complete 
examinations to you  (e.g. checking heart 
beats, chest, eyes, blood tests  etc.)? 
Other (specify) 22 7.5%
Apart from prescribing pills, what other tasks does your doctor perform during the visit?  
(you can choose more than one answer). 
The doctor gives you information about BP during the visit? 59 20.3%
The doctor does a complete physical check up during the visit? 49 16.9%
The doctor gives you information about the best life style for you? 97 33.4%
The doctor explains to you the importance of controlling BP.? 60 20.7%
The doctor does nothing during the visit rather than prescribing drugs? 113 39%
Once 44 15.05%
Twice 57 19.52 %
3 times or more 55 18.83%
How many times were you hospitalized 
because of your HTN complications? 
None 136 46.6%
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5.3.2. Section three: Knowledge and perception of hypertension disease related questions 
In this section, sixteen questions were formulated to assess the participants' knowledge and 
perception of their hypertension. The questions discussed the main aspects of the disease and 
its treatment protocols as seen in table (5.4). The findings showed a variation in knowledge 
and weaknesses were mainly in questions related to etiology and treatment of hypertension. 
For example, 32.6% (n=95) indicated that hypertension is “always and often” inherited, 
27.8% (n= 81) said that there is” always and often” a difference in the risk of getting 
hypertension between males and females. 
Further, 24% (n=70) indicated that they “sometimes” felt that it was not necessary to take 
their medications. 16.8% (n=49) thought that it was “always or often” safe to decrease or 
increase their dose without consulting their doctors. Finally, 17.1% (n=50) of participants 
believed that hypertension “always or often” could be prevented. For more details refer to 
table (5.4). 
Table (5.4): The participants’ answers to the questions related to their knowledge and 
perception about hypertension disease. 
Variable Always Often Sometimes Rarely Never 
No. 64 109 92 26 1 In general, you consider yourself to be in 
good health. % 21.9% 37.3% 31.6% 8.9% 0.3% 
 
No. 28 132 110 20 2 Your blood pressure is well- 
Controlled. % 9.6% 45.2% 37.7% 6.8% 0.7% 
 
No. 97 99 75 18 3 You consider hypertension as 
a serious problem. % 33.2% 33.9% 25.7% 6.2% 1% 
 
No. 82 96 82 23 9 Hypertension may lead to other serious 
problems (stroke, heart attack, renal 
failure… etc) 
% 28.1% 32.8% 28.1% 7.9% 3.1% 
 
No. 44 51 90 54 53 You think hypertension has hereditary 
basis. % 15.0% 17.5% 30.8% 18.5% 18.2% 
 
No. 37 44 74 67 70 You think the risk of getting HTN differs 
between males & females. % 12.7% 15.1% 25.3% 22.9% 24% 
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No. 74 121 59 25 13 You think the risk of hypertension 
increases with age. % 25.3% 41.4% 20.2% 8.6% 4.5% 
 
No. 116 99 57 11 9 Decreasing tension and anger helps in 
controlling blood pressure. % 39.7% 33.9% 19.5% 3.8% 3.1% 
 
No. 85 110 68 16 13 Dietary changes (e.g. less salt) may help 
in controlling blood pressure. % 29.1% 37.7% 23.3% 5.5% 4.4% 
 
No. 55 69 89 54 24 Physical exercise may help in controlling 
my blood pressure. % 18.9% 23.7% 30.6% 18.6% 8.2% 
 
No. 121 94 50 16 11 You think that it is necessary to take 
HTN medications regularly % 41.4% 32.2% 17.1% 5.5% 3.8% 
 
No. 82 101 81 18 9 You think that HTN medications help 
me to control your BP. % 28.2% 34.7% 27.8% 6.2% 3.1% 
 
No. 20 38 70 76 88 You feel it is safe or not necessary to 
take your medications. % 6.8% 13% 24% 26% 30.2% 
 
No. 12 37 67 68 108 You think it is safe to increase/decrease 
your dose without consulting my doctor. % 4.1% 12.7% 22.9% 23.3% 37% 
 
No. 23 45 94 76 54 Hypertension medications have serious 
side effects on your health. % 7.9% 15.4% 32.2% 26% 18.5% 
 
No. 15 35 85 75 82 Hypertension can be prevented or its risk 
can be decreased. % 5.1% 12% 29.1% 25.7% 28.1% 
 
5.3.3. Section four:  The duration of illness related questions: 
This section assesses the effect of the duration of their illness on the participants' compliance 
with their treatment regimen as seen in table (5.5). This section included four questions. For 
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example, about half of the participants (50.7%, n=148) said it “always and often” affected 
their desire to take the drugs, 33.9% (n=99) indicated that as "sometimes" and 15.4% (n=45) 
reported that their desire of taking the antihypertensive medications was “rarely and never” 
affected by the duration of illness. 
Table (5.5): The participants’ responses to the questions related to the duration of illness 
and its effect on their compliance with treatment. 
Variable Always Often Sometimes Rarely Never 
No. 39 109 99 20 25 The long duration of your illness affects 
your desire to take my drugs. 
 
% 13.4% 37.3% 33.9% 6.8% 8.6% 
No. 10 40 110 77 55 Because of the chronic nature of HTN, 
you don’t take your drugs continuously. 
 
% 3.4% 13.7% 37.7% 26.4% 18.8% 
No. 13 35 84 98 62 Because of the chronic nature of HTN, 
you don’t follow the diet regimen and 
don’t do recommended life-style changes. 
% 4.4% 12% 28.8% 33.6% 21.2% 
No. 19 66 113 52 42 Because of the chronic nature of HTN 
you feel sad and depressed. % 6.5% 22.6% 38.7% 17.8% 14.4% 
 
5.3.4. Section five: The drugs’ regimen related questions: 
This section included five questions to explore the effect of the drugs’ regimen on the 
participants’ compliance as seen in table (5.6). For example, nearly half of the participants 
(51.4%, n=150) indicated that the frequent dosing of their drugs “always and often’ affected 
their desire to take them, about one third (33.9%, n=99) said their desire to take the drugs was 
“sometimes” affected by the frequent dosing and 14.7% (n=43) reported that their desire to 
take the antihypertensive drugs was “rarely and never” affected by the number of times they 
had to take them per day.  
Regarding their ability to remember their drugs regimen all the time, 33.2% (n=97) of the 
participants said it was “always and often” difficult for them to remember their drugs regimen 
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all the time, 44.9% (n=131) responded “sometimes”. Finally, 26% (n=76) stated that the 
frequent change of their drugs’ regimen by their doctor “always or often” decreased their 
desire of taking them whereas 37.3% (n=109) of them stated it as “rarely or never”. Also the 
majority of the participants (72% (n=210) claimed that their adherence would have been 
“always or often” increased if they found all their drugs in one combined pill. (See table 5.6). 
Table (5.6): The participants’ responses to the questions related to the drugs’ regimen: 
Variable  Always Often Sometimes Rarely Never 
 
No. 46 104 99 21 22 Your drugs regimen (many times a day) 
decreases your desire of taking them. % 15.8% 35.6% 33.9% 7.2% 7.5% 
No. 16 81 131 38 26 Your drugs regimen (many times a day), 
makes it difficult to remember them. % 5.5% 27.7% 44.9% 13% 8.9% 
No. 24 82 110 43 33 The drugs you take for other chronic 
conditions affect your adherence to the 
treatment plan of hypertension. 
% 8.2% 28.1% 37.7% 14.7% 11.3% 
No. 22 54 107 68 41 Frequent change of your drugs or drugs 
regimen by your doctor decreases your desire 
of taking them regularly. 
% 7.5% 18.5% 36.7% 23.3% 14% 
No. 134 76 50 15 17 If you find all your drugs in one combined 
pill, this will increase your adherence to your 
drug regimen. 
% 46% 26% 17.1% 5.1% 5.8% 
 
5.3.5. Section six: The participants’ relationship with the medical staff related questions:  
As seen in table (5.7), this section included twelve questions that assess the effect of 
participants’ relationship with the medical staff on their compliance with their treatment 
regimen or plan. In general, the findings revealed a good relationship between the participants 
and their treating doctor and the medical staff. For example, 53.1% (n=155) of the 
participants indicated that they were “always or often” seen by the same doctor when they 
visited the clinic, 26.7% (n=78) reported that as “sometimes”.  
Regarding the way they were treated during their visits to the clinic, 61.6% (n=180) of 
participants indicated that the doctor “always or often” treated them well during the visit and 
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only 5.8% (n=17) said they were “rarely or never” treated respectfully by the doctor. 
Furthermore, 49.3% (n=144) of the participants were “always or often” satisfied with the 
medical care they received in the clinic. Whereas, (50.7%, n=148) of the participants stated 
that the doctor hurried too much in order to finish the visit quickly and only 20.9% (n=61) 
answered that by “rarely or never”. (See table 5.7). 
Table (5.7): The participants’ responses to the questions related to their relationship 
with the medical staff. 
Variable  Always 
 
Often Some-
times 
Rarely Never 
No. 56 99 78 33 26 The same doctor sees you in 
every visit you do to the clinic. % 19.2% 33.9% 26.7% 11.3% 8.9% 
No. 57 123 95 15 2 The doctor treats you with respect 
when you visit the clinic. % 19.5% 42.1% 32.5% 5.1% 0.7% 
No. 48 96 115 19 14 You are satisfied with the medical 
care you receive in the clinic. % 16.4% 32.9% 39.4% 6.5% 4.8% 
No. 37 81 104 43 27 The doctor allows you to say 
everything you think is important 
for you. 
% 12.7% 27.7% 35.6% 14.7% 9.2% 
No. 14 26 54 82 116 The doctor makes you feel foolish 
and embarrassed during the visit. % 4.8% 8.9% 18.5% 28.1% 39.7% 
No. 30 73 121 44 24 The doctor acts too serious and 
formal toward you during the visit. % 10.3% 25% 41.4% 15.1% 8.2% 
No. 61 87 83 40 21 The doctor is in hurry and wants 
to finish the visit quickly. % 20.9% 29.8% 28.4% 13.7% 7.2% 
No. 23 56 125 52 36 The doctor ignores what you tell 
him about your condition. % 7.9% 19.2% 42.8% 17.8% 12.3% 
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No. 32 67 124 45 24 If you have a medical question, 
you can reach the doctor and ask 
him without problem. 
% 11% 22.9% 42.5% 15.4% 8.2% 
No. 34 76 105 50 27 The doctor listens carefully to 
what you have to tell him. % 11.6% 26% 36% 17.1% 9.2% 
No. 21 62 87 76 46 The doctor spends plenty of time 
with you during the visit. % 7.2% 21.2% 29.8% 26% 15.8% 
No. 81 101 72 27 11 The medical staff deals with you 
friendly and with respect during 
the visit. 
% 27.7% 34.6% 24.7% 9.2% 3.8% 
 
5.3.6. Section seven: The clarity of drugs’ usage instructions related questions: 
The questionnaire included nine questions related to the clarity of the drugs-usage instructions 
given to the patient by the treating doctor and the medical staff in general. (See table 5.8) 
The majority of the participants (72.6%, n=212) indicated that the drugs-usage instructions 
were “always or often” clear and simple. Further, More than one third of the participants 
(35.9%, n=105) indicated that the staff “always or often” explained to them the necessary life 
style modifications for their disease. Finally, 33.2% (n=97) of them reported that the treating 
doctor “always or often” gave them information or special advices to maintain their health 
and avoid illness, 41.1% (n=120) said “sometimes” and 25.7% (n=75) responded that they 
were “rarely or never” advised in this regard.  
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Table (5.8): The participants’ responses to the questions related to the clarity of drugs’ 
usage instructions: 
Variable Always Often Sometimes Rarely Never 
No. 96 116 59 18 3 The drug usage instructions given 
by the doctor are clear to me. % 32.9% 39.7% 20.2% 6.2% 1% 
No. 48 57 96 68 23 The medical staff explains the 
necessary life style modifi-
cations for my condition. 
% 16.4% 19.5% 32.9% 23.3% 7.9% 
No. 41 40 56 56 99 The medical staff show and train 
me how to perform self 
measurement of BP. 
% 14% 13.7% 19.2% 19.2% 33.9% 
No. 66 91 98 29 8 The medical staff explains to me 
the importance of blood pressure 
control. 
% 22.6% 31.2% 33.6% 9.9% 2.7% 
No. 55 139 87 9 2 The medical staff uses clear and 
simple language when giving me 
the instructions.  
% 18.8% 47.6% 29.8% 3.1% 0.7% 
No. 36 57 130 48 21 The doctor tells me the reasons 
for every medical test he 
recommends for me. 
% 12.4% 19.5% 44.5% 16.4% 7.2% 
No. 39 57 112 63 21 When my doctor changes my 
drug(s), he explains to me the 
reasons behind that. 
% 13.4% 19.5% 38.3% 21.6% 7.2% 
No. 20 41 79 72 80 The doctor uses difficult medical 
terms without explaining to me 
what they mean. 
% 6.8% 14% 27.1% 24.7% 27.4% 
No. 35 62 120 49 26 The doctor gives me information 
and advices about different ways 
to avoid illness and maintain 
health. 
% 12% 21.2% 41.1% 16.8% 8.9% 
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5.3.7. Section eight: The family support related questions:  
The degree of support that the family offers to their hypertensive patient in order to get the 
best results of treatment plan is another crucial factor that might affect patient's compliance. 
This section consisted of seven questions to explore this variable as seen in table (5.9) below. 
Table (5.9): The participants’ responses to the questions related to their family support. 
Variable Always Often Sometimes Rarely Never 
No. 104 105 46 24 13 Your family reminds you to take 
your hypertension’s medications. % 35.6% 36% 15.7% 8.2% 4.5% 
No. 79 110 75 13 15 Your family helps you to take 
your hypertension’s medications. % 27.1% 37.7% 25.7% 4.4% 5.1% 
No. 94 88 71 20 19 Your family helps you financially 
to get your hypertension’s 
medications when you need. 
% 32.2% 30.1% 24.3% 6.8% 6.6% 
No. 81 66 54 42 49 Your family helps you to measure 
your blood pressure. % 27.7% 22.6% 18.5% 14.4% 16.8% 
No. 141 62 62 12 15 Your family helps you to reach 
the medical facility if you are 
tired or sick. 
% 48.3% 21.2% 21.2% 4.1% 5.2% 
No. 59 115 77 28 13 Your family helps you to 
accomplish the life-style changes 
recommended by your doctor 
% 20.2% 39.4% 26.4% 9.6% 4.4% 
No. 74 78 99 25 16 Your family encourages you to be 
compliant with your treatment 
plan. 
% 25.3% 26.7% 33.9% 8.6% 5.5% 
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5.3.8. Section nine: The regularity on appointments and treatment plan related 
questions.  
Thirteen questions were included in this section which discussed the participants’ regularity 
on the doctor appointments and their adherence to the treatment plans recommended to them 
as seen in table (5.10). For example, the vast majority of them (77.8%, n=227) indicated that 
they were “always or often” regular on their doctor's appointments, 14.4% (n=42) indicated 
that they were “sometimes”, and only 7.8% (n=23) reported that they were “rarely or never” 
regular on their doctor appointments.  
Regarding how often they measure their blood pressure, 41.4% (n=121) said they “always or 
often” did that, 33.9% (n=99) responded “sometimes”. For their weight, only 30.8% (n=90) of 
the study participants said that they “always or often” maintained a healthy weight as advised 
by their doctors and 31.2% (n=91) reported they “sometimes’ tried to do that. Finally, 62% 
(n=181) of the participants reported that they “always or often” used their medications on 
regular basis as prescribed by their doctors (See table 5.9). 
Table (5.10): The respondents’ answers to the questions related to their regularity on 
their doctor appointment and treatment plans. 
Variable  Always Often Sometimes Rarely Never 
No. 122 105 42 9 14 You are always regular at your doctor’s 
appointments. % 41.8% 36% 14.4% 3% 4.8% 
No. 41 80 99 39 33 You measure your blood pressure on 
regular basis. % 14% 27.4% 33.9% 13.4% 11.3% 
No. 13 45 101 55 78 You do physical exercises according to 
your doctor’s advice.  % 4.5% 15.4% 34.6% 18.8% 26.7% 
No. 22 68 91 58 53 You maintain a healthy weight according 
to your doctor’s advice. % 7.5% 23.3% 31.2% 19.9% 18.1% 
No. 48 94 99 30 21 You eat healthy foods (e.g. less salt etc) 
according to your doctor’s advice. % 16.4% 32.2% 33.9% 10.3% 7.2% 
No. 77 104 89 14 8 You use your antihypertensive drugs on 
regular basis as prescribed by your doctor % 26.4% 35.6% 30.5% 4.8% 2.7% 
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No. 14 39 93 95 51 You forget to take your medications 
because You have a busy life. % 4.8% 13.4% 31.8% 32.5% 17.5% 
No. 10 31 79 72 100 When You feel well, you stop taking your 
antihypertensive medications. % 3.4% 10.6% 27.1% 24.7% 34.2% 
No. 19 24 86 74 89 When You feel bad due to the side effects 
of drugs, you stop taking them without 
consulting your doctor. 
% 6.5% 8.2% 29.5% 25.3% 30.5% 
No. 117 114 43 10 8 You visit the doctor personally for the 
follow-up and the drug prescription. % 40.1% 39% 14.7% 3.4% 2.8% 
No. 91 114 71 7 9 You wait for a long time in the reception 
area whenever you visit the clinic. % 31.2% 39% 24.3% 2.4% 3.1% 
No. 48 109 114 12 9 If you know that the medications will 
increase your weight, will you continue 
taking them. 
% 16.5% 37.3% 39% 4.1% 3.1% 
No. 52 91 96 34 19 If you know that the medications will 
affect your sexual life, will you continue 
taking them. 
% 17.8% 31.2% 32.9% 11.6% 6.5% 
 
5.3.9. Section ten: The cost of treatment related questions:  
Six questions discussed the effect of treatment's cost on the participants’ compliance with 
their hypertension treatment plans as shown in table (5.11). For example, the participants 
were asked if the amounts that they paid for their health care were more than what they could 
normally afford and 26.4% (n=77) of the participants indicated that the health care costs were 
“always or often” more than what they could afford, the same percentages (26.4%, n=77) said 
the costs were “sometimes” beyond their affordability and 47.2% (n=138) said that the costs 
were “rarely or never” more than what they could afford.  
Also, 16% (n=48) of the participants reported that they “always or often” did not follow their 
drugs' regimen or they ever went without the medical care they needed because they could not 
afford it, 43.8% (n=128) responded “sometimes”, and 40.1% (n=117) indicated that they 
“rarely or never” went without the medical care they needed due to their inability of paying 
the costs. For full details refer to table (5.11).  
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Table (5.11): The participants’ answers to the questions related to the cost of treatment 
and their compliance with the treatment plans. 
Variable Always Often Sometime Rarely Never
No. 33 44 77 94 44 You have to pay for your 
medical care more than what you 
can afford. 
% 11.3% 15.1% 26.4% 32.2% 15% 
No. 13 34 128 71 46 You don’t follow drugs regimen 
or go without medical care 
because you can’t afford. 
% 4.5% 11.6% 43.8% 24.3% 15.8% 
No. 25 47 116 70 34 It is a problem for you to cover 
your share of the cost of medical 
care. 
% 8.6% 16.1% 39.7% 24% 11.6% 
No. 17 55 114 59 47 You worry about having to pay 
large medical bills.  % 5.9% 18.8% 39% 20.2% 16.1% 
No. 41 81 90 46 34 The amounts you pay to cover 
your medical needs are 
reasonable. 
% 14% 27.7% 30.8% 15.8% 11.7% 
No. 12 31 68 104 77 The high cost of your 
medications and treatment plan 
makes you less compliant with 
them. 
% 4.1% 10.6% 23.3% 35.6% 26.4% 
 
5.4. The participants’ responses to the questionnaire items by some independent 
variables. 
Cross-tabulation by using the Chi-squared test and Fisher exact test was done to assess the 
relationship between the questions of the questionnaire and some independent variables. The 
statistical significance was defined as a P-value of ≤ 0.05.  
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5.4.1. Cross-tabulation of the participants' responses to the questionnaire items by their 
gender.   
The findings revealed that there are no statistically significant differences between males and 
females’ responses to any of the  questions related to the participants' knowledge, the duration 
of their illness, their regularity on doctor appointments, their relationship with the medical 
staff, the family support they receive, and the costs of the treatment plan(See appendix D).   
For the drugs regimen items, cross-tabulation by gender revealed a statistically significant 
difference between males and females for one question only (q4). For example, the 
participants were asked if the frequent change of the their drugs or drugs' regimen by the 
doctor decreased their desire to take their medications and 27.3% of males versus 25.2% of 
females indicated that their desire was “always or often” decreased by the frequent change of 
their drugs or drugs regimen, 29.7% of males versus 41.4% of females said “sometimes” and 
43% of males versus 33.4% of females reported that as "rarely or never" (p= 0.04). (See table 
1, appendix D). 
 
As for the clarity of drugs’ usage instruction, cross tabulation showed no statistical significant 
relationship with their gender except questions 2 and 7. For example, the participants were 
asked about the clarity of information given to them by the medical staff about the life style 
changes and 35.5% of the males versus 36.2% of the females indicated that that medical staff 
members “always or often” gave them clear information about the necessary life style changes 
for their condition, while 37.2% of males versus 29.9% of females said “sometimes" and 
27.3% of males versus 33.9% of females reported that as “rarely or never” (p = 0.01). (See 
table 2, appendix D). 
For drugs' changes, 38.8% of the males versus 28.7% of the females said that the doctor 
“always or often” explained any change he/she made to their drugs, 28.9% of male versus 
45% of females responded “sometimes” and 32.3% of males versus 26.3% of females 
responded that as “rarely or never”. (p = 0.00). (See table 2, appendix D). 
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5.4.2. Cross tabulation of the participants’ responses to the questionnaire's items by the 
clinic they attended: 
In addition to gender, cross tabulation was done between all items of questionnaire and the 
clinic they attended for their medical care as shown in (appendix D). The findings revealed 
statistically significant differences for most of the questions related to the participants’ 
knowledge and perception about hypertension disease (except q1, q2, q3, q5, q7, q15). For 
example, 55% of Yatta versus 59% of Dora and 67.9% of Karanteena clinic participants 
believed that hypertension may “always or often” lead to other serious conditions such as 
heart attack or stroke (p=0.04) . Also, 33% of Yatta versus 24.1% of Dora and 25.7% of 
Karanteena thought that the risk of getting hypertension “always or often” differed according 
to gender (p=0.01) (See table 3, appendix D).  
 
Also, the majority of participants of Dora clinic (87.9%) versus 60% of Yatta and 75.2% of 
Karanteena indicated that decreasing tension and anger “always or often” helped to control 
their blood pressure (p=0.00). Further, 56% of Yatta versus 73.5% of Dora and 71.5% of 
Karanteena participants said they that the dietary changes “always or often” helped to control 
the blood pressure (p=0.04).  
  
For the importance of physical activity in the control of blood pressure, 37% of Yatta versus 
22.9% of Dora and 21.2% of Karanteena participants said that physical activity “rarely or 
never” helped them to control their blood pressure (p=0.01). Whereas, 56% of Yatta versus 
81.9% of Dora and 75.2% of Karanteena participants thought that it is “always or often” 
necessary to take the hypertension medications regularly (p=0.00). 
 
When the participants were asked if they think that the medications helped them to control 
their blood pressure, 53% of Yatta versus 74.7% of Dora and 62.4% of Karanteena 
participants responded “always or often” (p=0.00) and 23% of Yatta versus 15.6% of Dora 
and 20.2% of Karanteena said they "always or often" felt safe not to take their 
antihypertensive medications while 36% of Yatta versus 8.4% of Dora and 24.8% of 
Karanteena participants reported that as “sometimes”. And 38% of Yatta versus 75.9% of 
Dora and 55% of Karnteena answered it  "rarely or never" (p=0.00).  
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Finally, 22% of Yatta versus 12% of Dora and 15.6% of Karanteena participants reported that 
they “always or often” felt safe to decrease or increase their drugs dose without consulting 
their doctor (p=0.00), and 40% of Yatta versus 72% of Dora and 53.2% of Karanteena 
participants believed that hypertension “rarely or never” could be prevented (p=0.00). 
 
In addition, cross tabulation between the clinics they attended and the duration of illness 
related items showed no statistically significant relationships. Further, only two questions (q2 
& q4) were statistically significant when cross tabulation was done between the clinic they 
attended and their drugs’ daily regimen (See table 4, appendix D). For example, 40% of Yatta 
versus 24.1% of Dora and 33.9% of Karanteena participants said it was “always or often” 
difficult for them to remember to take their drugs due to their frequent daily regimen 
(p=0.02). Whereas 39% of Yatta versus 10.8% of Dora and 25.7% of Karanteena participants 
indicated that the frequent change of their drugs or drugs’ regimen by the doctor “always or 
often” decreased their desire to take them (p=0.00). 
 
For medical staff relationship, cross tabulation showed significant differences between the 
three clinics for all questions except for (q1, q3, q4, q6, q10). For example, 47% of Yatta 
versus 78.3% of Dora and 62.4% of Karanteena participants reported that the doctor “always 
or often” treated them with respect during the visit while 44% of Yatta versus 20.5% of Dora 
and 31.2% of Karanteena responded “sometimes” (p=0.00). (See table 5, appendix D). 
 
Moreover, 23% of Yatta versus 14.4% of Dora and 17.4% of Karanteena reported that the 
treating doctor “sometimes” made them feel foolish and embarrassed (p=0.03). Also, 35% of 
Yatta versus 16.9% of Dora and 27.5% of Karanteena participants indicated that the doctor 
“always or often” ignored what they wanted to tell him/her and 31% of Yatta versus 53% of 
Dora and 45.9% of Karanteena participants said that it “sometimes” happened (p=0.04). 
 
Furthermore, only 42% of Yatta versus 25.3% of Dora and 33% of Karanteena participants 
reported that they were “always or often” able to reach the doctor to ask him medical 
questions without a problem while 33% of Yatta versus 49.4% of Dora and  45.9% of 
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Karanteena participants responded as “sometimes” (p=0.00). Also 34% of Yatta versus 38.6% 
of Dora and 40.3% of Karanteena participants reported that the doctor “always or often” 
listened carefully to what they wanted to tell him/her (p=0.01). 
For the way they were treated by the medical staff; 49% of Yatta versus 69.8% of Dora and 
68.8% of Karanteena participants said they were “always or often” treated with respect while 
32% of Yatta versus 25.35 of Dora and 17.4% of Karanteena participants answered it as 
“sometimes” (p=0.03). 
Regarding the clarity of drugs usage instruction, the findings revealed significant relationship 
between the clinics they attended and four questions only (q2, q3, q4, q6). (See table 6, 
appendix D). For example, 46% of Yatta versus 36.2% of Dora and 26.7% of Karanteena 
participants indicated that the medical staff ‘always or often” explained and gave them clear 
information about the necessary life style changes for their condition while 32% of Yatta 
versus 34.9% of Dora and 32.1% of Karanteena responded “sometimes” (p=0.02).  
 
Participants were also asked if the medical staff ever showed or trained them to measure their 
blood pressure by themselves and 44% of Yatta versus 55.6% of Dora and 59.6% of 
Karanteena participants indicated that they were “rarely or never” trained to do so (p=0.00) 
meanwhile 68% of Yatta participants versus 37.4% of Dora and 53.2% of Karanteena 
participants reported that the medical staff “always or often” explained to them the 
importance of blood pressure control for their health (p=0.00). 
 
Also, when the participants were asked if the treating doctor ever explained to them the 
reasons behind the medical tests he/she ordered for them, 29% of Yatta versus 24.1% of Dora 
and 18.4% of Karanteena participants said they were “rarely or never” told the reasons of the 
medical tests they ordered to do by their doctor (p=0.00). 
 
Cross tabulation between family support related questions and the clinic they attended showed 
significant relationship with two questions only (q3, q5). (See table 7, appendix D). For 
example, 60% of  Yatta 56.6% of Dora and 68.8% of Karanteena participants reported that 
their families “always or often” helped them financially to get their medications and 28% of 
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Yatta versus 27.8% of Dora and 18.4% of Karanteena participants responded “sometimes” 
(p=0.04). 
 
Furthermore, 59% of Yatta versus 71.1% of Dora and 77.9% of Karanteena participants said 
that their families “always or often” helped them to reach the medical facility (clinic or 
hospital) when they were tired or sick and 29% of Yatta versus 15.7% of Dora and 18.4% of 
Karanteena responded as “sometimes” (p=0.00).  
 
For the questions related to participants' regularity on their doctor appointments, cross 
tabulation showed statistically significant relationship for six questions (q1, q2, q7, q8, q11, 
q12). (See table 8, appendix D). For example, 68% of Yatta versus 80.7% of Dora and 84.4% 
of Karanteena participants said that they were “always or often” regular at their doctor 
appointments while 22% of Yatta versus 14.5% of Dora and 7.3% of Karanteena stated it as 
“sometimes” (p=0.00). Also, 40% of Yatta versus 39.8% of Dora and 44% of Karanteena 
participants stated that they “always or often” measured their blood pressure on regular basis 
whereas 38% of Yatta versus 25.2% of Dora and 36.7% of Karanteena indicated that they 
only “sometimes” measured their blood pressure on regular basis (p=0.00). 
 
Further, 25% of Yatta versus 19.3% of Dora and 11% of Karanteena participants stated that 
they “always or often” forgot to take their medications because of their busy life while 26% of 
Yatta versus 36.1% of Dora and 33.9% of Karanteena participants answered “sometimes” 
(p=0.04). Also, 25% of Yatta versus 3.6% of Dora and 12% of Karanteena participants 
indicated that they had “always or often” stopped taking their medications when they felt 
well, while 27% of Yatta versus 28.9% of Dora and 25.7% of Karanteena participants 
responded that they “sometimes” did that (p=0.00). 
 
furthermore, 53% of Yatta versus 54.2% of Dora and 54.1% of Karanteena participants said 
that they would “always or often” continue to take their antihypertensive medication even if 
they knew that they increase their weight and 35% of Yatta versus 39.8% of  Dora and 42.2% 
of Karanteena participants answered it as “sometimes” (p=0.02). 
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Finally, 45% of Yatta versus 50.6% of Dora and 51.4% of Karanteena participants indicated 
that they would “always or often” continue to take their medications even if they knew that 
they would affect their sexual life (p=0.00).  
 
Finally, cross tabulation between participants’ responses to the questions related to the cost of 
treatment and the clinic they attended, revealed statistically significant relationship for three 
questions (q2, q3, q6). (See table 9, appendix D). For example, only 23% of Yatta versus 
16.6% of Dora and 9.2% of Karanteena participants said that they “always or often” did not 
follow their drugs regimen or went without the medical care they needed because they could 
not pay the expenses (p=0.05). 
 
Also, 26% of Yatta versus 25.3% of Dora and 13.8% of Karanteena participants claimed that 
they “always or often” had a problem to cover their share of the cost for the medical care they 
receive in the clinic, while 38% of Yatta versus 26.5% of Dora and 40.3% of Karanteena 
participants reported this as "rarely or never" (p=0.00). Finally, 21% of Yatta versus 15.1% of 
Dora and 8.3% of Karanteena participants said that the high cost of their treatment plans 
“always or often” made them less compliant, whereas, 53% of Yatta versus 58.4% of Dora 
and 73.4% of Karanteena participants reported that as “rarely or never” (p=0.01).  
  
5.4.3. Cross tabulation of the participants’ responses to the questionnaire's items by 
their age group: 
 Only three questions (q4, q10, q15) related to the participants' knowledge were statistically 
significant when cross tabulation was done according to the age group of the participant. (See 
table 10, appendix D). For example, 63.7% of the young participants versus 69.4% of the old 
participants thought that hypertension “always or often” leads to other serious conditions 
(p=0.01). Further, more than half of the young participants (51%) versus 37.9% of the old 
participants believed that physical activity “always or often” helped them to control their 
blood pressure (p=0.04). 
Further, 22.5% of the young participants versus 23.7% of the old participants “always or 
often” thought that hypertension drugs had serious side effects that may affect their health, 
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whereas 51% of the young participants versus 41% of the old participants stated it as “rarely 
or never” (p=0.04) 
Regarding the duration of hypertension disease; only one question was statistically significant 
(q3). (See table 11, appendix D). 59.8% of the young participants versus 52.1% of the old 
participants indicated that they “rarely or never” did not follow the diet regimen or the life 
style changes needed for their  
 
For the drugs’ regimen, three questions were statistically significant (q1, q2, q3). (See table 
12, appendix D). For example, 42.1% of the young participants versus 56.3% of the old 
participants indicated that the frequent dosing of their drugs “always or often” decreased their 
desire to take them every day while 35.3% of the young participants versus 33.1% of the old 
participants said that it was “sometimes” the case with them (p=0.05).  
Also, 32.3% of the young participants versus 33.7% of the old participants reported that they 
"always or often" had difficulty to remember their drugs regimen all the time, whereas 36.3% 
of the young participants versus 49.5% of the old participants answered that as “sometimes” 
and 31.4% of the young participants versus 16.8% of the old participants answered it as 
"rarely or never" (p=0.00). 
 Further, 28.4% of the young participants versus 40.5% of the old participants said that the 
drugs they were taking for other chronic conditions had “always or often” decreases their 
desire to take the antihypertensive medications or to follow the life style changes 
recommended by their treating doctor and 35.3% of the young participants versus 38.9% of 
the old participants responded “sometimes” (p=0.01). 
Furthermore, the relationship with the medical staff did not differ significantly between the 
young (≤55years) and old participants (>55years) except (q6) for which only 16.6% of the 
young participants versus 26.7% of the old participants reported that the doctor was “rarely or 
never” formal and impersonal toward them during the visit while 44.2% of the young 
participants versus 30.7% of the old participants said “always or often” and 39.2% of the 
young participants versus 42.6% of the old participants stated it as “sometimes” (p=0.05). 
(See table 13, appendix D). 
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In addition to previous results, cross tabulation between participants’ responses to the 
questions related to the clarity of drugs usage instructions and their age group revealed no 
statistically significant differences except for one question only (q3). The same percentages of 
the young and old participants (53%) reported that they were “rarely or never” trained how to 
perform self measurement of their blood pressure and 12.7% of the young participants versus 
22.6% of the old participants said they were “sometimes” trained to do so whereas 34.2% of 
the young participants versus 24.2% of the old participants stated it as “always or often” 
(p=0.04). (See table 14, appendix D). 
Similarly, most of the questions related to participants' regularity on doctor appointments 
revealed statistically significant differences between the different age groups for three 
questions only (q2, q12, and q13). (See table 15, appendix D). For example, 52% of the young 
participants versus 35.8% of the old participants reported that they “always or often” 
measured their blood pressure on regular basis and 33.3% of the young participants versus 
34.2% of the old participants said they “sometimes” did that (p=0.01). 
Also, 44.1% of the young participants versus 58.9% of the old participants believed that if 
they knew that their drugs would increase their weight they would “always or often” continue 
to take them, whereas 46.1% of the young participants versus 35.3% of the old participants 
stated it as “sometimes” (p=0.05). Further, 38.2% of the young participants versus 54.7% of 
the old participants said they would “always or often” use their drugs even if they knew they 
would affect their sexual life and 43.1% of the young participants versus 27.4% of the old 
participants responded “sometimes” (p=0.02).  
 Finally, cross tabulation did not reveal statistically significant differences between the young 
and old participants’ responses to any of the questions related to their family support or the 
effect of the costs of their treatment plans on their compliance. 
  
5.4.4. Cross tabulation of the participants’ responses to the questionnaire's items by 
their marital status: 
Also, cross-tabulation between participants’ responses to questions related to their knowledge 
and perception of hypertension and their marital status revealed that only two questions (q3, 
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q5) had statistically significant relationship (See table 16, appendix D). For example, 50% of 
the single participants versus 36.2% of the married participants and 25.8% of the widow 
reported that they “always” considered hypertension as a serious problem. Whereas 20% of 
the single participants and 24.2% of the married participants versus 33.3% of the widow 
participants stated it as “sometimes” (p=0.01). Moreover 40% of the single participants and 
29% of the married participants versus 88.9% of the divorced and 53% of the widow 
participants stated that they “rarely or never” thought hypertension has hereditary basis 
(p=0.00). 
 
In addition, only one of the four questions related to the duration of illness revealed 
statistically significant relationship with participants’ marital status. 80% of the single 
participants and 44.9% of the married participants versus 44.6% of the divorced and 65.2% of 
the widow participants stated that the long duration of their illness “always or often” affected 
their desire to take their medications. Whereas 38.6% of the married and 22.3% of the 
divorced participants versus 25.7% of the widow participants responded by “sometimes” 
while 20% of the single participants and 16.5% of the married participants versus 33.4% of 
the divorced and 9.1% of the widows stated it as “rarely or never” (p=0.00).(See table 17, 
appendix D).  
 
For drugs' regimen, three questions (q1, q2, q3) yielded statistically significant relationship 
with marital status (See table 18, appendix D). For example, 60% of the single participants 
and 48.7% of the married participants versus 59.1% of the widow participants and 44.4% of 
the divorced reported that the frequent dosing of their drugs “always or often” decreased their 
desire to take them every day. Whereas, 10% of the single participants and 35.3% of the 
married participants versus 44.5% of the divorced and 31.8% of the widow participants stated 
it as “sometimes” (p=0.01). 
 
Also, 50% of the single participants and 29.5% of the married participants versus 42.3% of 
the widow participants and 33.3% of the divorced participants indicated that it was “always or 
often” difficult for them to remember their drugs’ regimen because they had to take their 
drugs many times a day. Further, 40% of the single participants and 44% of the married 
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participants versus 33.3% of the divorced and 50% of the widow participants stated that it was 
“sometimes” difficult for them to remember their drugs regimen (p=0.02). 
 
Further, 30% of the single participants and 32.8% of the married participants versus 66.6% of 
the divorced and 43.9% of the widow participants reported that the drugs they were taking for 
chronic conditions other than hypertension “always or often” decreased their desire to take 
their antihypertensive drugs. Whereas, 60% of the single participants and 37.7% of the 
married participants versus 11.1% of the divorced and 37.9% of the widow participants 
indicated that as ‘sometimes” (p=0.05). 
 
Furthermore, no statistically significant differences were observed between participants’ 
responses to the questions related to the relationship with the medical staff and their marital 
status except one question (q2) for which 70% of the single participants, 61.8% of the married 
participants and 66.7% of the divorced participants versus 59% of the widow participants 
indicated that the doctor had “always/often” treated them with respect during their 
visit.(p=0.01). (See table 19, appendix D). 
 
Also, only three (q5, q6, q8) out of nine questions related to the clarity of drugs usage 
instructions had revealed statistically significant relationship with the participants’ marital 
status (See table 20, appendix D). For example, 60% of the single participants and 67.6% of 
the married participants versus 66.7% of the divorced and 63.7% of the widow participants 
said that the medical staff “always or often” used clear and simple language when they gave 
them information and instructions regarding their disease control and medication. Whereas, 
none of the single participants and 3.9% of the married participants versus 22.2% of the 
divorced and 1.5% of the widow participants reported it as "rarely or never" (p=0.01). 
 
Moreover, three items (q3, q4, q7) related to the family support had statistically significant 
relationship with the participants' marital status (See table 21, appendix D). For example, 40% 
of the single participants, 63.8% of the married participants and 55.6% of the divorced 
participants versus 62.1% of the widow participants stated that their families “always or 
often” helped them financially to get their medications. Whereas, 20% of the single 
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participants, 24.6% of the married participants and 22.2% of the divorced participants versus 
25.3% of the widow participants responded by "sometimes" (p=0.03). 
 
Also, 30% of the single participants, 52.2% of the married participants and 44.4% of the 
divorced participants versus 48.5% of the widow participants stated that their families 
“always or often” helped them in measuring their blood pressure, whereas 20% of the single 
participants, 29.4% of the married participants and 44.4% of the divorced participants versus 
36.3% of the widow participants reported that their families “rarely or never” helped them in 
measuring their blood pressure (p=0.05). 
 
Similar to previous findings, only three (q1, q4, q9) out of thirteen questions related to the 
participants’ regularity on doctor appointments and the treatment plan revealed statistically 
significant relationship with their marital status (See table 22, appendix D). For example, 60% 
of the single participants and 76.8% of the married participants versus 66.7% of the divorced 
and 84.8% of the widow participants reported that they were “always or often” regular at their 
doctor appointments (p=0.05). 
 
Furthermore, 40% of the single participants and 33.4% of the married participants versus  
25.8% of the widow participants reported that they “always or often” managed to maintain a 
healthy weight whereas 60% of the single participants and 32.8% of the married participants 
versus 66.7% of the divorced and 46.9% of the widow participants stated that they “rarely or 
never” managed to maintain a healthy weight as advised by their doctor (p=0.02). 
 
Regarding the treatment costs, two questions (q1, q3) of this section had statistically 
significant relationship with marital status (See table 23, appendix D). For example, 50% of 
the single participants and 26.6% of the married participants versus 22.3% of the divorced and 
22.7% of the widow participants stated that they “always or often” had to pay for the medical 
care more than what they can afford and 50% of the single participants and 22.7% of the 
married participants versus 33.3% of the divorced and 33.3% of the widow participants stated 
it as “sometimes” (p=0.00). 
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Finally, 30% of the single participants and 24.6% of the married participants versus 22.7% of 
the widow participants and 33.3% of the divorced participants reported that they “always or 
often” had a problem to cover their share of the cost of their medical care (p=0.01). 
 
5.4.5. Cross tabulation of the participants’ responses to the questionnaire’s items by 
their level of education: 
Seven out of sixteen questions related to the participants' knowledge and perception of 
hypertension (HTN) revealed statistically significant relationship with the participants’ level 
of education (See table 24, appendix D). For example, 44.8% of the none educated 
participants and 61.3% of those who got primary education versus 77.6% of those who got 
elementary education and 65.1% of those who got university education believed themselves to 
be “always or often” in good health whereas 38.1% of the none educated and 32.5% of those 
who got primary education versus 26.7% of those who got secondary education stated it as 
“sometimes” (p=0.00). 
 
Furthermore, 61.9% of the none educated participants and 63.3% of those who got elementary 
education versus 60% of those who got secondary education and 74.4% of those who got 
university education believed that hypertension may “always or often” lead to other serious 
conditions while 27.6% of the none educated participants and 32.7% of those who got 
elementary education versus 33.3% of those who got secondary education and 13.9% of those 
who got university education indicated this as “sometimes”. Also, 10.5% of the none educated 
participants and 4% of those who got elementary education versus 13.4% of those who got 
secondary education and 11.7% of those who got university education responded by "rarely or 
never" (p=0.02).  
 
Moreover, 38.1% of the none educated participants and 37.6% of those who got primary 
education versus 53.3% of those who got secondary education and 58.1% of those who got 
university education thought that physical exercise “always or often” helped them to control 
their blood pressure whereas 30.5% of the none educated participants and 33.3% of those who 
got primary education versus 13.3% of those who got secondary education and 27.9% of 
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those who got university education thought that physical exercises “sometimes” helped them 
to control their blood pressure (p=0.01).   
 
Similarly, 64.8% of the none educated participants and 55.1% of those who got primary 
education and 63.3% of those who got elementary education versus 53.4% of those who got 
secondary education and 74.4% of those who got university education believed that 
hypertension drugs “always or often” helped them to control their blood pressure, whereas 
7.6% of the none educated participants and 10.1% of those who got primary education and 
10.2% of those who got elementary education versus 13.3% of those who got secondary 
education and 9.3% of those who got university education indicated that the drugs “rarely or 
never’ helped them to control their blood pressure (p=0.04).   
 
For the duration of illness related questions, two questions (q1 & q2) had statistically 
significant relationship with the participants’ level of education (See table 25, appendix D). 
For example, 56.2% of the none educated participants and 48.9% of those who got elementary 
education and 48.9% of those who got elementary education versus 46.7% of those who got 
secondary education and 32.5% of those who got university education reported that the long 
duration of their illness “always or often” affected their desire to take their hypertension drugs 
whereas 17.1% of the none educated participants and 7.6% of those who got primary 
education and 12.3% of those who got elementary education versus 20% of those who got 
secondary education and 27.9% of those who got university education stated it as “rarely or 
never” (p=0.03).  
 
Finally, 19.9% of the none educated participants, 18.8% of those who got primary education 
participants and 12.3% of those who got elementary education versus 26.6% of those who got 
secondary education and 9.3% of those who got university education reported that because of 
the chronic nature of hypertension they “always or often” did not take their hypertension 
drugs continuously (p=0.05). 
 
In addition, only one question related to drugs’ regimen (q4) had statistically significant 
relationship with the level of education (See table 26, appendix D). For example, 34.3% of the 
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none educated participants and 33.7% of those who got primary education and 46.6% of those 
who got secondary education versus more than half 51.1% of those who got university 
education said that the frequent change of their drugs regimen “rarely or never” decreased 
their desire to take them (p=0.03). 
 
The cross tabulation between the participants’ responses to questions related to their 
relationship with the medical staff and their level of education showed statistically significant 
relationship for four questions (q1, q2, q3, q11) (See table 27, appendix D). For example, 
48.6% of the none educated participants, 45% of those who got primary education and 53% of 
those who got elementary education versus 53.3% of those who got secondary education 
79.1% of those who got university education indicated that they were “always or often” seen 
by the same doctor in every visit they did to the clinic while 22.8% of the none educated 
participants and 25% of those who got primary education versus 26.7% of those who got 
secondary education and 9.3% of those who got university education indicated it as “rarely or 
never” (p=0.00). 
 
Also, 62.8% of the none educated participants, 61.2% of those who got elementary education 
versus 40% of those who got secondary education and 74.5% of those who got university 
education stated that the doctor “always or often” treated them with respect when they visited 
the clinic whereas 26.7% of the none educated participants and 40% of those who got primary 
education versus 53.3% of those who got secondary education and 23.2% of those who got 
university education stated it as “sometimes” (p=0.00).   
 
Four questions (q1, q3, q6, q8) related to the clarity of drugs’ usage instructions had 
statistically significant relationship with the participants’ level of education (See table 28, 
appendix D). For example, the majority of the none educated participants (76.2%)  and 66.2% 
of those who got primary education and 73.5% of those who got elementary education versus 
66.7% of those who got secondary education and 76.8% of those who got university 
education indicated that the drugs usage instructions written by the doctor were “always or 
often” clear to them. Whereas, 17.1% of the none educated participants and 28.8% of those 
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who got primary education versus 20% of those who got secondary education and 14% of 
those who got university education stated it as “sometimes” (p=0.02). 
 
Further, 21.9% of the none educated participants, 23.7% of those who got primary education, 
and 30.6% of those who got elementary education versus 46.6% of those who got secondary 
education and 39.5% of those who got university education indicated that the medical staff 
“always or often” trained them to do self measurement of their blood pressure whereas 57.1% 
of the none educated participants, 50% of those who got primary education and 63.3% of 
those who got elementary education versus 26.6% of those who got secondary education and 
46.5% of those who got university education reported that as “rarely or never” (p=0.04). 
 
For the family support, three questions (q1, q4, q7) had statistically significant relationship 
with the participants’ level of education (See table 29, appendix D). For example, 71.4% of 
the none educated participants and 65% of those who got primary education versus 60% of 
those who got secondary education and 83.7% of those who got university education reported 
that their families “always or often” reminded them about their drugs while 13.4% of the none 
educated participants and 16.3% of those who got primary education versus 6.7% of those 
who got secondary education and 11.9% of those who got university education and  
responded by “rarely or never” (p=0.03). 
Also, 47.6% of the none educated participants, 41.2% of those who got primary education, 
and 46.9% of those who got elementary education versus 40% of those who got secondary 
education and 81.4% of those who got university education indicated that their families 
“always or often” helped them in measuring their blood pressure whereas 39.1% of the none 
educated participants, 36.3% of those who got primary education and 22.5% of those who got 
elementary education versus 46.7% of those who got secondary education stated it as “rarely 
or never” (p=0.00).  
In accordance with previous results, participants’ responses to the questions related to their 
regularity on doctor’s appointments and treatment plan showed statistically significant 
relationship with level of education in four questions (q2, q5, q8, q10) (See table 30, appendix 
D). For example, 25.7% of the none educated participants,42.4% of those who got primary 
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education and 49% of those who got elementary education versus 66.6% of those who got 
secondary education and 60.5% of those who got university education indicated that they 
“always or often” measured their blood pressure on regular basis whereas 41% of the none 
educated participants, 23.9% of those who got primary education, and 14.3% of those who got 
elementary education versus 13.4% of those who got secondary education and 2.3% of those 
who got university education and responded by “rarely or never” (p=0.00).  
Moreover, 55.2% of the none educated participants, 46.3% of those who got primary 
education, and 44.9% of those who got elementary education versus 26.6% of those who got 
secondary education and 48.8% of those who got university education reported that they 
“always or often” managed to eat healthy food as advised by their doctor whereas 10.5% of 
the none educated participants, 20% of those who got primary education and 22.4% of those 
who got elementary education versus 33.3% of those who got secondary education and 18.6% 
of those who got university education and said that they “rarely or never” managed to do that 
(p=0.01). 
Also, 20% of the none educated participants and 10.2% of those who got elementary 
education versus 40% of those who got secondary education and 11.5% of those who got 
university education stated that they “always or often” stopped taking their medications when 
they felt better whereas 59.1% of the none educated participants and 62.5% of those who got 
primary education and 51% of those who got elementary education versus 60% of those who 
got secondary education and 60.6% of those who got university education said that they 
“rarely or never” did that (p=0.00). 
Finally, only one question (q1) related to the treatment costs revealed a statistically significant 
relationship with the participants’ level of education (See table 31, appendix D). For example, 
26.6% of the none educated participants, 33.7% of those who got primary education and 
10.2% of those who got elementary education versus 20% of those who got secondary 
education and 32.6% of those who got university education indicated that they “always or 
often” had to pay for their medical costs more than what they could afford. Whereas 48.6% of 
the none educated participants, 45.1% of those who got primary education and 49% of those 
who got elementary education versus 60% of those who got secondary education and 41.8% 
of those who got university education indicated that as “rarely or never” (p=0.00). 
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5.4.6. Cross tabulation of the participants’ responses to the questionnaire items related 
to the duration of their illness: 
Cross tabulation was done between the participants’ responses to the questions related to their 
knowledge and perception of hypertension and the duration of their illness, only one question 
(q1) showed a statistically significant relationship (See table 32, appendix D). For example, 
64% of those who were diseased for less than ten years and 45.8% of those who were 
diseased for ten to twenty years versus 70.6% of those who were diseased for twenty years or 
more indicated that they “always or often” considered themselves to be in good health. 
Whereas, 28.6% of those who were diseased for less than ten years and 42.2% of those who 
were diseased for ten to twenty years versus 11.8% of those who were diseased for twenty 
years or more stated it as “sometimes” (p=0.02). 
Also, cross tabulation between the duration of the disease and participants’ responses to 
questions related to the effect of hypertension as a chronic disease on their compliance 
revealed statistically significant relationship for one question only (See table 33, appendix D). 
For example, 13.1% of those who were diseased for less than ten years and 21.7% of those 
who were diseased for ten to twenty years versus 29.4% of those who were diseased for 
twenty years or more indicated that they “always or often” did not follow their diet regimen or 
the necessary life style changes due to the chronic nature of hypertension. Whereas, 57.7% of 
those who were diseased for less than ten years and 51.8% of those who were diseased for ten 
to twenty years versus 35.3% of those who were diseased for twenty years or more reported 
that as “rarely or never” (p=0.04). 
 
In addition, no significant relationship was found between duration of hypertension disease 
and the daily drugs' regimen, the participants’ relationship with the medical staff or the clarity 
of the drugs’ usage instructions given to them by the medical staff. 
 
For family support related items, only two questions (q3 & q6) had statistically significant 
relationship with the duration period of their disease (See table 34, appendix D). For example, 
68.2% of participants who were diseased for less than ten years and 54.3% of those who were 
diseased for ten to twenty years versus 35.3% of those who were diseased for twenty years or 
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more stated that their families “always or often” helped them financially to get their 
medications when they needed (p=0.00). 
 
Also, 63.1% of participants who were diseased for less than ten years and 50.6% of those who 
were diseased for ten to twenty years versus 64.7% of those who were diseased for twenty 
years or more reported that their families “always or often” helped them to accomplish the life 
style changes as required by their treating doctor. Further, 11.4% of those who were diseased 
for less than ten years and 20.5% of those who were diseased for ten to twenty years versus 
11.8% of those who were diseased for twenty years or more stated it as “rarely or never” 
(p=0.04). 
Moreover, cross-tabulation between the participants’ responses to the thirteen questions 
related to their regularity on doctor’s appointments and the duration of their illness revealed 
statistically significant relationship for three questions only (q1, q4, q13) (See table 35, 
appendix D). For example,  81.3% of those who were diseased for less than ten years and 
69.9% of those who were diseased for ten to twenty years versus 76.4% of those who were 
diseased for twenty years or more indicated that they were ‘always or often” regular at their 
doctor appointments (p=0.05).  
 
Also, 28.7% of those who were diseased for less than ten years and 31.3% of those who were 
diseased for ten to twenty years versus 52.9% of those who were diseased for twenty years or 
more stated that they “always or often” managed to maintain healthy weight as advised by 
their doctor. Whereas, 34.8% of those who were diseased for less than ten years and 45.8% of 
those who were diseased for ten to twenty years versus 35.3% of those who were diseased for 
twenty years or more reported that as “rarely or never” (p=0.00). 
 
Finally, 46.3% of those who were diseased for less than ten years and 56.6% of those who 
were diseased for ten to twenty years versus 41.2% of those who were diseased for twenty 
years or more stated that they would “always or often” use their drugs even if they knew that 
these drugs would affect their sex life. Whereas, 13.6% of those who were diseased for less 
than ten years and 26.5% of those who were diseased for ten to twenty years versus 29.4% of 
those who were diseased for twenty years or more answered this “rarely or never”. (p=0.00) 
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Lastly, three questions (q2, q4, q5) related to the treatment costs showed statistically 
significant relationship with the duration of illness (See table 36, appendix D). For example, 
only 10.4% of those who were diseased for less than ten years and 28.9% of those who were 
diseased for ten to twenty years versus 17.6% of those who were diseased for twenty years or 
more indicated that the expenses “always or often” prevented them from following their drugs 
regimen or forced them to go without the medical care they needed. While, 42.7% of those 
who were diseased for less than ten years and 32.6% of those who were diseased for ten to 
twenty years versus 47.1% of those who were diseased for twenty years or more indicated that 
as “rarely or never” (p=0.01). 
 
Moreover, only 21.9% of those who were diseased for less than ten years and 27.7% of those 
who were diseased for ten to twenty years versus 41.2% of those who were diseased for 
twenty years or more stated that they “always or often” worried about having to pay large 
medical pills. Whereas, 35.9% of those who were diseased for less than ten years and 36.2% 
of those who were diseased for ten to twenty years versus 41.2% of those who were diseased 
for twenty years or more stated that as “rarely or never” (p=0.00). 
 
Finally, 38% of those who were diseased for less than ten years and half (50.6%) of those who 
were diseased for ten to twenty years versus 41.1% of those who were diseased for twenty 
years or more reported that the amounts they pay to cover their medical needs were “always 
or often” reasonable. 27.6% of those who were diseased for less than ten years and only 
22.9% of those who were diseased for ten to twenty years versus 47.1% of those who were 
diseased for twenty years or more answered this question as "rarely or never"  (p=0.03). 
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5.5. Binary logistic regression 
The logistic regression analysis was used to evaluate the association between the patient's 
compliance expressed as the level of blood pressure control and some other independent 
variables of the questionnaire as shown in table (5.12) below. The model with non-
compliance as the dependent variable included the following independent variables (the 
reference categories are mentioned first): gender (female, male), body mass index (normal, 
obese, overweight), duration of illness (<10years, ≥10<20 years, ≥20 years), the presence of 
diabetes as co-morbidity (no, yes), the number of anti-hypertensive drugs prescribed (one, 
two, three or more ), the frequency of doctor visits (once a month, once every three months, 
once every six months, more than six months), the clarity of medical instructions (always/ 
often, sometimes, rarely/never), the family and social support and encouragement (always/ 
often, sometimes, rarely/never), stoppage of the anti-hypertensive medications due to their 
adverse effects (always/often, sometimes, rarely/never), the perception of hypertension as a 
serious disease (always/often, sometimes, rarely/never). P-values of ≤ 0.05 were considered 
statistically significant in all analysis.  
The logistic regression analysis of the study population revealed that the covariates gender, 
body mass index, the duration of illness, being diabetic, the number of drugs, the frequency of 
doctor visits, the clarity of medical instructions, the family support, the drugs' side effects, the 
belief that hypertension is serious health problem and the cost of the treatment plan 
significantly influence the compliance rate of the patients which is expressed as the blood 
pressure control outcome (<140/90 mmHg).  
For example, the analysis revealed that the male participants were 1.591 (95% CI, 1.992-
2.551) times non-compliant (have BP≥140/90mmHg) than females with a significance 
p=0.05. Also the body mass index appeared to have an overall significant relationship 
(p=0.00) with the BP level and those who were overweight were 1.941 (95% CI, 1.047-3.599: 
p=0.03) times less compliant than those with normal BMI and those with obese BMI were 
3.078  (95%CI, 1.509-6.279: p=0.00) times less compliant than those with normal BMI. 
The effect of the duration of illness was highly significant (p=.02) and those who were 
diseased for ≥10<20 years were 1.477 (95%CI, .878-2.487: p=0.14) times less compliant than 
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those who were diseased for less than ten years, while those who were diseased for twenty 
years or more were four times (95%CI, 1.345-11.819) less compliant than those who were 
diseased for less than ten years with a significant p-value = 0.01. 
Further, the effect of having diabetes as another chronic diseases was examined and the 
results showed that those participants who were suffering from diabetes in addition to 
hypertension were 1.825 (95%CI, 1.825-1.110: p=0.01) times less compliant than those who 
were non-diabetic. Also, the number of drugs taken to treat hypertension revealed an overall 
statistically significant (p=0.00) effect on the level of blood pressure and those who were 
taking two drugs were 3.623 (95%CI, 1.833-7.161: p=0.00) times less compliant than those 
who were taking only one drug and those who were taking three drugs to treat their 
hypertension were 3.380 (95%CI, 1.537-7.434: p=0.002) times less compliant than those 
taking only one drug.  
Furthermore, the frequency of the doctor visits for the follow up and the drugs prescription 
revealed statistically significant (p=0.02) association with the blood pressure level, and those 
who visited their doctor only once in every three months were 2.886 (95%CI, 1.434-5.807: 
p=0.00) times less compliant when compared to those who visited the doctor regularly every 
month, as well those who visited their doctor every six months were 2.389 (95%CI, 0.936-
6.164: p=0.06) times less compliant than the monthly-visit regulars and those who visited 
their doctor less frequently than that were 1.962 (95% CI, 0.269-14.322: p=0.5) times less 
compliant. The last two findings were not statistically significant. 
The participants perception of hypertension as a serious problem revealed an overall 
statistically significant effect on the BP level (p=0.03) and those who considered HTN is 
"sometimes" a serious condition were 2.680 (95%CI, 1.430-5.023: p=0.02) times less 
compliant when compared to those who considered it to be "always or often" a serious 
problem. Those who considered it to be "rarely or never" serious condition were 2.345 
(95%CI, 1.845-6.510: p=0.00) times less compliant than those who considered it to be 
"sometimes” a serious problem. 
As regard to the clarity of the drugs usage instructions, it appeared to have a statistically 
significant relationship with the BP level (p=.01). For example, those who reported that the 
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instructions were only "sometimes" clear were 2.436 (95% CI, 1.248-4.755: p=0.00) times 
less compliant than those who reported that the instruction were "always or often" clear and 
those who indicated that the instructions were "rarely or never" clear were 5.720 (95% CI, 
1.096-12.607: p=0.00) times less compliant than those who responded "sometimes”.  
Also, the family encouragement revealed statistically significant association with blood 
pressure (p=.01) and those who said that they "sometimes" got family encouragement were 
2.082 (95%CI, 1.441-1.721: p=0.02) times less compliant than those who "always or often" 
received encouragement and those who reported that they "rarely of never" got family 
encouragement were 2.940 (95%CI, 1.155-7.481: p=0.02) times less compliant than those 
who "sometimes" got family encouragement to be more compliant with their treatment plans. 
As well, the side effects of the drugs taken for the treatment of hypertension and the stoppage 
of treatment due to these side effects revealed a statistically significant relationship with the 
blood pressure level (p=0.00) but the internal differences between the participants were not 
statistically significant. 
Finally, the cost of the treatment plan showed statistically significant relationship with the 
compliance rate with treatment and those who reported that the cost was "sometimes" 
reasonable to them were 2.235 (95%CI, 1.256-5.044: p=0.02) times less compliant than those 
who said the cost was "always or often" reasonable, and those who stated that the cost was 
"rarely or never" reasonable were 4.260 (95%CI, 1.856-11.502: p=0.00) times less compliant.   
On the contrary, logistic regression analysis revealed that the patients age group, education 
level, work status, smoking status, marital status, family history, daily dosing, and regimen 
interruptions did not affect the compliance of the participants with their treatment regimen. 
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Table (5.12): Binary logistic regression with BP level 
 
 Variable B S.E. Wald Df Sig. Exp(B) 95.0% C.I. for EXP(B) 
 Sex: Ref: female 
(male) 
 
.464 
 
.241 
 
3.714 
1 
1 
 
.05 
1 
1.591 
 
1.992 
 
2.551 
 BMI. (ref=normal)     9.584 2 .00  1     
  (overweight) .663 .315 4.437 1 .03 1.941 1.047 3.599 
  (obese) 1.124 .364 9.553 1 .00 3.078 1.509 6.279 
 Age group (ref=age≤55years) 
(>55 years) 
 
.373 
 
.252 
 
2.191 
1 
1 
 
.13 
1 
1.453 
. 
886 
 
2.382 
 Education (ref=non educated)     8.171 4 .08 1      
   (primary) .388 .298 1.689 1 .19 1.474 .821 2.645 
   (elementary) -.345 .359 .922 1 .33 .708 .350 1.432 
   (secondary) .154 .554 .077 1 .78 1.167 .394 3.454 
   (university) -.661 .393 2.832 1 .09 .516 .239 1.115 
 Work (ref=employed)     8.099 4 .08  1     
  (unemployed) .956 .438 4.765 1 .02 2.603 1.103 6.143 
  (retired) .596 .611 .952 1 .32 1.815 .548 6.008 
  (house wife) .340 .386 .776 1 .37 1.405 .659 2.997 
  (own business) 1.030 .491 4.394 1 .03 2.800 1.069 7.333 
 Smoking (ref= never smoke)     8.323 4 .08  1     
  (Smoke<10 cigarettes) -1.139 .515 4.889 1 .02 .320 .117 .879 
  (Smoke10-20 cigarettes) -1.088 .635 2.932 1 .08 .337 .097 1.170 
  (Smoke >20 cigarettes) -1.447 .771 3.521 1 .06 .235 .052 1.066 
  (Ex-smoker) -1.355 .477 8.059 1 .00 .258 .101 .657 
 Marital status (ref=single)     .587 3 .89  1     
  (married) -.302 .648 .217 1 .64 .739 .208 2.633 
  (divorced) -.693 .949 .534 1 .46 .500 .078 3.210 
  (widowed) -.368 .680 .292 1 .58 .692 .183 2.626 
 Illness duration (ref=<10years)     7.504 2 .02  1     
  (>=10<20yrs) .390 .266 2.157 1 .02 1.477 1.878 2.487 
  (>=20years) 1.386 .553 6.290 1 .01 4.000 1.354 11.819 
 Presence of diabetes(ref=no) 
 (yes) 
 
.601 
 
.253 
 
5.632 
1 
1 
 
.01 
1 
1.825 
 
1.110 
 
2.998 
 Number of drugs(ref=one)     14.116 2 .00  1     
  (Two drugs) 
 
1.287 .348 13.704 1 .00 3.623 1.833 7.161 
  (Three drugs or more) 
 
1.218 .402 9.172 1 .00 3.380 1.537 7.434 
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Family history (ref=no) 
(yes) 
 
.292 
 
.241 
 
1.472 
1 
1 
 
.22 
1 
1.339 
 
.835 
 
2.147 
    2.510 2 .28 1     
.406 .262 2.395 1 .12 1.501 .897 2.510 
.367 .386 .908 1 .34 1.444 .678 3.074 
Daily drugs regimen (ref=once) 
(twice a day) 
(3 times or more per day) 
           
Regimen interruptions (ref=none) 
               once 
                twice 
               Three times or more 
 
.758 
.814 
.693 
 
.466 
.487 
.425 
3.320 
2.645 
2.798 
2.661 
  3 
  1 
  1 
  1 
.34 
.10 
.09 
.10 
1 
2.133 
2.256 
2.000 
 
.856 
.870 
.870 
 
5.317 
5.855 
4.600 
Frequency of doctor visits   
(ref=once a month) 
 Once every three months 
 Once every 6 months 
 More than 6 months 
 
 
1.060 
.875 
.674 
 
 
.357 
.480 
1.014 
 
11.160 
8.822 
3.320 
.442 
 
  3 
  1 
  1 
  1 
 
.02 
.00 
.06 
.50 
 
1 
2.886 
2.389 
1.962 
 
 
1.434 
.936 
.269 
 
 
5.807 
6.146 
14.322 
Consider HTN serious problem: 
             (ref=always or often) 
              sometimes 
              rarely or   never 
 
 
.986 
.85 2
 
 
.321 
.521
 
10.435 
9.456 
2.676
 
2 
1 
1
 
.03 
.02 
.00
 
1 
2.680 
2.345 
 
 
1.430 
1.845
 
 
5.023 
6.510
Instructions are clear 
            (ref=always or often) 
             sometimes 
             rarely or never 
 
 
.890 
1.744
 
 
.341 
.570
 
13.134 
6.805 
9.347
 
2 
1 
1
 
.01 
.00 
.00
 
1 
2.436 
5.720 
 
 
1.248 
1.096
 
 
4.755 
12.607
Family encouragement 
            (ref=always or often) 
            sometimes 
            rarely or never 
 
 
.734 
1.078
 
 
.318 
.477
 
13.200 
5.336 
5.122
 
2 
1 
1
 
.01 
.02 
.02
 
1 
2.082 
2.940 
 
 
1.441 
1.155
 
 
1.721 
7.481
Stoppage due to side effects 
            (ref= always or often) 
            sometimes 
            rarely or never 
 
 
.434 
.888
 
 
.509 
.529
 
16.157 
.727 
2.819
 
2 
1 
1
 
.00 
.03 
.04
 
1 
1.543 
2.412 
 
 
1.569 
1.146
 
 
4.183 
1.160
The amount you pay to cover your 
share of cost is reasonable 
            (ref= always or often) 
            Sometimes 
            Rarely or never  
 
 
 
.886 
.863 
 
 
 
.320 
.544 
 
 
12.135 
8.449 
2.556 
 
 
2 
1 
1 
 
 
.01 
.02 
.00 
 
 
1 
2.235 
4.260 
 
 
 
1.256 
1.856 
 
 
 
5.044 
11.502 
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5.6. Summary 
• Two hundred ninety two hypertensive patients participated in the current study. 
According to the PHC clinic they attend, 37.3% (n=109) attended Karanteena clinic, 
28.4% (n=83) attended Dora clinic and 34.2% (n= 100) attended Yatta clinic. 
 
• Out of 292 participants, 169 (57.9%) had controlled blood pressure level (<140/90 mm 
Hg) and were considered to be compliant with their treatment plan, whereas 123 
(42.1%) had a blood pressure measurement of ≥140/90 mmHg and were considered 
non-compliant with their treatment regimen. 
 
• Regarding their gender, 41.4% were males and 58.6% were female patients. Their 
ages ranged from thirty seven to eighty seven years and 65.1% of them were over 55 
years of age. 
 
• The majority were house wives (48.3%), only (13.7%) were employed, (18.8%) were 
unemployed, (5.5%) were retired from their jobs and (11.3%) had their own business.  
 
• Only 23.6% of the participants had normal body mass index (18.5-24.99kg/m2), 53.1% 
were overweight (25-29.99 kg/m2) and 23.3% were obese (>30kg/m2). 
 
• 47.6% of the participants were diagnosed as hypertensive by chance while performing 
a routine check up and 52.4% of them were diagnosed after they complained from the 
symptoms of hypertension.  
 
• 65.75% of the participants suffered from hypertension for less than 10 years, 28.08% 
had the diseases for ≥10<20 years, and 6.17% of them were diseased for twenty years 
or more. 
   
• The logistic regression analysis revealed that the following variables had statistically 
significant relationship with the compliance rate: gender, BMI, duration of illness, 
107 
 
being diabetic, number of drugs, frequency of doctor visits, clarity of instructions, 
family support, side effects of the drugs, the perception of hypertension as a serious 
problem, and the cost. 
 
•  The logistic regression analysis revealed that the participants' age group, education 
level, work status, smoking status, marital status, family history with hypertension, 
daily dosing, and regimen interruptions did not have statistically significant 
relationship with compliance. 
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Chapter Six 
Discussion 
6.1. Introduction  
This chapter discusses the major findings of the present study and the interpretation of its 
findings in relation to previously conducted studies found in literature review. The 
participants' characteristics and their responses to the questionnaire items are discussed. Also, 
the relationship between some selected dependent and independent variables are highlighted 
by using many statistical analyses tests. For example, frequency and percentages were 
calculated for each variable and question and cross tabulation was done between some 
independent variables such as age, gender, education level, marital status…..etc and both their 
compliance rate and their answers to all research questions. To test the relationships, further 
logistic regression analysis was utilized. The results of these statistical tests are discussed in 
each of the following sections: 
• Section one: The characteristics of the participants. 
• Section two: Compliance rate. 
• Section three: The participants' responses to the questionnaire items. 
• Section four:  Limitations and recommendations 
6.2. Section one: The characteristics of the current study's participants:  
The majority of the participants were females (58.6%) whereas (41.4%) were males.  
Regarding the ages of the participants, they were middle-aged to elderly and their ages ranged 
between  37-87 years of which 65.1% were above 55 years.  
Most of the subjects were from low socioeconomic status as 13.0% of them reported earning 
≤1000 NIS, 35.1% earned 1001-2000 NIS, 25.3%  earned  2001-3000 NIS and 9.6% indicated 
that their monthly income was more than 3000 NIS, whereas 16.8% were without income at 
all. These findings may indicate that nearly two third of the participants (61%) of the 
participants were under the Palestinian poverty line which is defined by the Palestinian 
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Central  Bureau of Statistics (PCBS) as a monthly income of less than 2375 NIS (PCBS, 
2010). Further, the majority of the participants were house wives (48.3%), only 13.7% were 
employed, 18.8% were unemployed, 5.5% were retired and 11.3% had their own business. 
These findings supported the Palestinian statistics’ findings which showed that the 
unemployment in Palestine reached 33.3% for those aged 15 years and older (PCBS, 2010).  
Regarding their place of residence, 37.3% were from Hebron, 34.2% were from Yatta, and 
28.5% were from Dora city. This  might be because of the proportional sampling that was 
utilized in the current study to select the participants from the three different primary care 
clinics in Hebron area. Also, the majority of the participants (76.4%) were either overweight 
(BMI=25-29.9 kg/m²) or obese (BMI=30 kg/m² or more) while only (23.6%) had normal 
body mass index (BMI=18.5-24.9 kg/m²). 
Furthermore, the vast majority of the participants (70.5%) were married, (3.4%) were single, 
(3.1%) were divorced, and (22.6%) were widowed. This finding may reflect the normal 
distribution of the participants’ age  as 90.8% of the Palestinian elderly males  (>60 years) are 
married, versus 42.8% of the elderly females, and 8.4% of the elderly males were widowed 
versus 49.7% of the elderly females (PCBS, 2010).  
As well, one third (34.9%) of the participants were illiterate, (26.7%) reported receiving 
primary education (1-6 years), (16.8%) got elementary education (7-9 years), (5.2%) reached 
the secondary school and (14.7%) had a college or university degree. These results are similar 
to the data shown by the Palestinian Central Bureau of Statistics which revealed that 44.8% of 
the old people (>60 years) in Palestine were illiterate in 2010 and those who got diploma or 
higher were not more than 8.2% of this age group (PCBS, 2010).  
Finally, more than half of the participants (55.1%) reported that they never smoke cigarettes 
and (37%) were smokers at the study time while (3.8%) were ex-smokers. This could be 
partially explained by the fact that (58.6%) of the study participants were females and 
smoking is unfamiliar habit among women in the conservative community of Hebron. Also, 
the data from PCBS showed that only 30.3% of old males versus only 2.7% of old females in 
Palestine were regular smokers in 2010.  
110 
 
The binary logistic regression analysis was utilized to reveal the relationship between the 
socio-demographic characteristics of the participants and other independent factors and their 
compliance with their treatment plans. This could be beneficial in the treatment of 
hypertensive patients in order to identify whether these variables are  risk or protective 
factors. The findings revealed that only participants' gender and body mass index had a 
statistically significant effect on their compliance. For example, males were 1.591 (OR: 
1.591: 95%CI, 1.992-2.551: p=0.05) times less compliant than females. This was similar to 
the results of a meta-analysis of several studies conducted by Jokisalo et al.(2002) which 
reported a slight difference as 14% of males and 13% of females were non-compliant with 
their antihypertensive medication. Also, Boris & Wijk (2009) and Bloom (1998) found that 
males were less compliant with their anti-hypertension treatment plans than females. Whereas 
Aguado et al. (2009); Al-Sowielem & Elzubair (1998) and Bovet (2002) reported no 
statistically significant differences between males and females which were supported by  Jin 
et al. (2008) who stated that gender is not a good predictor of non-compliance. On the 
contrary, Munger et al. (2007) indicated that women exhibited more non-adherence than men. 
Also, regarding the participants body mass index, the logistic regression revealed that those 
who were overweight were 1.941 (95%CI, 1.047-3.599: p=0.03) times less compliant than 
those with normal BMI and the obese patients were 3.078 (95%CI, 1.509-6.279: p=0.00) 
times less compliant than those with normal body mass index. This suggests the body mass 
index as a risk factor for non-compliance and an obstacle in the controlling of blood pressure 
level as the majority of the overweight (57.8%) and obese (69.1%) were females. This may 
require more attention for increasing the motivation for the healthy life style among the 
patients who attend PHC. These results were in line with other previous observations. For 
example, the American Obesity Association stated that the prevalence of hypertension was 5-
6 times greater among obese compared to non-obese American individuals aged 20-45 years 
(AOA, 2010). Also, Ham & Yang (2011) found that overweight patients had lower rates of 
blood pressure control and suggested to reduce uncontrolled BP, that public health efforts 
should target these patients. Moore et al (2006) who conducted a screening in the public 
schools of Oklahoma, USA found that being overweight as an adult is associated with 
elevated blood pressure and that relative risk (RR) for those with BMI at or above  the 85th 
percentile for their age group and getting persisted high blood pressure after three readings 
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was (RR=6.70; 95% CI, 1.99–22.55). Similarly, Karlberg et al. (2000) stated that among 
children, both systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 
significantly (P=0.05) and positively related to body mass index (BMI) values in obese and 
non-obese groups after adjustment for age, gender, and height. Finally, Lioyd-Jones et al. 
(2000) reported that obesity was significantly associated with lack of blood pressure control 
(OR for BMI≥30 versus <25 kg/m2, 1.49, 95% CI 1.08 to 2.06, P<0.05). 
On the other hand, the logistic analysis of the current study revealed no statistically significant 
relationship between compliance rate and the participants age group (p=0.13), their marital 
status (p=0.89), their level of education (p=0.08), their work status (p=0.08), and their 
smoking status (p=0.08). This was in line with some of the previous studies in literature while 
other studies revealed different results. For example, Alba Aguado et al. (2009) and Bovet et 
al. (2002) reported no statistically significant differences between old and young patient 
regarding their compliance rates, whereas Al-Swielem & Elzubair (1998); Bloom (1998); and 
Jin et al. (2008) found that elderly people were more likely to be compliant than the young. 
On the contrary, Eugenia et al. (2005) found that the compliance was more common among 
those aged <60 years (22.3% vs. 3.8% of those over 60, p=0.005). Another study showed that 
only 20% of the old patient (≥65years) exhibit good compliance (Munger et al. 2007). 
Furthermore, Boris & Wijk (2009) who analyzed and compared data from three different 
countries (Pennsylvania, USA; British Columbia, Canada; and Netherlands) on the 
compliance of hypertensive patients to their treatment found that older age was associated 
with lower rate of compliance in the three populations (Boris & Wijk, 2009). 
Also and in contrary to the current findings, Jin et al. (2008) found that the status of being 
married was positively associated with patient's medication compliance and Morgado et al. 
(2010) revealed that married participants were more likely to be compliant with their 
treatment (OR, 5.3; 95% CI, 1.7-16.4; P<0.004). 
Finally, similar to the current study findings, Bovet (2002) indicated that there was no 
statistically significant association between the education level of the hypertensive patients 
and their compliance rate. While some studies such as Jokisalo et al. (2002) and Jin et al. 
(2008) and Eugenia et al. (2005) found that compliance was higher in those with better level 
of education (17.6% lyceum or university graduates versus 9% in those with lower education, 
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p<0.05). On other hand, Al-Sowielem and Elzubair (1998) showed that the compliance rate 
was significantly higher among illiterate participants than the educated ones (Al-Sowielem & 
Elzubair 1998).  
6.3. Section two: Compliance rate  
The management of hypertension and other chronic diseases is widely practiced in the 
primary healthcare centers in Palestine. This study tried to explore the factors that affect the 
compliance of hypertensive patients with their treatment plan and regimen in the primary 
health care clinics. Although some factors that affect compliance are complex, several factors 
with consistent impact on compliance have been identified. In general, the results of the 
current study are similar to the findings of many other previous studies which appear in the 
literature. These showed that there is a low rate of compliance with the treatment plan of 
hypertension and that non-compliance is an important factor that prevents patients from 
achieving the desired healthcare outcomes (Elzubair et al., 2000; Sigrid et al., 2001; Al-
Soweilem & Elzubair, 1998; Hajjar, 2003; Bovet et al. 1994). 
Many methods for measuring the compliance rate have been reported in the literature, but 
none of them was claimed to be optimal or gold standard. Some of these methods are 
subjective in their nature such as asking the patients themselves to rate their compliance with 
their treatment or by using a standardized, patient-administered questionnaire. Other methods 
are objective approaches such as the tablets count method, the use of medication events 
monitoring devices, revision of pharmacy records, the therapeutic outcome method and the 
biochemical markers analysis. 
In the current study, a combination of both subjective and objective methods for measuring 
the patients' compliance rate were utilized. For the objective assessment of compliance the 
therapeutic outcome that is the patient's blood pressure as an indicator of compliance was 
used because it is an easy, fast and convenient for both of the patients and the researcher. For 
the subjective assessment of compliance the participants were asked many subjective 
questions regarding their compliance with the different aspects of the treatment plan. For 
example, the participants were asked about their regularity on the doctor's appointments, their 
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compliance with the doctor advices regarding their diet and physical activity and finally their 
regularity on taking their medications as prescribed to them.   
The findings revealed that only 57.9% of the participants were complaint with their treatment 
plan and had their blood pressure level <140/90 mm Hg. However, 77.8% of the participants 
reported that they were always / often regular at their doctor appointments, and only 62% of 
them indicated that they always / often take their antihypertensive drugs on regular basis as 
prescribed. Further, only 41.4% of them reported that they "always / often" measured their BP 
on regular basis, 30.8% "always / often" managed to maintain a healthy weight as advised, 
and 48.6% "always / often" ate healthy foods as advised by their doctor. 
Also, the participants' compliance was assessed by six subjective questions that are related to 
important aspects of hypertension treatment. In general, the majority of those participants who 
obeyed the doctor's recommendations had controlled (<140/90 mmHg) blood pressure and 
were considered compliant. Three out of six questions showed statistically significant 
differences between the participants. For example, those who measured their BP on regular 
basis, those who managed to do physical exercise and those who managed to eat healthy 
foods as advised by their doctor had significant lower BP levels than others who did not obey 
the doctors' advices. The participants' compliance according to their statistically significant 
answers to these subjective questions was little bit more than their compliance which was 
assessed by objective measurement of their blood pressure (i.e.57.9%), this difference might 
be due to the exaggerated positive self-reported answers of the participants to these questions 
(See table 5.2).  
These results indicate that the participants' obediance of the doctor's advices increases their 
ability to control their blood pressure significantly. This is in line with the findings from a 
cross-sectional study conducted by Elzubair et al., (2000) which reported that only 59.6% of 
the hypertensive patients were compliant with their treatment plans (Elzubair et al., 2000) and 
similar to the findings of the study conducted by Sigrid et al., (2001) which reported that 58% 
of the participants had their blood pressure controlled and were compliant with their treatment 
plans (Sigrid et al., 2001). Likewise, Cramer et al. (2008), who defined compliance as the 
patient's possession of medications for more than 80% of their days on therapy, found that 
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only 59% of patients were compliant to their treatment in a follow up for one year (Cramer et 
al. 2008).  
These findings were higher than those reported by other studies. For example, in Saudi 
Arabia, Al-Soweilem & Elzubair (1998) indicated that only 34.2% of the participants had 
controlled blood pressure and were compliant with their treatment plans (Al-Soweilem & 
Elzubair, 1998). Also, Bovet et al. (1994) found that in the first month of follow up, only 46% 
of the patients achieved good compliance, and only 26% achieved this level at the twelfth 
month of follow up (Bovet et al., 1994). As well, Eugenia et al. (2005) reported lower 
compliance to antihypertensive treatment and found only 15% while Morgado et al. (2010) 
reported that 48.2% of the participants were highly compliant with their medications and only 
33.0% of them attained controlled blood pressure levels (Morgado et al. 2010).  
On other hand, some studies in the literature reported higher compliance rates than the current 
study. For example, Jokisalo et al. (2002) in Finland found that 86% of the hypertensive 
patients were compliant with their treatment plans (Jokisalo et al.2002) while Cathrene et al. 
(1995) in the United Kingdom revealed that 95% of the participants were compliant with their 
treatment plans (Cathrene et al.1995). These findings of high rates of compliance might be 
due to the high-quality of the healthcare services that are available in these developed 
countries or because they have adopted different mechanisms in measuring the compliance 
rate as Jokisalo used self-reported non-compliance method and Cathrene used the tablet- 
count method. 
Further, as mentioned previously, cross tabulation was done between the participants' 
compliance rate and some independent variables (table 5.1). Findings showed that only 
gender, BMI, and smoking status had statistically significant relationship, while the age, the 
clinic they attended, the marital status, the education level, the work status, and the monthly 
income did not. For example, females were more compliant than males (62.6% vs. 51.2%, 
p=0.05) and those with normal body mass index were more compliant than others with higher 
BMI (72.5% of normal, 56.8% of over weight, 45.6% of obese, p=0.00). Also, smokers were 
(55-57%) less compliant than non or ex-smokers (61-64%). 
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In Palestine, improving the compliance rate of the chronically diseases patients and 
particularly hypertension would be very necessary for the patients and the health care system 
because of the high morbidity and mortality of cardiovascular diseases. For example, the 2011 
bi-annual report of the Palestinian Ministry of Health showed that cardiovascular diseases 
were accounted for 20.44% (n=727) of the total deaths and were considered the main leading 
cause of death in Palestine, whereas cerebra vascular diseases caused 11.3% (n= 402) of the 
total deaths and were the second cause. It also revealed that hypertension alone had caused 
3.59% (n=128) of the total deaths. Also, as hypertension is a well recognized risk factor for 
the cardiovascular and cerebra vascular diseases such as stroke, heart attack ..etc, patients’ 
compliance with their treatment plan and the control of their blood pressure levels could 
reduce these dangerous complication, saving large amounts of money spent on the treatment 
and rehabilitation of such complications and reduce the rate of admissions in the Palestinian 
hospitals. So the compliance rate of 57.9% may not considered high from the public health 
point of view as the findings showed that 65.75% (n=192) of the participants were diseased 
for less than ten years and the logistic regression revealed that their compliance rate will  
decrease if the duration of their disease increases. Further, this percentage (57.9%) may not 
reflect the actual percentage of the patients who are compliant with their hypertensive 
treatment plan because the data collection depends on self reported questionnaire so the 
patients may exaggerate their answers. This conclusion is supported by the results which 
showed that as high percentages of   the participants (53.4%) were readmitted to the hospitals 
once or more because of their disease and 46.6% were never admitted. So the high admission 
rate may reflect the non compliance of these patients with their treatment plan. In order to 
overcome this discrepancy between the findings of the self reported questionnaire and their 
actual compliance rate, further quantitative studies are required to assess the relapse rate 
among the hypertensive patients in Palestine by using other methods such as checking the 
number of their readmission to the hospitals as recorded in their files or  performing blood test  
In summary, these findings may require appropriate management and monitoring of 
hypertension by the health team in primary care,  the patients and their families. 
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6.4. Section two: The participants' responses to the questionnaire's items  
This section discusses the other 9 variables that may affect the compliance rate of the 
hypertensive patients with their treatment plan as the follows: 
6.4.1. Medical history 
A medical history is a record of health information about a person and his or her close 
relatives. These factors can give clues to medical conditions that they have and help the 
healthcare professionals to determine whether an individual is at an increased risk of 
developing a particular condition or not. Knowing one’s medical history allows the health 
care provider to take steps to reduce his or her risk of developing the disease or its 
complications and to form a suitable treatment plan such as recommending more frequent 
screening or by encouraging regular checkups and adopting healthier lifestyle (Louise, 2011).  
In the current study, slightly less than half (47.6%) of the study participant were diagnosed by 
chance while doing a routine check of their blood pressure. This could be justified by the 
asymptomatic nature of hypertension which necessitates the developing of an effective 
screening strategy for hypertension as otherwise such big percentage (47.6%) will go 
unrecognized and untreated. Bovet et al. (2002) found that the mean compliance rate for the 
participants who knew their blood pressure before diagnosis was significantly higher than 
those who did not know (84% vs. 50%, p=0.028) (Bovet et al. 2002). Whereas, Al-Sowielem 
& Elzubair (1998) did not find any significant effect of the way of diagnosis of hypertension 
on the patients compliance rates (Al-Sowielem & Elzubair, 1998). 
Also, the majority of the participants (69.5%) reported suffering from different co-morbidities 
such as diabetes, asthma and arthritis. For example, 32.2% of them were diabetic, and as a 
consequence, they had to take other drugs to treat these co-morbidities. This might increase 
the total number of drugs they have to take every day, add more pressure on them, increase 
their costs and may compromise their compliance with their treatment plans. The logistic 
regression showed that being diabetic and hypertensive at the same time significantly  
decreases the patient's compliance rate as diabetic patients were 1.825 times less likely to 
have their blood pressure controlled than those non-diabetic hypertensive patients (OR, 1.825; 
95%CI, 1.110-2.998; P=0.01). This finding was in line with those reported by Sigrid et al. 
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(2011) who found that the hypertensive patients who suffered from diabetes as a co-morbidity 
were significantly less likely to be compliant and less to reach the BP control level than those 
without diabetes (26% vs. 64%, p < 0.001) (Sigrid  et al. 2011). Similarly, Morgado et al. 
(2010) found that diabetes hypertensive patients were less likely to have controlled blood 
pressure  (OR, 4.4; 95% CI, 1.4-13.5; P<0.011) than those with hypertension alone (Morgado 
et al. 2010). As well, Munger et al. (2007) stated that the patient's adherence with the 
antihypertensive agents was consistently lower in patients with other chronic conditions. On 
the contrary, Al-Sowielem & Elzubair (1998) claimed that the presence of other chronic 
disease did not significantly affect the compliance rate (Al-Sowielem & Elzubair, 1998). 
Further, more than half of them (56.8%) reported a family history of hypertension. Many 
previous studies (Al-Sowielem & Elzubair 1998; and Nuesch 2001) found that the family 
history had no effect on the patient's compliance rate. Similarly, in the current study, the 
logistic regression of the family history was not statistically significant (OR, 1.339; 95%CI, 
0.835-2.147; p=0.22). However, as more than half of the participants reported a family history 
of hypertension, this might be taken into account as a risk factor in any screening program 
that might be implemented in the future for early detection and treatment of hypertension.  
Regarding medication, findings showed that there are problems  with frequent changing of 
drugs by the treating doctors and patients’ interruption of their schedule. For example, 
frequent changing of antihypertensive drugs or drugs' regimen make it difficult for the patient 
to adhere strictly to the treatment plan as they need time to get acquainted to the new regimen 
(Eugenia et al. 2005). Eugenia et al. (2005) found that the compliance rate was better among 
those participants who had never changed their antihypertensive drugs or regimen (95.1% 
versus 25.5% among those with at least one change, p<0.005) (Eugenia et al. 2005). In the 
current study, only 26.7% of the participants reported that they had never changed their drugs' 
regimen while the majority (73.3%) had changed their drugs' regimen once or more. So it is 
important that the primary care doctors consider the effect of changing drugs on the 
compliance of the patients with their treatment plan. 
Also taking antihypertensive drugs regularly as prescribed is an important factor to keep 
blood pressure under control and within the recommended level. In this study, only 11% 
(n=32) of the participants stated that they had never interrupted their drugs' regimen, 50% 
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(n=145) did that once or more and 39.4% (n=115) said that they did not ’t remember. The 
logistic regression revealed that it had no statistically significant (p= 0.34) relationship with 
their compliance rate.    
Finally, self and regular measurement of blood pressure is useful for the assessment of the 
treatment effects by the doctor and is valuable for the patients in improving the management 
of their high blood pressure. The patient gains a strong sense of responsibility for his/her 
health and become more motivated to control hypertension by improved diet, physical activity 
and proper use of medication which can reduce the complications of hypertension and 
minimize the frequency of patient's hospitalization (Morgado et al. 2010). Checking blood 
pressure at a home setting where the patients spend most of their time is an important aspect 
of managing hypertension in order to help the patients and their treating doctor to detect any 
possible complication at early stages and it is highly recommended by the American Heart 
Association (AHA, 2010). A significant percentage of the patients (67.2%) of the current 
study reported that they did not have a sphygmomanometer at homes. One possible 
explanation is that most of the participants were poor and unemployed so they can not buy a 
blood pressure measuring machine or they may not consider it as an important device to have 
at home. Further, they may depend on health professionals to measure it during their visit to 
the clinic because they are not trained to measure it by themselves. 
 In addition to the previous problem of the lack or the unavailability of blood pressure 
devices, the findings supported the lack of blood pressure measurement training of the 
patients by the health professionals which affected the patients’ frequency of measuring their 
blood pressure. For example, only 5.1% of them reported that they measured their blood 
pressure every day and more than half (53.1%) of them reported that they were "rarely or 
never" trained to measure their blood pressure by health professionals. Morgado et al.(2010) 
indicated that the lack of blood pressure regular monitoring was associated with higher rates 
of non-compliance and uncontrolled blood pressure (OR, 2.5; 95%CI, 1.2-5.2; P=0.015) and 
similar results were reported by Coyne et al. (2000). Home monitoring is an easy step that the 
patient can perform  to improve his/her condition and  blood pressure monitors are available 
widely in the market and in different models (manual and digital devices) and prices. So it's 
important to know the right method of blood pressure measurement to avoid mistakes. This 
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could only be achieved by training the patients by qualified professionals such as nurses and 
doctors (ESH, 2008). There is a need to increase the awareness of nurses and medical staff 
about the importance of self management  by the patients themselves in primary care because 
this action may help in decreasing the work load on the staff and encouraging  the client to 
monitor any complication early. 
6.4.2. Participants' knowledge and perceptions 
The participants’ knowledge and perceptions about hypertension were explored and the 
results revealed a variation in their knowledge. For example, the participants’ answers 
revealed poor knowledge regarding the possibility of preventing hypertension by modifying 
its risk factors, the differences in hypertension's risk between males and females, the effect of 
physical exercise on controlling blood pressure and the role of heredity in developing the 
disease.  
For example, only 17.1% of the studied patients believed that the risk of hypertension could 
"always or often" be prevented and less than one third (27.8%) believed that the susceptibility 
of getting hypertension differs according to gender. Also 42.6% of them believed that 
physical exercise could "always or often" help them to control their hypertension. As well,  
despite the high percentage of positive family history of hypertension  (56.8%), only 32.5% of 
the patients were aware about the role of hereditary in the etiology of the disease and there 
were slight differences between the none educated and educated patients regarding this 
statement. For instance,  36.2% of the non-educated and 34.7% of those who got elementary 
education versus 34.9% of those who got university education stated that they "always or 
often" thought that hypertension has hereditary basis.  Further less than half of the participants 
(42.6% (n=124)) believed that physical activity "always or often" helped them in controlling 
their blood pressure. 
The lack of knowledge among hypertensive patients is also supported by Jin et al. (2008) who 
found that the patients’ knowledge about their hypertension diseases and treatment aspects is 
not always adequate, as some patients lack understanding of the role their therapies play in the 
treatment while others lack knowledge about the disease itself and the consequences of poor 
120 
 
compliance. He concluded that the patient's education and counseling about the disease and its 
treatment are very important to enhance compliance (Jin et al. 2008). 
On contrary, the current results revealed better knowledge in other aspects of the disease such 
as the effect of old age on the risk of developing the disease, the effect of salt intake on blood 
pressure levels, the effect of stress and anger on hypertension control and their perception of 
hypertension as a serious problem. For example, more than two thirds (67.1%) of the 
participants thought that hypertension is "always or often" a serious problem and 60.9% of 
them believed that it could "always or often" lead to other serious problems such as stroke, 
heart attack and renal failure. This influenced the participants' compliance to their treatment 
as those who "sometimes" considered it to be serious were 2.680 (95%CI, 1.430-5.023; 
p=0.02) times less compliant when compared to those who considered it to so "always or 
often". As well, those who answered by "rarely or never" were 2.345 (95%CI, 1.845-6.510; 
p=0.00) times less compliant than those who responded "always or often" to the related 
question. This was in consistency with the results of Morgado et al. (2010) who reported that 
the patient's unawareness of the hypertension risks double-folds (OR=2.1, P=0.026) their non-
adherence. Also, Bovet et al. (2002) stated that those patients who had good health awareness 
in general were better compliers with their treatment plans and patients who were 
knowledgeable about the risks of hypertension were more compliant to treatment than others 
(OR, 2.1; 95%CI, 1.1-4.2; P<0.026) (Morgado et al. 2010). Similar findings were reported by 
Coyne et al. (2000).  
In addition, 66.7% of them believed that the risk of the disease increases by age, two thirds 
(66.8%) reported that regulating salt intake could always or often help to control their blood 
pressure, and finally, 73.6% of the participants believed that stress and anger "always or 
often" affects blood pressure level. This might be gained through their experience with the 
disease or through the advices frequently given to them by the treating doctor or medical staff 
such as being relax and staying away from nervousness. Finally, 54.8% (n=160) of them 
reported that their adherence to the diet regimen and the life style changes recommended to 
them by their treating doctors were "rarely or never" affected by the chronic nature of their 
hypertension. 
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Moreover, the comparison between the different clinics revealed a variation regarding their 
knowledge. For example, those from Yatta clinic showed poor knowledge regarding the 
complications of high blood pressure (55% of Yatta versus 59% of Dora and 67.9% of 
Karanteena clinic participants), and gender risk in comparison with other clinics  (33% of 
Yatta versus 24.1% of Dora and 25.7% of Karanteena) (p=0.01).  
Finally, some questions were answered positively by low percentage of clients but their 
answers may indicate further risk in future from the point view of public health. For example 
19.8 of the participants reported that they "always or often" felt safe or not necessary to take 
their medications and 16.8% of them thought it was "always or often" safe to increase or 
decrease their dose without consulting the treating doctor. These findings emphasize the 
important role of the primary healthcare providers in educating the patients during their clinic 
visits about the risk of stopping or changing the dose of their medication without consulting 
their doctors  
The knowledge about the disease and its treatment is an important factor in achieving the 
targets of the therapy and affect the insight and attitude of the patients toward their treatment 
plan and disease (Jokisalo et al. 2001). Some researchers suggested awareness campaigns and 
mass screening programs to successfully carry out public health interventions, by addressing 
the existing gaps in the prevention and the control of hypertension and other cardiovascular 
diseases (Gupta, 2009). For example,  it was found that the participants who thought that the 
current life style was important for future health achieved better (81%) compliance rate versus 
(51%) for other participants (Bovet et al. 2002). As well, it was found that the participants 
who were aware of the target blood pressure for their cases were more compliant to their 
treatment plans than those who were not aware of that (OR, 3.7; 95% CI, 1.9-7.4; P<0.001), 
and the patients who knew the exact indications of their drugs were more compliant to 
treatment plans (OR, 2.4; 95%CI, 1.1-5.2; P<0.021) (Morgado et al. 2010).  
Therefore more effort should be dedicated to educate the patients in primary health care  
clinics about their disease and to correct their misconceptions by conducting seminars or 
workshops and devoting more of the staff time to the patients’ education. 
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6.4.3. Duration of the disease and treatment period 
The long duration of the disease and treatment period may make the patients feel bored and 
affect their desire to take their drugs regularly as prescribed by their doctor (Chapman et al. 
2005). The results of this study revealed that the majority of the participants (65.75%) 
suffered from hypertension for less than ten years, 28.08% of them were having the disease 
for ≥10<20 years, and 5.82% were diseased for twenty years or more. This long duration 
affected their desires to take their medications as about half of the participants (50.7%) 
indicated that the long duration of their disease "always or often" affected their desire to take 
their antihypertensive medications. The logistic regression analysis of the current study 
revealed that the patients’ compliance was inversely and significantly related to the life span 
of the disease and those who had a long duration of the disease were less compliant than those 
who had short duration. For example, those who were ill for ≥10<20 years were less 
compliant than those who were ill for less than 10 years (OR,1.477; 95%CI, 1.878-2.487; 
p=0.02) and those who were diseased for 20 years or more were four times less compliant 
when compared with those who were diseased for less than 10 years (OR, 4.0; 95%CI, 1.354-
11.819; p=0.01). This result was on contrary with Nuesch et al. (2001) who found that there 
were no differences between compliant and non-compliant patients depending on the duration 
and extent of the treatment of their hypertension but similar to Bovet et al. (2002) study which 
found that fewer than half (46%) of the new hypertension patients followed the achieved 
satisfactory compliance rate in the first month, and only about one-quarter (26%) achieved 
this level by the twelfth month. Likewise, Jin et al. (2008) stated that the duration of treatment 
period adversely affected the compliance and that acute illnesses are associated with higher 
compliance than chronic diseases (Jin et al. 2008). Also, Chapman et al. (2005), who defined 
compliance as at least 80% of days potentially covered with medications, found that  the 
compliance rate of the patients decreases as the duration of the treatment increases dropping 
from 45% at 3 months to 36% at 12 months after initiation of therapy (Chapman et al. 2005). 
Therefore the healthcare provider should consider this problem and continuously encourage 
the patient to adhere to the treatment plan. 
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6.4.4.   Treatment schedule 
The treatment schedule or the daily drug's regimen is a very important factor that may affect 
the patient's compliance. The simpler the treatments' schedule, the more the patient's 
compliance. In order for the antihypertensive medications to be effective, the patient should 
take them exactly as they are prescribed. This is called compliance or adherence. It means 
taking the correct doses of the prescribed medication(s) by the correct way and at specific 
time intervals as they are supposed to take them. It’s the responsibility of the treating doctor 
to choose the most simple and effective treatment schedule for his/her patients after 
discussing that with them (Nuesch et al., 2001). 
In the current study, the findings revealed that slightly more than one third (35.29%) of the 
study participants were having single daily dose, 51.36% were on twice daily dosing (BID) 
and 13.35% were on three doses a day (TID) or more. This affected their desire to take their 
medications as nearly half of the participants (51.4%) indicated that the frequent dosing of 
their drugs "always or often" affected their desire to take them. However, the logistic 
regression analysis showed that the frequency of daily dosing did not have a statistically 
significant effect on the compliance rate or on the blood pressure control level (OR,1.5; 95% 
CI, 0.897-2.510; P=0.28). It was in contrary to the findings of many previous studies which 
showed that simplifying the medication regimen significantly affected the compliance with 
the treatment plans. For example, Nuesch et al. (2001) found that the patient's compliance 
dropped significantly from 93% (SD 16%) with a once daily dosing regimen to 77% for twice 
daily dosing regimen (Nuesch et al. 2001). Also, Eugenia et al. (2005) reported that 
compliance was more common among those taking one tablet per day than those taking more 
than one tablet (37.8% vs. 8.2%, p<0.005) (Eugenia et al. 2005) and Iskedjian et al. (2002) 
found that the mean compliance of those on once-daily dosing was 91.4% and exceeded the 
compliance among those with multiple daily doses (83.2%); OR=4.46, P< 0.001 (Iskedjian et 
al. 2002). Similar results were also reported by Dunbar-Jacob et al.(2003); Dulmen et 
al.(2007); Thrail et al.(2004); and Boris & Wijk (2009), Eisten et al.(1990), Lee et al. (1996), 
Schroeder et al.(2004), Jing Jin et al. (2008), Coyne et al. (2000) and Jokisalo et al. (2002). 
Further, in addition to the frequent dosing, the majority of the participants were taking more 
than one drug as (57.2%) used two drugs for their hypertension, (21.6%) of them had a single 
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antihypertensive drug, and 21.2% took three drugs or more. The logistic analysis of the study 
findings revealed that the patient's compliance rate was more with mono-therapy than with 
those taking two, three drugs or more (p=0.00). For example, those patients who were taking 
two drugs were (OR, 3.623; 95%CI, 1.833-7.161; p=0.00) less compliant than those who were 
taking only one drug and those who were taking three drugs or more were (OR, 3.380; 
95%CI, 1.537-7.434; p=0.00) less compliant. This coincides with results from previous 
studies of Ingrersoll & Cohen (2008), Dulmen et al. (2007), Bloom (1998), Sigrid et al. 
(2011) and Munger et al. (2007) which also showed that mono-therapy significantly improved 
compliance whereas the literature review conducted by Jin et al. (2008) and the study 
conducted in Saudi Arabia by Al-Sowielem & Elzubair (1998) concluded that compliance did  
not correlate with the number of drugs prescribed. Interestingly, other studies found that the 
higher number of medications predicted better compliance (George & Shalansky, 2007). For 
example, Jokisalo et al. (2002) reported that compliance was more prevalent in the 
hypertensive group with two drugs than in that with one drug (OR: 0.47, 95% CI: 0.23-0.97) 
(Jokisalo et al.2002). 
Furthermore, because of the occurrence of the side effects of the drugs taken for the treatment 
of hypertension the patients may hesitate to take them which may affect their compliance 
negatively. The findings of the current study revealed that 23.3% of the participants reported 
that their drugs "always or often" had side effects which affected their health, and 32.2% 
indicated that as "sometimes". The logistic regression analysis revealed a statistically 
significant (p=0.00) relationship between the side effects and the patients non-compliance 
with their treatment plans. For example, those who said they "sometimes" had drugs' side 
effect were (OR, 1.543; 95%CI, 1.569-4.183; p=0.03) more complaints than those who 
"always or often" experienced the side effects and those patients who indicated that they 
"rarely or never" had side effects were (OR, 2.412; 95%CI, 1.146-1.160, p=0.04) more 
compliant than others. 
Also Jokisalo et al. (2002) found an association between non-compliance and the experience 
of adverse drug effects, and the patients who had experienced adverse drug effects were 
significantly more likely to be non-compliant (17%) than those without adverse drug effects 
(11%) (OR, 1.41; 95% CI, 1.03, 1.94; p<0.05). As well, Morgado et al. (2010) concluded that 
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those patients who reported drugs side effects were less likely (OR=3.7, 95% CI, 1.6-8.3; 
P<0.002) to be compliant with their medications. Similar results were reported by Guo et al, 
(2001); Thrail et al. (2004); Bloom (1998); Coyne et al. (2000); and Munger et al. (2007). 
Therefore, one suggested strategy to overcome this problem is that the treating doctor may 
titrate the drug's dose to every patient individually, so that he/she can determine the minimum 
effective dose of each drugs. Also, he/she can prescribe combination pills which contain more 
than one drug but in less amounts. Further, close monitoring of drugs’ side effects and their 
affects on patients’ compliance in primary care can be done by increasing doctors’ awareness 
about  their effect on patients’ compliance. 
6.4.5. The patient- prescriber relationship 
The patient-prescriber relationship is another crucial factor that may affect the patient's 
compliance, and a healthy relationship based on trust, support, empathy, and respect could 
improve the compliance rate (Jin et al. 2008; Coyne et al. 2000; and Thrail et al. 2004).  
Dulmen et al. (2007) reported that good communication between the doctors and the patients 
increases compliance as it increases the patients' knowledge about the disease and its 
treatment and correct the misconceptions that they may have about their disease. As well, it 
improves the trust and the good relationship between the patient and the physician (Dulmen et 
al. 2007). 
In general, the findings revealed positive relationship between the patients and their treating 
doctors as the majority of them (61.6%) reported that the doctor "always or often" treated 
them with respect during the visit. Also, 53.1% of the participants indicated that they were 
"always or often" seen by the same doctor in every visit they did to the clinic, whereas 20.2% 
of them stated that they were seen by different doctor in every visit. Being followed by the 
same doctor is very critical for building trust between the patient and his/her treating doctor, 
Eugenia et al. (2005) found that the compliance rate among those patients who never changed 
their doctor was better than others who had changed doctors (33.8% versus 6.9%, p<0.005). 
Further, they also found that the compliance was more common among patients being 
followed by the private doctor (25% versus 10% of those followed by a doctor on duty, 
p<0.005). This difference was attributed to the effect of counseling, which was more 
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frequently provided by the private doctors (59.3% versus 9.3% of doctors on governmental 
duty, p< 0.001) (Eugenia et al. 2005). 
When comparing between the different clinics, the weak relationship between the patient and 
the medical staff was reported by the participants in Yatta clinic and the strongest was 
reported in Dora clinic. For example, 47% of Yatta versus 78.3% of Dora and 62.4% of 
Karanteena participants reported that they were "always or often" treated with respect by the 
doctor (p=0.00). Also, 23% of Yatta versus 14.4% of Dora and 17.4% of Karanteena 
participants said they were "sometimes" made feel foolish by the treating doctor (p=0.03). As 
well, 35% of Yatta versus 16.9% of Dora and 27.5% of Karanteena participants indicated that 
they were "always or often" ignored by their doctors (p=0.04). Further, only 49% of Yatta 
versus 69.8% of Dora and 68.8% of Karanteena participants said they were "always or often" 
treated with respect by the medical staff (p=0.03). 
On other hand, the findings revealed deficits in some of the communication skills such as the 
lack of listening and the hurries to treat the patients. For example only 36.6% of the 
participants stated that the doctor "always or often" listened carefully to them, and about half 
of them (50.7%) reported that the doctor "always or often" hurried too much in order to finish 
the visit quickly, while 28.4% responded as "sometimes". One possible explanation for these 
findings is the work load and the large number of patients who attend these clinics as there are 
5000 patients who regularly attend Karanteena clinic for the health services (448 of them are 
hypertensive), 3700 patients attend Dora clinic (342 of them are hypertensive), and 4500 
patients attend Yatta clinic (410 of them are hypertensive). As a consequence, there is may be 
no enough time for counseling or communication between the doctors and the patients rather 
than prescribing medications. These findings may emphasize the need to improve the 
relationship between the patients and the medical staff by improving their communication 
skills. Further, it may be advisable that the administrations of these clinics do the necessary 
amendments to lower the work load of the staff or to arrange the case loads over the working 
days in order to spare some time for the communication and the education of patients in order 
to answer their questions. As good communication is one of the best ways to build trust and to 
start a good relationship between the doctor and his/her patients (Cooper et al 2009), it has 
been found that communication skills programs for the doctors treating hypertensive patients 
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were positively associated with the patients’ compliance and hence improve their health 
outcomes by increasing patient's engagement, activation, and motivation to comply with the 
treatment plan of their disease (Cooper et al 2009). 
6.4.6. Clarity of instructions 
The clarity of the instruction given to the patients regarding the drugs usage and the necessary 
life style modifications is another factor that may motivate the patients to follow their 
treatment plans. Also the medical recommendations should be simple and clear for them. The 
findings of the current study did not reveal a complain regarding this issue as the majority of 
the participants (72.6%) reported that the drugs-usage instructions were "always or often" 
clear and simple, 20.2% reported that the instructions were "sometimes" clear and 7.2% said 
they were rarely if at all clear to them.   
The logistic regression analysis revealed that the clarity of the medical instructions directly 
and positively affects the rate of compliance of the hypertensive patients. For example, the 
participants who reported that the instructions were "sometimes" clear to them were (OR, 
2.436; 95%CI, 1.248-4.755; p=0.00)  less compliant than those who indicated that they were 
"always or often" clear whereas those who reported that the instructions were "rarely or 
never" clear for them were less compliant with their treatment plans (OR, 4.260; 95%CI, 
1.856-11.502; p=0.00). 
This is in consistency with the finding of Jokisalo (2002) who found that patients with 
system-oriented problems such as lack of clear instructions and information were four times 
more likely to be non-compliant with their treatment plans. As well, Mahender et al. (1978) 
and Torrey (2009) stated that the clarity of written instructions for taking medications 
positively influenced the patients' compliance with treatment. 
6.4.7. Family support 
The social and family support affect positively e patient's  attitudes towards their diseases and 
its treatment, and their motivation to comply with their  treatment plan and to implement it as 
prescribed by their treating doctors (Dulmen et al. 2007). 
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For example, Jin et al. (2008) stated that the patients who had an emotional support and help 
from the family members, the friends or the healthcare providers were more likely to be 
compliant with their treatment plan. In addition, Schroeder et al. (2004) reported that the 
motivational strategies applied on the patients were successful and they increased their 
adherence by 23%. Also, Dulmen et al. (2007) found that the practical social and family 
support yielded significantly high effect on patients' compliance and  there was a 0.65 SD 
difference in compliance between the patients receiving the practical social support for their 
treatment regimens and those did not receiving this  support. 
The current study findings showed  that most of the participants received a good support from 
their family members including financial aids, taking medication, seeking medical services 
and encouragement to follow up their treatment. For example, 71.8% of them reported that 
they "always or often" were  reminded about their medications by their family members, 
64.8% indicated that they "always or often" got help from their family members in taking 
their medications, and 62.3% stated that they "always or often" had financial support 
whenever they needed. Further, 69.5% of them reported that their family members "always or 
often"  helped them to reach the medical facility when they were ill, and 52% of them said 
they were "always or often" encouraged by their family members to comply with their 
treatment plans. One possible explanation of the high percentage of family support is the 
nature of the Hebron community and its social values which emphasize the role of the 
extended family in protecting its members and providing a help and a support particularly for  
sick people. 
Also, the logistic regression of the current study revealed that family encouragement had 
statistically significant (p=0.01) effect on the patients' compliance as those who reported that 
they "sometimes" received family encouragement were (OR, 2.082; 95%CI, 1.441-1.721; 
p=0.02) less compliant than those who "always or often" received such support and those who 
said that they "rarely or never" got family encouragement were (OR, 2.940; 95%CI, 1.155-
7.481; p=0.02) less compliant with their treatment plans.  
Moreover, the participants of Karanteena reported receiving better family support than those 
of Dora and Yatta clinics. For example, 24% of Yatta versus 26.5% of Dora and 44% of 
Karanteena participants reported that they "always" got financial help from their family to buy  
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their medications when they needed (p=0.04). As well, 59% of Yatta versus 71.1% of Dora 
and 77.9% of Karanteena participants stated that their families "always or often" helped them 
to reach the medical facility (clinic or hospital) when they were tired or sick (p=0.00). So, the 
patients' families in Yatta clinic could be included in an education programs that target 
patients’ support to ensure their support and participation in the treatment plans of their 
relatives.  
Furthermore, when family support was compared between patients according to the duration 
of their disease, the newly diseased patients (<10years) reported more family support and 
encouragement that other patients who were diseased for longer periods. This could be 
justified by the fact that the long duration of disease may affect the patients as well as their 
families and may decrease their desire to follow up their treatment plan. 
6.4.8. Regularity on the follow ups and the treatment plan 
In addition to the previous variables, the study explored some behavioral aspects of the 
patients' non-compliance such as the frequency of doctor visits and their regularity on the 
follow ups. Regular contact between the patient and the treating doctor has been shown to 
improve the patients' regularity on their treatment plan and to reduce the possible 
complication of hypertension that evolve from a poor drug compliance (Burnier, 2007).  
The findings of the current study revealed high rate of follow up as  the majority of the 
participants (77.8%) reported that they were "always or often" regular at their doctor's 
appointments. Also 53.8% of them were visiting their doctor regularly every month, 21.9% 
did that more than once a month, 14.4% every three months, and only 8.2% of them were 
visiting their doctor less frequently. One possible explanation of the high commitment of the 
patients to their appointment is their easily access to the medical services in their place of 
residence and their need to receive their freely drugs monthly. Another possible explanation is 
that as these patients consider or perceive their disease as a “serious” as mentioned 
previously, this may motivate them to follow up their medical visits with their doctors. 
Further the majority of the participants had a family history of hypertension, so they may 
learn this behavior from their family members in addition to the family support. Finally, the 
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data collection of this study depends on self reported questionnaire so the participants may 
exaggerate their answers  
The logistic regression of the findings of the current study revealed that the frequency of 
doctor visit significantly improved the patients' compliance as those who were visiting their 
doctor every three months were (OR, 2.886; 95%CI, 1.434-5.807; p=0.00) less compliant 
when compared to those who visited their doctor regularly every month. 
Also Bovet et al. (2002) reported that among the participants who attended follow up 
regularly, satisfactory compliance was found initially in a large proportion of the participants 
(73.9%), which decreased to 52.2% by the sixth month and 54.5% by the twelfth month. Also, 
the participants who attending follow up irregularly, satisfactory compliance was found only 
among 29.4% of the patients by the first month and 5.9% by the twelfth month (Bovet et al. 
2002). Likewise, Al-Sowielem & Elzubair (1998) stated that the patients who were regular on 
follow-up had higher compliance rate than those who were irregular (37.8% vs. 17.6%, 
p<0.02) (Al-Sowielem & Elzubair 1998).   
6.4.9. The costs 
The cost of the treatment is the final factor that this study explored because the chronic 
diseases and particularly hypertension are costly and the therapy may constitute a large 
portion of patients’ income. In this study, despite the fact that more than 95.8% of the 
participants pay only small amounts of money for their treatment plan as a co-payment, the 
logistic regression analysis revealed that the cost was an important factor that affected  their 
compliance significantly. However, the participants’ answers varied regarding this issue. For 
example, 41.7% of the participants said that the amounts they paid to cover their medical 
needs were "always or often" reasonable, 30.8% stated that as "sometimes" and only 14.7% of 
them said their compliance was "always or often" affected by the high cost of their treatment 
plan. This was not a surprise because the participants were selected from the primary health 
care clinics which belong to the Palestinian Ministry of Health in which drugs are free and the 
patients may pay only very small amount of co-payment. It was reported that 19.56% of the 
population of the West Bank (105223 families = 491887 individuals) were covered by one 
form of  different types of health insurance whereas Gaza Strip's population were 100% 
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covered by free health insurance (Palestine MoH 2010). However, one possible reason for the 
complaining of the participants regarding the cost is the low rate of employment rate among 
them as 16.8% of them were without income at all and more than 65.1% of them were poor 
according the criteria of the Palestinian Central Bureau of Statistics as shown in section one of 
this chapter. 
This was supported by the findings of the logistic regression which revealed a significant 
relationship as those participants who stated that the amounts they pay to cover their share of 
the treatment plan were "sometimes" reasonable were (OR, 2.235; 95%CI, 1.256-5.044; p= 
0.02) less compliant that those participants who said that the amount was "always or often" 
reasonable, and those who indicated that the amounts were "rarely or never" reasonable were 
(OR, 4.260; 95%CI, 1.856-11.502, p=0.00) less compliant with their treatment plan. 
When participants were compared according to their level of education, those with high level 
of education were the least to have problems with the cost. For example, 44.1% of those who 
got university degree versus 30.5% of the none educated participants stated that they "rarely 
or never" had a problem to cover their share of the costs. One possible explanation is that 65% 
of those holding university degree were earning more than 2001 NIS a month versus 20.20% 
of the none educated and 30.3% of the none educated were without income at all versus 00% 
of those with university degree (p=0.00). When comparing the participants according to the 
clinic they attended, the results showed that 66.68% of Yatta participants were poor (earning 
≤2000 NIS) or without income at all in comparison with 62.21% of Dora participants and 
62.04% of Karanteena participants (p=0.043). This may indicate the need to revise the co-
payment policy in PHC in poor areas such as Yatta by the Palestinian Ministry of Health.   
Previous studies such as Elzubair et al. (2000) revealed that the only variable that was 
positively and significantly associated with non-compliance was being unable to buy the 
drugs (p<0.001) (Elzubair et al. 2000).  Similarly, Guo et al (2001); Sigrid et al. (2011); 
Munger  et al.(2007); Coyne et al. (2000); and Jing Jin et al. (2008) showed that the financial 
problems of the patients or their inability to purchase their drugs, specially those who had no 
insurance cover or had low income, significantly and adversely affects their compliance with 
their treatment plans. 
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6.5. Conclusion  
This might be the first study in Palestine assessing the compliance rate of the hypertensive 
patients with their treatment plan and regimen. In general, the findings  indicated low level of 
compliance (57.9%) with the treatment plans among the hypertensive patients who attended 
the PHC clinics in Hebron area. However, 77.8% of the participants reported that they were 
always / often regular at their doctor appointments, but only 62% of them indicated that they 
always / often take their  antihypertensive drugs on regular basis as prescribed. Therefore, 
there was a discrepancy between compliance rate as reported by the participants and the high  
rate relapse or readmission to the hospitals because of their disease.   
Also the findings of this study revealed many strength factors as reported by the participants  
such as the availability of the participants' family support, the clarity of the drugs-usage 
instructions, the good relationship between the patients and the medical staff and their 
regularity on appointment and follow up. On the other hand, it showed weaknesses in some 
aspects such as their knowledge about their disease, their communication skills with the 
treating doctor such as listening, the effect of the duration of illness on their  desire to take 
their medication  and frequent dosing. 
Further, the logistic regression of the study findings revealed statistically significant 
relationship between the participants' compliance rate and their gender, BMI, the duration of 
their illness, having diabetes as a co-morbidity, the number of drugs they are taking, the 
frequency of doctor visits, their family support, the clarity of the medical instructions, the side 
effects of their drugs, their perception of hypertension disease and the cost of their treatment 
plan.  
On the contrary, the logistic regression showed that the participants’ age, education level, 
work status, smoking status, marital status, family history, daily dosing, and regimen 
interruptions did not affect their compliance with their treatment plans.   
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6.6. Section four: limitations and recommendations 
6.6.1. Limitations: 
There are some limitations in the current study. For example, this study utilized a cross-
sectional design, due to the limitation of the available time and scarcity of resources. This 
makes it difficult to assess accurately the magnitude of effect exerted by each factor or to 
differentiate precisely whether the interaction between these factors would be additive or 
antagonistic. Also, this type of design may have limitations in the generalization of the results 
to a wider population since it measures both the prevalence of the outcomes and the 
determinants in a population at a point in time or over a short period of time (Horn et al. 
2008). Nevertheless, the cross sectional studies are highly useful for descriptive purposes and 
it is relatively quick, cheap and easy to undertake (Grove & Burns, 2005; Monsen & Horn, 
2008).  
The data collection for this study was done using a self-reported questionnaire. So, the 
reliability of the results may be affected, since the participants may hesitate to express their 
points of view or they may describe their own thought, feelings or behaviors in spurious way 
to please the researcher (Mitchell, 2000). Further, the sample included the users of the 
governmental primary healthcare services and only in Hebron district which may add 
limitation on the generalization of the results to other areas of Palestine or to the users of the 
private healthcare sector. 
6.6.2. Recommendations: 
According to the findings of the current study the following recommendations are suggested 
for the medical staff, the Palestinian Ministry of Health, the research in addition to specific 
recommendations for each factor that may affect the compliance rate of the patients with their 
hypertension treatment plan.   
Recommendations for the treating medical staff: 
• Educate and increase the patients’ awareness  about the importance of their compliance with 
their treatment plan and the factors that may affect them in addition to the risk of non 
compliance.   
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• Train the patients on self management such as measuring their blood pressure by 
themselves.  
• Observe and monitor patients’ regularity and commitment to their follow-ups and 
appointment. 
 
• Involve the patients and their family members in the treatment plan to enhance their 
cooperation and adherence to it. 
 
• Allocate more of the medical staff's time for the counseling and education of the 
hypertensive patients. 
 
• Pay more attention to hypertensive patients with other co-morbidity and particularly 
diabetes mellitus as they are less compliant than others in addition to  overweight and obese 
patients.  
 
• Educate the hypertensive patients about their disease, risk factors, life style modification, 
exercise, etiology and treatment to decrease the relapse rate and the complications of 
hypertension.  
 
Recommendations for the Palestinian Ministry of Health: 
• Increase the staffing per clinic to decrease the current load of work on the staffs. 
 
• Conduct training workshops or seminars for all health care staff members in primacy care 
clinics to increase their awareness about the factors that may affect the compliance of the 
hypertensive patients and particularly clinics that serve poor or disadvantage people. 
 
• Conduct communication workshops for the medical staff to improve their communication 
and counseling skills. 
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• Revise and amend the co-payment and the insurance fees' strategies regularly and 
particularly for poor people. 
 
•  As possible  avoid frequent changing of the treating doctors in the primary health care 
clinics. 
Recommendations for research: 
• Further research is required involving patients from other cities in West Bank and Gaza 
Strip, as well as patients from a variety of different settings such as governmental, UNRWA, 
NGOs, and private sector. 
 
• Further research is needed to assess the factors that affect patient's compliance from the 
perspective of the doctors and other health care providers. 
 
• Further qualitative studies are required to explore in depth the factors that may contribute to 
patients non-compliance with their treatment plans and regimen. 
 
Recommendations for medical history factor: 
• The treating doctor should check and evaluate his/her patients' compliance with their 
treatment plans in every visit or at regular intervals. 
• Encourage the clients to have their own blood pressure devices at home. 
• Train the clients how to measure their blood pressure by the medical staff. 
• Emphasize to the patients the importance of not  interrupting their drugs' regimen and not to 
change the doses without discussing it prior with their treating doctor. 
• To focus more on hypertensive patients with co-morbidity such diabetic mellitus.  
• To decrease the frequency of changing medication by the treating doctors and increase 
doctors’ awareness about this issue.  
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Recommendations for participants’ knowledge and perception component: 
• Patients should be educated about their disease, its risk factors, etiology and treatment. 
• Patients should be informed about the possible complications of their disease and the best 
ways to stop or delay such complications. 
• Patient's misconceptions about hypertension should be thoroughly assessed and corrected.  
• Patients should be encouraged to keep their regularity on their medication and adherence to 
the prescribed doses.  
• Patients' education can be achieved by various methods such as counseling, seminars, 
posters, brochures …etc. 
Recommendations for the disease duration component: 
• Patients who had the disease for long period should be assessed more frequently for their 
compliance with the treatment plan and regimen. 
• Patients who are diseased for long period should be screened more frequently for the 
possible complications of hypertension.  
Recommendation for the treatment schedule component: 
• The medical staff should provide the patients with the simplest treatment schedule as 
possible. 
• It is better to treat the hypertensive patients with mono-therapy than other multiple therapies 
and as possible with the least number of dosing . 
• Combination pills may be recommended to be used more frequently in primary health care 
clinics to reduce the number of drugs and to minimize the occurrence of the side effects. 
Recommendation for the patient-prescriber relationship component:  
• The treating doctors and medical teams in general should keep a good relationship with their 
patients and to deal with them respectfully and particularly in poor areas. 
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• The treating doctors have to spend sometime to listen to their patients and answer their 
questions. 
• There is a need to decrease the work load of the medical staff  or increasing their number in 
primary care clinics for better treatment and outcomes 
Recommendations for the clarity of instructions component: 
• The treating doctors should continue giving his/her patients clear and simple instructions 
about their medication; their use, dose and timing. 
• The pharmacist should also write down the instructions about the drugs usage in clear and 
understandable language and he should emphasize these instructions verbally to the patient. 
• The medical staff in general have to continue using simple language when talking to the 
patients and avoid the medical terminology. 
Recommendation for the family support component: 
In general the findings showed good family support. This good support should be maintained 
and increased and this might be achieved by: 
•  Incorporating the family members in the treatment plan and the counseling sessions with 
their relatives on patient's consent. 
• Family members could be invited to the education workshops or lectures about hypertension 
disease.   
• Recommendations for the regularity on appointment and follow ups components: 
• There is a need to keep and increase patients’ motivation to follow up their appointment and 
visits to the primary clinic  by:  
• Scheduling patients’ appointments according to their convenience. 
• Discussing the importance of keeping and following their appointment with their treating 
doctors and possible risks of not doing that. 
138 
 
Recommendations for the cost of treatment component: 
• The co-payments should be reviewed regularly and the strategy of the insurance and the co-
payments should be re-evaluated from time to time taking into account the poverty and 
unemployment rates in the Palestinian territories. 
• More effort should be dedicated to improve the insurance coverage rate in the Palestinian 
territories to reduce the costs of treatment of the chronically diseased patients as cost of 
treatment plan was significantly associated with the patients' compliance. 
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Appendix B. 
 
 
 
Greetings, 
 
Mohammad Wridat is a student conducting a study "Compliance with antihypertensive 
treatment among the patients who attend the PHC clinics in Hebron" as a requirement for a 
master's degree in Public Health from Al-Quds University- Abu Deis. 
 
I ask for your help to complete this questionnaire, with emphasis that all information will be 
treated in full confidentiality and will only be used for the purpose of scientific research. Your 
participation in this study is voluntary and you don’t need to write your name on the 
questionnaire. 
The undersigned agrees to participate in this questionnaire. 
 
 
Signature: 
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Appendix C. (Questionnaire). 
 
Section one: Socioeconomic-demographic data  
 
No. Questions  
1. Sex:      a- Male                                        b-Female
2. Age (years):  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
3. Place of residency: ………………………. 
4. Marital status:      
  b-Single              a- Married             c-Divorced              d- Widow
5. Education level you have completed: 
a-None               b- Primary                               c- Elementary     
           d-Secondary                 e-University degree                       
6. Work status:
a- Employed                 b- Unemployed                         c- Retired 
             d- House wife                           e- Own business  
7. Income status:
a- ≤1000 NIS                      b- 1001-2000 NIS                c- 2001-3000 NIS 
                 d- >3000 NIS                                  e-  None 
8. Weight in kg: ……………
9. Height in meters: ……… 
BMI: …………… 
10 Smoking status:  
a-Smoke<10 cigarettes  per day         b- Smoke 10-20 cigarettes  per day                
 c- Smoke >20 cigarettes per day        d- Ex-smoker (when did you quit)               
e- Never smoked  
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Section two: Medical history 
 
No.  Questions  
11  When you were diagnosed as hypertensive:. . . . . . . . . . . . . . . 
12  How were you diagnosed as hypertensive: 
   a-Accidentally(screening during routine visit)
   b-By symptoms (after complaining of HTN symptoms such as headache, fatigue and 
dizziness).      
13  When were you prescribed an antihypertensive medication for the first time?... 
14  In addition to HTN, please indicate below which chronic condition(s) you have:
a-diabetes         b- asthma          c- heart diseases      d-arthritis         e- cancer
f-other conditions (specify): . . . . . . . . . . . . . . . .. 
15  Do you take drugs for other diseases than HTN? 
a-yes                                        b-no 
16 If yes, how many drugs? 
a-one                              b- two                    c-  3 or more 
17 How many drugs do you take to treat your HTN (including diuretics):
a- One drug                     b- Two drugs                        c- Three drugs or more 
18 Where you get your HTN medications from: 
a- Primary Health Care Centers 
 b- I get some from UN clinics  
c-I buy some from the private sector  
d-Others (specify)……………. 
19 How do you get your HTN medications: 
   a- Free 
   b- I pay the co-payments only           
   b- Not free (I pay full price of the drugs) 
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20 Does any of your family members have HTN?
a-Yes                                                         b- No 
21 If yes, what is his/her relation to you? 
a-Brother          b- Sister              c-Mother            d-Father         
e- son               f- daughter          g-Other(specify)……………
22 How many times do you take your drug(s) per day? 
a-once a day        b- twice a day          c- three times a day     
d- more than three times a day 
23 How many times did you stop taking your medications in the last month (against  what 
is prescribed for you by the doctor) ? 
a- once only      b- twice   c- three times or more  d- none       c- don’t remember 
24 How many times did your doctor change your drug-regimen since you started taking 
HTN medications?   
a- once                 b- twice                c- three times or more       
d-never                           e- I cannot remember  
25 Do you have a sphygmomanometer at home? 
a- yes                                                  b- no 
26 How often do you measure your BP.? 
a-  I don’t measure it at all           b- once a day                c- once a week                        
d- once  a month        e- once  every three  months     f- others (specify)……. 
27 How often do you visit your treating doctor (the clinic)? 
a-once a month                             b-more than once a month 
c-at least once every three months                 d- once every six months. 
e- others(specify)………….  
28 How often does your doctor do complete examinations to you  (e.g. checking heart 
beats, chest, eyes, blood tests  etc.): 
a-every visit                b- every month                 c- every 3 months    
           d- every 6 months               e- other (specify): ………….
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29 Apart from prescribing pills, what other tasks does your doctor perform during the 
visit?  
 a- Give you information about HTN. 
b- Do physical examination such as: the eye, the pulse, the heart….etc 
c- Provide instructions about  the life style such as: exercise, less fat in food…etc 
d- Explain the importance of  BP control such as: it decreases the risk of heart diseases 
and other HTN complications. 
e- Nothing of the above 
30 How many times were you hospitalized because of your HTN or its complications 
(such as stroke and chest pain ) or the side effects of its medications ( such as insomnia, 
headache and swollen legs) since you were  diagnosed with HTN: 
a-once                     b- twice                     c- 3 times or more           d- never  
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Section three: Patient’s perception  and  knowledge 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     In general I consider myself in good health 31
     My BP is well controlled 32
     I consider HTN as a serious problem 33
     I think that HTN leads to other serious 
conditions (e.g. stroke, heart attack and 
renal failure etc.) 
34
     I think that HTN has hereditary basis 35
     I think that being male or female will affect 
the risk of getting HTN 
36
     I think that HTN risk increases with age 37
     I think that decreasing tension and anger 
will help me in controlling my BP 
38
     I think that dietary changes (e.g. less 
sodium intake) will help me in controlling 
my BP.
39
     I think that physical exercise will help me in 
controlling my BP.  
40
     I think that it is necessary to take HTN 
medications all the time 
41
     I think that HTN medications help me to 
control my HTN 
42
     sometimes  feel it is safe or not 
necessary to take your medications 
43
     I feel it is safe to increase or decrease your 
medication dose without consulting your 
doctor 
44
     I think that my HTN medications have 
serious side effects that may affect my 
health 
45
     I think that HTN is a disease that can be 
prevented 
46
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Section four: Duration of illness 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     The long duration of my illness affect my 
desire to take my medication 
47
     Because hypertension is a chronic disease, I 
do not take my medication regularly 
48
     Because hypertension is a chronic disease, I 
do not follow the diet regimen or change my 
lifestyle according to my doctor advice 
49
     Because hypertension is a chronic disease, it 
makes me feel sad and depressed. 
50
                                      Section five: Treatment schedule 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     Because I have to take my drug(s) many 
times a day, it decreases my desire to take 
them every day
51
     Because I have to take my drug(s) many 
times a day, it is difficult for me to 
remember this all the time 
52
     The drugs I take for  chronic conditions 
other than HTN, decreases my desire to take 
HTN medications and follow lifestyle 
regimen 
53
     Changing my drugs-regimen by my doctors 
frequently decreases my desire to take these 
drugs 
54
     If you find all your drugs in one pill, this 
will increase your regularity in taking them.
55
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Section six: Patient-physician relationship 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     The same doctor sees me in every visit I do 
to the clinic
56
     The doctor treats you with respect when you 
visit him in the clinic 
57
     You are satisfied with the medical care you 
receive 
58
     The doctor allows you to say everything 
you think is important for you during the 
visit  
59
     The doctor makes you feel foolish 
sometimes during the visit
60 
     The doctor acts too serious/formal  and 
impersonal toward you
61
     The doctor during your examination or visit 
sometimes hurry too much to finish it 
quickly
62
     The doctor sometimes ignores what you tell 
him/her
63
     If you have a medical question, you can 
reach the doctor for help without a problem
64
     The doctor listens carefully to what you 
have to tell him/her
65
     Your doctor spends plenty of time with you 
during the visit
66
     When you visit the clinic, the medical staff 
(nurses/pharmacist etc) deals with you 
friendly and with respect
67
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Section seven: Clarity of instruction of treatment 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     The drug- use instructions written by the 
doctor are clear to you
68
     The medical staff (nurse/doctor) explain and 
give you clear information  about the 
necessary life style modifications for your 
condition
69
     The medical staff (nurse/doctor) show and 
train you how to perform  self measurement 
of your BP
70
     The medical staff (nurse/doctor) explain to 
you or give you information about the 
importance of BP control 
71
     The medical staff (doctor, nurse) use clear 
and simple language when they give you 
instructions about  your disease's control 
and medication
72
     Your doctor explains  the reasons for 
performing the medical tests such as 
cholesterol level and lipid profile for you 
73
     When your doctor changes your drugs,  he 
explains to you the reason for that
74
     The  doctor uses difficult medical terms 
without explaining to you what they mean
75
     The doctor gives you advices and 
information about different ways to avoid 
illness and maintain health
76
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Section eight: Family support 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     Your family members remind you about 
your medications
77
     Your family members help you in taking 
your medications
78
     Your family members help you financially 
to get your medications when you need
79
     Your family members help you in 
measuring your BP
80
     Your family members help you in reaching 
the medical facility (e.g. the clinic or 
hospital) if you are tired or sick
81
     Your family members help you to 
accomplish the life style modifications 
(such as  getting you less fatty foods, less 
salty foods, or performing exercises  etc. ) if 
it is required by your doctor
82
     Your family members encourage you to be 
compliance with your medication and 
treatment plan
83
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Section nine: Regularity  & treatment follow up 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     You are always regular at your doctor's 
appointments
84
     You  measure  your BP on  regular basis85
     You manage to do physical exercises as 
advised by your  doctor
86
     You manage to maintain a healthy weight as 
advised by your doctor
87
     You manage to eat healthy food (e.g. less 
salt) as advised by your doctor
88
     You manage to use your HTN drugs on 
regular basis as prescribed to you
89
     You forget taking your medication because 
you have busy life
90
     When you feel better, you stop taking your 
medication
91
     If you feel worse because of the side effects 
of your  medicine (such as insomnia, 
headache and swollen ankles) you stop 
taking it without consulting your doctor
92
     You always visit your doctor personally for 
drug prescription
93
     You are kept waiting for a long time in 
reception area when you are at the doctor’s 
office
94
     If you know that your medication will 
increase your weight, you will continue 
taking them
95
     If you know that your medication will affect 
your sex life, you will continue taking them.
96
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Section ten: Cost of treatment 
 
NeverRarely Some-
times
OftenAlwaysParagraphNo
     You have to pay for your medical care more 
than what you can afford
97
     The amount you have to pay to cover your 
medical needs is reasonable
98
     Some times it is a problem to cover your 
share of the cost for a medical care
99
     Sometimes you worry about having to pay 
large medical bills
100
     Sometimes you  do not follow your drug 
regimen or you go without the medical care 
you need because you can not afford the 
expenses
101
     High cost of your medication and treatment 
plan such as diet  make you less compliance 
with your treatment regimen
102
 
 
THANKS…………. 
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Appendix - D. 
Table (1):Cross-tabulation of the participants’ responses to the questions related to their 
drugs regimen by gender. 
 
Always Often Some- Rarely Never Variable 
se
x 
F. % F. % F. % F. % F. % 
P 
 Having to take your 
drug(s) many times a 
day decreases your 
desire to take  them 
every day 
M 
F 
18 
28 
 
14.9 
16.4 
48 
56 
39.7 
32.7 
38 
61 
31.3 
35.7 
7 
14 
5.8 
8.2 
10 
12 
8.3 
7 
.70 
Because you have to 
take your drug(s) 
many times a day, it is 
difficult to remember 
this all the time 
M 
F 
6 
10 
5 
5.8 
30 
51 
25 
29.8 
59 
72 
48.5 
42.1 
15 
23 
12.4 
13.5 
11 
15 
9.1 
8.8 
.82 
The drugs you take for 
chronic conditions 
other than HTN, 
decreases your desire 
to take HTN drugs and 
follow lifestyle 
changes. 
M 
F 
10 
14 
8.3 
8.2 
32 
50 
26.4 
29.3 
44 
66 
36.4 
38.6 
16 
27 
13.2 
15.8 
19 
14 
15.7 
8.1 
.38 
Changing your drugs 
regimen by your 
doctors frequently 
decreases your desire 
to take these drugs 
M 
F 
8 
14 
6.6 
8.2 
25 
29 
20.7 
17 
36 
71 
29.7 
41.4 
27 
41 
22.3 
24 
25 
16 
20.7 
9.4 
.04 
If  you find all your 
drugs in one pill ,this 
will increase your 
regularity in taking 
them 
M 
F 
59 
75 
48.7 
43.8 
25 
51 
20.7 
29.8 
22 
28 
18.2 
16.4 
7 
8 
5.8 
4.7 
8 
9 
6.6 
5.3 
.52 
All p-values were derived using the chi-squared test. 
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Table (2):Cross-tabulation of the participants’ responses to the questions related to the 
drugs-usage instructions by their gender 
Always Often Some-time Rarely Never Variable 
 
   F. % F. % F. % F. % F. % P. 
The drug usage 
instructions 
written by the 
doctor clear to you 
M 
F 
37 
59 
30.6 
34.5 
45 
71 
37.2 
41.5 
28 
31 
23.1 
18.1 
9 
9 
7.4 
5.3 
2 
1 
1.7 
0.6 
.57 
The medical staff  
explains and gives 
you clear 
information  about 
the necessary life 
style changes for 
your condition 
M 
F 
24 
24 
19.8 
14 
19 
38 
15.7 
22.2 
45 
51 
37.2 
29.9 
30 
38 
24.8 
22.2 
3 
20 
2.5 
11.7 
.01 
The medical staff 
shows and trains 
you  to perform 
self measurement 
of BP. 
M 
F 
17 
24 
14 
14 
16 
24 
13.2 
14 
22 
34 
18.2 
19.9 
20 
36 
16.5 
21 
46 
53 
38.1 
31.1 
.74 
The medical staff 
explains to you 
the importance of 
BP. Control 
M 
F 
32 
34 
26.4 
19.9 
40 
51 
33.1 
29.8 
40 
58 
33.1 
33.9 
8 
21 
6.6 
12.3 
1 
7 
0.8 
4.1 
.15 
The medical staff  
uses clear and 
simple language 
when they give 
you instructions 
about  your 
disease's control 
and medication 
M 
F 
23 
32 
19 
18.7 
63 
76 
52.1 
44.4 
32 
55 
26.4 
32.2 
3 
6 
2.5 
3.5 
0 
2 
0 
1.2 
.50 
Your doctor 
explains  the 
reasons for 
performing the 
medical tests  for 
you 
M 
F 
20 
16 
16.6 
9.4 
19 
38 
15.7 
22.2 
57 
73 
47 
42.7 
15 
33 
12.4 
19.3 
10 
11 
8.3 
6.4 
.12 
When your doctor 
changes your 
drugs, he explains 
to you the reason 
for that 
M 
F 
16 
23 
13.2 
13.5 
31 
26 
25.6 
15.2 
35 
77 
28.9 
45 
25 
38 
20.7 
22.2 
14 
7 
11.6 
4.1 
.00 
The doctor uses 
difficult medical 
terms without 
explaining  what 
they mean 
M 
F 
9 
11 
7.4 
6.4 
15 
26 
12.4 
15.2 
30 
49 
24.8 
28.7 
38 
34 
31.4 
19.9 
29 
51 
24 
29.8 
.23 
 
 
The doctor gives 
you advices and 
information about 
different ways to 
avoid illness and 
maintain health 
M 
F 
21 
14 
17.4 
8.2 
28 
34 
23.1 
19.9 
42 
78 
34.7 
45.6 
22 
27 
18.2 
15.8 
8 
18 
6.6 
10.5 
.06 
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Table (3):Cross-tabulation of the participants’ responses to the questions related to 
knowledge and perception about hypertension disease by the clinic they attend. 
Always Often Sometimes Rarely Never Variable 
C
lin
ic
 
F. % F. % F. % F. % F. % 
   P. 
In general do you consider yourself 
to be in good health. 
Y 
D 
K 
30 
15 
19 
30 
18.1 
17.4 
34 
29 
46 
34 
34.9 
42.2 
27 
29 
36 
27 
34.9 
33 
8 
10 
8 
8 
12.1 
7.4 
1 
0 
0 
1 
0 
0 
.27 
Do you consider your BP to be well 
controlled. 
Y 
D 
K 
9 
6 
13 
9 
7.2 
11.9 
42 
44 
46 
42 
53 
42.2 
41 
27 
42 
41 
32.6 
38.5 
6 
6 
8 
6 
7.22 
7.3 
2 
0 
0 
2 
0 
0 
.47 
Do you consider HTN as a serious 
problem 
Y 
D 
K 
34 
28 
35 
34 
33.7 
32.1 
28 
29 
42 
28 
34.9 
38.5 
27 
19 
29 
27 
22.9 
26.6 
8 
7 
3 
8 
8.5 
2.8 
3 
0 
0 
3 
0 
0 
.18 
HTN leads to other serious conditions Y 
D 
K 
26 
28 
28 
26 
33.7 
25.7 
29 
21 
46 
29 
25.3 
42.2 
33 
24 
25 
33 
28.9 
22.9 
6 
10 
7 
6 
12.1 
6.4 
6 
0 
3 
6 
0 
2.8 
.04 
HTN has hereditary basis Y 
D 
K 
18 
11 
15 
18 
13.2 
13.8 
18 
16 
17 
18 
19.3 
15.6 
27 
24 
39 
27 
28.9 
35.8 
20 
12 
22 
20 
14.5 
20.2 
17 
20 
16 
17 
24.1 
14.6 
.63 
The risk of getting HTN is affected 
by gender 
Y 
D 
K 
19 
8 
10 
19 
9.6 
9.2 
14 
12 
18 
14 
14.5 
16.5 
32 
15 
27 
32 
18.1 
24.8 
17 
18 
32 
17 
21.7 
29.4 
18 
30 
22 
18 
36.1 
20.1 
.01 
HTN risk increases with age Y 
D 
K 
23 
19 
32 
23 
22.9 
29.4 
38 
35 
48 
38 
42.2 
44 
20 
21 
18 
20 
25.3 
16.5 
10 
7 
8 
10 
8.4 
7.3 
9 
1 
3 
9 
1.2 
2.8 
.19 
Decreasing tension and anger will 
help you in controlling your BP. 
Y 
D 
K 
24 
44 
48 
24 
53 
44 
36 
29 
34 
36 
34.9 
31.2 
29 
7 
21 
29 
8.4 
19.3 
5 
2 
4 
5 
2.4 
3.7 
6 
1 
2 
6 
1.3 
1.8 
.00 
That dietary changes  will help you in 
controlling your BP. 
Y 
D 
K 
20 
34 
31 
20 
41 
28.4 
36 
27 
47 
36 
32.5 
43.1 
32 
15 
21 
32 
18.1 
19.3 
5 
4 
7 
5 
4.8 
6.4 
7 
3 
3 
7 
3.6 
2.8 
.04 
Physical activity will help you in 
controlling your BP 
Y 
D 
K 
17 
19 
19 
17 
22.9 
17.4 
22 
17 
30 
22 
20.5 
27.5 
24 
28 
37 
24 
33.7 
33.9 
20 
15 
19 
20 
18.1 
17.4 
17 
3 
4 
17 
4.8 
3.8 
.01 
You think that it is necessary to take 
HTN medications regularly. 
Y 
D 
K 
39 
46 
36 
39 
55.4 
33 
26 
22 
46 
26 
26.5 
42.2 
19 
12 
19 
19 
14.5 
17.4 
9 
2 
5 
9 
2.4 
4.6 
7 
1 
3 
7 
1.2 
2.8 
.00 
You think that HTN medications help 
you to control your BP. 
Y 
D 
K 
23 
37 
22 
23 
44.6 
20.2 
30 
25 
46 
30 
30.1 
42.2 
32 
15 
34 
32 
18.1 
31.2 
11 
3 
4 
11 
3.6 
3.8 
4 
2 
3 
4 
2.4 
2.8 
.00 
Do you feel it is safe or not necessary 
to take your medication 
Y 
D 
K 
7 
4 
9
7 
4.8 
8.3
16 
9 
13
16 
10.8
11.9
36 
7 
27
36 
8.4 
24.8
24 
23 
29 
24 
27.7 
26.6 
17 
40 
31 
14 
48.2 
28.4
.00 
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It is safe to increase or decrease your 
medication dose without consulting 
your doctor. 
Y 
D 
K 
7 
1 
4
7 
1.2 
3.7
15 
9 
13
15 
10.8
11.9
26 
10 
31
26 
12 
28.4
27 
17 
24 
27 
20.5 
22 
25 
46 
37 
25 
55.5 
34
.00 
HTN medications have serious side 
effects that may affect your health 
Y 
D 
K 
10 
8 
5 
10 
9.6 
4.6 
17 
7 
21 
17 
8.4 
19.3
29 
26 
39 
29 
31.3 
35.8
28 
18 
30 
28 
21.7 
27.5 
16 
24 
14 
16 
29 
12.8
.06 
HTN is a disease that can be 
prevented 
Y 
D 
K 
3 
4 
8 
3 
4.8 
7.3 
17 
7 
11 
17 
8.4 
10.1
40 
13 
32 
40 
15.7 
29.4
25 
23 
27 
25 
27.7 
24.8 
15 
36 
31 
15 
43.4 
28.4
.00 
All p-values were derived using the chi-squared test.  
Y: Yatta clinic, D: Dora clinic, K: Karanteena clinic 
 
Table (4):Cross-tabulation of the participants’ responses to the questions related to their 
drugs regimen by the clinic they attend 
Always Often Sometime Rarely Never Variable 
 
cl
in
ic
 
F. % F. % F. % F. % F. % 
P 
you have to take your 
drug(s) many times a day, 
it decreases your desire to 
take  them every day 
Y 
D 
K 
 
21 
8 
17 
21 
9.7 
15.6 
35 
23 
46 
35 
27.7 
42.2 
29 
38 
32 
29 
45.8 
29.4 
5 
7 
9 
5 
8.4 
8.3 
10 
7 
5 
10 
8.4 
4.5 
.06 
Because you have to take 
your drug(s) many times a 
day, it is difficult to 
remember this all the time 
Y 
D 
K 
10 
1 
5 
10 
1.2 
4.5 
30 
19 
32 
30 
22.9 
29.4 
46 
40 
45 
46 
48.2 
41.3 
9 
10 
19 
9 
12 
17.4 
5 
13 
8 
5 
15.7 
7.4 
.02 
The drugs you take for 
chronic conditions other 
than HTN decreases your 
desire to take the HTN 
medications and follow 
lifestyle changes 
Y 
D 
K 
12 
5 
7 
12 
6 
6.4 
32 
25 
25 
32 
30.1 
22.9 
32 
30 
48 
32 
36.1 
44 
17 
9 
17 
17 
10.8 
15.6 
7 
14 
12 
7 
17 
11.1 
.17 
Changing your drugs 
regimen by your doctors 
frequently decreases your 
desire to take these drugs 
Y 
D 
K 
15 
2 
5 
15 
2.4 
4.6 
24 
7 
23 
24 
8.4 
21.1 
26 
38 
43 
26 
45.8 
39.4 
25 
22 
21 
25 
26.5 
19.3 
10 
14 
17 
10 
16.9 
15.6 
.00 
If  you find all your drugs 
in one pill, this will 
increase your  regularity 
in taking them 
Y 
D 
K 
45 
38 
51 
45 
45.8 
46.8 
20 
24 
32 
20 
28.9 
29.4 
23 
13 
14 
23 
15.7 
12.8 
6 
2 
7 
6 
2.4 
6.4 
6 
6 
5 
6 
7.2 
4.6 
.46 
All p-values were derived using the chi-squared test. 
Y: Yatta clinic, D: Dora clinic, K: Karanteena clinic 
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Table (5):Cross-tabulation of the participants’ responses to the questions related to their 
relationship with the medical staff by the clinic they attend 
Always Often Sometime Rarely Never Variable 
 cl
in
i
F. % F. % F. % F. % F. % 
P 
Same doctor sees you in 
every visit you do to the 
clinic 
Y 
D 
K 
20 
16 
20 
20 
19.3 
18.3 
31 
28 
40 
31 
33.7 
36.7 
21 
24 
33 
21 
28.9 
30.3 
16 
8 
9 
16 
9.6 
8.3 
12 
7 
7 
12 
8.5 
6.4 
.49 
The doctor treats you 
with respect when you 
visit him in the clinic 
Y 
D 
K 
13 
28 
16 
13 
33.7 
14.7 
34 
37 
52 
34 
44.6 
47.7 
44 
17 
34 
44 
20.5 
31.2 
8 
1 
6 
8 
1.2 
5.5 
1 
0 
1 
1 
0 
.9 
.00 
You are satisfied with 
the medical care you 
receive 
Y 
D 
K 
15 
17 
16 
15 
20.5 
14.7 
31 
28 
37 
31 
33.7 
33.9 
37 
31 
47 
37 
37.3 
43.1 
8 
6 
5 
8 
7.2 
4.6 
9 
1 
4 
9 
1.3 
3.7 
.32 
The doctor allows you 
to say everything you 
think is important for 
you during the visit 
Y 
D 
K 
11 
16 
10 
11 
19.3 
9.2 
30 
20 
31 
30 
24.1 
28.4 
31 
32 
41 
31 
38.6 
37.6 
13 
10 
20 
13 
12 
18.4 
15 
5 
7 
15 
6 
6.4 
.12 
The doctor makes you 
feel foolish sometimes 
during the visit 
Y 
D 
K 
10 
0 
4 
10 
0 
3.7 
5 
9 
12 
5 
10.8 
11 
23 
12 
19 
23 
14.4 
17.4 
29 
25 
28 
29 
30.1 
25.7 
33 
37 
46 
33 
44.7 
42.2 
.03 
The doctor during your 
examination or visit 
sometimes hurry too 
much to finish it 
quickly 
Y 
D 
K 
23 
13 
25 
23 
15.7 
22.9 
20 
33 
34 
20 
39.8 
31.2 
32 
23 
28 
32 
27.7 
25.7 
17 
9 
14 
17 
10.8 
12.8 
8 
5 
8 
8 
6 
7.4 
.27 
The doctor  ignores 
what you tell him/her 
 
Y 
D 
K 
9 
2 
12 
9 
2.4 
11 
26 
12 
18 
26 
14.5 
16.5 
31 
44 
50 
31 
53 
45.9 
20 
13 
19 
20 
15.7 
17.4 
14 
12 
10 
14 
14.4 
9.2 
.04 
If you have a medical 
question, you can reach 
the doctor for help 
without a problem 
Y 
D 
K 
14 
6 
12 
14 
7.2 
11 
28 
15 
24 
28 
18.1 
22 
33 
41 
50 
33 
49.4 
45.9 
13 
20 
12 
13 
24.1 
11 
12 
1 
11 
12 
1.2 
10.1 
.00 
The doctor listens 
carefully to what you 
have to tell him/her 
Y 
D 
K 
12 
14 
8 
12 
16.9 
7.3 
22 
18 
36 
22 
21.7 
33 
34 
36 
35 
34 
43.4 
32.1 
17 
14 
19 
17 
16.8 
17.4 
15 
1 
11 
15 
1.2 
10.2 
.01 
Your doctor spends 
plenty of time with you 
during the visit 
Y 
D 
K 
9 
6 
6 
9 
7.2 
5.5 
24 
10 
28 
24 
12 
25.7 
27 
30 
30 
27 
36.1 
27.5 
23 
29 
24 
23 
34.9 
22 
17 
8 
21 
17 
9.8 
19.3 
.09 
When you visit the 
clinic, the medical staff 
deals with you friendly 
and with respect 
Y 
D 
K 
20 
28 
33 
20 
33.7 
30.3 
29 
30 
42 
29 
36.1 
38.5 
32 
21 
19 
32 
25.3 
17.4 
14 
3 
10 
14 
3.7 
9.2 
5 
1 
5 
5 
1.2 
4.6 
.03 
All p-values were derived using the chi-squared test. 
Y: Yatta clinic, D: Dora clinic, K: Karanteena clinic 
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Table (6):Cross-tabulation of the participants’ responses to the questions related to the 
clarity of drugs –usage instructions by the clinic they attend 
Always Often Sometime Rarely Never Variable 
 
 c
lin
ic
   
 
F. % F. % F. % F. % F. % 
P 
The drug- use 
instructions written 
by the doctor are 
clear to you. 
Y 
D 
K 
36 
31 
30 
36 
37.3 
27.5 
37 
34 
45 
37 
41 
41.3 
18 
16 
25 
18 
19.3 
22.9 
8 
2 
8 
8 
2.4 
7.1 
2 
0 
1 
2 
0 
1.2 
.53 
The medical staff  
explain and give you 
clear information  
about the necessary 
life style changes for 
your condition 
Y 
D 
K 
20 
19 
9 
20 
22.9 
8.3 
 
26 
11 
20 
26 
13.3 
18.4 
32 
29 
35 
32 
34.9 
32.1 
17 
17 
34 
17 
20.5 
31.2 
5 
7 
11 
5 
8.4 
10 
.02 
The medical staff 
shows and trains you 
how to perform self 
measurement of your 
BP. 
Y 
D 
K 
20 
8 
13 
20 
9.6 
11.9 
15 
9 
16 
15 
10.8 
14.7 
21 
20 
15 
21 
24 
13.8 
8 
16 
32 
8 
19.3 
29.4 
36 
30 
33 
36 
36.3 
30.2 
.00 
The medical staff  
explains to you or 
give you information 
about the importance 
of BP. control 
Y 
D 
K 
31 
13 
22 
31 
15.7 
20.2 
37 
18 
36 
37 
21.7 
33 
19 
40 
39 
19 
84.1 
35.7 
9 
11 
9 
9 
13.3 
8.3 
4 
1 
3 
4 
1.2 
2.8 
.00 
The medical staff 
uses clear and simple 
language when they 
give you instructions 
about  your disease's 
control and 
medication 
Y 
D 
K 
19 
22 
14 
19 
26.5 
12.8 
 
46 
33 
60 
46 
39.8 
55 
30 
25 
32 
30 
30.1 
29.4 
3 
3 
3 
3 
3.6 
2.8 
2 
0 
0 
 
2 
0 
0 
.20 
Your doctor explains  
the reasons for 
performing the 
medical tests  for you 
Y 
D 
K 
15 
17 
4 
15 
20.5 
3.7 
17 
16 
24 
17 
19.3 
22 
39 
30 
61 
39 
36.1 
55.9 
16 
17 
15 
16 
20.5 
13.8 
13 
3 
5 
13 
3.6 
4.6 
.00 
When your doctor 
changes your drugs, 
he explains to you the 
reason for that 
Y 
D 
K 
16 
11 
12 
16 
13.3 
11 
20 
15 
22 
20 
18.1 
20.2 
37 
31 
44 
37 
37.3 
40.4 
15 
23 
25 
15 
27.7 
22.9 
12 
3 
6 
12 
3.6 
5.5 
.26 
The doctor uses 
difficult medical 
terms without 
explaining to you 
what they mean 
Y 
D 
K 
9 
5 
6 
9 
6 
5.5 
17 
9 
15 
17 
10.8 
13.8 
26 
22 
31 
26 
26.5 
28.4 
28 
18 
26 
28 
21.7 
23.9 
20 
29 
31 
20 
35 
28.4 
.54 
The doctor gives you 
advices  about 
different ways to 
avoid illness and 
maintain health 
Y 
D 
K 
15 
5 
15 
15 
6 
13.8 
24 
19 
19 
24 
22.9 
17.4 
38 
39 
43 
38 
47 
39.4 
11 
16 
22 
11 
19.3 
20.2 
12 
4 
10 
12 
4.8 
9.2 
.17 
All p-values were derived using the chi-squared test. 
Y: Yatta clinic, D: Dora clinic, K: Karanteena clinic. 
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Table (7):Cross-tabulation of the participants’ responses to the questions related to their 
family support by the clinic they attend 
Always Often Sometime Rarely Never Variable 
 
cl
in
ic
 
F. % F. % F. % F. % F. % 
P 
Your family members 
remind you about 
your medications 
Y 
D 
K 
36 
32 
37 
36 
38.6 
33.9 
35 
26 
44 
35 
31.3 
40.4 
14 
17 
15 
14 
20.5 
13.8 
11 
6 
7 
11 
8.4 
6.4 
5 
1 
6 
5 
1.2 
5.5 
.54 
Your family members 
help you in taking 
your medications 
Y 
D 
K 
21 
24 
34 
21 
28.9 
31.2 
40 
27 
43 
40 
32.5 
39.4 
30 
24 
21 
30 
29 
19.3 
5 
4 
4 
5 
4.8 
3.7 
4 
4 
7 
4 
4.8 
6.4 
.57 
Your family members 
help you financially 
to get your medic-
ations when you need 
Y 
D 
K 
24 
22 
48 
24 
26.5 
44 
36 
25 
27 
36 
30.1 
24.8 
28 
23 
20 
28 
27.8 
18.4 
5 
9 
6 
5 
10.8 
5.5 
7 
4 
8 
7 
4.8 
7.3 
.04 
Your family  helps 
you in measuring 
your BP 
Y 
D 
K 
25 
21 
35 
25 
25.3 
32.1 
25 
17 
24 
25 
20.5 
22 
16 
21 
17 
16 
25.3 
15.6 
14 
10 
18 
14 
12 
16.5 
20 
14 
15 
20 
16.9 
13.8 
.60 
Your family helps 
you in reaching the 
medical facility  if 
you are tired or sick 
Y 
D 
K 
33 
48 
60 
33 
57.8 
55 
26 
11 
25 
26 
13.3 
22.9 
29 
13 
20 
29 
15.7 
18.4 
7 
2 
3 
7 
2.4 
2.8 
5 
9 
1 
5 
10.8 
.9 
.00 
Your family helps 
you to accomplish the 
life style changes if it 
is required by your 
doctor 
Y 
D 
K 
20 
20 
19 
20 
24 
17.4 
38 
30 
47 
38 
36.1 
43.1 
25 
24 
28 
25 
29.1 
25.7 
13 
5 
10 
13 
6 
9.2 
4 
4 
5 
4 
4.8 
4.6 
.82 
Your family 
encourage you to be 
compliance with your 
medication and 
treatment plan 
Y 
D 
K 
23 
25 
26 
23 
30.1 
23.9 
28 
20 
30 
28 
24 
27.5 
35 
25 
39 
35 
30.1 
35.8 
7 
12 
6 
7 
14.6 
5.5 
7 
1 
8 
7 
1.2 
7.3 
.22 
All p-values were derived using the chi-squared test. 
Y: Yatta clinic, D: Dora clinic, K: Karanteena clinic 
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Table (8):Cross-tabulation of the participants’ responses to the questions related to their 
regularity on doctor appointments and treatment plan by the clinic they attended 
Always Often Sometime Rarely Never Variable 
 
C
lin
ic
 
F. % F. % F. % F. % F. % 
P 
You are always regular 
at your doctor 
appointments 
Y 
D 
K 
47 
28 
47 
47 
33.7 
43.1 
21 
39 
45 
21 
47 
41.3 
22 
12 
8 
22 
14.5 
7.3 
4 
2 
3 
4 
2.4 
2.8 
6 
2 
6 
6 
2.4 
5.5 
.00 
You  measure  your BP 
on  regular basis 
Y 
D 
K 
10 
17 
14 
10 
20.5 
12.8 
30 
16 
34 
30 
19.3 
31.2 
38 
21 
40 
38 
25.2 
36.7 
11 
12 
16 
11 
14.5 
14.7 
11 
17 
5 
11 
20.5 
4.6 
.00 
You manage to do 
physical exercises as 
advised by your  
doctor 
Y 
D 
K 
4 
3 
6 
4 
3.6 
5.5 
16 
9 
20 
16 
10.8 
18.3 
37 
23 
41 
37 
27.7 
37.6 
18 
18 
19 
18 
21.7 
17.4 
25 
30 
23 
25 
36.2 
21.3 
.38 
You manage to 
maintain a healthy 
weight as advised by 
your doctor 
Y 
D 
K 
9 
7 
6 
9 
8.4 
5.5 
22 
17 
29 
22 
20.5 
26.6 
30 
21 
40 
30 
25.3 
36.7 
18 
24 
16 
18 
28.9 
14.7 
21 
14 
18 
21 
16.9 
16.5 
.29 
You manage to eat 
healthy food  as 
advised by your doctor 
Y 
D 
K 
17 
14 
17 
17 
16.9 
15.6 
32 
25 
37 
32 
30.1 
33.9 
30 
33 
36 
30 
39.8 
33.1 
11 
6 
13 
11 
7.2 
11.9 
10 
5 
6 
10 
6 
5.5 
.82 
You manage to use 
your HTN drugs on 
regular basis as 
prescribed to you 
Y 
D 
K 
24 
28 
25 
24 
33.7 
22.9 
33 
31 
40 
33 
37.3 
36.7 
37 
21 
31 
37 
25.4 
28.4 
3 
1 
10 
3 
1.2 
9.2 
3 
2 
3 
3 
2.4 
2.8 
.13 
 You forget taking 
your medication 
because you have busy 
life 
Y 
D 
K 
7 
5 
2 
7 
6 
1.8 
18 
11 
10 
18 
13.3 
9.2 
26 
30 
37 
26 
36.1 
33.9 
32 
18 
45 
32 
21.7 
41.3 
17 
19 
15 
17 
22.9 
13.8 
.04 
When you feel better, 
you stop taking your 
medication 
Y 
D 
K 
6 
0 
4 
6 
0 
3.7 
19 
3 
9 
19 
3.6 
8.3 
27 
24 
28 
27 
28.9 
25.7 
23 
17 
32 
23 
20.5 
29.4 
25 
39 
36 
25 
47 
32.9 
.00 
You always visit your 
doctor personally for 
drug prescription 
Y 
D 
K 
46 
34 
37 
46 
40.9 
33.9 
33 
29 
52 
33 
35 
47.7 
16 
12 
15 
16 
14.5 
13.8 
3 
5 
2 
3 
6 
1.8 
2 
3 
3 
2 
3.6 
2.8 
.39 
You are kept waiting 
for a long time in 
reception area when 
you are at the doctor's 
office 
 
 
Y 
D 
K 
30 
28 
33 
30 
33.7 
30.3 
40 
31 
43 
40 
37.3 
39.5 
20 
22 
29 
20 
26.6 
26.6 
4 
1 
2 
4 
1.2 
1.8 
6 
1 
2 
6 
1.2 
1.8 
.48 
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If you know that your 
medication will 
increase your weight , 
you will continue 
taking them 
Y 
D 
K 
13 
19 
16 
13 
22.9 
14.7 
40 
26 
43 
40 
31.3 
39.4 
35 
33 
46 
35 
39.8 
42.2 
4 
4 
4 
4 
4.8 
3.7 
8 
1 
0 
8 
1.2 
0 
.02 
If you know that your 
medication will affect 
your sex life, you will 
continue taking them 
Y 
D 
K 
13 
24 
15 
13 
28.9 
13.8 
32 
18 
41 
32 
21.7 
37.6 
31 
23 
42 
31 
27.8 
38.5 
17 
10 
7 
17 
12 
6.4 
7 
8 
4 
7 
9.6 
3.7 
.00 
All p-values were derived using the chi-squared test. 
Y: Yatta clinic, D: Dora clinic, K: Karanteena clinic 
 
Table (9):Cross-tabulation of the participants’ responses to the questions related to the 
cost of their treatment by the clinic they attended 
Always Often Sometime Rarely Never Variable 
 C
lin
ic
 
F. % F. % F. % F. % F. % 
P 
You have to pay for 
your medical care more 
than what you can 
afford 
Y 
D 
K 
15 
9 
9 
15 
10.8 
8.3 
21 
11 
12 
21 
13.3 
11 
28 
22 
27 
28 
26.5 
24.8 
23 
28 
43 
23 
25.7 
39.4 
13 
13 
18 
13 
15.7 
16.5 
.20 
 You do not follow your 
drug regimen or you go 
without the medical 
care you need because 
you cannot afford the 
expenses 
Y 
D 
K 
5 
5 
3 
5 
6 
2.8 
18 
9 
7 
18 
10.8 
6.4 
48 
32 
48 
48 
38.6 
44 
20 
19 
32 
20 
22.9 
29.4 
9 
18 
19 
9 
21.7 
17.4 
.05 
 It is a problem to cover 
your share of the cost 
for a medical care 
Y 
D 
K 
13 
9 
3 
13 
10.8 
2.8 
23 
12 
12 
23 
14.5 
11 
26 
40 
50 
26 
48.2 
45.9 
24 
15 
31 
24 
18.1 
28.4 
14 
7 
13 
14 
8.4 
11.9 
.00 
 You worry about 
having to pay large 
medical bills 
Y 
D 
K 
8 
7 
2 
8 
8.4 
1.8 
26 
11 
18 
26 
13.3 
16.5 
30 
36 
48 
30 
43.4 
44 
22 
13 
24 
22 
15.6 
22.1 
14 
16 
17 
14 
19.3 
15.6 
.07 
The amount you have to 
pay to cover your 
medical needs is 
reasonable 
Y 
D 
K 
9 
12 
20 
9 
14.5 
18.3 
31 
18 
32 
31 
21.7 
29.4 
35 
30 
25 
35 
36.1 
22.9 
15 
14 
17 
15 
16.9 
15.6 
10 
9 
15 
10 
10.8 
13.8 
.32 
High cost of your drugs 
and the treatment plan 
in general makes me 
less compliant with my 
treatment regimen 
Y 
D 
K 
7 
2 
3 
7 
1.8 
2.8 
14 
11 
6 
14 
13.3 
5.5 
26 
22 
20 
26 
26.5 
18.3 
25 
25 
54 
25 
30.1 
49.5 
28 
23 
26 
28 
28.3 
23.9 
.01 
All p-values were derived using the chi-squared test. 
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Table (10):Cross-tabulation of the participants’ responses to the questions related to 
their knowledge and perception of hypertension by their age group. 
Always Often Sometime Rarely Never Variable 
    
A
ge
   
 
F. % F. % F. % F. % F. % 
P 
In general you consider 
yourself to be in good 
health 
≤55 
> 55 
24 
40 
23.5 
21.1 
41 
68 
40.2 
35.8 
31 
61 
30.4 
32.1 
6 
20 
5.9 
10.5 
0 
1 
0 
0.5 
 .60 
 You consider your BP to 
be well controlled. 
≤55 
> 55 
13 
15 
12.7 
7.9 
46 
86 
45.1 
45.3 
40 
70 
39.3 
36.9 
3 
17 
2.9 
8.9 
0 
2 
0 
1 
.17 
 You consider HTN as a 
serious problem 
≤55 
>55 
36 
61 
41.4 
32.1 
38 
61 
37.3 
32.1 
19 
56 
18.6 
29.5 
7 
11 
0.7 
5.8 
2 
1 
2 
0.5 
.26 
You think that HT leads to 
other serious conditions. 
≤55 
>55 
37 
45 
36.2 
33.6 
28 
68 
27.5 
35.8 
27 
55 
26.5 
28.9 
4 
19 
3.9 
0.1 
6 
3 
5.9 
1.6 
 .01 
 You think that HTN has 
hereditary basis. 
≤55 
>55 
18 
26 
17.6 
13.7 
21 
30 
20.6 
15.8 
31 
59 
30.4 
31.5 
13 
41 
12.7 
21.6 
19 
34 
18.7 
17.4 
.65 
 You think that being male 
or female will affect the 
risk of getting HTN. 
≤55 
>55 
14 
23 
13.8 
12.1 
14 
30 
13.8 
15.8 
27 
47 
26.5 
24.7 
23 
44 
22.5 
23.2 
24 
46 
23.4 
24.2 
.98 
 You think that HTN risk 
increases with age. 
≤55 
>55 
28 
46
27.5 
24.1
45 
76
44.1 
40
19 
40
18.6 
21.1
6 
19
5.9 
10 
4 
9 
3.9 
4.8 
.70 
Decreasing tension and 
anger will help you in 
controlling your BP. 
≤55 
>55 
43 
73 
42.2 
38.4 
36 
63 
35.3 
33.2 
17 
40 
16.7 
21.1 
5 
6 
4.5 
3.2 
1 
8 
1 
4.1 
.44 
 You think that dietary 
changes  will help you 
in controlling your BP. 
≤55 
>55 
32 
53 
31.4 
27.9 
44 
66 
43.1 
34.7 
21 
47 
20.6 
24.8 
4 
12 
3.9 
6.3 
1 
12 
1 
6.3 
.13 
 You think that physical 
activity will help you in 
controlling your BP. 
≤55 
>55 
21 
34 
20.6 
17.9 
31 
38 
30.4 
20 
33 
56 
32.4 
29.5 
11 
43 
10.7 
22.6 
6 
18 
5.9 
10 
.04 
 You think that it is 
necessary to take HTN 
medications regularly. 
≤55 
>55 
49 
72 
48 
37.9 
34 
60 
33.3 
31.6 
13 
37 
12.7 
19.5 
4 
12 
3.9 
6.3 
2 
9 
2.1 
4.7 
.23 
 You think that HTN 
medications help you to 
control your BP. 
≤55 
>55 
33 
49 
32.4 
26.3 
38 
63 
37.2 
33.2 
21 
60 
20.6 
31.6 
9 
9 
8.8 
4.7 
1 
8 
1 
4.2 
.08 
 You feel it is safe or not 
necessary to take your 
medication. 
≤55 
>55 
5 
15 
4.9 
7.9 
10 
28 
9.8 
14.7 
28 
42 
27.5 
22.1 
24 
52 
23.5 
27.4 
35 
53 
34.3 
27.5 
.38 
 It is safe to increase or 
decrease your drugs dose 
without consulting your 
doctor 
≤55 
>55 
2 
10 
2 
5.3 
15 
22 
14.7 
11.6 
20 
47 
19.6 
24.7 
30 
38 
29.4 
20 
35 
73 
34.3 
38.4 
.21 
 You think that your HTN 
medications have serious 
side effects that may 
affect your health 
≤55 
>55 
9 
14 
8.8 
7.4 
14 
31 
13.7 
16.3 
27 
67 
26.5 
35.3 
37 
39 
36.3 
20.5 
15 
39 
14.7 
20.5 
.04 
 You think that HTN is a 
disease that can be 
prevented 
≤55 
>55 
5 
10 
4.9 
5.3 
13 
22 
12.7 
11.6 
35 
50 
34.3 
26.3 
21 
54 
22.4 
28.4 
28 
54 
25.7 
28.4 
.53 
All p-values were derived using the chi-squared test. 
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Table (11):Cross-tabulation of the participants’ responses to the questions related to the 
duration of illness by their age group. 
Always Often Sometime Rarely Never Variable 
  
ag
e 
 
F. % F. % F. % F. % F. % 
P 
The long duration of 
your illness affect 
your desire to take 
your medication 
≤55 
>55 
10 
29 
9.8 
15.3 
39 
70 
38.2 
36.8 
33 
66 
32.4 
34.7 
7 
13 
6.9 
6.8 
13 
12 
12.7 
6.4 
.30 
Because HTN is a 
chronic disease, you 
do not take your 
drugs continuously. 
≤55 
>55 
1 
9 
1 
4.7 
16 
24 
15.7 
12.6 
37 
73 
36.3 
38.4 
22 
55 
21.6 
29 
26 
29 
25.4 
15.3 
.08 
Because HTN is a 
chronic disease, you 
do not follow the diet 
regimen or change 
your  lifestyle 
according to your 
doctor advice 
≤55 
>55 
2 
11 
 
1.9 
5.8 
6 
29 
 
5.9 
15.3 
33 
51 
32.4 
26.8 
34 
64 
33.3 
33.7 
27 
35 
26.5 
18.4 
.04 
Because HTN is a 
chronic disease, it 
makes you feel sad 
and depressed 
≤55 
>55 
6 
13 
5.5 
6.8 
25 
41 
 
24.5 
21.6 
32 
81 
31.8 
42.6 
19 
33 
18.6 
17.4 
20 
22 
19.6 
11.6 
.23 
 
Table (12):Cross-tabulation of the participants’ responses to the questions related to the 
drugs’ regimen by their age group. 
Always Often Sometime Rarely Never Variable 
 a
ge
  
F. % F. % F. % F. % F. % 
P 
Because you have to 
take your drug(s) many 
times a day, it decreases 
your desire to take  
them every day 
≤55 
>55 
14 
32 
13.7 
16.8 
29 
75 
28.4 
39.5 
36 
63 
35.3 
33.1 
11 
10 
10.8 
5.3 
12 
10 
11.8 
5.3 
.05 
Because you have to 
take your drug(s) many 
times a day, it is 
difficult to remember 
that all the time 
≤55 
>55 
4 
12 
3.9 
6.3 
29 
52 
28.4 
27.4 
37 
94 
36.3 
49.5 
14 
24 
13.8 
12.6 
18 
8 
17.6 
4.2 
.00 
The drugs you take for 
chronic conditions other 
than HTN, decrease 
your desire to take HTN 
medications and follow 
lifestyle regimen 
≤55 
>55 
3 
21 
2.9 
11 
26 
56 
25.5 
29.5 
36 
74 
35.3 
38.9 
19 
24 
18.7 
12.6 
18 
15 
17.6 
8 
.01 
Changing your drugs 
regimen by your doctor 
frequently decreases  
your desire to take them 
≤55 
>55 
8 
14 
7.8 
7.4 
18 
36 
17.6 
18.9 
33 
74 
32.4 
38.9 
27 
41 
26.5 
21.6 
16 
25 
15.7 
13.2 
.76 
If you find all my drugs 
in one pill, this will 
increase your regularity 
in taking them 
≤55 
>55 
48 
86 
47 
45.3 
23 
53 
22.5 
27.9 
18 
32 
17.7 
16.8 
5 
10 
4.9 
5.3 
8 
9 
7.9 
4.7 
.75 
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Table (13):Cross-tabulation of the participants’ responses to the questions related to the 
participants relationship with the medical staff by their age group. 
Always Often Sometime Rarely Never Variable 
 A
g
e F. % F. % F. % F. % F. % 
P 
The same doctor sees 
you in every visit you 
do to the clinic 
≤55 
>55 
22 
34 
21.6 
17.9 
32 
67 
31.4 
35.3 
29 
49 
28.4 
25.8 
7 
26 
6.9 
13.7 
12 
14 
11.7 
7.3 
.27 
The doctor treats you 
with respect when you 
visit him in the clinic 
≤55 
>55 
21 
36 
20.6 
18.9 
42 
81 
41.2 
42.6 
36 
59 
35.3 
31 
2 
13 
1.9 
7 
1 
1 
1 
0.5 
.43 
You are satisfied with 
the medical care you 
receive 
≤55 
>55 
14 
34 
13.7 
17.9 
33 
63 
32.4 
33.2 
45 
70 
44.1 
36.8 
6 
13 
5.9 
6.8 
4 
10 
3.9 
5.3 
.74 
The doctor allows you 
to say everything you 
think is important for 
you during the visit 
≤55 
>55 
16 
21 
15.7 
11 
26 
55 
25.5 
28.9 
36 
68 
35.3 
35.8 
17 
26 
16.7 
13.7 
7 
20 
6.8 
10.6 
.59 
The doctor makes 
you feel foolish 
sometimes during 
the visit 
≤55 
>55 
6 
8 
5.9 
4.2 
9 
17 
8.8 
8.9 
17 
37 
16.7 
19.5 
29 
53 
28.4 
27.9 
41 
75 
40.2 
39.5 
.95 
The doctor acts too 
serious/formal  and 
impersonal toward you 
≤55 
>55 
12 
18 
11.8 
9.5 
33 
40 
32.4 
21.2 
40 
81 
39.2 
42.6 
8 
36 
7.8 
18.9 
9 
15 
8.8 
7.8 
.05 
The doctor during your 
examination or visit 
hurries too much to 
finish it quickly. 
≤55 
>55 
24 
37 
23.5 
19.5 
27 
60 
26.5 
31.6 
29 
54 
28.5 
28.4 
19 
21 
18.6 
11 
3 
18 
2.9 
9.5 
.09 
The doctor  ignores 
what you tell him/her 
≤55 
>55 
8 
15 
7.8 
7.9 
19 
37 
18.6 
19.5 
47 
78 
46.2 
41 
20 
32 
19.6 
16.8 
8 
28 
7.8 
14.8 
.51 
If you have a medical 
question, you can 
reach the doctor for 
help without a problem 
≤55 
>55 
12 
20 
11.8 
10.5 
28 
39 
27.5 
20.5 
40 
84 
39.2 
44.2 
13 
32 
12.7 
16.8 
9 
15 
8.8 
8 
.61 
 
The doctor listens 
carefully to what you 
have to tell him/her 
≤55 
>55 
 
8 
26 
7.8 
13.7 
33 
43 
32.4 
22.6 
37 
68 
36.3 
35.8 
18 
32 
17.6 
16.8 
6 
21 
5.9 
11.1 
.17 
Your doctor spends 
plenty of time with 
you during the visit 
≤55 
>55 
7 
14 
6.9 
7.4 
27 
35 
26.5 
18.4 
24 
63 
23.5 
33.2 
27 
49 
26.5 
25.8 
17 
29 
16.6 
15.2 
.37 
When you visit the 
clinic, the medical 
staff deals with you 
friendly and with 
respect 
≤55 
>55 
29 
52 
28.4 
27.4 
32 
69 
31.4 
36.3 
26 
46 
25.5 
24.2 
11 
16 
10.8 
8.4 
4 
7 
3.9 
3.7 
.91 
All p-values were derived using the chi-squared test. 
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Table (14):Cross-tabulation of the participants’ responses to the questions related to the 
clarity of drugs usage instructions by their age group. 
Always Often Sometime 
 
Rarely Never Variable 
 
 
ag
e F. 
 
% F. % F. % F. % F. % 
P 
The drug- usage 
instructions written by the 
doctor are clear to you 
≤55 
>55 
29 
67 
28.4 
35.3 
45 
71 
44.1 
37.4 
17 
42 
16.6 
22.1 
9 
9 
9 
4.7 
2 
1 
1.9 
0.5 
.21 
The medical staff explains 
and gives you clear 
information about the 
necessary life style 
modifications for you. 
≤55 
>55 
17 
31 
16.6 
16.3 
20 
37 
19.6 
19.5 
32 
64 
31.4 
33.7 
27 
41 
26.5 
21.6 
6 
17 
5.9 
8.9 
.81 
The medical staff trains 
you how to perform self 
measurement of your BP. 
≤55 
>55 
17 
24 
16.6 
12.6 
18 
22 
17.6 
11.6 
13 
43 
12.7 
22.6 
25 
31 
24.7 
16.3 
29 
70 
28.4 
36.9 
.04 
The medical staff  explains 
to you or gives you 
information about the 
importance of BP. control 
≤55 
>55 
28 
38 
27.5 
20 
30 
61 
29.4 
32.1 
32 
66 
31.4 
34.7 
8 
21 
7.8 
11.1 
4 
4 
3.9 
2.1 
.47 
The medical staff uses 
clear  language when they 
give you instructions about  
your disease's control and 
medication 
≤55 
>55 
20 
35 
19.6 
18.4 
45 
94 
44.1 
49.5 
32 
55 
31.4 
28.9 
5 
4 
4.9 
2.1 
0 
2 
0 
1.1 
.50 
Your doctor explains  the 
reasons for performing the 
medical tests for you 
≤55 
>55 
13 
23 
12.7 
12.1 
20 
37 
19.6 
19.5 
47 
83 
46.1 
43.7 
14 
34 
13.7 
17.9 
8 
13 
7.9 
6.8 
.92 
When your doctor changes 
your drugs, he explains to 
you the reason for that 
≤55 
>55 
15 
24 
14.7 
12.6 
25 
32 
24.5 
16.8 
37 
75 
36.3 
39.5 
15 
48 
14.7 
25.3 
10 
11 
9.8 
5.8 
.12 
The doctor uses difficult 
medical terms without 
explaining  what they mean 
≤55 
>55 
10 
10 
9.8 
5.3 
14 
27 
13.7 
14.2 
23 
56 
22.5 
29.5 
32 
40 
31.5 
21 
23 
57 
22.5 
30 
.11 
The doctor gives you 
advices and information 
about different ways to 
avoid illness and maintain 
health 
≤55 
>55 
14 
21 
13.7 
11 
21 
41 
20.6 
21.6 
41 
79 
40.2 
41.6 
14 
35 
13.7 
18.4 
12 
14 
11.8 
7.4 
.59 
All p-values were derived using the chi-squared test. 
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Table (15):Cross-tabulation of the participants’ responses to the questions related to 
their regularity on doctor appointments and treatment plan by their age group.  
Always Often Sometime Rarely Never Variable 
A
ge
  
F. % F. % F. % F. % F. % 
P 
you are always regular at 
your doctor 
appointments 
≤55 
>55 
49 
73 
48 
38.4 
32 
73 
31.4 
38.4 
14 
28 
13.7 
14.7 
4 
5 
3.9 
2.6 
3 
11 
3 
5.9 
.41 
You  measure  your BP 
on  regular basis 
≤55 
>55 
16 
25 
15.7 
13.2 
37 
43 
36.3 
22.6 
34 
65 
33.3 
34.2 
10 
29 
9.8 
15.3 
5 
28 
4.9 
14.7 
.01 
You manage to do 
physical exercises as 
advised by your  doctor 
≤55 
>55 
5 
8 
4.9 
4.2 
18 
27 
17.6 
14.2 
40 
61 
39.2 
32.1 
18 
37 
17.6 
19.5 
21 
57 
20.7 
30 
.42 
You manage to maintain 
a healthy weight as 
advised by your doctor 
≤55 
>55 
6 
16 
5.9 
8.4 
27 
41 
26.5 
21.6 
31 
60 
30.4 
31.6 
18 
40 
17.6 
21 
20 
33 
19.6 
17.4 
.76 
You manage to eat 
healthy food as advised 
by your doctor 
≤55 
>55 
18 
30 
17.6 
15.8 
26 
68 
25.5 
35.8 
41 
58 
40.2 
30.5 
12 
18 
11.8 
9.5 
5 
16 
4.9 
8.4 
.22 
You manage to use your 
HTN drugs on regular 
basis as prescribed to 
you 
≤55 
>55 
24 
53 
23.5 
27.9 
32 
72 
31.8 
37.9 
36 
53 
35.3 
27.9 
7 
7 
6.8 
3.7 
3 
5 
2.6 
2.6 
.42 
You forget taking your 
medications because you 
have a busy life 
≤55 
>55 
5 
9 
4.9 
4.7 
14 
25 
13.7 
13.2 
28 
65 
27.5 
34.2 
40 
55 
39.2 
28.9 
15 
36 
14.7 
19 
.43 
When you feel better, 
you stop taking your 
drugs. 
≤55 
>55 
5 
5 
4.9 
2.6 
14 
17 
13.7 
8.9 
24 
55 
23.5 
28.9 
22 
50 
21.6 
26.3 
37 
63 
36.3 
33.3 
.41 
If you feel worse because 
of the side effects of your  
drugs, you stop taking it 
without consulting your 
doctor 
≤55 
>55 
10 
9 
9.8 
4.7 
12 
12 
11.8 
6.3 
29 
57 
28.4 
30 
23 
51 
22.5 
26.8 
28 
61 
27.5 
32.2 
.19 
You always visit your 
doctor personally for 
drug prescription 
≤55 
>55 
44 
73 
43.1 
38.4 
36 
78 
35.3 
41 
18 
25 
17.7 
13.2 
3 
7 
2.9 
3.7 
1 
7 
1 
3.7 
.44 
You are kept waiting for 
a long time in reception 
area when you are at the 
doctor's office. 
≤55 
>55 
36 
55 
35.3 
28.9 
34 
80 
33.3 
42.1 
23 
48 
22.6 
25.4 
5 
2 
4.9 
1 
4 
5 
3.9 
2.6 
.14 
if you know that your 
medication will increase 
your weight, you will 
continue taking them 
≤55 
>55 
9 
39 
8.8 
20.5 
36 
73 
35.3 
38.4 
47 
67 
46.1 
35.3 
6 
6 
5.9 
3.2 
4 
5 
3.9 
2.6 
.05 
if you know that your 
medication will affect 
your sex life, you will 
continue taking them 
≤55 
>55 
10 
42 
9.8 
22.1 
29 
62 
28.4 
32.6 
44 
52 
43.1 
27.4 
12 
22 
11.8 
11.6 
7 
12 
6.9 
6.3 
.02 
All p-values were derived using the chi-squared test. 
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Table (16):Cross-tabulation of the participants’ responses to the questions related to 
knowledge and perception of hypertension by their marital status. 
Always Often Sometime Rarely Never Variable 
 
Marital 
status F. % F. % F. % F. % F. % 
P 
In general, do you 
consider yourself to be 
in good health? 
Single 
Married 
Divorce 
Widow. 
3 
42 
3 
16 
30 
20.3 
33.3 
24.3 
4 
83 
2 
20 
40 
40.1 
22.3 
30.3 
2 
66 
1 
23 
20 
31.9 
11.1 
34.8 
1 
15 
3 
7 
10 
7.2 
33.3 
10.6 
0 
1 
0 
0 
0 
.5 
0 
0 
.42 
Do you consider your 
BP to be well controlled 
? 
Single 
Married 
Divorce 
Widow. 
3 
24 
0 
1 
30 
11.6 
0 
1.5 
3 
92 
2 
35 
30 
44.4 
22.3 
53.1 
4 
77 
6 
23 
40 
37.2 
66.6 
34.8 
0 
12 
1 
7 
0 
5.8 
11.1 
10.6 
0 
2 
0 
0 
0 
1 
0 
0 
.09 
Do you consider HTN 
as a serious problem? 
 
Single 
Married 
Divorce 
Widow. 
5 
75 
0 
17
50 
36.2 
0 
25.8
3 
66 
7 
23
30 
31.9 
77.8 
34.8
2 
50 
1 
22
20 
24.2 
11.1 
33.3
0 
14 
0 
4
0 
6.7 
0 
6.1 
0 
2 
1 
0 
0 
1 
11.1 
0 
.01 
Do you think that HTN 
leads to other serious 
conditions? 
Single 
Married 
Divorce 
Widow. 
3 
65 
1 
13 
30 
31.4 
11.1 
19.7 
3 
70 
3 
20 
30 
33.8 
33.3 
30.3 
3 
51 
3 
25 
30 
24.6 
33.3 
37.9 
1 
14 
2 
6 
10 
6.8 
22.3 
9.1 
0 
7 
0 
2 
0 
3.4 
0 
3 
.58 
Do you think that HTN 
has hereditary basis? 
Single 
Married 
Divorce 
Widow. 
1 
38 
0 
5 
10 
18.4 
0 
7.6 
1 
33 
1 
16 
10 
15.9 
11.1 
24.2 
4 
76 
0 
10 
40 
36.7 
0 
15.2 
1 
27 
4 
22 
10 
13.1 
44.4 
33.3 
3 
33 
4 
13 
30 
15.9 
44.5 
19.7 
.00 
Do you think that being 
male or female will 
affect the risk of getting 
HTN? 
Single 
Married 
Divorce 
Widow. 
1 
25 
2 
9 
10 
12.1 
22.3 
13.6 
1 
30 
0 
13 
10 
14.5 
0 
19.7 
4 
59 
1 
10 
40 
28.5 
11.1 
15.2 
1 
44 
2 
20 
10 
21.3 
22.3 
30.3 
3 
49 
4 
14 
30 
23.6 
44.3 
21.2 
.37 
Do you think that HTN 
risk increases with age? 
 
Single 
Married 
Divorce 
Widow. 
4 
50 
2 
18
40 
24.2 
22.3 
27.3
3 
84 
5 
29
30 
40.6 
55.4 
43.9
2 
45 
2 
10
20 
21.7 
22.3 
15.2
0 
22 
0 
3
0 
10.6 
0 
4.5 
1 
6 
0 
6 
10 
2.9 
0 
9.1
.41 
Do you think that 
decreasing tension and 
anger will help you in 
controlling your BP? 
Single 
Married 
Divorce 
Widow. 
5 
82 
4 
25 
50 
39.6 
44.5 
37.9 
0 
73 
3 
23 
0 
35.3 
33.3 
34.8 
4 
42 
1 
10 
40 
20.3 
11.1 
15.2 
1 
7 
1 
2 
10 
3.4 
11.1 
3 
0 
3 
0 
6 
0 
1.4 
0 
9.1 
.07 
Do you think that 
dietary changes will 
help you in controlling 
your BP? 
Single 
Married 
Divorce 
Widow. 
2 
60 
4 
19 
20 
29 
44.5 
28.8 
4 
82 
2 
22 
40 
39.6 
22.3 
33.3 
3 
47 
3 
15 
30 
22.7 
33.3 
22.7 
0 
11 
0 
5 
0 
5.3 
0 
7.6 
1 
7 
0 
5 
10 
3.4 
0 
7.6 
.82 
Do you think that 
physical activity will 
help you in controlling 
your BP? 
Single 
Married 
Divorce 
Widow. 
2 
41 
2 
10 
20 
19.8 
22.2 
15.2 
5 
44 
4 
16 
50 
21.3 
44.4 
24.2 
0 
68 
1 
20 
0 
32.9 
11.1 
30.3 
1 
36 
2 
15 
10 
17.4 
22.3 
22.7 
2 
17 
0 
5 
20 
8.6 
0 
7.6 
.30 
 
Do you think that it is 
necessary to take HTN 
medications regularly? 
 
Single 
Married 
Divorce 
Widow 
9 
84 
4 
24 
90 
40.6 
44.5 
36.4 
0 
69 
1 
24 
0 
33.3 
11.1 
36.4 
0 
33 
4 
13 
0 
15.9 
44.4 
19.7 
1 
13 
0 
2 
10 
6.3 
0 
3 
0 
8 
0 
3 
0 
3.9 
0 
4.5 
.07 
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Do you think that HTN 
medications help you to 
control your BP? 
Single 
Married 
Divorce 
Widow 
2 
62 
4 
14 
20 
30 
44.4 
21.2 
2 
74 
2 
23 
20 
35.7 
22.2 
34.8 
5 
51 
1 
24 
50 
24.6 
11.1 
36.4 
1 
10 
2 
5 
10 
4.8 
22.3 
7.6 
0 
9 
0 
0 
0 
4.9 
0 
0 
.14 
Do you feel it is safe or 
not necessary  to take 
your medication? 
Single 
Married 
Divorce 
Widow 
1 
14 
2 
3 
10 
6.8 
22.3 
4.5 
1 
26 
2 
9 
10 
12.6 
22.2 
13.6 
2 
46 
0 
22 
20 
22.2 
0 
33.3 
3 
58 
1 
14 
30 
28 
11.1 
21.2 
3 
63 
4 
18 
30 
30.4 
44.4 
27.4 
.45 
You feel it is safe to 
increase or decrease 
your medication dose 
without consulting your 
doctor? 
Single 
Married 
Divorce 
Widow 
0 
9 
0 
3 
0 
4.3 
0 
4.5 
2 
26 
0 
9 
20 
12.6 
0 
13.6 
3 
42 
3 
19 
30 
20.3 
33.3 
28.5 
2 
53 
2 
11 
20 
25.6 
22.3 
16.7 
3 
77 
4 
24 
30 
37.2 
44.4 
36.4 
.87 
Do you think that your 
HTN medications have 
serious side effects that 
may affect your health? 
Single 
Married 
Divorce 
Widow 
0 
18 
0 
5 
0 
8.7 
0 
7.6 
3 
30 
1 
11 
30 
14.5 
11.1 
16.7 
3 
66 
4 
21 
30 
31.9 
44.5 
31.8 
3 
55 
1 
17 
30 
26.6 
11.1 
25.8 
1 
38 
3 
12 
10 
18.3 
33.3 
18.1 
.91 
Do you think that HTN 
is a disease that can be 
prevented? 
Single 
Married 
Divorce 
Widow 
0 
12 
0 
3 
0 
5.8 
0 
4.5 
1 
27 
2 
5 
10 
13 
22.3 
7.6 
5 
59 
1 
20 
50 
28.5 
11.1 
30.3 
4 
51 
2 
18 
40 
24.7 
22.2 
27.3 
0 
58 
4 
20 
0 
28 
44.4 
30.3 
.56 
All p-values were derived using the chi-squared test. 
 
Table (17):Cross-tabulation of the participants’ responses to the questions related to the 
duration of their illness by their marital status. 
Always Often Sometime Rarely Never Variable 
 
Marital 
status F. % F. % F. % F. % F. % 
P 
The long duration 
of your illness 
affect your desire 
to take your 
medication. 
Single 
Married 
Divorce 
Widow. 
4 
21 
2 
12 
40 
10.1 
22.3 
18.2 
4 
72 
2 
31 
40 
34.8 
22.3 
47 
0 
80 
2 
17 
0 
38.6 
22.3 
25.7 
0 
13 
1 
6 
0 
6.4 
11.1 
9.1 
2 
21 
2 
0 
20 
10.1 
22.3 
0 
.00 
Because HTN  is a 
chronic disease, 
you do not take 
your medication 
continuously 
Single 
Married 
Divorce 
Widow. 
0 
6 
0 
4 
0 
2.9 
0 
6.1 
2 
25 
2 
11 
20 
12.1 
22.3 
16.7 
7 
74 
3 
26 
70 
35.7 
33.3 
39.4 
0 
61 
1 
15 
0 
29.5 
11.1 
22.6 
1 
41 
3 
10 
10 
19.8 
33.3 
15.2 
.34 
Because HTN. is a 
chronic disease, 
you do not follow 
the diet regimen 
or change your  
lifestyle according 
to your doctor 
advice 
Single 
Married 
Divorce 
Widow. 
1 
7 
1 
4 
10 
3.4 
11.1 
6.1 
1 
24 
0 
10 
10 
11.6 
0 
15.2 
5 
55 
2 
22 
50 
26.6 
22.3 
33.3 
0 
78 
2 
18 
0 
37.7 
22.2 
27.3 
3 
43 
4 
12 
30 
20.7 
44.4 
18.1 
.23 
Because HTN. is a 
chronic disease, it 
makes you feel 
sad and depressed 
Single 
Married 
Divorce 
Widow 
1 
14 
1 
3 
10 
6.8 
11.1 
4.5 
2 
47 
2 
15 
20 
22.7 
22.3 
22.6 
2 
79 
4 
28 
20 
38.2 
44.4 
42.7 
4 
34 
2 
12 
40 
16.4 
22.2 
18.1 
1 
33 
0 
8 
10 
15.9 
0 
12.1 
.84 
All p-values were derived using the chi-squared test. 
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Table (18):Cross-tabulation of the participants’ responses to the questions related to the 
drugs’ regimen by their marital status. 
Always Often Sometime Rarely Never Variable 
 
 
Marital 
status 
 
F. % F. % F. % F. % F. % 
P 
Because you have 
to take your 
drug(s) many 
times a day, it 
decreases your 
desire to take  
them every day 
Single 
Married 
Divorce 
Widow. 
5 
28 
1 
12 
50 
13.4 
11.1 
18.2 
1 
73 
3 
27 
10 
35.3 
33.3 
40.9 
1 
73 
4 
21 
10 
35.3 
44.5 
31.8 
3 
14 
0 
4 
30 
6.8 
0 
6.1 
0 
19 
1 
2 
0 
9.2 
11.1 
3 
.01 
Because you have 
to take your 
drug(s) many 
times a day, it is 
difficult for you to 
remember this all 
the time 
Single 
Married 
Divorce 
Widow. 
0 
8 
0 
8 
0 
3.9 
0 
12 
5 
53 
3 
20 
50 
25.6 
33.3 
30.3 
4 
91 
3 
33 
40 
44 
33.3 
50 
1 
31 
3 
3 
10 
14.9 
33.4 
4.5 
0 
24 
0 
2 
0 
11.6 
0 
3 
.02 
The drugs you 
take for chronic 
conditions other 
than HTN, 
decreases your 
desire to take 
antihypertensive 
medications and 
follow lifestyle 
changes. 
Single 
Married 
Divorce 
Widow. 
0 
12 
3 
9 
0 
5.8 
33.3 
13.6 
3 
56 
3 
20 
30 
27 
33.3 
30.3 
6 
78 
1 
25 
60 
37.7 
11.1 
37.9 
1 
32 
2 
8 
10 
15.5 
22.3 
12.1 
0 
29 
0 
4 
0 
14 
0 
6.1 
.05 
Changing your 
drugs regimen by 
your doctors 
frequently 
decreases your 
desire to take these 
drugs 
Single 
Married 
Divorce 
widow 
3 
11 
1 
7 
30 
5.3 
11.1 
10.6 
1 
40 
0 
13 
10 
19.3 
0 
19.7 
5 
78 
2 
22 
50 
37.7 
22.3 
33.3 
1 
49 
3 
15 
10 
23.7 
33.3 
22.8 
0 
29 
3 
9 
0 
14 
33.3 
13.6 
.13 
If you find all your 
drugs in one pill, 
this will increase 
your regularity in 
taking them. 
Single 
Married 
Divorce 
widow 
7 
91 
3 
33 
70 
44 
33.3 
50 
1 
56 
2 
17 
10 
27 
22.3 
25.8 
0 
39 
2 
9 
0 
18.8 
22.3 
13.6 
1 
9 
2 
3 
10 
4.4 
22.3 
4.5 
1 
12 
0 
4 
10 
5.8 
0 
6.1 
.40 
All p-values were derived using the chi-squared test. 
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Table (19):Cross-tabulation of the participants’ responses to the questions related to 
their relationship with the medical staff by their marital status. 
Always Often Sometime Rarely Never Variable 
 
Marital 
status. F. % F. % F. % F. % F. % 
P 
The same doctor sees 
you in every visit you do 
to the clinic 
Single 
Married 
Divorce 
Widow. 
4 
37 
5 
10 
40 
17.9 
55.5 
15.2 
3 
71 
0 
25 
30 
34.3 
0 
37.9 
2 
56 
2 
18 
20 
27 
22.3 
27.2 
0 
25 
1 
7 
0 
12.1 
11.1 
10.6 
1 
18 
1 
6 
10 
8.7 
11.1 
9.1 
.28 
The doctor treats you 
with respect when you 
visit him in the clinic 
Single 
Married 
Divorce 
Widow 
2 
46 
2 
7 
20 
22.2 
22.3 
10.5 
5 
82 
4 
32 
50 
39.6 
44.4 
48.5 
3 
70 
1 
21 
30 
33.8 
11.1 
31.8 
0 
9 
1 
5 
0 
4.4 
11.1 
7.6 
0 
0 
1 
1 
0 
0 
11.1 
1.5 
.01 
You are satisfied with 
the medical care you 
receive 
Single 
Married 
Divorce 
Widow 
1 
37 
3 
7 
10 
17.9 
33.3 
10.5 
4 
66 
1 
25 
40 
31.9 
11.1 
37.9 
4 
80 
4 
27 
40 
38.6 
44.5 
41 
0 
15 
0 
4 
0 
7.2 
0 
6.1 
1 
9 
1 
3 
10 
4.4 
11.1 
4.5 
.75 
The doctor allows you to 
say everything you think 
is important for you 
during the visit 
Single 
Married 
Divorce 
Widow 
0 
31 
0 
6 
0 
15 
0 
9.1 
2 
58 
4 
17 
20 
28 
44.5 
25.8 
6 
72 
3 
23 
60 
34.8 
33.3 
34.8 
1 
27 
1 
14 
10 
13 
11.1 
21.2 
1 
19 
1 
6 
10 
9.2 
11.1 
9.1 
.66 
The doctor makes you 
feel foolish sometimes 
during the visit 
Single 
Married 
Divorce 
Widow 
1 
9 
0 
4 
10 
4.4 
0 
6.1 
1 
18 
2 
5 
10 
8.7 
22.3 
7.6 
2 
39 
1 
12 
20 
18.8 
11.1 
18.1 
3 
57 
3 
19 
30 
27.5 
33.3 
28.8 
3 
84 
3 
26 
30 
40.6 
33.3 
39.4 
.98 
The doctor acts too 
serious / formal  and 
impersonal toward you 
Single 
Married 
Divorce 
Widow 
0 
20 
1 
9 
0 
9.7 
11.1 
13.6 
0 
58 
1 
14 
0 
28 
11.1 
21.2 
8 
83 
6 
24 
80 
40.1 
66.7 
36.4 
1 
33 
0 
10 
10 
15.9 
0 
15.2 
1 
13 
1 
9 
10 
6.3 
11.1 
13.6 
.16 
The doctor during your 
examination or visit 
sometimes hurry too 
much to finish it quickly 
Single 
Married 
Divorce 
Widow 
3 
43 
3 
12 
30 
20.8 
33.3 
18.2 
5 
53 
4 
25 
50 
25.6 
44.5 
37.9 
1 
66 
1 
15 
10 
31.9 
11.1 
22.7 
0 
30 
1 
9 
0 
14.5 
11.1 
13.6 
1 
15 
0 
5 
10 
7.2 
0 
7.6 
.44 
The doctor sometimes 
ignores what you tell him 
/ her. 
Single 
Married 
Divorce 
Widow 
3 
12 
1 
7 
30 
5.8 
11.1 
10.6 
0 
40 
3 
13 
0 
19.3 
33.3 
19.7 
5 
87 
3 
30 
50 
42 
33.3 
45.5 
2 
41 
2 
7 
20 
19.9 
22.3 
10.6 
0 
27 
0 
9 
0 
13 
0 
13.6 
.17 
If you have a medical 
question, you can reach 
the doctor for help 
without a problem. 
Single 
Married 
Divorce 
Widow 
2 
21 
0 
9 
20 
10.1 
0 
13.6 
0 
55 
1 
11 
0 
26.6 
11.1 
16.7 
7 
84 
6 
27 
70 
40.6 
66.7 
40.9 
1 
31 
1 
12 
10 
15 
11.1 
18.2 
0 
16 
1 
7 
0 
7.7 
11.1 
10.6 
.38 
The doctor listens 
carefully to what you 
have to tell him / her. 
Single 
Married 
Divorce 
Widow 
0 
27 
0 
7 
0 
13 
0 
10.6 
4 
53 
2 
17 
40 
25.7 
22.3 
25.8 
4 
76 
3 
22 
40 
36.7 
33.3 
33.3 
0 
33 
4 
13 
0 
15.9 
44.4 
19.7 
2 
18 
0 
7 
20 
8.7 
0 
10.6 
.44 
Your doctor spends 
plenty of time with you 
during the visit 
Single 
Married 
Divorce 
Widow 
1 
12 
2 
6 
10 
5.8 
22.3 
9.1 
1 
46 
1 
14 
10 
22.2 
11.1 
21.2 
4 
65 
1 
17 
40 
31.4 
11.1 
25.8 
1 
51 
3 
21 
10 
24.7 
33.3 
31.8 
3 
33 
2 
8 
30 
15.9 
22.2 
12.1 
.51 
When you visit the 
clinic, the medical staff 
deals with you friendly 
and with respect 
Single 
Married 
Divorce 
Widow 
0 
65 
0 
16 
0 
31.4 
0 
24.2 
4 
68 
4 
25 
40 
32.8 
44.5 
38 
3 
50 
3 
16 
30 
24.2 
33.3 
24.2 
1 
18 
2 
6 
10 
8.7 
22.2 
9.1 
2 
6 
0 
3 
20 
2.9 
0 
4.5 
.14 
*All p-values were derived using the chi-squared test. 
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Table (20):Cross-tabulation of the participants’ responses to the questions related to the 
drugs-usage instructions by their marital status. 
Always Often Sometime Rarely Never Variable 
 
 
Marital 
status 
F. % F. % F. % F. % F. % 
P 
The drug- use 
instructions written 
by the doctor are 
clear to you. 
Single 
Married 
Divorce 
Widow. 
5 
64 
3 
24 
50 
30.9 
33.3 
36.4
3 
88 
2 
23
30 
42.5 
22.3 
34.8
1 
40 
3 
15
10 
19.3 
33.3 
22.7
0 
13 
1 
4
00 
6.3 
11.1 
6.1
1 
2 
0 
0 
10 
1 
00 
00 
.28 
The medical staff 
explains and gives 
you clear information 
about the necessary 
life style 
modifications for 
your condition. 
Single 
Married 
Divorce 
Widow. 
0 
30 
4 
14 
00 
14.5 
44.5 
21.2 
4 
39 
2 
12 
40 
18.8 
22.3 
18.2 
5 
68 
3 
20 
50 
32.9 
33.3 
30.3 
1 
52 
0 
15 
10 
25.1 
00 
22.7 
0 
18 
0 
5 
00 
8.7 
00 
7.6 
.21 
The medical staff 
shows and trains you 
how to perform self 
measurement of  BP. 
Single 
Married 
Divorce 
Widow. 
1 
27 
5 
8 
10 
13 
55.5 
12.1 
2 
25 
2 
11 
20 
12.1 
22.3 
16.7 
2 
40 
1 
13 
20 
19.3 
11.1 
19.7 
2 
40 
1 
13 
20 
19.3 
11.1 
19.7 
3 
75 
0 
21 
30 
36.3 
00 
31.8 
.14 
The medical staff 
explains to you or 
give you information 
about the importance 
of BP. control 
Single 
Married 
Divorce 
Widow 
3 
44 
3 
16 
30 
21.3 
33.3 
24.2 
4 
64 
3 
20 
40 
30.9 
33.3 
30.3 
1 
70 
3 
24 
10 
33.8 
33.3 
36.4 
1 
24 
0 
4 
10 
11.6 
00 
6.1 
1 
5 
0 
2 
10 
2.4 
00 
3 
.80 
The medical staff 
uses clear and simple 
language when they 
give you instructions 
about  your disease's 
control and 
medication 
Single 
Married 
Divorce 
Widow 
3 
39 
2 
11 
30 
18.8 
22.3 
16.7 
3 
10
1 
4 
31 
30 
48.8 
44.4 
47 
 
 
4 
59 
1 
23 
40 
28.5 
11.1 
34.8 
0 
8 
1 
0 
00 
3.9 
11.1 
00 
0 
0 
1 
1 
00 
00 
11.1 
1.5 
.01 
Your doctor explains 
the reasons for 
performing the 
medical tests for you. 
Single 
Married 
Divorce 
Widow 
2 
32 
1 
1 
20 
15.5 
11.1 
1.5 
4 
31 
2 
20 
40 
15 
22.3 
30.3 
4 
95 
2 
29 
40 
45.9 
22.3 
43.9 
0 
34 
3 
11 
00 
16.4 
33.3 
16.7 
0 
15 
1 
5 
00 
7.2 
11.1 
7.6 
.03 
When your doctor 
changes your drugs, 
he explains to you the 
reason for that. 
Single 
Married 
Divorce 
Widow 
3 
31 
1 
4 
30 
15 
11.1 
6.1 
1 
42 
1 
13 
10 
20.3 
11.1 
19.7 
4 
77 
4 
27 
40 
37.2 
44.5 
40.9 
1 
43 
1 
18 
10 
20.8 
11.1 
27.2 
1 
14 
2 
4 
10 
6.7 
22.2 
6.1 
.48 
The doctor uses 
difficult medical 
terms without 
explaining to you 
what they mean. 
Single 
Married 
Divorce 
Widow 
0 
17 
1 
2 
00 
8.2 
11.1 
3 
6 
22 
2 
11 
60 
10.6 
22.3 
16.7 
3 
54 
3 
19 
30 
26.1 
33.3 
28.8 
0 
56 
1 
15 
00 
27.1 
11.1 
22.7 
1 
58 
2 
19 
10 
28 
22.3 
28.8 
.01 
The doctor gives you 
advices and 
information about 
different ways to 
avoid illness and 
maintain health. 
Single 
Married 
Divorce 
Widow 
2 
30 
0 
3 
20 
14.5 
00 
4.5 
1 
38 
2 
21 
10 
18.4 
22.3 
31.8 
7 
83 
5 
25 
70 
40 
55.5 
37.9 
0 
37 
1 
11 
00 
17.9 
11.1 
16.7 
0 
19 
1 
6 
00 
9.2 
11.1 
9.1 
.17 
All p-values were derived using the chi-squared test. 
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Table (21):Cross-tabulation of the participants’ responses to the questions related to 
family support by their marital status. 
Always Often Sometime Rarely Never Variable 
 
Marital 
status F. % F. % F. % F. % F. % 
P 
Your family  
reminds you about 
your medications 
Single 
Married 
Divorce 
widow 
4 
77 
2 
21 
40 
37.2 
22.3 
31.8
4 
73 
2 
26
40 
35.3 
22.2 
39.4
0 
34 
2 
10
00 
16.4 
22.2 
15.2
2 
15 
2 
5
20 
7.2 
22.2 
7.6
0 
7 
1 
4 
00 
3.9 
11.1 
6 
.61 
Your family  helps 
you in taking your 
medications 
Single 
Married 
Divorce 
Widow 
1 
63 
1 
14 
10 
30.4 
11.1 
21.2
4 
77 
3 
26
40 
37.2 
33.3 
39.4
5 
49 
3 
18
50 
23.7 
33.3 
28.3
0 
10 
0 
3
00 
4.8 
00 
3.5
0 
8 
2 
5 
00 
3.9 
22.3 
7.6 
.26 
 
 
Your family  helps 
you financially to 
get your medication 
when you need 
Single 
Married 
Divorce 
Widow 
2 
68 
1 
23 
20 
32.9 
11.1 
34.8 
2 
64 
4 
18 
20 
30.9 
44.5 
27.3 
2 
51 
2 
16 
20 
24.6 
22.2 
25.3 
4 
12 
1 
3 
40 
5.8 
11.1 
3.5 
0 
12 
1 
6 
00 
5.8 
11.1 
9.1 
.03 
Your family  helps 
you in measuring 
your BP. 
Single 
Married 
Divorce 
Widow 
2 
61 
1 
17 
20 
29.5 
11.1 
25.8
1 
47 
3 
15
10 
22.7 
33.3 
22.7
5 
38 
1 
10
50 
18.4 
11.1 
15.2
1 
33 
3 
5
10 
15.9 
33.3 
7.6
1 
28 
1 
19 
10 
13.5 
11.1 
28.7
.05 
Your family  helps 
you in reaching the 
medical facility  if 
you are tired or sick 
Single 
Married 
Divorce 
Widow 
3 
100 
0 
34 
30 
48.3 
00 
51.5 
2 
47 
1 
12 
20 
22.7 
11.1 
18.2 
2 
44 
3 
13 
20 
21.3 
33.3 
20.7 
2 
6 
0 
4 
20 
2.9 
00 
6.1 
1 
10 
1 
3 
10 
4.8 
11.1 
3.5 
.48 
Your family helps 
you to accomplish 
the required life 
style changes. 
Single 
Married 
Divorce 
Widow 
0 
43 
1 
15 
00 
20.8 
11.1 
22.7 
3 
87 
2 
23 
30 
42 
22.2 
34.8 
4 
50 
3 
20 
40 
24.2 
33.3 
30.3 
2 
20 
2 
4 
20 
9.6 
22.3 
6.1 
1 
7 
1 
4 
10 
3.4 
11.1 
6.1 
.45 
Your family 
encourages you to 
be compliant with 
your medication 
and treatment plan 
Single 
Married 
Divorce 
Widow 
0 
58 
0 
16 
00 
28 
00 
24.2 
2 
55 
0 
21 
20 
26.6 
00 
31.8 
5 
70 
5 
19 
50 
33.8 
55.6 
28.8 
2 
18 
0 
5 
20 
8.7 
00 
7.6 
1 
6 
4 
5 
10 
2.9 
44.4 
7.6 
.00 
All p-values were derived using the chi-squared test. 
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Table (22):Cross-tabulation of the participants’ responses to the questions related to 
their regularity on appointments and the treatment plan by their marital status. 
Always Often Sometime 
 
Rarely Never Variable 
 
 
Marital 
status 
 F. % F. % F. % F. % F. % 
P 
you are always regular at 
your doctor 
appointments 
Single 
Married 
Divorce 
Widow. 
3 
85 
6 
28 
30 
41.1 
66.7 
42.4 
3 
74 
0 
28 
30 
35.7 
00 
42.4 
4 
32 
2 
4 
40 
15.5 
22.2 
6.1 
0 
4 
1 
4 
00 
1.9 
11.1 
6.1 
0 
12 
0 
2 
00 
5.8 
00 
3 
.05 
You  measure  your BP 
on  regular basis 
 
 
Single 
Married 
Divorce 
Widow. 
1 
31 
1 
8 
10 
15 
11.1 
12.1 
3 
60 
3 
14 
30 
29 
33.3 
21.2 
5 
67 
2 
25 
50 
32.4 
22.2 
37.9 
0 
30 
1 
8 
00 
14.5 
11.1 
12.1 
1 
19 
2 
11 
10 
9.1 
22.3 
16.7 
.75 
You manage to do 
physical exercises as 
advised by your  doctor 
Single 
Married 
Divorce 
Widow. 
2 
8 
0 
3 
20 
3.9 
00 
3.5 
2 
36 
1 
6 
20 
17.4 
11.1 
9.1 
3 
75 
2 
21 
30 
36.2 
22.2 
31.8 
0 
40 
1 
14 
00 
19.3 
11.1 
21.2 
3 
48 
5 
22 
30 
23.2 
55.6 
33.3 
.16 
You manage to maintain 
a healthy weight as 
advised by your doctor 
Single 
Married 
Divorce 
Widow. 
3 
14 
0 
5 
30 
6.8 
00 
7.6 
1 
55 
0 
12 
10 
26.6 
00 
18.2 
0 
70 
3 
18 
00 
33.8 
33.3 
27.3 
4 
37 
3 
14 
40 
17.9 
33.3 
21.2 
2 
31 
3 
17 
20 
14.9 
33.4 
25.7 
.02 
You manage to eat 
healthy food as advised 
by your doctor 
Single 
Married 
Divorce 
Widow. 
1 
35 
1 
11 
10 
16.9 
11.1 
16.7 
1 
69 
3 
21 
10 
33.3 
33.3 
31.8 
6 
65 
5 
23 
60 
31.4 
55.6 
34.8 
0 
24 
0 
6 
00 
11.6 
00 
9.1 
2 
14 
0 
5 
20 
6.8 
00 
7.6 
.52 
You manage to use your 
HTN drugs on regular 
basis as prescribed to 
you 
Single 
Married 
Divorce 
Widow. 
0 
59 
3 
15 
00 
28.5 
33.3 
23.7 
2 
74 
4 
24 
20 
35.7 
44.5 
36.4 
6 
61 
2 
20 
60 
29.6 
22.2 
30.3 
1 
10 
0 
3 
10 
4.8 
00 
3.5 
1 
3 
0 
4 
10 
1.4 
00 
6.1 
.26 
Sometimes you forget 
taking your medication 
because you have busy 
life 
Single 
Married 
Divorce 
Widow. 
1 
9 
0 
4 
10 
4.3 
00 
6.1 
3 
31 
0 
5 
30 
14.9 
00 
7.6 
2 
63 
3 
25 
20 
30.1 
33.3 
37.8 
2 
66 
5 
22 
20 
31.9 
55.6 
33.3 
2 
38 
1 
10 
20 
18.8 
11.1 
15.2 
.57 
When you feel better, 
you stop taking your 
medication 
Single 
Married 
Divorce 
Widow. 
1 
7 
0 
2 
10 
3.4 
00 
3 
1 
21 
2 
7 
10 
10.1 
22.2 
10.6 
4 
58 
0 
17 
40 
28 
00 
25.7 
4 
47 
5 
16 
40 
22.8 
55.6 
24.3 
0 
74 
2 
24 
00 
35.7 
22.2 
36.4 
.25 
If you feel worse because 
of the side effects of your  
medicine you stop taking 
it without consulting 
your doctor 
Single 
Married 
Divorce 
Widow. 
1 
14 
0 
4 
10 
6.8 
00 
6.1 
5 
15 
0 
4 
50 
7.2 
00 
6.1 
0 
66 
4 
16 
00 
31.9 
44.5 
24.2 
2 
49 
2 
21 
20 
23.7 
22.2 
31.8 
2 
63 
3 
21 
20 
30.4 
33.3 
31.8 
.00 
You always visit your 
doctor personally for 
drug prescription 
 
 
Single 
Married 
Divorce 
Widow. 
4 
94 
1 
18 
40 
45.4 
11.1 
27.3 
4 
72 
5 
33 
40 
34.8 
55.6 
50 
1 
31 
1 
10 
10 
15 
11.1 
15.2 
1 
6 
1 
2 
10 
2.9 
11.1 
3 
0 
4 
1 
3 
00 
1.9 
11.1 
4.5 
.15 
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You are kept waiting for 
a long time in reception 
area when you are at the 
doctor's office 
Single 
Married 
Divorce 
Widow 
3 
68 
4 
16 
30 
32.9 
44.5 
24.2 
1 
78 
2 
33 
10 
37.7 
22.2 
50 
6 
49 
1 
15 
60 
23.7 
11.1 
22.8 
0 
5 
1 
1 
00 
2.3 
11.1 
1.5 
0 
7 
1 
1 
00 
3.4 
11.1 
1.5 
.09 
if you know that your 
medication will increase 
your weight , you will 
continue taking them 
Single 
Married 
Divorce 
Widow 
2 
35 
1 
10 
20 
16.9 
11.1 
15.2 
3 
76 
2 
28 
30 
36.7 
22.2 
42.4 
4 
83 
4 
23 
40 
40.1 
44.5 
34.9 
1 
8 
1 
2 
10 
3.9 
11.1 
3 
0 
5 
1 
3 
00 
2.4 
11.1 
4.5 
.85 
if you know that your 
medication will affect 
your sex life, you will 
continue taking them 
Single 
Married 
Divorce 
Widow 
4 
35 
2 
11 
40 
16.9 
22.2 
16.7 
2 
62 
3 
24 
20 
30 
33.3 
36.4 
3 
75 
0 
18 
30 
36.2 
00 
27.3 
0 
21 
4 
9 
00 
10.1 
44.5 
13.5 
1 
14 
0 
4 
10 
6.8 
00 
6.1 
.08 
All p-values were derived using the chi-squared test. 
Table (23):Cross-tabulation of the participants’ responses to the questions related to 
their treatment costs by their marital status. 
 
Always Often Sometimes Rarely Never Variable 
 
 
Marital 
status 
 F. % F. % F. % F. % F. % 
P 
You have to pay for 
your medical care more 
than what you can 
afford 
Single 
Married 
Divorce 
Widow. 
5 
25 
0 
3 
50 
12.1 
00 
4.5 
0 
30 
2 
12 
00 
14.5 
22.3 
18.2 
5 
47 
3 
22 
50 
22.7 
33.3 
33.3 
0 
72 
1 
21 
00 
34.8 
11.1 
31.8 
0 
33 
3 
8 
00 
15.9 
33.3 
12.2 
.00 
You do not follow your 
drug regimen or you go 
without the medical 
care you need because 
you cannot afford the 
expenses 
Single 
Married 
Divorce 
Widow. 
0 
11 
0 
2 
00 
5.3 
00 
3 
2 
26 
2 
4 
20 
12.6 
22.2 
6.1 
6 
79 
4 
39 
60 
38.2 
44.5 
59.1 
2 
54 
1 
14 
20 
26.1 
11.1 
21.2 
0 
37 
2 
7 
00 
17.8 
22.2 
10.6 
.22 
It is a problem to cover 
your share of the cost 
for a medical care 
Single 
Married 
Divorce 
Widow. 
0 
16 
3 
6 
00 
7.7 
33.3 
9.1 
3 
35 
0 
9 
30 
16.9 
00 
13.6 
1 
83 
1 
31 
10 
40.1 
11.1 
47 
6 
47 
4 
13 
60 
22.7 
44.5 
19.7 
0 
26 
1 
7 
00 
12.6 
11.1 
10.6 
.01 
You worry about having 
to pay large medical 
bills. 
Single 
Married 
Divorce 
Widow. 
1 
11 
0 
5 
10 
5.3 
00 
7.6 
0 
41 
2 
12 
00 
19.8 
22.2 
18.2 
4 
83 
2 
25 
40 
40.1 
22.2 
37.9 
4 
47 
2 
6 
40 
22.7 
22.3 
9.1 
1 
25 
3 
18 
10 
12.1 
33.3 
27.2 
.07 
The amount you have to 
pay to cover your 
medical needs is 
reasonable 
Single 
Married 
Divorce 
Widow. 
0 
33 
0 
8 
00 
15.9 
00 
12.1 
1 
55 
2 
23 
10 
26.6 
22.3 
34.8 
6 
65 
3 
16 
60 
31.4 
33.3 
24.3 
1 
31 
1 
13 
10 
15 
11.1 
19.7 
2 
23 
3 
6 
20 
11.1 
33.3 
9.1 
.22 
High cost of your 
medication and the 
treatment plan in 
general makes me less 
compliant with my 
treatment regimen 
Single 
Married 
Divorce 
Widow. 
1 
10 
0 
1 
10 
4.8 
00 
1.5 
0 
25 
1 
5 
00 
12.1 
11.1 
7.6 
3 
49 
2 
14 
30 
23.7 
22.3 
21.2 
3 
72 
3 
26 
30 
34.8 
33.3 
39.4 
3 
51 
3 
20 
30 
24.6 
33.3 
30.3 
.90 
All p-values were derived using the chi-squared test. 
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Table (24):Cross-tabulation of the participants’ responses to the questions related to 
their knowledge and perception of hypertension by their level of education. 
Always Often Sometimes Rarely Never Variable 
Ed
uc
at
io
n 
freq % freq % freq % freq % freq % 
P 
In general you consider 
yourself to be in good 
health. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
21 
15 
12 
3 
13 
20 
18.8 
24.5 
20 
30.2 
26 
34 
26 
8 
15 
24.8 
42.5 
53.1 
53.3 
34.9 
40 
26 
8 
4 
14 
38.1 
32.5 
16.3 
26.7 
32.6 
18 
5 
2 
0 
1 
17.1 
6.2 
4.1 
0 
2.3 
0 
0 
1 
0 
0 
0 
0 
2 
0 
0 
.00 
You consider your BP 
to be well controlled 
None 
Prim. 
Elem. 
Sec. 
Univ. 
7 
7 
6 
3 
5 
6.7 
8.8 
12.2 
20 
11.6 
53 
32 
21 
6 
20 
50.5 
40 
42.9 
40 
46.5 
35 
33 
20 
6 
16 
33.3 
41.2 
40.9 
40 
37.2 
10 
7 
1 
0 
2 
9.5 
8.8 
2 
0 
4.7 
0 
1 
1 
0 
0 
0 
1.2 
2 
0 
0 
.68 
You consider HTN as a 
serious problem 
None 
Prim. 
Elem. 
Sec. 
Univ. 
40 
17 
16 
5 
19 
38.1 
21.2 
32.8 
33.3 
44.2 
37 
31 
15 
5 
11 
35.2 
38.8 
30.6
33.3 
25.6 
23 
26 
11 
5 
10 
21.9 
32.5 
22.4 
33.3 
23.3 
4 
6 
6 
0 
2 
3.8 
7.5 
12.2 
0 
4.6 
1 
0 
1 
0 
1 
1 
0 
2 
0 
2.3 
.35 
You think that HTN 
leads to other serious 
conditions  
None 
Prim. 
Elem. 
Sec. 
Univ. 
30 
16 
9 
6 
21 
28.6 
20 
18.4 
40 
48.8 
35 
25 
22 
3 
11 
33.3 
31.3 
44.9 
20 
25.6 
29 
27 
16 
4 
6 
27.6 
32.5 
32.7 
26.7 
13.9 
8 
11 
1 
1 
2 
7.6 
13.9 
2 
6.7 
4.7 
3 
1 
1 
1 
3 
2.9 
1.3 
2 
6.7 
7 
.02 
You think that HTN has 
hereditary basis 
None 
Prim. 
Elem. 
Sec. 
Univ. 
19 
10 
9 
2 
4 
18.1 
12.5 
18.4 
13.3 
9.3 
19 
9 
8 
4 
11 
18.1 
11.3 
16.3 
26.7 
25.6 
28 
31 
20 
5 
6 
26.7 
38.8 
40.8 
33.3 
13.9 
20 
19 
10 
0 
5 
19 
23.8 
20.4 
0 
11.6 
19 
11 
2 
4 
17 
18.1 
13.6 
4.1 
26.7 
39.6 
.00 
You think that the risk 
of getting HTN is 
affected by gender. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
19 
5 
9 
1 
3 
18.1 
6.3 
18.4 
6.7 
7 
16 
14 
6 
1 
7 
15.2 
17.5 
12.2 
6.7 
16.3 
23 
23 
10 
7 
11 
21.9 
28.8 
20.4 
46.7 
25.6 
24 
21 
15 
2 
5 
22.9 
26.3 
30.6 
13.3 
11.6 
23 
17 
9 
4 
17 
21.9 
21.1 
18.4 
26.6 
39.5 
.10 
You think that HTN 
risk increases with age 
None 
Prim. 
Elem. 
Sec. 
Univ. 
27 
16 
10 
5 
16 
25.7 
20 
20.4 
33.3 
37.2 
42 
37 
20 
5 
17 
40 
46.3 
40.8 
33.3 
39.5 
22 
12 
12 
5 
8 
21 
15 
25.5 
33.3 
18.6 
6 
12 
7 
0 
0 
5.5 
15 
13.3 
0 
0 
8 
3 
0 
0 
2 
7.6 
3.7 
0 
0 
4.7 
.07 
You think that 
decreasing tension and 
anger will help you in 
controlling your BP. 
 
 
None 
Prim. 
Elem. 
Sec. 
Univ. 
47 
33 
17 
5 
14 
44.8 
41.3 
34.7 
33.3 
32.6 
32 
28 
17 
4 
18 
30.5 
35 
34.7 
26.7 
41.8 
19 
14 
9 
5 
10 
18.1 
17.5 
18.4 
33.3 
23.3 
2 
3 
5 
1 
0 
1.8 
3.7 
10.2 
6.7 
0 
5 
2 
1 
0 
1 
4.8 
2.5 
2 
0 
2.3 
.50 
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You think that dietary 
changes will help you in 
controlling your BP 
None 
Prim. 
Elem. 
Sec. 
Univ. 
30 
22 
11 
6 
16 
28.6 
27.5 
22.4 
40 
37.2 
35 
33 
20 
4 
18 
33.3 
41.3 
40.8 
26.7 
41.8 
26 
18 
13 
5 
6 
24.8 
22.5 
26.5 
33.3 
14 
6 
5 
5 
0 
0 
5.7 
6.2 
10.3 
0 
0 
8 
2 
0 
0 
3 
7.6 
2.5 
0 
0 
7 
.30 
You think that physical 
activity will help you in 
controlling your BP 
None 
Prim. 
Elem. 
Sec. 
Univ. 
18 
13 
6 
6 
12 
17.1 
16.3 
12.2 
40 
27.9 
22 
17 
15 
2 
13 
21 
21.3 
30.6 
13.3 
30.2 
32 
26 
17 
2 
12 
30.5 
33.3 
34.8 
13.3 
27.9 
28 
17 
6 
1 
2 
26.8 
21.3 
12.2 
6.7 
4.7 
5 
6 
5 
4 
4 
4.8 
7.5 
10.2 
26.7 
9.3 
.01 
You think that it is 
necessary to take HTN 
drugs regularly 
None 
Prim. 
Elem. 
Sec. 
Univ. 
43 
31 
15 
4 
28 
41 
38.8 
30.6 
26.7 
65.1 
37 
23 
21 
4 
9 
35.2 
28.8 
42.8 
26.7 
20.9 
18 
18 
8 
3 
3 
17.1 
22.5 
16.3 
20 
7 
7 
3 
2 
1 
3 
6.7 
3.7 
4.1 
6.6 
7 
0 
5 
3 
3 
0 
0 
6.2 
6.2 
20 
0 
.00 
You think that HTN 
drugs help you to 
control your BP 
None 
Prim. 
Elem. 
Sec. 
Univ. 
28 
25 
7 
4 
18 
26.7 
31.3 
14.3
26.7 
41.8 
40 
19 
24 
4 
14 
38.1 
23.8 
49 
26.7 
32.6 
29 
27 
13 
5 
7 
27.6 
34.8 
26.5 
33.3 
16.3 
8 
3 
2 
2 
3 
7.6 
3.8 
4.1 
13.3 
7 
0 
5 
3 
0 
1 
0 
6.3 
6.1 
0 
2.3 
.04 
You feel it is safe or not 
necessary to take your 
drugs. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
9 
3 
5 
1 
2 
8.6 
3.7 
10.2 
6.7 
4.7 
14 
8 
7 
3 
6 
13.3 
10 
14.3 
20 
14 
28 
20 
12 
4 
6 
26.7 
25 
24.5 
26.7 
14 
25 
21 
14 
5 
11 
23.8 
26.3 
28.6 
33.3 
25.6 
29 
28 
11 
2 
18 
27.6 
35 
22.4 
13.3 
41.7 
.75 
You feel it is safe to 
increase or decrease 
your drug dose without 
consulting your doctor 
None 
Prim. 
Elem. 
Sec. 
Univ. 
5 
3 
1 
3 
0 
4.8 
3.7 
2 
20 
0 
12 
12 
6 
1 
6 
11.4 
15 
12.2 
6.7 
14 
24 
19 
16 
2 
6 
22.9 
23.7 
32.8 
13.3 
14 
22 
19 
13 
5 
9 
21 
23.7 
26.5 
33.3 
20.9 
42 
27 
13 
4 
22 
39.9 
33.9 
26.5 
26.7 
51.1 
.12 
You think that your 
HTN drugs have serious 
side effects that may 
affect your health 
None 
Prim. 
Elem. 
Sec. 
Univ. 
5 
4 
9 
1 
4 
4.8 
5 
18.4 
6.7 
9.3 
16 
11 
8 
2 
8 
15.2 
13.8 
16.3 
13.3 
18.7 
32 
31 
17 
5 
9 
30.5 
38.8 
34.7 
33.3 
20.9 
20 
20 
12 
6 
18 
19 
25 
24.5 
40 
41.8 
32 
14 
3 
1 
4 
30.5 
17.4 
6.1 
6.7 
9.3 
.00 
You think that HTN is a 
disease that can be 
prevented. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
8 
1 
2 
1 
3 
7.6 
1.3 
4.1 
6.7 
7 
6 
8 
10 
2 
9 
5.7 
10 
20.4 
13.3 
20.9 
25 
23 
16 
7 
14 
23.8 
28.7 
32.7 
46.7 
32.6 
32 
24 
8 
4 
7 
30.5 
30 
16.3 
26.6 
16.3 
34 
24 
13 
1 
10 
32.4 
30 
26.5 
6.7 
23.1 
.07 
All p-values were derived using the chi-squared test. 
None= no education at all, Prim. = primary (1-6 years), Elem. =elementary education (7-9 
years), Sec. = secondary education (10-12 years), Univ. =university or college education. 
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Table (25):Cross-tabulation of the participants’ responses to the questions related to the 
duration of illness by their level of education.  
Always Often Sometime
s
Rarely Never Variable 
Ed
uc
at
io
n 
F. % F. % F. % F. % F. % 
P 
The long duration of 
your illness affect your 
desire to take your 
drugs 
None 
Prim. 
Elem. 
Sec. 
Univ. 
16 
13 
6 
0 
4 
15.2 
16.2 
12.2 
0 
9.3 
43 
31 
18 
7 
10 
41 
38.7 
36.7 
46.7 
23.2 
28 
30 
19 
5 
17 
26.7 
37.5 
38.8 
33.3 
39.6 
11 
3 
2 
2 
2 
10.5 
3.8 
4.1 
13.3 
4.7 
7 
3 
4 
1 
10 
6.6 
3.8 
8.2 
6.7 
23.2 
.03 
Because HTN is a 
chronic disease, you 
do not take your drugs 
continuously. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
7 
1 
2 
0 
0 
6.6 
1.3 
4.1 
0 
0 
14 
14 
4 
4 
4 
13.3 
17.5 
8.2 
26.6 
9.3 
33 
30 
26 
7 
14 
31.4 
37.5 
53.1 
46.8 
32.6 
28 
22 
14 
2 
11 
26.7 
27.5 
28.5 
13.3 
25.5 
23 
13 
3 
2 
14 
22 
16.2 
6.1 
13.3 
32.6 
.05 
Because HTN is a 
chronic disease, you 
do not follow the diet 
regimen or change 
your  lifestyle 
according to your 
doctor advice 
None 
Prim. 
Elem. 
Sec. 
Univ. 
6 
4 
1 
0 
2 
5.7 
5 
2 
0 
4.6 
17 
10 
6 
1 
1 
16.2 
12.5 
12.2 
6.7 
2.3 
27 
22 
17 
7 
11 
25.7 
27.5 
34.7 
46.7 
25.5 
31 
32 
18 
5 
12 
29.5 
40 
36.7 
33.3 
28 
24 
12 
7 
2 
17 
22.9 
15 
14.4 
13.3 
39.6 
.15 
Because HTN is a 
chronic disease, it 
makes you feel sad and 
depressed 
None 
Prim. 
Elem. 
Sec. 
Univ. 
9 
2 
3 
0 
5 
8.6 
2.5 
6.1 
0 
11.6 
21 
22 
12 
5 
6 
20 
27.5 
24.5 
33.3 
14 
41 
35 
21 
4 
12 
39 
43.7 
42.9 
26.7 
28 
16 
12 
10 
3 
11 
15.2 
15 
20.4 
20 
25.5 
18 
9 
3 
3 
9 
17.2 
11.3 
6.1 
20 
20.9 
.27 
All p-values were derived using the chi-squared test. 
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Table (26):Cross-tabulation of the participants’ responses to the questions related to 
their drugs' regimen by their education level 
Always Often Sometime Rarely Never p. Variable 
Ed
uc
at
io
n 
F. % F. % F. % F. % F. %  
Because you have to 
take your drug(s) 
many times a day, it 
decreases your desire 
to take them every 
day. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
17 
11 
7 
3 
8 
16.2 
13.8 
14.3 
20 
18.6 
36 
39 
18 
4 
7 
34.3 
48.7 
36.7 
26.7 
16.3 
38 
20 
16 
6 
19 
36.2 
25 
32.7 
40 
44.2 
4 
6 
6 
2 
3 
3.8 
7.5 
12.2 
13.3 
7 
10 
4 
2 
0 
6 
9.5 
5 
4.1 
0 
13.9 
.12 
Because you have to 
take your drug(s) 
many times a day, it 
is difficult for you to 
remember this all the 
time 
None 
Prim. 
Elem. 
Sec. 
Univ. 
9 
4 
1 
2 
0 
 8.6 
5 
2 
13.3 
0 
29 
25 
16 
3 
8 
27.6 
31.3 
32.7 
20 
18.6 
49 
35 
23 
6 
18 
46.7 
43.8 
46.9 
40 
41.9 
13 
7 
6 
3 
9 
12.4 
8.8 
12.3 
20 
20.9 
5 
9 
3 
1 
8 
4.7 
11.1 
6.1 
6.7 
18.6 
.17 
The drugs you take 
for chronic conditions 
other than HTN 
decreases your desire 
to take HTN drugs 
and follow lifestyle 
changes 
None 
Prim. 
Elem. 
Sec. 
Univ. 
13 
6 
3 
1 
1 
12.4 
7.5 
6.1 
6.7 
2.3 
32 
18 
16 
6 
10 
30.5 
22.5 
32.7 
40 
23.2 
37 
38 
16 
5 
14 
35.2 
47.5 
32.7 
33.3 
32.7 
15 
9 
9 
2 
8 
14.3 
11.25 
18.4 
13.3 
18.6 
8 
9 
5 
1 
10 
7.6 
11.25 
10.1 
6.7 
23.2 
.29 
Changing your drugs 
regimen by your 
doctors frequently 
decreases your desire 
to take these drugs 
None 
Prim. 
Elem. 
Sec. 
Univ. 
8 
5 
0 
3 
6 
7.6 
6.3 
0 
20 
13.9 
17 
19 
10 
1 
7 
16.2 
23.8 
20.4 
6.8 
16.4 
44 
29 
22 
4 
8 
41.9 
36.2 
44.9 
26.6 
18.6 
25 
20 
9 
4 
10 
23.8 
25 
18.4 
26.6 
23.2 
11 
7 
8 
3 
12 
10.5 
8.7 
16.3 
20 
27.9 
.03 
If I find all my drugs 
in one pill, this will 
increase my 
regularity in taking 
them 
None 
Prim. 
Elem. 
Sec. 
Univ. 
53 
26 
22 
7 
26 
50.5 
32.5 
44.9 
46.6 
60.5 
30 
22 
14 
3 
7 
28.6 
27.5 
28.6 
20 
16.4 
11 
21 
8 
4 
6 
10.5 
26.3 
16.3 
26.7 
13.9 
5 
7 
3 
0 
0 
4.8 
8.7 
6.1 
0 
0 
6 
4 
2 
1 
4 
5.6 
5 
4.1 
6.7 
9.2 
.14 
All p-values were derived using the chi-squared test. 
None= no education at all, Prim. = primary (1-6 years), Elem. =elementary education (7-9 
years), Sec. = secondary education (10-12 years), Univ. =university or college education. 
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Table (27):Cross-tabulation of the participants’ responses to the questions related to the 
patient’s relationship with the medical staff by their level of education. 
Always 
 
Often Sometime Rarely Never Variable 
 
 
 E
du
c-
at
io
n 
F. % F. % F. % F. % F. % 
P 
The same doctor sees 
you in every visit you 
do to the clinic 
None 
Prim. 
Elem. 
Sec. 
Univ. 
17 
12 
3 
2 
22 
16.2 
15 
6.1 
13.3 
51.2 
34 
24 
23 
6 
12 
32.4 
30 
46.9 
40 
27.9 
30 
24 
16 
3 
5 
28.6 
30 
32.7 
20 
11.6 
9 
15 
6 
2 
1 
8.6 
18.7 
12.2 
13.3 
2.3 
15 
5 
1 
2 
3 
14.2 
6.3 
2.1 
13.4 
7 
.00 
The doctor treats you 
with respect when you 
visit him in the clinic 
None 
Prim. 
Elem. 
Sec. 
Univ. 
18 
10 
7 
2 
20 
17.1 
12.5 
14.3 
13.3 
46.5 
48 
36 
23 
4 
12 
45.7 
45 
46.9 
26.7 
28 
28 
32 
17 
8 
10 
26.7 
40 
34.7 
53.3 
23.2 
9 
2 
2 
1 
1 
8.6 
2.5 
4.1 
6.7 
2.3 
2 
0 
0 
0 
0 
1.9 
0 
0 
0 
0 
.00 
You are satisfied with 
the medical care you 
receive 
None 
Prim. 
Elem. 
Sec. 
Univ. 
17 
12 
3 
1 
15 
16.2 
15 
6.1 
6.7 
34.9 
39 
26 
18 
4 
9 
37.1 
32.5 
36.7 
26.7 
20.9 
40 
34 
23 
7 
11 
38.1 
42.5 
47 
46.6 
25.6 
4 
7 
2 
2 
4 
3.8 
8.7 
4.1 
13.3 
9.3 
5 
1 
3 
1 
4 
4.8 
1.3 
6.1 
6.7 
9.3 
.04 
The doctor allows you 
to say everything you 
think is important for 
you during the visit. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
16 
7 
3 
2 
9 
15.2 
8.7 
6.1 
13.3 
20.9 
32 
20 
15 
2 
12 
30.5 
25 
30.6 
13.3 
27.9 
35 
31 
18 
7 
13 
33.4 
38.7 
36.7 
46.7 
30.2 
18 
13 
6 
1 
5 
17.1 
16.3 
12.2 
6.7 
11.7 
4 
9 
7 
3 
4 
3.8 
11.3 
14.4 
20 
9.3 
.37 
The doctor makes you 
feel foolish sometimes 
during the visit 
None 
Prim. 
Elem. 
Sec. 
Univ. 
3 
3 
4 
1 
3 
2.8 
3.7 
8.2 
6.7 
7 
9 
9 
5 
1 
2 
8.6 
11.3 
10.2 
6.7 
4.7 
18 
17 
8 
4 
7 
17.1 
21.2 
16.3 
26.6 
16.3 
28 
24 
20 
4 
6 
26.7 
30 
40.8 
26.6 
14 
47 
27 
12 
5 
25 
44.8 
33.8 
24.5 
33.4 
58 
.23 
The doctor acts too 
serious/formal and 
impersonal toward you 
during the visit. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
13 
8 
3 
1 
5 
12.4 
10 
6.1 
6.7 
11.6 
19 
21 
15 
6 
12 
18.1 
26.2 
30.6 
40 
27.9 
44 
38 
19 
3 
17 
41.9 
47.6 
38.7 
20 
39.5 
20 
10 
5 
3 
6 
19 
12.5 
10.2 
20 
14 
9 
3 
7 
2 
3 
8.6 
3.7 
14.4 
13.3 
7 
.49 
The doctor during your 
examination or visit 
sometimes hurries too 
much to finish it 
quickly. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
18 
19 
9 
3 
12 
17.1 
23.7 
18.4 
20 
27.9 
40 
18 
16 
5 
8 
38.1 
22.5 
32.7 
33.3 
18.6 
22 
28 
15 
2 
16 
21 
35 
30.5 
13.3 
37.2 
16 
9 
5 
4 
6 
15.2 
11.3 
10.2 
26.7 
14 
9 
6 
4 
1 
1 
8.6 
7.5 
8.2 
6.7 
2.3 
.30 
The doctor sometimes 
ignores what you tell 
him. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
7 
5 
6 
3 
2 
6.7 
6.2 
12.2 
20 
4.7 
23 
18 
7 
2 
6 
21.9 
22.5 
14.3 
13.3 
14 
43 
35 
23 
7 
17 
41 
43.7 
47 
46.7 
39.5 
16 
14 
8 
3 
11 
15.2 
17.6 
16.3 
20 
25.5 
16 
8 
5 
0 
7 
15.2 
10 
10.2 
0 
16.3 
.64 
If you have a medical 
question, you can reach 
the doctor for help 
without a problem 
 
None 
Prim. 
Elem. 
Sec. 
Univ. 
11 
6 
6 
3 
6 
10.5 
7.5 
12.2 
20 
14 
21 
17 
14 
2 
13 
20 
21.2 
28.6 
13.3 
30.2 
47 
41 
14 
6 
16 
44.7 
51.3 
28.6 
40.1 
37.2 
19 
12 
7 
2 
5 
18.1 
15 
14.3 
13.3 
11.6 
7 
4 
8 
2 
3 
6.7 
5 
16.3 
13.3 
7 
.44 
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The doctor listens 
carefully to what you 
have to tell him/her 
None 
Prim. 
Elem. 
Sec. 
Univ. 
7 
14 
7 
1 
5 
6.7 
17.5 
14.3 
6.7 
11.6 
27 
19 
17 
3 
10 
25.7 
23.7 
34.7 
20 
23.2 
41 
27 
15 
6 
16 
39 
33.8 
30.6 
40 
37.3 
18 
16 
5 
3 
8 
17.1 
20 
10.2 
20 
18.6 
12 
4 
5 
2 
4 
11.5 
5 
10.2 
13.3 
9.3 
.74 
Your doctor spends 
plenty of time with you 
during the visit 
 
None 
Prim. 
Elem. 
Sec. 
Univ. 
11 
6 
0 
3 
1 
10.5 
7.5 
0 
20 
2.3 
19 
11 
17 
2 
13 
18.1 
13.8 
34.7 
13.3 
30.2 
30 
35 
13 
1 
8 
28.6 
43.8 
26.5 
6.7 
18.6 
28 
23 
11 
5 
9 
26.7 
28.8 
22.4 
33.3 
20.9 
17 
5 
8 
4 
12 
16.1 
6.1 
16.4 
26.7 
28 
.00 
When you visit the 
clinic, the medical staff 
deals with you friendly 
and with respect 
None 
Prim. 
Elem. 
Sec. 
Univ. 
30 
19 
16 
2 
14 
28.6 
23.7 
32.6 
13.3 
32.6 
35 
29 
18 
4 
15 
33.3 
36.3 
36.7 
26.7 
34.9 
25 
19 
13 
5 
10 
23.8 
23.8 
26.7 
33.3 
23.2 
8 
12 
1 
3 
3 
7.6 
15 
2 
20 
7 
7 
1 
1 
1 
1 
6.7 
1.2 
2 
6.7 
2.3 
.44 
All p-values were derived using the chi-squared test. 
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Table (28):Cross-tabulation of the participants’ responses to the questions related to the 
clarity of drugs-usage instructions by their level of education. 
Always Often Sometimes Rarely Never Variable 
Ed
uc
-
at
io
n 
F. % F. % F. % F. % F. % 
P 
The drug- use 
instructions written by 
the doctor are clear to 
you 
None 
Prim. 
Elem. 
Sec. 
Univ. 
44 
20 
10 
2 
20 
41.9 
25 
20.4 
13.3 
46.5 
36 
33 
26 
8 
13 
34.3 
41.2 
53.1 
53.4 
30.3 
18 
23 
9 
3 
6 
17.1 
28.8 
18.4 
20 
14 
7 
4 
3 
2 
2 
6.7 
5 
6.1 
13.3 
4.6 
0 
0 
1 
0 
2 
0 
0 
2 
0 
4.6 
.02 
The medical staff 
explains and gives you 
information about the 
life style changes 
needed for you. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
18 
14 
7 
1 
8 
17.1 
17.5 
14.3 
6.7 
18.6 
19 
17 
4 
4 
13 
18.1 
21.2 
8.2 
26.6 
30.2 
31 
27 
22 
5 
11 
29.5 
33.8 
44.9 
33.4 
25.6 
26 
16 
15 
4 
7 
24.8 
20 
30.6 
26.6 
16.3 
11 
6 
1 
1 
4 
10.5 
7.5 
2 
6.7 
9.3 
.41 
The medical staffs 
shows and train you 
how to perform self 
measurement of your 
BP 
None 
Prim. 
Elem. 
Sec. 
Univ. 
13 
8 
9 
2 
9 
12.4 
10 
18.4 
13.3 
20.9 
10 
11 
6 
5 
8 
9.5 
13.7 
12.2 
33.3 
18.6 
22 
21 
3 
4 
6 
21 
26.3 
6.1 
26.8 
14 
16 
17 
15 
2 
6 
15.2 
21.2 
30.6 
13.3 
14 
44 
23 
16 
2 
14 
41.9 
28.8 
32.7 
13.3 
32.5 
.04 
The medical staff 
explain to you or give 
you information about 
the importance of BP. 
control 
None 
Prim. 
Elem. 
Sec. 
Univ. 
22 
13 
13 
2 
16 
21 
16.2 
26.5 
13.3 
37.2 
28 
25 
15 
8 
15 
 26.7 
31.2 
30.6 
53.3 
34.9 
35 
35 
16 
3 
9 
33.3 
43.8 
32.7 
20 
21 
16 
6 
4 
1 
2 
15.2 
7.5 
8.2 
6.7 
4.6 
4 
1 
1 
1 
1 
3.8 
1.3 
2 
6.7 
2.3 
.13 
The medical staff use 
clear and simple 
language when they 
give you instructions 
about  your disease's 
control and drugs 
None 
Prim. 
Elem. 
Sec. 
Univ. 
22 
14 
7 
2 
10 
21 
17.5 
14.3 
13.3 
23.3 
48 
35 
21 
9 
26 
45.7 
43.7 
42.8 
60 
60.5 
29 
31 
17 
3 
7 
27.6 
38.8 
34.7 
20 
16.2 
4 
0 
4 
1 
0 
3.8 
0 
8.2 
6.7 
0 
2 
0 
0 
0 
0 
1.9 
0 
0 
0 
0 
.13 
Your doctor explains  
the reasons for 
performing the medical 
tests  for you 
 
None 
Prim. 
Elem. 
Sec. 
Univ. 
11 
8 
2 
3 
12 
10.5 
10 
4.1 
20 
27.9 
24 
12 
10 
1 
10 
22.9 
15 
20.4 
6.7 
23.3 
41 
42 
23 
8 
16 
39 
52.5 
46.9 
53.3 
37.2 
24 
13 
7 
1 
3 
22.9 
16.2 
14.3 
6.7 
7 
5 
5 
7 
2 
2 
4.7 
6.3 
14.3 
13.3 
4.6 
.01 
When your doctor 
changes your drugs, he 
explains to you the 
reason for that 
None 
Prim. 
Elem. 
Sec. 
Univ. 
14 
11 
3 
3 
8 
13.3 
13.7 
6.1 
20 
18.6 
17 
13 
10 
4 
13 
16.2 
16.3 
20.4 
26.6 
30.2 
43 
32 
21 
4 
12 
40.9 
40 
42.8 
26.7 
27.9 
28 
19 
9 
1 
6 
26.7 
23.7 
18.5 
6.7 
14 
3 
5 
6 
3 
4 
2.9 
6.3 
12.2 
20 
9.3 
.13 
The doctor uses difficult 
medical terms without 
explaining to you what 
they mean. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
5 
1 
7 
0 
7 
4.8 
1.3 
14.3 
0 
16.3 
20 
11 
8 
0 
2 
19 
13.7 
16.3 
0 
4.6 
26 
24 
14 
7 
8 
24.8 
30 
28.6 
46.7 
18.6 
20 
20 
11 
5 
16 
19 
25 
22.4 
33.3 
37.2 
34 
24 
9 
3 
10 
32.4 
30 
18.4 
20 
23.3 
.00 
The doctor gives you 
advices and information 
about different ways to 
avoid illness and 
maintain health 
None 
Prim. 
Elem. 
Sec. 
Univ. 
10 
10 
2 
3 
10 
9.5 
12.5 
4.1 
20 
23.3 
20 
19 
10 
5 
8 
19 
23.7 
20.4 
33.3 
18.6 
44 
32 
21 
5 
18 
41.9 
40 
42.9 
33.3 
41.9 
22 
11 
10 
2 
4 
21 
13.7 
20.4 
13.4 
9.3 
9 
8 
6 
0 
3 
8.6 
10.1 
12.2 
0 
6.9 
.44 
All p-values were derived using the chi-squared test. 
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Table (29):Cross-tabulation of the participants’ responses to the questions related to the 
family support by their level of education. 
Always Often Sometime Rarely Never Variable 
   Ed
uc
at
F. % F. % F. % F. % F. % 
P 
Your family reminds 
you about your 
drugs 
None 
Prim. 
Elem. 
Sec. 
Univ. 
37 
24 
18 
2 
23 
35.2 
30 
36.7 
13.3 
53.5
38 
28 
19 
7 
13
36.2 
35 
38.8 
46.7 
30.2
16 
15 
8 
5 
2
15.2 
18.7 
16.3 
33.3 
4.6
10 
11 
1 
1 
1
9.5 
13.7 
2 
6.7 
2.3
4 
1 
3 
0 
4 
3.9 
2.6 
6.2 
0 
9.6 
.03 
Your family helps 
you in taking your 
drugs 
None 
Prim. 
Elem. 
Sec. 
Univ. 
24 
23 
11 
3 
18 
22.9 
28.7 
22.4 
20 
41.9
40 
28 
17 
8 
17
38.1 
35 
34.7 
53.3 
39.5
30 
22 
17 
2 
4
28.6 
27.5 
34.7 
13.3 
9.6
5 
3 
2 
1 
2
4.8 
3.8 
4.1 
6.7 
4.6
6 
4 
2 
1 
2 
5.6 
5 
4.1 
6.7 
4.6 
.58 
Your family helps 
you financially to 
get your drug when 
you need. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
36 
25 
13 
4 
16 
34.3 
31.2 
26.5 
26.8 
37.2
30 
26 
17 
2 
13
28.6 
32.5 
34.7 
13.3 
30.2
23 
24 
10 
5 
9
21.9 
30 
20.4 
33.3 
20.9
9 
4 
3 
2 
2
8.6 
5 
6.1 
13.3 
4.6
7 
1 
6 
2 
3 
6.6 
1.3 
12.3 
13.3 
7.1 
.56 
Your family helps 
you in measuring 
your BP. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
27 
17 
13 
4 
20 
25.7 
21.2 
26.5 
26.7 
46.5
23 
16 
10 
2 
15
21.9 
20 
20.4 
13.3 
34.9
14 
18 
15 
2 
5
13.3 
22.5 
30.6 
13.3 
11.6
11 
20 
6 
4 
1
10.5 
25 
12.2 
26.7 
2.3
30 
9 
5 
3 
2 
28.6 
11.3 
10.3 
20 
4.6 
.00 
Your family helps 
you in reaching the 
medical facility  if 
you are tired or sick 
None 
Prim. 
Elem. 
Sec. 
Univ. 
51 
43 
17 
4 
26 
48.6 
53.7 
34.7 
26.7 
60.5
19 
15 
13 
5 
10
18.1 
18.7 
26.5 
33.3 
23.3
25 
15 
13 
5 
4
23.8 
18.7 
26.5 
33.3 
9.3
3 
5 
2 
1 
1
2.9 
6.2 
4.1 
6.7 
2.3
7 
2 
4 
0 
2 
6.6 
2.7 
8.2 
0 
4.6 
.33 
Your family helps 
you to accomplish 
the life style 
modifications if it is 
required by your 
doctor 
None 
Prim. 
Elem. 
Sec. 
Univ. 
26 
10 
9 
4 
10 
24.8 
12.5 
18.4 
26.6 
23.3 
30 
32 
25 
5 
23 
28.6 
40 
51 
33.3 
53.5 
33 
25 
9 
4 
6 
31.4 
31.2 
18.4 
26.7 
14 
11 
9 
4 
1 
3 
10.5 
11.1 
8.2 
6.7 
6.9 
5 
4 
2 
1 
1 
4.7 
5 
4 
6.7 
2.3 
.31 
Your family 
encourages you to 
be compliant with 
your medication and 
treatment plan 
None 
Prim. 
Elem. 
Sec. 
Univ. 
24 
21 
6 
2 
21 
22.9 
26.2 
12.2 
13.3 
48.8
23 
18 
21 
5 
11
21.9 
22.5 
42.8 
33.3 
25.6
38 
33 
15 
6 
7
36.1 
41.3 
30.7 
40 
16.3
11 
6 
4 
1 
3
10.5 
7.5 
8.2 
6.7 
7
9 
2 
3 
1 
1 
8.6 
2.5 
6.1 
6.7 
2.3 
.01 
All p-values were derived using the chi-squared test. 
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Table (30):Cross-tabulation of the participants’ responses to the questions related to 
regularity on doctor appointments and the treatment plan by their level of education. 
Always Often Sometime Rarely Never Variable 
ed
uc
at
io
n 
 
F. % F. % F. % F. % F. % 
P 
you are always regular 
at your doctor 
appointments 
None 
Prim. 
Elem. 
Sec. 
Univ. 
43 
29 
18 
8 
24 
41 
36.2 
36.7 
53.3 
55.8
37 
34 
21 
4 
9
35.2 
42.5 
42.9 
26.7 
20.9
16 
11 
6 
2 
7
15.2 
13.7 
12.2 
13.3 
16.3
3 
3 
2 
0 
1
2.9 
3.7 
4.1 
0 
2.3 
6 
3 
2 
1 
2 
5.7 
3.9 
4.1 
6.7 
4.7
.87 
You  measure  your BP 
on  regular basis 
None 
Prim. 
Elem. 
Sec. 
Univ. 
9 
11 
7 
5 
9 
8.6 
13.7 
14.3 
33.3 
20.9
18 
23 
17 
5 
17
17.1 
28.7 
34.7 
33.3 
39.6
35 
27 
18 
3 
16
33.3 
33.7 
36.7 
20 
37.2
19 
11 
6 
2 
1
18.1 
13.7 
12.2 
13.4 
2.3 
24 
8 
1 
0 
0 
22.9 
10.2 
2.1 
0 
0
.00 
You manage to do 
physical exercises as 
advised by your  doctor 
None 
Prim. 
Elem. 
Sec. 
Univ. 
3 
3 
2 
1 
4 
2.8 
3.7 
4.1 
6.7 
9.3
15 
10 
8 
2 
10
14.3 
12.5 
16.3 
13.3 
23.2
27 
28 
22 
7 
17
25.7 
35 
44.9 
46.7 
39.5
21 
21 
7 
2 
4
20 
26.2 
14.3 
13.3 
9.4 
39 
18 
10 
3 
8 
37.2 
22.6 
20.4 
20 
18.6
.13 
You manage to 
maintain a healthy 
weight as advised by 
d t
None 
Prim. 
Elem. 
Sec. 
Univ. 
8 
2 
5 
1 
6 
7.6 
2.5 
10.2 
6.6 
14
19 
17 
17 
3 
12
18.1 
21.2 
34.7 
20 
27.9
28 
32 
13 
3 
15
26.7 
40 
26.5 
20 
34.9
25 
17 
7 
4 
5
23.8 
21.2 
14.3 
26.7 
11.6 
25 
12 
7 
4 
5 
23.8 
15 
14.3 
26.7 
11.6
.15 
You manage to eat 
healthy food as advised 
by your doctor 
None 
Prim. 
Elem. 
Sec. 
Univ. 
16 
8 
9 
2 
13 
15.2 
10 
18.4 
13.3 
30.2
42 
29 
13 
2 
8
40 
36.3 
26.5 
13.3 
18.6
36 
27 
16 
6 
14
34.3 
33.7 
32.7 
40.1 
32.6
4 
8 
7 
5 
6
3.8 
10 
14.3 
33.3 
14 
7 
8 
4 
0 
2 
6.7 
10 
8.1 
0 
4.6
.01 
You manage to use your 
HTN drugs on regular 
basis as prescribed to 
None 
Prim. 
Elem. 
Sec. 
Univ. 
31 
19 
13 
3 
11 
29.5 
23.6 
26.5 
20 
25.6
41 
29 
18 
2 
14
39 
36.2 
36.7 
13.3 
32.6
24 
27 
17 
7 
14
22.9 
33.6 
34.7 
46.7 
32.6
5 
4 
0 
2 
3
4.8 
5 
0 
13.3 
6.9 
4 
1 
1 
1 
1 
3.8 
1.2 
2 
6.7 
2.3
.56 
You forget taking your 
drugs because you have 
busy life 
None 
Prim. 
Elem. 
Sec. 
Univ. 
6 
1 
3 
0 
4 
5.7 
1.2 
6.1 
0 
9.3
13 
12 
7 
2 
5
12.4 
15 
14.3 
13.3 
11.6
34 
28 
15 
6 
10
32.4 
35 
30.6 
40 
23.3
32 
27 
18 
3 
15
30.5 
33.6 
36.7 
20 
34.9 
20 
12 
6 
4 
9 
19 
15 
12.3 
26.7 
20.9
.84 
When you feel better, 
you stop taking your 
medications. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
5 
0 
1 
2 
2 
4.8 
0 
2 
13.3 
4.6
16 
4 
4 
4 
3
15.2 
5 
8.2 
26.7 
6.9
22 
26 
19 
0 
12
20.9 
32.5 
38.8 
0 
27.9
23 
28 
13 
2 
6
21.9 
35 
26.5 
13.3 
14 
39 
22 
12 
7 
20 
37.2 
27.5 
24.5 
46.7 
46.6
.00 
Because of the side 
effects of your  
medicine ,  you stop 
taking it without 
consulting your doctor 
None 
Prim. 
Elem. 
Sec. 
Univ. 
8 
4 
3 
0 
4 
7.6 
5 
6.1 
0 
9.3
6 
5 
7 
3 
3
5.7 
6.2 
14.3 
20 
6.9
29 
24 
20 
3 
10
27.6 
30 
40.8 
20 
23.2
26 
23 
12 
4 
9
24.8 
28.7 
24.5 
26.7 
20.9 
36 
24 
7 
5 
17 
34.3 
30 
14.3 
33.3 
39.5
.32 
You visit your doctor 
personally for drug 
prescription 
None 
Prim. 
Elem. 
Sec. 
Univ. 
37 
29 
16 
7 
28 
35.2 
36.2 
32.6 
46.6 
65.1 
42 
34 
24 
7 
7 
40 
42.5 
49 
46.6 
16.3 
15 
14 
5 
1 
8 
14.3 
17.5 
10.2 
6.8 
18.6 
6 
2 
2 
0 
0 
5.7 
2.5 
4.1 
0 
0 
5 
1 
2 
0 
0 
4.8 
1.3 
4.1 
0 
0 
.05 
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You are kept waiting 
for a long time in 
reception area when you 
are at the doctor's 
office. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
28 
25 
14 
6 
18 
26.7 
31.2 
28.6 
40 
41.9 
48 
32 
17 
6 
11 
45.7 
40 
34.7 
40 
25.6 
24 
20 
17 
2 
8 
22.9 
25 
34.7 
13.3 
18.6 
3 
1 
0 
1 
2 
2.9 
1.2 
0 
6.7 
4.7 
2 
2 
1 
0 
4 
1.8 
2.5 
2 
0 
9.2 
.21 
If you know that your 
drugs will increase your 
weight, you will 
continue taking them. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
24 
11 
6 
1 
6 
22.9 
13.7 
12.2 
6.7 
14
41 
29 
14 
7 
18
39 
36.2 
28.6 
46.6 
41.9
32 
36 
27 
6 
13
30.5 
45 
55.2 
40 
30.2
3 
3 
1 
1 
4
2.8 
3.9 
2 
6.7 
9.3 
5 
1 
1 
0 
2 
4.8 
1.2 
1 
0 
4.6
.22 
If you know that your 
drugs will affect your 
sex life, you will 
continue taking them. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
24 
10 
6 
2 
10 
22.9 
12.5 
12.2 
13.4 
23.2
34 
27 
15 
5 
10
32.4 
33.7 
30.6 
33.3 
23.2
23 
29 
23 
5 
16
21.9 
36.2 
46.9 
33.3 
37.2
16 
5 
4 
3 
6
15.2 
6.2 
8.2 
20 
14 
8 
9 
1 
0 
1 
7.6 
11.4 
2.1 
0 
2.4
.08 
  
Table (31):Cross-tabulation of the participants’ responses to the questions related to the 
cost of treatment by their level of education. 
Always Often Sometime Rarely Never Variable 
Ed
uc
at
io
n 
F. % F. % F. % F. % F. % 
P 
You have to pay for 
your medical care 
more than what you 
can afford. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
12 
8 
2 
3 
8 
11.4 
10 
4.1 
20 
18.6 
16 
19 
3 
0 
6 
15.2 
23.7 
6.1 
0 
14 
26 
17 
20 
3 
11 
24.8 
21.2 
40.8 
20 
25.6 
39 
25 
19 
5 
6 
37.1 
31.2 
38.8 
33.3 
14 
12 
11 
5 
4 
12 
11.5 
13.9 
10.2 
26.7 
27.8 
.00 
You do not follow 
your drug regimen or 
you go without the 
medical care you 
need because you 
cannot afford the 
expenses. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
5 
3 
2 
0 
3 
4.8 
3.7 
4.1 
0 
7 
13 
8 
6 
2 
5 
12.4 
10 
12.2 
13.3 
11.6 
47 
34 
26 
6 
15 
44.7 
42.6 
53.1 
40 
34.9 
21 
27 
12 
2 
9 
20 
33.7 
24.5 
13.3 
20.9 
19 
8 
3 
5 
11 
18.1 
10 
6.1 
33.3 
25.6 
.28 
It is a problem to 
cover your share of 
the cost for a medical 
care. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
11 
8 
2 
2 
2 
10.5 
10 
4.1 
13.3 
4.7 
23 
10 
5 
1 
8 
21.9 
12.5 
10.2 
6.7 
18.6 
39 
38 
21 
4 
14 
37.1 
47.5 
42.9 
26.7 
32.6 
24 
14 
17 
6 
9 
22.9 
17.5 
34.7 
40 
20.8 
8 
10 
4 
2 
10 
7.6 
12.5 
8.2 
13.3 
23.3 
.10 
You worry about 
having to pay large 
medical bills. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
7 
7 
0 
0 
3 
6.7 
8.7 
0 
0 
7 
22 
14 
9 
2 
8 
21 
17.5 
18.4 
13.3 
18.6 
43 
31 
25 
4 
11 
41 
38.6 
51 
26.7 
25.6 
15 
18 
8 
5 
13 
14.2 
22.5 
16.3 
33.3 
30.2 
18 
10 
7 
4 
8 
17.1 
12.5 
14.3 
26.7 
18.6 
.32 
The amount you have 
to pay to cover your 
medical needs is 
reasonable. 
None 
Prim. 
Elem. 
Sec. 
Univ. 
11 
16 
7 
0 
7 
10.5 
20 
14.3 
0 
16.3 
38 
21 
13 
2 
7 
36.2 
26.2 
26.5 
13.4 
16.3 
30 
25 
18 
5 
12 
28.6 
31.3 
36.8 
33.3 
27.9 
16 
12 
5 
3 
10 
15.2 
15 
10.2 
20 
23.3 
10 
6 
6 
5 
7 
9.5 
7.5 
12.2 
33.3 
16.3 
.10 
High cost of your 
drugs and the 
treatment plan in 
general makes me 
less compliant with 
my treatment regimen 
None 
Prim. 
Elem. 
Sec. 
Univ. 
4 
2 
2 
0 
4 
3.8 
2.5 
4.1 
0 
9.3 
9 
9 
6 
3 
4 
8.6 
11.2 
12.2 
20 
9.3 
28 
20 
9 
1 
10 
26.6 
25 
18.4 
6.7 
23.3 
34 
32 
24 
3 
11 
32.4 
40 
49 
20 
25.6 
30 
17 
8 
8 
14 
28.6 
21.2 
16.3 
53.3 
32.5 
.14 
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Table (32):Cross-tabulation of the participants’ responses to the questions related to 
their knowledge and perception of hypertension by the duration of their illness. 
Always Often Sometime Rarely Never Variable 
D
ur
a-
tio
n F. % F. % F. % F. % F. % 
P 
In general you 
consider yourself to be 
in good health 
<10 
10<20 
>=20 
45 
12 
7 
23.4 
14.5 
41.2 
78 
26 
5 
40.6 
31.3 
29.4 
55 
35 
2 
28.6 
42.2 
11.8 
14 
9 
3 
7.4 
10.8 
17.6 
0 
1 
0 
0 
1.2 
0 
.02 
You consider your BP 
to be well controlled 
<10 
10<20 
>=20 
20 
7 
1 
10.4 
8.4 
5.9 
88 
35 
9 
45.8 
42.2 
52.9 
75 
30 
5 
39 
36.1 
29.4 
9 
9 
2 
4.8 
10.8 
11.8 
0 
2 
0 
0 
2.5 
0 
.24 
You consider HTN as 
a serious problem 
<10 
10<20 
>=20 
64 
30 
3 
33.3 
36.1 
17.6 
67 
29 
3 
34.9 
34.9 
17.6 
45 
20 
10 
23.4 
24.1 
58.9 
13 
4 
1 
6.8 
4.9 
5.9 
3 
0 
0 
1.6 
0 
0 
.13 
You think that HTN 
leads to other serious 
conditions  
<10 
10<20 
>=20 
53 
26 
3 
27.6 
31.3 
17.6 
67 
22 
7 
34.9 
26.5 
41.2 
52 
25 
5 
27.1 
30.1 
29.4 
14 
7 
2 
7.3 
8.4 
11.8 
6 
3 
0 
3.1 
3.7 
0 
.87 
You think that HTN 
has hereditary basis. 
<10 
10<20 
>=20 
23 
17 
4 
12 
20.5 
23.5 
40 
10 
1 
20.8 
12 
5.9 
62 
23 
5 
32.3 
27.7 
29.4 
30 
18 
6 
15.6 
21.7 
35.3 
37 
15 
1 
19.3 
18.1 
5.9 
.09 
You think that being 
male or female will 
affect your risk of 
getting HTN. 
<10 
10<20 
>=20 
27 
8 
2 
14 
9.6 
11.8 
30 
12 
2 
15.6 
14.5 
11.8 
47 
22 
5 
24.5 
26.5 
29.4 
36 
26 
5 
18.8 
31.3 
29.4 
52 
15 
3 
27.1 
18.1 
17.6 
.44 
You think that HTN 
risk increases with age 
<10 
10<20 
>=20 
50 
21 
3 
26 
25.3 
17.6 
82 
28 
11 
42.8 
33.8 
64.7 
40 
18 
1 
20.8 
21.7 
5.9 
13 
10 
2 
6.8 
12 
11.8 
7 
6 
0 
3.6 
7.2 
0 
.24 
You think that 
decreasing tension and 
anger will help you in 
controlling your BP 
<10 
10<20 
>=20 
72 
41 
3 
37.5 
49.4 
17.6 
70 
22 
7 
36.5 
26.5 
41.2 
35 
16 
6 
18.2 
19.3 
35.3 
9 
2 
0 
4.7 
2.4 
0 
6 
2 
1 
3.1 
2.4 
5.9 
.22 
You think that dietary 
changes  will help you 
in controlling your BP 
<10 
10<20 
>=20 
54 
27 
4 
28.1 
32.5 
23.5 
80 
24 
6 
41.7 
28.9 
35.3 
44 
21 
3 
23 
25.4 
17.6 
7 
7 
2 
3.6 
8.4 
11.8 
7 
4 
2 
3.6 
4.8 
11.8 
.29 
You think that physical 
activity will help you 
in controlling your BP 
<10 
10<20 
>=20 
36 
14 
5 
18.8 
16.9 
29.4 
50 
16 
3 
26 
19.3 
17.6 
58 
28 
3 
30.2 
33.7 
17.6 
32 
19 
3 
16.7 
24.1 
17.6 
16 
5 
3 
8.3 
6 
17.6 
.50 
You think that it is 
necessary to take HTN 
medications regularly 
<10 
10<20 
>=20 
80 
36 
5 
41.7 
43.4 
29.4 
61 
24 
9 
31.8 
28.9 
52.9 
31 
18 
1 
16.1 
21.7 
5.9 
11 
4 
1 
5.7 
4.8 
5.9 
9 
1 
1 
4.7 
1.2 
5.9 
.45 
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You think that HTN 
medications help you 
to control your BP 
<10 
10<20 
>=20 
54 
26 
2 
28.1 
31.3 
11.8 
73 
22 
6 
38 
26.5 
35.3 
47 
28 
6 
24.5 
33.7 
35.3 
10 
6 
2 
5.2 
8.5 
11.8 
8 
0 
1 
4.2 
0 
5.9 
.18 
You sometimes  feel it 
is safe or not necessary  
to take your 
medication 
<10 
10<20 
>=20 
13 
7 
0 
6.8 
8.4 
0 
22 
11 
5 
11.5 
13.3 
29.4 
43 
22 
5 
22.4 
26.5 
29.4 
55 
19 
2 
28.6 
22.9 
11.8 
59 
24 
5 
30.7 
28.9 
29.4 
.41 
You feel it is safe to 
increase or decrease 
your medication dose 
without consulting 
your doctor 
<10 
10<20 
>=20 
8 
3 
1 
4.2 
3.6 
5.9 
19 
13 
5 
9.9 
15.7 
29.4 
47 
17 
3 
24.5 
20.5 
17.6 
51 
14 
3 
26.6 
16.9 
17.6 
67 
36 
5 
34.8 
43.3 
29.4 
.24 
You think that your 
HTN medications have 
serious side effects that 
may affect your health 
<10 
10<20 
>=20 
12 
11 
0 
6.3 
13.3 
0 
27 
12 
6 
14 
14.4 
35.3 
62 
29 
3 
32.3 
34.9 
17.6 
55 
17 
4 
28.6 
20.5 
23.5 
36 
14 
4 
18.8 
16.9 
23.5 
.11 
You think that HTN is 
a disease that can be 
prevented. 
<10 
10<20 
>=20 
7 
6 
2 
3.6 
7.2 
11.8 
31 
3 
1 
16.1 
3.6 
5.9 
58 
22 
5 
30.3 
26.6 
29.4 
48 
23 
4 
25 
27.7 
23.5 
48 
29 
5 
25 
34.9 
29.4 
.09 
All p-values were derived using the chi-squared test. 
 
Table (33):Cross-tabulation of the participants’ responses to the questions related to the 
effect of the chronic nature of hypertension by the duration of their illness. 
Always Often Sometime Rarely Never Variable 
du
ra
tio
n 
  
 
F. % F. % F. % F. % F. % 
P 
The long duration of 
your illness affect your 
desire to take your 
medication 
<10 
10<20 
>=20 
21 
13 
5 
10.9 
15.7 
29.4 
71 
32 
6 
37 
38.6 
35.3 
66 
28 
5 
34.4 
33.7 
29.4 
14 
6 
0 
7.3 
7.2 
0 
20 
4 
1 
10.4 
4.8 
5.9 
.42 
Because HTN is a 
chronic disease, you 
do not take your 
medication 
continuously. 
<10 
10<20 
>=20 
7 
2 
1 
3.6 
2.4 
5.9 
25 
11 
4 
13 
13.3 
23.5 
77 
25 
8 
40.1 
30.1 
47.1 
52 
21 
4 
27.1 
25.3 
23.5 
31 
24 
0 
16.2 
28.9 
0 
.13 
Because HTN is a 
chronic disease, you 
do not follow the diet 
regimen or change 
your  lifestyle 
according to your 
doctor advice 
<10 
10<20 
>=20 
8 
3 
2 
4.2 
3.6 
11.8 
17 
15 
3 
8.9 
18.1 
17.6 
56 
22 
6 
29.2 
26.5 
35.3 
75 
19 
4 
39.1 
22.9 
23.5 
36 
24 
2 
18.6 
28.9 
11.8 
 
 
.04 
Because HTN is a 
chronic disease, it 
makes you feel sad and 
depressed 
<10 
10<20 
>=20  
11 
6 
2 
5.7 
7.2 
11.8 
46 
18 
2 
24 
21.7 
11.8 
70 
36 
7 
36.5 
43.4 
41.1 
39 
12 
1 
20.3 
14.4 
5.9 
26 
11 
5 
13.5 
13.3 
29.4 
.41 
All p-values were derived using the chi-squared test. 
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Table (34): Cross-tabulation of the participants’ responses to the questions related to 
their family support by the duration of their illness. 
Always 
 
Often Sometime Rarely Never Variable 
du
ra
tio
n 
In
 y
ea
rs
 
F. % F. % F. % F. % F. % 
P 
Your family  
reminds you about 
your medications 
<10 
10<20 
>=20 
65 
32 
7 
33.9 
38.7 
41.2 
73 
28 
4 
38 
33.7 
23.5 
33 
10 
3 
17.7 
12 
17.6 
14 
8 
2 
7.3 
9.6 
11.8 
6 
5 
1 
3.1 
6 
5.9 
.80 
Your family  helps 
you in taking your 
medications 
<10 
10<20 
>=20 
52 
23 
4 
27.1 
27.7 
23.5 
74 
29 
7 
38.6 
35 
41.2 
50 
21 
4 
26 
25.3 
23.5 
10 
2 
1 
5.2 
2.4 
5.9 
6 
8 
1 
3.1 
9.6 
5.9 
.61 
Your family  helps 
you financially to 
get your medications 
when you need 
<10 
10<20 
>=20 
63 
27 
4 
32.8 
32.5 
23.5 
68 
18 
2 
35.4 
21.8 
11.8 
40 
25 
6 
20.8 
30.1 
35.3 
9 
10 
1 
4.7 
12 
5.9 
12 
3 
4 
6.3 
3.6 
23.5 
.00 
Your family helps 
you in measuring 
your BP 
<10 
10<20 
>=20 
59 
19 
3 
30.7 
22.9 
17.6 
47 
13 
6 
24.5 
15.7 
35.3 
31 
21 
2 
16.2 
25.2 
11.8 
25 
15 
2 
13 
18.1 
11.8 
30 
15 
4 
15.6 
18.1 
23.5 
.25 
Your family helps 
you in reaching the 
medical facility  if 
you are tired or sick 
<10 
10<20 
>=20 
89 
45 
7 
46.4 
54.2 
41.2 
48 
12 
2 
25 
14.5 
11.8 
37 
20 
5 
19.3 
24.1 
29.4 
8 
2 
2 
4.2 
2.4 
11.8 
10 
4 
1 
5.2 
4.8 
5.9 
.34 
Your family helps 
you to accomplish 
the life style changes  
if it is required by 
your doctor 
<10 
10<20 
>=20 
34 
23 
2 
17.7 
27.7 
11.8 
87 
19 
9 
45.4 
22.9 
52.9 
49 
24 
4 
25.5 
28.9 
23.5 
15 
12 
1 
7.8 
14.5 
5.9 
7 
5 
1 
3.6 
6 
5.9 
.04 
Your family  
encourages you to 
be more compliant 
with your 
medication and 
treatment plan 
<10 
10<20 
>=20 
 
45 
24 
5 
23.4 
28.9 
29.4 
59 
17 
2 
30.7 
20.5 
11.8 
67 
25 
7 
35 
30.2 
41.2 
14 
10 
1 
7.3 
12 
5.9 
7 
7 
2 
3.6 
8.4 
11.8 
.22 
All p-values were derived using the chi-squared test. 
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Table (35): Cross-tabulation of the participants’ responses to the questions related to 
their regularity on appointments and treatment plan by the duration of their illness. 
Always Often Sometime Rarely Never Variable 
D
ur
a
-ti
on
 
F. % F. % F. % F. % F. % 
P 
You are always regular 
at your doctor 
appointments 
<10 
10<20 
>=20 
85 
27 
10 
44.3 
32.6 
58.8 
71 
31 
3 
37 
37.3 
17.6 
25 
16 
1 
13 
19.3 
5.9 
5 
2 
2 
2.6 
2.4 
11.8 
6 
7 
1 
3.1 
8.4 
5.9 
.05 
You measure your BP on 
regular basis. 
<10 
10<20 
>=20 
30 
10 
1 
15.6 
12 
5.9 
59 
15 
6 
30.7 
18.1 
35.3 
63 
31 
5 
32.8 
37.3 
29.4 
24 
11 
4 
12.6 
13.3 
23.5 
16 
16 
1 
8.3 
19.3 
5.9 
.09 
You manage to do 
physical exercises as 
advised by your  doctor 
<10 
10<20 
>=20 
9 
4 
0 
4.7 
4.8 
0 
32 
11 
2 
16.7 
13.3 
11.8 
72 
24 
5 
37.5 
28.9 
29.4 
34 
15 
6 
17.7 
18.1 
35.3 
45 
29 
4 
23.4 
34.9 
23.5 
.40 
You manage to maintain 
a healthy weight as 
advised by your doctor 
<10 
10<20 
>=20 
14 
5 
3 
7.3 
6 
17.6 
41 
21 
6 
21.4 
25.3 
35.3 
70 
19 
2 
36.5 
22.9 
11.8 
43 
13 
2 
22.3 
15.7 
11.8 
24 
25 
4 
12.5 
30.1 
23.5 
.00 
You manage to eat 
healthy food  as advised 
by your doctor 
<10 
10<20 
>=20 
32 
12 
4 
16.7 
14.5 
23.5 
65 
27 
2 
33.9 
32.5 
11.8 
61 
29 
9 
31.7 
35 
52.9 
23 
7 
0 
12 
8.4 
0 
11 
8 
2 
5.7 
9.6 
11.8 
.30 
You manage to use your 
HTN drugs on regular 
basis as prescribed. 
<10 
10<20 
>=20 
46 
27 
4 
24 
32.5 
23.5 
68 
29 
7 
35.4 
34.9 
41.7 
62 
22 
5 
32.3 
26.5 
29.4 
11 
3 
0 
5.7 
3.6 
0 
5 
2 
1 
2.6 
2.4 
5.9 
.80 
You forget taking your 
medication because you 
have busy life. 
<10 
10<20 
>=20 
10 
3 
1 
5.2 
3.6 
5.9 
25 
12 
2 
13 
14.5 
11.8 
60 
27 
6 
31.3 
32.5 
35.3 
67 
23 
5 
34.9 
27.7 
29.4 
30 
18 
3 
15.6 
21.7 
17.6 
.94 
When you feel better, 
you stop taking your 
medication 
<10 
10<20 
>=20 
5 
5 
0 
2.6 
6 
0 
20 
10 
1 
10.5 
12 
5.9 
50 
23 
6 
26 
27.7 
35.3 
50 
16 
6 
26 
19.4 
35.3 
67 
29 
4 
34.9 
34.9 
23.5 
.63 
If you feel worse because 
of the side effects of your 
medicine you stop taking 
it without consulting 
your doctor. 
<10 
10<20 
>=20 
10 
8 
1 
5.2 
9.6 
5.9 
18 
5 
1 
9.4 
6 
5.9 
56 
25 
5 
29.2 
30.1 
29.4 
45 
21 
8 
23.4 
25.3 
47 
63 
24 
2 
32.8 
28.9 
11.8 
.38 
You always visit your 
doctor personally for 
drug prescription 
<10 
10<20 
>=20 
79 
32 
6 
41.1 
38.6 
35.3 
83 
24 
7 
43.2 
28.9 
41.2 
22 
18 
3 
11.5 
21.7 
17.6 
5 
5 
0 
2.6 
6 
0 
3 
4 
1 
1.6 
4.8 
5.9 
.11 
You are kept waiting for 
a long time in reception 
area when you visit the 
doctor.  
<10 
10<20 
>=20 
56 
30 
5 
29.2 
36.1 
29.4 
78 
28 
8 
40.6 
33.8 
47.1 
44 
24 
3 
22.9 
28.9 
17.6 
6 
0 
1 
3.1 
0 
5.9 
8 
1 
0 
4.2 
1.2 
0 
.37 
if you know that your 
medication will increase 
your weight , you will 
continue taking them 
<10 
10<20 
>=20 
28 
16 
4 
14.6 
19.3 
23.5 
71 
35 
3 
37 
42.2 
17.6 
81 
24 
9 
42.2 
28.9 
53 
6 
5 
1 
3.1 
6 
5.9 
6 
3 
0 
3.1 
3.6 
0 
.33 
if you know that your 
medication will affect 
your sex life, you will 
continue taking them 
<10 
10<20 
>=20 
30 
21 
1 
15.6 
25.3 
5.9 
59 
26 
6 
30.7 
31.3 
35.3 
77 
14 
5 
40.1 
16.9 
29.4 
18 
12 
4 
9.4 
14.5 
23.5 
8 
10 
1 
4.2 
12 
5.9 
.00 
All p-values were derived using the chi-squared test. 
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Table (36): Cross-tabulation of the participants’ responses to the questions related to the 
costs of their treatment plans by the duration of their illness. 
Always Often Sometime Rarely Never 
 
Variable 
D
ur
at
io
n 
  
In
 y
ea
rs
 
F. % F. % F. % F. % F. % 
P 
You have to pay for 
your medical care more 
than what you can 
afford 
<10 
10<20 
>=20 
17 
15 
1 
8.9 
18.1 
5.9 
26 
14 
4 
13.5 
16.9 
23.5 
47 
26 
4 
24.5 
31.3 
23.5 
68 
20 
6 
35.4 
24.1 
35.3 
34 
8 
2 
17.7 
9.6 
11.8 
.14 
You do not follow your 
drug regimen or you go 
without the medical 
care you need because 
you cannot afford the 
expenses 
<10 
10<20 
>=20 
5 
8 
0 
2.6 
9.6 
0 
15 
16 
3 
7.8 
19.3 
17.6 
90 
32 
6 
46.9 
38.6 
35.3 
50 
15 
6 
26 
18.1 
35.3 
32 
12 
2 
16.7 
14.5 
11.8 
.01 
It is a problem to cover 
your share of the cost 
for a medical care 
<10 
10<20 
>=20 
13 
12 
0 
6.8 
14.5 
0 
25 
19 
3 
13 
22.9 
17.6 
81 
28 
7 
42.2 
33.7 
41.2 
47 
18 
5 
24.5 
21.7 
29.4 
26 
6 
2 
13.5 
7.2 
11.8 
.12 
You worry about having 
to pay large medical 
bills 
<10 
10<20 
>=20 
7 
10 
0 
3.6 
12 
0 
35 
13 
7 
18.3 
15.7 
41.2 
81 
30 
3 
42.2 
36.1 
17.6 
44 
13 
2 
22.9 
15.7 
11.8 
25 
17 
5 
13 
20.5 
29.4 
.00 
The amount you have to 
pay to cover your 
medical needs is 
reasonable 
<10 
10<20 
>=20 
28 
9 
4 
14.6 
10.8 
23.5 
45 
33 
3 
23.4 
39.8 
17.6 
66 
22 
2 
34.4 
26.5 
11.8 
28 
12 
6 
14.6 
14.5 
35.3 
25 
7 
2 
13 
8.4 
11.8 
.03 
High cost of your 
medication and the 
treatment plan  makes 
you less compliant with 
your  treatment regimen 
<10 
10<20 
>=20 
6 
4 
2 
3.1 
4.8 
11.8 
19 
9 
3 
9.9 
10.8 
17.6 
39 
24 
5 
20.3 
29 
29.4 
72 
30 
2 
37.5 
36.1 
11.8 
56 
16 
5 
29.2 
19.3 
29.4 
.19 
All p-values were derived using the chi-squared test. 
 
 
 
  
